N-CSRS 1 d145284dncsrs.htm HARDING, LOEVNER FUNDS, INC. Harding, Loevner Funds, Inc.
Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM N-CSR

CERTIFIED SHAREHOLDER REPORT OF REGISTERED

MANAGEMENT INVESTMENT COMPANIES

Investment Company Act file number             811-07739                                     

                                         Harding, Loevner Funds, Inc.                                        

(Exact name of registrant as specified in charter)

400 Crossing Boulevard

Fourth Floor

                         Bridgewater, NJ 08807                        

(Address of principal executive offices) (Zip code)

Marcia Y. Lucas, Esq.

The Northern Trust Company

333 South Wabash Ave

Chicago, IL 60604

With a copy to:

Stephen H. Bier, Esq.

Dechert LLP

1095 Avenue of the Americas

                    New York, NY 10036                    

(Name and address of agent for service)

Registrant’s telephone number, including area code: (877) 435-8105

Date of fiscal year end: 10/31

Date of reporting period: 04/30/2021


Table of Contents

Item 1. Reports to Stockholders.

 

(a)

The following is a copy of the report transmitted to shareholders pursuant to Rule 30e-1 under the Investment Company Act of 1940 (17 CFR 270.30e-1)


Table of Contents

LOGO

 

Global Equity Portfolio    Institutional Emerging Markets Portfolio    Global Equity Research Portfolio
International Equity Portfolio    Emerging Markets Portfolio    International Equity Research Portfolio
International Small Companies Portfolio    Frontier Emerging Markets Portfolio    Emerging Markets Research Portfolio
Chinese Equity Portfolio      
           

The Prospectus, SAI, and the Fund’s annual and semi-annual reports are also available free of charge on Harding Loevner’s website at hardingloevnerfunds.com.

 

Reports and other information about the Fund are also available on the EDGAR database on the Commission’s

   Internet site at SEC.gov or by electronic request at the following e-mail address: publicinfo@sec.gov. A duplication fee will be applied to written requests and needs to be paid at the time your request is submitted.    As with all mutual funds, the Securities and Exchange Commission has not approved or disapproved these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.


Table of Contents

Harding Loevner Funds

Global equity investing for institutions is Harding Loevner’s exclusive focus. Through Harding Loevner Funds it offers distinct global strategies based on its quality-and-growth investment philosophy. It seeks to purchase shares of growing, financially strong, well-managed companies at favorable prices. Harding Loevner manages each of the Funds’ Portfolios according to a disciplined, research-based investment process. It identifies companies with sustainable competitive advantages and assesses the durability of their earnings growth by conducting in-depth fundamental research into global industries. In constructing portfolios, Harding Loevner diversifies carefully to limit risk.

Receive Investor Materials Electronically

Shareholders may sign up for electronic delivery of investor materials. By doing so, you will receive the information faster and help us reduce the impact on the environment of providing these materials. To enroll in electronic delivery,

 

  1.

Go to http://www.icsdelivery.com

 

  2.

Select the first letter of your brokerage firm’s name.

 

  3.

From the list that follows, select your brokerage firm. If your brokerage firm is not listed, electronic delivery may not be available. Please contact your brokerage firm.

 

  4.

Complete the information requested, including the e-mail address where you would like to receive notifications for electronic documents.

Your information will be kept confidential and will not be used for any purpose other than electronic delivery. If you change your mind, you can cancel electronic delivery at any time and revert to physical delivery of your materials. Just go to http://www. icsdelivery.com, perform the first three steps above, and follow the instructions for cancelling electronic delivery. If you have any questions, please contact your brokerage firm.

 

 

 

2

 

  


Table of Contents

Table of Contents

 

 

 

 

4

 

   Letter to Our Shareholders
       

 

6

 

   Global Equity Portfolio
            

 

10

 

   International Equity Portfolio
            

 

14

 

   International Small Companies Portfolio
            

 

18

 

   Emerging Markets Portfolio
            

 

22

 

   Chinese Equity Portfolio
            

 

26

 

   Frontier Emerging Markets Portfolio
       

 

30

 

   Global Equity Research Portfolio
            

 

34

 

   International Equity Research Portfolio
            

 

38

 

   Emerging Markets Research Portfolio

 

Contact

 

 

Harding, Loevner Funds, Inc.

c/o Northern Trust

Attn: Funds Center, Floor 38

333 South Wabash Avenue

Chicago, IL 60604

 

Phone: (877) 435-8105

Fax: (312) 267-3657

www.hardingloevnerfunds.com

  

Must be preceded or accompanied by a current Prospectus.

Quasar Distributors, LLC, Distributor

 

 

 

3

 


Table of Contents

Letter To Our Shareholders

April 30, 2021

 

 

LOGO

David Loevner, CFA, CIC

Chairman of the Funds and

Chief Executive Officer of the Adviser

Ferrill Roll, CFA

Chief Investment Officer of the Adviser

Simon Hallett, CFA

Vice Chairman of the Adviser

Last fall, in our Fiscal Year 2020 Annual Report and Commentary, we expressed some incredulity at “value” investing’s much ballyhooed demise. We had no unique insight to offer about the outlook for the value style other than noting that each prior reading of its last rites seemed to presage its roaring back to life. And, lo and behold, our October 31 missive presciently, if inadvertently, anticipated the turn in market style that coincided with the announcements of the first highly effective COVID-19 vaccines and the imminent change of US presidential administration.

Since November the “value” half of the MSCI All Country World Index has outperformed its “growth” counterpart by more than fifteen percentage points. More significant for us, however, has been the outperformance, by a country mile, of stocks of more leveraged, more cyclical, and less profitable companies relative to the stocks of higher-quality companies that are not so encumbered. The prospect of re-opening economies brightened the outlook for every business (save for the few that provide remote-working tools or home delivery), but it’s been the weakest companies—especially those that were severely challenged during the lockdowns—whose outlook has brightened the most. The Biden administration’s spending plans for consumer relief today and infrastructure tomorrow have further re-enlivened such companies’ prospects. Our portfolio managers, in varying degrees, had been leaning against the then-prevailing winds by resisting the pie-in-the-sky valuations of many of the fastest-growing companies, while maintaining exposure to growth businesses. A related, but separate, trade-off also vexed them: the one between rich valuation and business quality. Their struggle with those trade-offs is the subject of many of the reports that follow this letter.

Another area where we’ve leaned against the wind is in capping the exposure to China permitted in our Emerging Markets Portfolio. China’s market capitalization has swelled on the back of rising valuations and new issuance. Thanks to improved access for foreign investors, the Chinese market has secured a pre-eminent place in passive indices, and as many new companies have gone public it has also become more diversified. We anticipated the

broad outline of this evolution some years ago, adding analytical resources, expanding company coverage, and raising our self-imposed ceiling on maximum exposure to the country. In the spring of last year, as China’s stock market rebounded rapidly, reflecting the country’s early control of the virus when the rest of the world was still floundering, we resisted the loud calls (including from some of our own colleagues) to raise our ceiling further. We demurred because of our aversion to changing sensible constraints while they are actually binding. Constraints in risk guidelines are a form of pre-commitment, meant to gird our loins precisely when market momentum and FOMO conspire mightily to induce us to throw caution to the wind. That resistance proved well-considered in the latter part of 2020 when Chinese share prices tumbled even as other markets rose on positive vaccine news. The twin reminders of internal risks emanating from Chinese regulatory unpredictability and external ones from US congressional and executive actions drove home that, like any investment, Chinese stocks are not a one-way bet. Once the clamor for more Chinese risk-taking had subsided, and in recognition of China’s growing heft in the MSCI EM Index, we did relax our fixed limit on China at year end, but still constrain our portfolio managers to not exceed the country’s weight in the index.

More newsworthy, perhaps, in recognition of our growing success at finding Chinese companies with enviable growth prospects that also meet our business-quality standards, we launched a new, dedicated Chinese Equity Portfolio providing interested investors more concentrated exposure to Chinese stocks using our time-tested and battle-hardened investment philosophy and process. You’ll find that Portfolio’s first appearance later in this report as well.

An area where we find ourselves tilted in the direction of prevailing winds is that of scrutinizing Environmental, Societal, and Governance (ESG) risks and opportunities. Alongside our longstanding focus on the risks of poor corporate governance, we escalated our analysts’ assessment of the E and the S risks five years ago, incorporating checklists that require rigorous investigation into a common set of potential ESG-specific hazards. Since then, the winds have only blown harder, as we have continued to hone our skills in this area, a natural refinement of the search for long-term sustainable businesses that has been the aim of our high-quality, growth-oriented investment philosophy from the very start.

Last year, we heightened our efforts to assess the materiality of specific ESG-related risks to each industry. Using the processes we’ve developed, our analysts are continually probing the logic and consistency of their assessments of such risks. We’re also making sure those processes keep pace with rapidly evolving best practices, including expanding our capacity for engaging with issuers and for reporting to our own clients on the impact of our

 

 

 

4

 

  


Table of Contents

companies’ activities along dimensions such as carbon emissions or diversity, as well as on the results of our engagements with their managements.

As we continue sharpening our focus on ESG, our overarching goal is to deliver strong risk-adjusted returns. Instead of fleeing from any perceived ESG risk regardless of its materiality or the potential opportunity cost of avoiding it, we aim to assess all risks, including ESG risks, properly, identifying which are material and the time frames under which their consequences might be realized. In some instances, we may identify companies or entire industries that have become mispriced in a crowding of the market into fashionable ESG themes. By identifying the most material and persistent trends affecting industries, our analysts are capable of discerning which companies may become impaired, which embroiled in mounting regulation, and which, unheralded today, may thrive. Indeed, recognizing and exploiting such trends is exactly what we expect the best companies to do.

Leaning against the wind is part and parcel of contrarian investing, and any investor must diverge from the crowd in some way to have a chance to outperform. The art comes in judging when and where to diverge, and when simply to accept and appreciate the breeze at your back. We are grateful for your continued trust in Harding Loevner, as we make those judgments.

 

 

Sincerely,

 

LOGO   LOGO   LOGO
David R. Loevner, CFA, CIC   Ferrill D. Roll, CFA   Simon Hallett, CFA

Opinions expressed are those of Harding Loevner and are not intended to be forecasts of future events, a guarantee of future results, nor investment advice. Please read the separate disclosure page for important information, including the risks of investing in the Portfolios. Past performance is not a guarantee of future results.

 

 

 

5

 


Table of Contents

Global Equity Portfolio

Institutional Investors: HLMVX & HLGZX | Individual Investors: HLMGX

 

 

Portfolio Management Team

 

LOGO

 

Peter Baughan, CFA

Co-Lead Portfolio Manager

 

Jingyi Li

Co-Lead Portfolio Manager

 

LOGO

 

Scott Crawshaw

Portfolio Manager

 

Christopher Mack, CFA

Portfolio Manager

LOGO

 

Richard Schmidt, CFA

Portfolio Manager

Performance Summary

For the Global Equity Portfolio, the Institutional Class gained 24.05%, the Institutional Class Z gained 24.08%, and the Advisor Class gained 23.90% (net of fees and expenses) in the six-month period ended April 30, 2021. The Portfolio’s benchmark, the MSCI All Country World Index, gained 28.29% (net of source taxes).

Market Review

Global stock markets increased in the six months ended April 30, as the rollout of several successful COVID-19 vaccines led to economic rebounds across the globe. All sectors and regions finished in positive territory for the period.

The closing months of 2020 saw a dramatic rise in global stock markets, despite an escalation in the global pandemic. The starting gun for the run-up was Pfizer’s announcement of better-than-expected results for its COVID-19 vaccine trials and was followed in rapid fire by positive reports from Moderna, AstraZeneca, and Sinopharm. Accelerated approvals gave investors further hope for some return to normal commerce in 2021, even as COVID-19 hospitalizations in the US and Europe soared.

In 2021, signs of a global economic rebound multiplied as the vaccination efforts began in earnest. In March, the IMF raised its global GDP growth forecast for 2021 to 6.0%. In the US, among the world’s leaders in vaccination rates, retail sales climbed to the strongest level on record and restaurant bookings and the number of airline passengers, while still below pre-COVID-19 levels, continued to improve. The Biden administration passed a colossal US$1.9 trillion relief package, the third such stimulus measure

Fund Facts at April 30, 2021

 

  
     
Total Net Assets    $1,708.4M     
     
Sales Charge    None     
     
Number of Holdings    74     
     
Turnover (5 Year Average)    44%     
     
Dividend Policy    Annual     
   
    

Institutional Investors

   Individual Investors
   
    

Inst Class

  

Inst Class Z 

  

Advisor Class

       
Ticker   

HLMVX

   HLGZX     HLMGX
       
CUSIP   

412295602

   412295727     412295206
       
Inception Date   

11/3/2009

   8/1/2017     12/1/1996
       
Minimum Investment1   

$100,000

   $10,000,000     $5,000
       
Net Expense Ratio2   

0.88%3

   0.80%4      1.07%5
       
Gross Expense Ratio2   

0.88%

   0.83%     1.07%

1Lower minimums available through certain brokerage firms. 2As of the most recent Prospectus and based on expenses for the fiscal year end. 3Harding Loevner has contractually agreed to cap the expense ratio at 0.90% through February 28, 2022. The expense ratio (without cap) is applicable to investors. 4The Net Expense Ratio is shown net of Harding Loevner’s contractual agreement through February 28, 2022. Harding Loevner’s contractual agreement caps the expense ratio at 0.80%. The Net Expense Ratio is applicable to investors. 5Harding Loevner has contractually agreed to cap the expense ratio at 1.20% through February 28, 2022. The expense ratio (without cap) is applicable to investors.

since the pandemic began, sending direct payments to millions of Americans and extending unemployment insurance. In China, electricity generation and rail cargo volume rose substantially year over year, but consumer spending remained subdued despite much of daily life having returned to normal. The recovery in Europe was even more uneven, amid the emergence of new more virulent virus strains and problems with its vaccine rollout extending or renewing lockdowns.

Better economic data coupled with seemingly unlimited central bank liquidity led to rising management confidence and a surge in mergers and acquisition activity (M&A). Company CEOs were not the only market participants infected with high confidence; investors became more sanguine as well. The growth of special-purpose acquisition companies (SPACs), a “backdoor” means of taking private companies public with minimal regulatory scrutiny, accounted for an unprecedented 25% of all US deals. Retail trading activity also rose sharply, with a record number of people opening online accounts, and option volumes rising dramatically. The speculative frenzy extended to initial public offerings (IPOs) in many markets, with shares of newly listed companies (many of them still loss-making) being met by strong institutional and retail demand.

 

 

 

6

 

  


Table of Contents

Performance (% total return)

 

   
     For periods ended March 31, 2021      For periods ended April 30, 2021  
       
     1      3      5      10      Since Inception*      1      3      5      10      Since Inception*  
               
     Year      Years      Years      Years      Nov-09      Aug-17      Dec-96      Year      Years      Years      Years      Nov-09      Aug-17      Dec-96  
                             

Global Equity Portfolio – Inst Class

     58.35        14.15        16.34        11.29        11.86                          50.36        16.47        17.27        11.38        12.29                    
                             

Global Equity Portfolio – Inst Class Z

     58.47        14.22                               14.54                 50.49        16.55                               15.86           
                             

Global Equity Portfolio - Advisor Class

     58.08        13.92        16.09        11.03                          8.24        50.09        16.24        17.02        11.10                          8.45  
                             

MSCI All Country World Index

     54.60        12.07        13.21        9.15        10.14        11.74               45.74        13.32        13.85        9.17        10.47        12.74         

Returns are annualized for periods greater than 1 year. *Inception of the Institutional Class, November 3, 2009. Inception of the Institutional Class Z, August 1, 2017. Inception of the Advisor Class, December 1, 1996. Index performance prior to January 1, 2001 cannot be shown since it relies on back-filled data.

Performance data quoted represents past performance; past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance of the Portfolio may be lower or higher than the performance quoted. Performance data current to the most recent month end may be obtained by calling (877) 435-8105 or visiting www.hardingloevnerfunds.com.

 

As homebuyers and corporate treasurers alike raced to lock in low interest rates, bond yields rose, with the yield on the US 10-year reaching pre-pandemic levels in March. Commodity prices, particularly those linked with industrial activity such as iron ore and copper, jumped higher, while Brent crude rose to over US$60 per barrel.

On a sector basis, Energy was the strongest performer, surging in lockstep with rising oil prices. Financials also performed strongly, aided by a steepening yield curve and surprisingly low credit defaults. Information Technology (IT) also outperformed despite heightened scrutiny from regulators in Europe, China, and the US. Less-cyclical sectors—Consumer Staples, Health Care, and Utilities—all underperformed for the period.

Viewed by geography, the eurozone outperformed as some of the countries hit hardest by the virus, such as Spain and Italy, began to recover. Canada was a big outperformer, helped by its large weighting in banks and Energy. In Europe outside the eurozone, the UK posted strong returns on the back of its expansive vaccination program. Japan significantly underperformed as the country instated a new, more stringent state of emergency in response to another virus wave. Emerging Markets (EMs) also underperformed as weakness in China due to its regulatory crackdowns on tech companies offset strong performance in Taiwan and Russia, where the global semiconductor shortage and the rise in the oil price helped the former’s IT and latter’s Energy companies, respectively.

Performance Attribution

The Portfolio underperformed due to both negative sector allocation and stock selection. Weak stocks in Communication Services and Consumer Discretionary detracted the most during the period. In the former, shares of Polish video game producer CD Projekt were buffeted as the highly anticipated launch of its game Cyberpunk 2077 was marred by bugs and the company

fell victim to a ransomware attack. In Consumer Discretionary, shares of Chinese e-commerce company Alibaba declined following the company’s withdrawal of its planned IPO for its Ant Financial affiliate under pressure from banking regulators. Additionally, Alibaba was also put on notice about the potentially anti-competitive practices of its core e-commerce business. The Portfolio’s overweight in Health Care and underweight in Energy also detracted.

Strong stocks in Industrials helped, particularly agricultural equipment manufacturer John Deere. The company delivered strong earnings and raised its guidance for 2021. Sales of Deere’s tractors and combine harvesters have been underpinned by Chinese demand for agriculture products and by the rebound in the bioethanol market accompanying the jump in oil prices. The Portfolio’s underweight in Consumer Staples and Utilities and overweight in Financials also helped.

Viewed by geography, the Portfolio underperformed in every major market outside the US. Weak stocks in EMs (CD Projekt and Alibaba) detracted the most from relative performance. Stocks in Europe both inside and outside the eurozone also detracted, particularly Swiss drug manufacturer Lonza, which declined amid rising investor interest in more cyclical sectors. The Portfolio’s cash weight during this period of strong equity returns also dragged on relative performance.

Strong stocks in the US contributed, especially SVB Financial Group; the bank has benefited from rising expectations for increased economic growth and higher interest rates. Electronic payment services company PayPal was another strong performer as the company reported strong revenue, earnings, and new-user growth through the period. Additionally, the company launched its new service that enables customers to buy, hold, and sell cryptocurrencies. The Portfolio’s underweight in Japan was also a modest contributor during the period.

 

 

 

 

7

 


Table of Contents

Perspective and Outlook

For the best part of our 30-year existence we’ve invested in high-quality, growing companies. That means we understand only too well the slings and arrows of performance that the market occasionally hurls the way of our quality-focused portfolio. During the recovery from the prolonged bear market that followed the bursting of the tech bubble in 2000 we suffered one of our worst periods of relative performance. As the profit slump—at the time the deepest since the 1930s—dragged into its second year, the US Federal Reserve led other central banks in further rounds of cutting interest rates in a bid to spur a stronger recovery. Investors who had fled the securities of barely profitable or highly leveraged companies reconsidered their cautious stance. Companies that were priced as if they might be the next round of bankruptcies suddenly looked like probable survivors, and their share prices leapt higher as investors adjusted to the upgraded prognosis. As cyclical and financial risks receded, stocks of the most stable companies, with ultra-conservative balance sheets and resilient profit margins, no longer transfixed investors, whose eyes wandered to less pristine corporate stories in hopes of a bargain. Over the ensuing 24 months, stocks of companies in the lowest tiers of quality, derided as junk, trounced by double digits those in the top tiers.

Judging by the performance of the different quintiles of the market sorted by our proprietary quality rankings, the shift in market style that coincided with the early November release of vaccine efficacy results matches in many ways the pattern of 2003-2004, and then some. Whereas two decades ago it took over two years for the bottom quintile to outpace the top by 19 percentage points, this latest go-round has produced a 23 percentage point gap between the same two groups in just five months, with a mostly monotonic progression of performance down the tiers of quality: the worse you were, the better you did.

The earlier episode drove home the perils of being too risk-averse! While wallowing in the depths of a deep recession and long bear market, we took comfort from the resilience and reasonable valuation of the best companies and—despite the obvious chasm in relative valuations that had opened up between stocks of the best and the next-best, let alone the worst—ultimately lost sight of the opportunity cost of future returns from what we did not own.

Over the last couple of years, as valuations for high-quality and rapidly growing companies have risen steadily, we’ve had to make difficult trade-offs in attempting to balance our commitment to these company attributes against the prices their shares fetch. Historically our debate has mostly concerned the trade-off between valuation and growth, but in this nascent recovery from the pandemic, the real issue—at least as far as relative performance goes—has turned out to be related more to trading off valuation against quality. Growth,

in contrast to quality, has not been a particularly good predictive factor recently: only the fastest growth quintile (sorted by our growth metric) has seriously lagged the index, while the other 80% of the market matched or bettered the market’s average performance since the beginning of November.

Although both high quality and faster growth have become highly priced in recent times, we’ve made no attempt to predict either inflation or interest rates, despite recognizing how these inputs have an immediate impact on stock valuations through their influence on discount rates. Considering such attempts a fool’s errand, we prefer instead to focus on discerning the enduring characteristics of companies themselves—characteristics that tend to persist across business cycles and political eras.

Our investment process is designed to give analysts the freedom, with few exceptions, to “go anywhere,” and locate the best businesses even in out-of-favor industries or countries. By keeping our opportunity set broad, always on the lookout for companies with strong competitive positions and secular growth tailwinds, the goal is to continuously furnish portfolio managers with sufficient raw materials from which to assemble diversified and

Portfolio Positioning (%) at April 30, 2021

 

Country/Region    Portfolio      Benchmark1  
     

Canada

     0.0        2.8  
     

Emerging Markets

     15.0        12.8  
     

Europe EMU

     6.8        8.6  
     

Europe ex-EMU

     6.9        7.9  
     

Frontier Markets2

     0.0         
     

Japan

     3.1        6.2  
     

Middle East

     0.0        0.2  
     

Pacific ex-Japan

     2.9        3.1  
     

United States

     63.9        58.4  
     

Cash

     1.4         
Sector    Portfolio      Benchmark  
     

Comm Services

     10.7        9.6  
     

Consumer Discretionary

     10.6        12.8  
     

Consumer Staples

     2.2        6.9  
     

Energy

     2.1        3.3  
     

Financials

     16.7        14.3  
     

Health Care

     20.8        11.3  
     

Industrials

     11.2        9.9  
     

Information Technology

     23.8        21.4  
     

Materials

     0.0        5.1  
     

Real Estate

     0.0        2.6  
     

Utilities

     0.5        2.8  
     

Cash

     1.4         

1 MSCI All Country World Index; 2 Includes countries with less-developed markets outside the index.

 

 

 

8

 

  


Table of Contents

differentiated portfolios of high-quality growing businesses. Our risk guidelines, including our portfolio limits on countries, sectors, and single companies, limit the worst of those inclinations, and we alter those limits only rarely and with great deliberation. In other words, don’t expect us to follow the current trend of some growth and momentum-oriented investors and to jettison our single holding limits to amass larger stakes in our favorite companies.

Portfolio Highlights

We ended the period overweight to Health Care, IT, Financials, Industrials, Communication Services, and underweight to Consumer Staples, Consumer Discretionary, Energy, and Utilities. The Portfolio had no holdings in Materials or Real Estate.

Health Care remains the Portfolio’s largest overweight, boosted by the purchase of two new US-based holdings—Edwards Lifesciences and UnitedHealth Group—and one new Chinese holding—WuXi Biologics. We believe Edwards, whose SAPIEN valve is the most implanted heart valve in the world, can continue to grow revenue and earnings for the foreseeable future due to the shift from open-heart surgery to transcatheter aortic valve replacement. UnitedHealth is one of the largest diversified healthcare companies in the United States and is pioneering innovative payment systems and health care delivery methods that should allow it to maintain its status as the premier private insurer. Additionally, legislative risk impacting the company has appeared to decrease post-election. Wuxi has become the dominant company in China’s rapidly growing biopharmaceutical industry and is gaining significant traction outside China as well. As Wuxi’s capabilities increase, we believe the company will win more late-stage development projects given its innovative manufacturing strategy and lower cost, highly talented workforce.

While we continue to be overweight the Financials sector, we have shifted the composition away from a group of banks located in struggling emerging economies in favor of enlarged holdings of two US banks: SVB Financial Group and First Republic Bank. Both cater to lucrative niche markets and prioritize impeccable service as a means of growing through referrals from their affluent and contented clientele.

In Energy, we bought two new holdings: US-based Schlumberger and Finland-based Neste. Schlumberger’s management has continually invested, through good times and bad, to extend its technological lead in oil servicing. Its latest moves include improving its data analytics platform to enable customers to leverage their data for greater efficiencies and embarking on new clean energy ventures. Over the last two decades Neste has developed technology that turns used cooking oil and waste animal fats into transport fuel and cultivated the requisite network to source and collect the feedstock. Most biodiesel fuels utilize crop-based feedstocks such as palm oil, a commodity widely blamed for deforestation; Neste’s next-generation process suffers no such overhang. We expect regulators in Europe, as part of their efforts to mitigate climate

Top Ten Holdings by Weight at April 30, 2021
Company    Sector    Country    %
       
SVB Financial Group    Financials    US    3.8
       
First Republic Bank    Financials    US    3.7
       
Alphabet    Comm Services    US    3.6
       
Amazon.com    Cons Discretionary    US    3.2
       
John Deere    Industrials    US    2.7
       
Illumina    Health Care    US    2.7
       
PayPal    Info Technology    US    2.6
       
Facebook    Comm Services    US    2.6
       
CME Group    Financials    US    2.4
       
Vertex Pharmaceuticals    Health Care    US    2.1

change, to continually raise mandates for use of biofuels while simultaneously penalizing sources that emanate from palm oil, placing the company at the juncture of two powerful secular trends.

We sold two Industrials holdings—US-based prototype-manufacturing service provider Protolabs and Finnish elevator-maker Kone—as outperformance led shares to appear overvalued. In Financials, we sold our position in Brazilian bank Itaú Unibanco as the company has not behaved as anticipated in the face of commodity-led reflationary trends and higher interest rates in Brazil. We also sold our sole Materials holding, German flavors-and-fragrance maker Symrise, as we felt we were not being adequately compensated for the stock’s lack of liquidity.

 

Please read the separate disclosures page for important information, including the risks of investing in the Portfolio.

 

 

 

 

9

 


Table of Contents

International Equity Portfolio

Institutional Investors: HLMIX & HLIZX | Individual Investors: HLMNX

 

 

Portfolio Management Team

 

LOGO

 

Ferrill Roll, CFA

Co-Lead Portfolio Manager

 

Andrew West, CFA

Co-Lead Portfolio Manager

 

LOGO

 

Bryan Lloyd, CFA

Portfolio Manager

 

Babatunde Ojo, CFA

Portfolio Manager

LOGO

 

Patrick Todd, CFA

Portfolio Manager

Performance Summary

For the International Equity Portfolio, the Institutional Class gained 24.26%, the Institutional Class Z gained 24.30%, and the Investor Class gained 24.11% (net of fees and expenses) in the six-month period ended April 30, 2021. The Portfolio’s benchmark, the MSCI All Country World ex-US Index, gained 27.41% (net of source taxes).

Market Review

International stock markets increased in the six months ended April 30, as the rollout of several successful COVID vaccines led to economic rebounds across the globe. All sectors and regions finished in positive territory for the period.

The closing months of 2020 saw a dramatic rise in global stock markets, despite an escalation in the global pandemic. The starting gun for the run-up was Pfizer’s announcement of better-than-expected results for its COVID-19 vaccine trials and was followed in rapid fire by positive reports from Moderna, AstraZeneca, and Sinopharm. Accelerated approvals gave investors further hope for some return to normal commerce in 2021, even as COVID-19 hospitalizations in the US and Europe soared.

In 2021, signs of a global economic rebound multiplied as the vaccination efforts began in earnest. In March, the IMF raised its global GDP growth forecast for 2021 to 6.0%. In the US, among the world’s leaders in vaccination rates, retail sales climbed to the strongest level on record and restaurant bookings and the number of airline passengers, while still below pre-COVID-19 levels, continued to improve. The Biden administration passed a colossal

Fund Facts at April 30, 2021

 

  
     
Total Net Assets    $20,439.7M     
     
Sales Charge    None     
     
Number of Holdings    58     
     
Turnover (5 Year Average)    18%     
     
Dividend Policy    Annual     
 
  

Institutional Investors

   Individual Investors
   
  

Inst Class

  

Inst Class Z

  

Investor Class

       
Ticker   

HLMIX

   HLIZX    HLMNX
       
CUSIP   

412295107

   412295719    412295503
       
Inception Date   

5/11/1994

   7/17/2017    9/30/2005
       
Minimum Investment1   

$100,000

   $10,000,000    $5,000
       
Net Expense Ratio2   

0.81%3

   0.73%4    1.13%5
       
Gross Expense Ratio2   

0.81%

   0.73%    1.13%

1Lower minimums available through certain brokerage firms; 2As of the most recent Prospectus and based on expenses for the fiscal year end. The Net Expense Ratio is shown net of Harding Loevner’s contractual agreement through February 28, 2022. 3Harding Loevner’s contractual agreement caps the Net Expense Ratio at 1.00%. 4Harding Loevner’s contractual agreement caps the net expense ratio at 0.80%. 5Harding Loevner’s contractual agreement caps the net expense ratio at 1.25%. The Net Expense Ratio is applicable to investors.

US$1.9 trillion relief package, the third such stimulus measure since the pandemic began, sending direct payments to millions of Americans and extending unemployment insurance. In China, electricity generation and rail cargo volume rose substantially year over year, but consumer spending remained subdued despite much of daily life having returned to normal. The recovery in Europe was even more uneven, amid the emergence of new more virulent virus strains and problems with its vaccine rollout extending or renewing lockdowns.

Better economic data coupled with seemingly unlimited central bank liquidity led to rising management confidence and a surge in mergers and acquisition activity (M&A). Company CEOs were not the only market participants infected with high confidence; investors became more sanguine as well. The growth of special-purpose acquisition companies (SPACs), a “backdoor” means of taking private companies public with minimal regulatory scrutiny, accounted for an unprecedented 25% of all US deals. Retail trading activity also rose sharply, with a record number of people opening online accounts, and option volumes rising dramatically. The speculative frenzy extended to initial public offerings (IPOs) in many markets, with shares of newly listed companies (many of them still loss-making) being met by strong institutional and retail demand.

As homebuyers and corporate treasurers alike raced to lock in low interest rates, bond yields rose, with the yield on the US 10-

 

 

 

10

 

  


Table of Contents

Performance (% total return)

 

 
     For periods ended March 31, 2021      For periods ended April 30, 2021  
       
      1      3      5      10      Since Inception*      1      3      5      10      Since Inception*  
               
      Year      Years      Years      Years      May-94      Jul-17      Sep-05      Year      Years      Years      Years      May-94      Jul-17      Sep-05  
                             

Intl Equity Portfolio – Inst Class

     50.49        9.01        12.17        7.52        6.85                          45.66        9.56        12.36        7.19        6.91                    
                             

Intl Equity Portfolio – Inst Class Z

     50.54        9.10                               9.96                 45.77        9.65                               10.38           
                             

Intl Equity Portfolio – Investor Class

     50.00        8.66        11.81        7.16                          7.27        45.25        9.21        11.99        6.83                          7.39  
                             

MSCI All Country World ex-US Index

     49.41        6.51        9.76        4.93               7.27        5.27        42.98        6.98        9.83        4.73               7.93        5.43  

Returns are annualized for periods greater than 1 year. *Inception of the Institutional Class, May 11, 1994. Inception of the Institutional Class Z, July 17, 2017. Inception of the Investor Class, September 30, 2005. Index performance prior to January 1, 2001 cannot be shown since it relies on back-filled data.

Performance data quoted represents past performance; past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance of the Portfolio may be lower or higher than the performance quoted. Performance data current to the most recent month end may be obtained by calling (877) 435-8105 or visiting www.hardingloevnerfunds.com.

 

year reaching pre-pandemic levels in March. Commodity prices, particularly those linked with industrial activity such as iron ore and copper, jumped higher, while Brent crude rose to over US$60 per barrel. On a sector basis, Energy was the strongest performer, surging in lockstep with rising oil prices. Financials also performed strongly, aided by a steepening yield curve and surprisingly low credit defaults. Information Technology (IT) also outperformed despite heightened scrutiny from regulators in Europe, China, and the US. Less-cyclical sectors—Consumer Staples, Health Care, and Utilities—all underperformed for the period.

Viewed by geography, the eurozone outperformed as some of the countries hit hardest by the virus, such as Spain and Italy, began to recover. Canada was a big outperformer, helped by its large weighting in banks and Energy. In Europe outside the eurozone, the UK posted strong returns on the back of its expansive vaccination program. Japan significantly underperformed as the country instated a new, more stringent state of emergency in response to another virus wave. Emerging Markets (EMs) also underperformed as weakness in China due to its regulatory crackdowns on tech companies offset strong performance in Taiwan and Russia, where the global semiconductor shortage and the rise in the oil price helped the former’s IT and latter’s Energy companies, respectively.

Performance Attribution

The Portfolio underperformed due to both negative sector allocation and stock selection. Weak stocks in Consumer Discretionary and Materials detracted the most during the period. In the former, shares of Japan’s largest home furnishing retailer NITORI fell as investors worried about their hostile acquisition of competing furniture retail chain Shimachu, rather than celebrating their 34th consecutive year of earnings growth. In Materials, shares of German flavors-and-fragrance maker Symrise declined as the company experienced slower organic sales growth in its beverage and sweets segments and faced rising raw

material prices. The Portfolio’s overweight in Health Care and Consumer Staples also detracted from relative returns.

Strong stocks in Industrials helped offset relative weakness in other sectors, particularly Alfa Laval, a Swedish manufacturer of specialty heat-transfer, centrifugal-separation, and fluid-handling products. Shares rose as management pointed to strong order growth in the latest quarter as evidence that its business momentum is accelerating. Additionally, Swedish compressor maker Atlas Copco benefited from recovering demand for compressors and raising expectations for expanded industrial and semiconductor capex. The Portfolio’s overweight in IT and underweight in Consumer Discretionary were also helpful.

Viewed by geography, most of the Portfolio’s underperformance was due to weak stocks in Japan. Shares of Unicharm, a manufacturer of hygiene and household cleaning products, declined in response to rising input costs (like oil) and a market style shift to stocks of more-cyclical companies. Chugai Pharmaceutical was hurt by a muted three-year revenue growth outlook and falling off -label usage of its rheumatoid arthritis drug Actemra, whose early promise as a COVID-19 treatment has been dampened by subsequent clinical study results. Weak stocks in Europe outside the eurozone also hurt, particularly Switzerland-based pharmaceutical and diagnostic equipment manufacturer Roche. Shares lagged in the more cyclicals-focused market rally despite the company having posted positive performance. The Portfolio’s cash weight during this period of strong equity returns also dragged on relative performance.

Strong stocks in EMs partially offset the drag from Japan, especially South Korean electronics manufacturer Samsung Electronics. Share benefitted due to improved pricing for its DRAM memory chips. The company also announced a new capital returns policy in January and forecasted a rosy outlook for memory demand into 2021. Taiwanese semiconductor contract manufacturer TSMC was another strong performer; the company

 

 

 

 

11

 


Table of Contents

has enjoyed strong demand for its high-performance chips from Apple (who unveiled new Mac and iPad models which utilize the TSMC-manufactured M1 processor) and other customers like NVIDIA and Mediatek (who rely on TSMC to execute its own leading-edge designs). At the same time, TSMC legacy nodes saw unusually high demand on widespread chip shortages from auto to consumer applications. Strong stocks in Pacific ex-Japan also contributed, especially Singapore-based bank DBS Group, which has continued to show strong business momentum, supported by the financial strength it has demonstrated throughout the pandemic.

Perspective and Outlook

For the best part of our 30-year existence we’ve invested in high-quality, growing companies. That means we understand only too well the slings and arrows of performance that the market occasionally hurls the way of our quality-focused portfolio. During the recovery from the prolonged bear market that followed the bursting of the tech bubble in 2000, we suffered one of our worst periods of relative performance. As the profit slump—at the time the deepest since the 1930s—dragged into its second year, the US Federal Reserve led other central banks in further rounds of cutting interest rates in a bid to spur a stronger recovery. Investors who had fled the securities of barely profitable or highly leveraged companies re-considered their cautious stance. Companies that were priced as if they might be the next round of bankruptcies suddenly looked like probable survivors, and their share prices leapt higher as investors adjusted to the upgraded prognosis. As cyclical and financial risks receded, stocks of the most stable companies, with ultra-conservative balance sheets and resilient profit margins, no longer transfixed investors, whose eyes wandered to less-pristine corporate stories in hopes of a bargain. Over the ensuing 24 months, stocks of companies in the lowest tiers of quality, derided as junk, trounced by double digits those in the top tiers.

Judging by the performance of the different quintiles of the market sorted by our proprietary quality rankings, the shift in market style that coincided with the early November release of vaccine efficacy results matches in many ways the pattern of 2003-2004, and then some. Whereas two decades ago it took over two years for the bottom quintile to out-pace the top by thirteen percentage points, this latest go-round has produced a 21 percentage point gap between the same two groups in just five months, with a mostly monotonic progression of performance down the tiers of quality: the worse you were, the better you did.

The earlier episode drove home the perils of being too risk-averse! While wallowing in the depths of a deep recession and long bear market, we took comfort from the resilience and reasonable valuation of the best companies and—despite the obvious chasm in relative valuations that had opened up between stocks of the best and the next-best, let alone

the worst—ultimately lost sight of the opportunity cost of future returns from what we did not own.

Over the last couple of years, as valuations for high-quality and rapidly growing companies have risen steadily, we’ve had to make difficult trade-offs in attempting to balance our commitment to these company attributes against the prices their shares fetch. Historically our debate has mostly concerned the trade-off between valuation and growth, but in this nascent recovery from the pandemic, the real issue—at least as far as relative performance goes—has turned out to be related more to trading off valuation against quality. Growth, in contrast to quality, has not been a particularly good predictive factor recently: only the fastest growth quintile (sorted by our growth metric) has seriously lagged the index, while the other 80% of the market matched or bettered the market’s average performance since the beginning of November.

Although both high quality and faster growth have become highly priced in recent times, we’ve made no attempt to predict either inflation or interest rates, despite recognizing how these inputs have an immediate impact on stock valuations through their

Portfolio Positioning (%) at April 30, 2021

 

Country/Region

 

   Portfolio      Benchmark1  
     

Canada

     1.9        6.8  
     

Emerging Markets

     24.5        30.8  
     

Europe EMU

     22.5        20.8  
     

Europe ex-EMU

     24.9        19.0  
     

Frontier Markets2

     0.0         
     

Japan

     12.9        14.8  
     

Middle East

     1.2        0.4  
     

Pacific ex-Japan

     8.6        7.4  
     

Other3

     1.1         
     

Cash

     2.4         

Sector

 

  

Portfolio

 

    

Benchmark1

 

 
     

Comm Services

     4.4        7.1  
     

Consumer Discretionary

     2.4        13.5  
     

Consumer Staples

     12.3        8.4  
     

Energy

     2.7        4.4  
     

Financials

     16.4        18.9  
     

Health Care

     12.4        8.9  
     

Industrials

     15.1        11.8  
     

Information Technology

     20.8        12.8  
     

Materials

     10.1        8.5  
     

Real Estate

     0.0        2.6  
     

Utilities

     1.0        3.1  
     

Cash

     2.4         

1MSCI All Country World ex-US Index; 2Includes countries with less-developed markets outside the index. 3Includes companies classified in countries outside the index.

 

 

 

12

 

  


Table of Contents

influence on discount rates. Considering such attempts a fool’s errand, we prefer instead to focus on discerning the enduring characteristics of companies themselves—characteristics that tend to persist across business cycles and political eras.

Our investment process is designed to give analysts the freedom, with few exceptions, to “go anywhere,” and locate the best businesses even in out-of-favor industries or countries. By keeping our opportunity set broad, always on the lookout for companies with strong competitive positions and secular growth tailwinds, the goal is to continuously furnish portfolio managers with sufficient raw materials from which to assemble diversified and differentiated portfolios of high-quality growing businesses. Our risk guidelines, including our portfolio limits on countries, sectors, and single companies, limit the worst of those inclinations, and we alter those limits only rarely and with great deliberation. In other words, don’t expect us to follow the current trend of some growth- and momentum-oriented investors and to jettison our single holding limits to amass larger stakes in our favorite companies.

Portfolio Highlights

Even after the sharp underperformance of high-quality stocks during the period, we remained concerned about stretched valuations. We sold German sportswear brand Adidas due to a high valuation coupled with concerns for its future growth path, trimmed expensive stocks within the IT and Health Care sectors—dominant Taiwan-based semiconductor foundry TSMC, French industrial software maker Dassault Systèmes, and Swiss-based contract pharmaceutical manufacturer Lonza—and opportunistically added on weakness to some more attractively valued stocks such as Chinese e-commerce giant Alibaba and Japanese drugmaker Shionogi.

Additionally, we made several new purchases at attractive entry points. CSPC Pharmaceuticals is one of China’s major pharmaceutical companies with a strong national sales presence, a portfolio of novel and generic pharmaceuticals already in the market, and a strong pipeline of products in development. We bought the shares on weakness triggered by government-mandated price cuts to the company’s largest seller, a drug used to treat hypertension and prevent strokes. Despite this short-term setback, we expect that higher volumes for the drug combined with new approvals will propel profit growth for years to come.

In Materials, we purchased Australian mining company BHP. We believe the market has undervalued its enduring competitive advantage due to its low-cost iron and copper mining operations which has allowed the company to deliver consistent profits and cash flows across the inevitable ups and downs of the global metals cycle. While the variability of commodity prices prevents BHP from scoring in the top ranks of measured quality, we are willing to bear some of that uncertainty in return for a more attractive valuation given the company’s strong business fundamentals.

Top Ten Holdings by Weight at April 30, 2021
Company    Sector    Country    %
       
Infineon Technologies    Info Technology    Germany    4.1
       
Samsung Electronics    Info Technology    South Korea    3.9
       
TSMC    Info Technology    Taiwan    3.7
       
Atlas Copco    Industrials    Sweden    3.5
       
L’Oréal    Cons Staples    France    3.3
       
AIA Group    Financials    Hong Kong    3.2
       
Adyen    Info Technology    Netherlands    3.1
       
BHP    Materials    Australia    3.0
       
Tencent    Comm Services    China    2.6
       
Schneider Electric    Industrials    France    2.6

In Utilities, we implemented a new position in ENN Energy, one of the largest natural gas distributors in China’s oligopolistic energy market. The company’s key competitive advantages include its scale, its access to an extensive gas distribution network, exclusive end market supply agreements with cities, and cost-effective upstream gas supply agreements with overseas suppliers. ENN Energy should benefit from rising natural gas demand in China as the country shifts away from coal, as well as industry consolidation and procurement savings opportunities stemming from gas market liberalization in China.

 

Please read the separate disclosures page for important information, including the risks of investing in the Portfolio.

 

 

 

 

13

 


Table of Contents

International Small Companies Portfolio

Institutional Investors: HLMRX | Individual Investors: HLMSX

 

 

Portfolio Management Team

 

LOGO

Jafar Rizvi, CFA

Co-Lead Portfolio Manager

Anix Vyas, CFA

Co-Lead Portfolio Manager

 

 

Performance Summary

For the International Small Companies Equity Portfolio, the Institutional Class gained 22.29% and the Investor Class gained 22.16% (net of fees and expenses) in the six-month period ended April 30, 2021. The Portfolio’s benchmark, the MSCI All Country World ex-US Small Cap Index, gained 34.44% (net of source taxes).

Market Review

International small cap stocks rose in the six-month period ended April 30, 2021, with all sectors and regions ending in positive territory. Towards the beginning of the period, accelerated approvals of COVID-19 vaccines gave investors hope for some return to normal commerce in 2021 even as COVID-19 hospitalizations in the US and Europe soared. After a pause in January as the world stood agape at the fraught events transpiring on the US political landscape, many of the trends that began with the vaccine announcement in early November resumed.

Signs of a global economic rebound multiplied as the vaccination efforts began in earnest. The IMF raised its global GDP growth forecast for 2021 by 0.3% to 6.0% since its last update in October. In the US, which has been among the world’s leaders in vaccination rates, retail sales climbed to the strongest level on record. Restaurant bookings and the number of airline passengers, while still below pre-COVID-19 levels, also continued to improve. The Biden administration passed a colossal US$1.9 trillion relief package, the third such stimulus measure since the pandemic began, sending direct payments to millions of Americans and extending unemployment insurance. The recovery in Europe, however, remained precarious, amid the emergence of new more contagious virus strains and problems with its vaccine rollout extending or renewing lockdowns.

Fund Facts at April 30, 2021

 

     
Total Net Assets    $519.8M     
     
Sales Charge    None     
     
Number of Holdings    85     
     
Turnover (5 Yr. Avg.)    31%     
     
Dividend Policy    Annual     
 
  

Institutional Investors

   Individual Investors
 
  

Institutional Class

  

Investor Class

     
Ticker    HLMRX    HLMSX
     
CUSIP    412295875    412295883
     
Inception Date    6/30/2011    3/26/2007
     
Minimum Investment1    $100,000    $5,000
     
Net Expense Ratio2    1.15%3    1.40%4
     
Gross Expense Ratio2    1.23%    1.55%
     

1Lower minimums available through certain brokerage firms; 2As of the most recent Prospectus dated February 28, 2021 and based on the fiscal year ended October 31, 2020. The Net Expense Ratio is shown net of Harding Loevner’s contractual agreement through February 28, 2022. 3Harding Loevner’s contractual agreement caps the net expense ratio at 1.15%. 4Harding Loevner’s contractual agreement caps the net expense ratio at 1.40%. The Net Expense Ratio is applicable to investors.

Better economic data coupled with seemingly unlimited central bank liquidity led to rising management confidence and a surge in mergers and acquisition activity (M&A). Global M&A reached a new record of US$1.3 trillion led by the US. Company CEOs were not the only market participants infected with high confidence; investors became more sanguine as well. The growth of special-purpose acquisition companies (SPACs), a “backdoor” means of taking private companies public with minimal regulatory oversight, accounted for an unprecedented 25% of all US deals.

Sector performance reflected the improved economic outlook with all sectors generating positive returns. The cyclical Materials and Industrials sectors were among the best performers during the period, benefitting most from the pickup in growth expectations, while the defensive Health Care sector lagged. The Consumer Discretionary sector benefitted from optimism that broader vaccine rollouts would normalize demand for goods and services, and Financials also rebounded, aided by a steepening yield curve and surprisingly low credit defaults. Less cyclical sectors such as Consumer Staples and Utilities fared less well, although finishing the six-month period strong nonetheless.

Viewed geographically, the EMU was the best performer, as some of the countries hardest hit by the virus were buoyed most by the vaccine developments. Returns in the UK, the largest weight in Europe ex-EMU, were helped by a last-minute Brexit trade deal. Emerging Markets (EMs) also outperformed, with good returns

 

 

 

14

 

  


Table of Contents

Performance (% total return)

 

   
     For periods ended March 31, 2021      For periods ended April 30, 2021  
       
     1      3      5      10      Since Inception*      1      3      5      10      Since Inception*  
           
      Year      Years      Years      Years      Jun-11      Mar-07      Year      Years      Years      Years      Jun-11      Mar-07  
                         

Intl Small Companies Portfolio – Inst Class

     59.86        7.64        11.42               8.00                 50.89        9.84        12.35               8.47           
                         

Intl Small Companies Portfolio – Investor Class

     59.47        7.37        11.13        7.85                 7.11        50.48        9.55        12.06        7.77                 7.43  
                         

MSCI All Country World ex-US Small Cap Index

     69.82        6.61        10.40        6.32        6.53               58.37        7.80        10.79        6.30        6.96         

Returns are annualized for periods greater than 1 year. *Inception of the Institutional Class, June 30, 2011. Inception of the Investor Class, March 26, 2007. Index performance prior to June 1, 2007 cannot be shown since it relies on back-filled data.

Performance data quoted represents past performance; past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance of the Portfolio may be lower or higher than the performance quoted. Performance data current to the most recent month end may be obtained by calling (877) 435-8105 or visiting www.hardingloevnerfunds.com.

 

 

from commodity-driven markets such as Russia, Brazil, and South Africa. Pacific ex-Japan also fared well, helped by Australia, which rebounded alongside a global recovery in commodity prices. While the Nikkei hit a three-decade high this quarter, the positive investor sentiment appears geared to larger, more export-driven companies, weighing on small cap returns in Japan.

By style, value was the standout, further reversing its lengthy period of underperformance and continuing the rally started in November. The cheapest stocks, heavily concentrated among financial and energy companies, outperformed the most expensive stocks by more than 1,000 basis points. Similarly, lower-quality companies, typically those with higher leverage and more volatile revenues and earnings, outperformed high-quality companies by more than 2,000 basis points. Shares of low-growth companies outperformed modestly, though with a less muted effect across quintiles of growth.

Performance Attribution

The Portfolio’s underperformance was driven primarily by weak stocks.

Our stocks in the Information Technology (IT) sector, and particularly the software and services industry where the shift toward cheaper, more cyclical stocks was pronounced and where we have a large weight, hurt the most during the six-month period. Companies such as Israeli-based cybersecurity specialist CyberArk and Canada-based supply chain management software provider Kinaxis were among the Portfolio’s largest relative detractors. Performance across the Portfolio suffered from the same valuation-related headwinds.

Another large detractor in IT was Finnish instrument producer Vaisala, which manufactures weather instruments used at airports and other testing and measurement devices used by pharmaceutical and utility customers. The unprecedented (and, we

think, temporary) slump in airline traffic during the pandemic has caused airport authorities to curb capital improvements, putting a dent in Vaisala’s earnings. However, safety remains an important priority for the authorities, and we expect regular replacement of existing weather-sensing systems and new investments particularly in EMs to continue to support the company’s growth longer term.

Consumer Staples also weighed negatively on returns. Egyptian packaged snack food company Edita, whose packaged cakes and croissants are mostly consumed by young people “on the go,” was hit hard by the lockdown as Egyptian schools and universities were closed from March to October. The stock languished throughout the year, trading near five-year lows, not seen since the Egyptian pound devaluation in late 2016.

Performance was weak across most regions, in Europe and Japan particularly, where some of the sharpest rotations in valuation style occurred. In Europe outside the monetary union, Swedish videogame maker Paradox Interactive detracted from returns following weak fourth-quarter results. The December release of its new game Empire of Sin disappointed, as did its revelation of unexpectedly higher depreciation expense. Paradox did, however, report a significant rise in monthly active users, a good signal for future revenues. In EMs, a region in which our stock selection fared slightly better, Indian life insurer Max Financial provided the largest boost to returns. The Indian insurance regulator provided long-awaited approval of a partnership with Axis Bank, which permits the large India-based bank to purchase up to 12% of Max Financial. The approval creates the potential for greater revenue synergies between the two companies by providing some assurance that Axis will collaborate with Max rather than compete against it. Max Financial’s top-line growth was 21% year-over-year in the fourth quarter and its market share of the premium-based life insurance business grew.

 

 

 

 

15

 


Table of Contents

Perspective and Outlook

Many have described the past year as “COVID time,” referring to an alternation of the monotony of social distancing with the fear of infection and death, and how each day seemed simultaneously to crawl and to fly. A similar phenomenon presented in our asset class. Rarely, if ever, has there been a period when an entire multi-year market cycle seemed packed into twelve months. In fact, when looking back and trying to make sense of our own Portfolio’s experience, it feels more appropriate to talk of the three distinct phases of the cycle since March.

The first started the week beginning March 9, when the index coughed up the first 15% of its value in a week. The selling was especially fierce in some of the lower-quality reaches of the Small Cap Index, where investors fled from financially weak companies as they sought safety and quality above all else. Our Portfolio’s permanent aversion to such companies helped limit the damage during this period, much like in past periods of market distress.

The second phase started in early May, as massive liquidity injections by the world’s central banks were initiated to help limit the economic damage. As people began to look beyond the present business distress, fear receded and expectations of a V-shaped recovery took hold. Investors’ attention turned from strong balance sheets to sustainable growth prospects, providing a further tailwind to a Portfolio that is also highly tilted toward the fastest growers.

This phase lasted until early November, when a flurry of vaccine breakthroughs encouraged the thought of a return to normalcy in 2021. International small caps jumped by nearly 1,400 bps during the month, led predominantly by lower-quality companies that were, during the first phase, thought to be at greatest financial risk. In this “junk” rally, our Portfolio lagged, ultimately giving up nearly 425 bps of relative performance in November alone. This trend continued until the end of March, after which growth stocks staged a brief recovery in April of this year. It is difficult to determine whether this recovery was the start of another regime shift; however, our focus on the long-term remains un-wavering. Our process affords us flexibility to pursue a number of avenues for seeking returns but stooping to pick up cigar butts isn’t one of them.

There is value in pausing here to reflect on how international small caps have performed through other market cycles. With the ever-valid caveat that the past is not a guarantee of future returns, history does provide an empirical basis for thinking about the returns from small caps. While international small caps are indisputably more volatile than international large caps, their returns have been demonstrably higher, by an average of 320 bps a year over the past twenty years, enough to outperform large caps on a risk-adjusted basis over that period (Sharpe ratio of 0.40 vs. 0.25). As active managers, though, we are attracted to the potential afforded by this vast opportunity set of over 10,000

listed businesses to generate alpha. Lax listing requirements across many markets allow many sub-par companies to sneak into the international small cap index. Given the sheer number of listings and the dearth of sell-side research on all but the largest, investment approaches that discriminate between companies that score highly on objective measures of quality and those that score the opposite tend to do well.4

Of course, our approach goes further. We emphasize quality (financial strength, distinguished track records, able management) but also growth. Through our bottom-up process we identify durable competitive advantages that enable companies to grow earnings reliably. A portfolio that scores high on quality and growth may shine in market environments such as those of 2020’s first two phases. But a feature of such a portfolio is that it will often appear expensive on metrics such as price-to-earnings and price-to-book ratios. This has increasingly been the case during the last half-decade, when high-quality growth stocks were rising in popularity (and price) because a slow-growing economy and low interest rates encouraged

Portfolio Positioning (%) at April 30, 2021

 

Country/Region

 

  

Portfolio

 

    

Benchmark1

 

 
     

Canada

     1.9        6.5  
     

Emerging Markets

     21.9        24.2  
     

Europe EMU

     21.4        14.9  
     

Europe ex-EMU

     29.2        24.3  
     

Frontier Markets2

     7.6         
     

Japan

     12.0        18.7  
     

Middle East

     1.5        1.7  
     

Pacific ex-Japan

     0.7        9.7  
     

Other3

     0.8         
     

Cash

     3.0         

Sector

 

  

Portfolio

 

    

Benchmark

 

 
     

Communication Services

     8.0        4.1  
     

Consumer Discretionary

     4.9        12.6  
     

Consumer Staples

     10.0        5.5  
     

Energy

     1.6        2.3  
     

Financials

     6.5        10.6  
     

Health Care

     11.3        7.4  
     

Industrials

     17.6        21.0  
     

Information Technology

     25.6        11.7  
     

Materials

     8.2        11.2  
     

Real Estate

     0.9        10.3  
     

Utilities

     2.4        3.3  
     

Cash

     3.0         

1MSCI All Country World ex-US Small Cap Index; 2Includes countries with less-developed markets outside the index; 3Includes companies classified in countries outside the index.

 

 

4Clifford S. Asness, Andrea Frazzini, Ronen Israel, Tobias J. Moskowitz, and Lasse Heje Pedersen, AQR, “Size Matters, If You Control Your Junk,” SSRN (January 2015); among other publications.

 

 

 

16

 

  


Table of Contents

investors to seek growth at almost any cost. Our response to this growing challenge has been incremental; we have reacted to perceived overvaluations, selling for something more reasonably priced, one stock at a time. Unfortunately, an incremental approach is ineffective (“too little too late”) once a junk rally begins. Regardless, factor rotation is not driving our decisions. We have no particular skill in identifying when style factors will be in or out of favor. Factors can rotate a few times even within a year, as they did in 2020. Our focus remains on identifying high-quality companies that can grow throughout market cycles. And we pay attention to valuations.

Portfolio Highlights

Our aim is to construct a well-diversified Portfolio that can withstand the full spectrum of “known unknowns” including short-term economic developments and bond yield fluctuations. The Portfolio is invested in businesses able to grow during downturns, such as our software holdings, as well as those reliant on expanding economic activity for growth. One example of the latter that we exited this period, though not by choice, was Signature Aviation, the leading UK-based fixed-base operator (FBO) of business jets, which is being taken private by a consortium of private equity firms. Travel limitations imposed by the pandemic presented challenges, but the company was able to surmount them.

We made four new purchases in the six-month period, each in a different sector, resulting in changes within the Portfolio’s sector exposures. In Industrials, we added HomeServe, a UK-based provider of subscription-based home repair service memberships in the UK, US, France, and Spain. It has exclusive long-term agreements with numerous utilities and municipal partners, and a large network of tradespeople, enabling the company to serve customers efficiently at lower costs. Increasing household formation underpins our expectations of sustainable long-term growth for the company.

Another UK company added during the period was Cranswick, which makes pork and poultry products on a private label basis. The company has 16 production facilities focused on everything from pig breeding and broiler farms to feed mills to preparation and packaging plants. All adhere to the latest environmental, ethical treatment, and non-GMO standards, which we think will allow Cranswick to achieve superior growth and profitability. Its poultry business, which is relatively new, is growing quickly by leveraging Cranswick’s existing customer relationships and reputation as a high-quality protein manufacturer.

We also purchased Solasto, the second-largest provider of outsourced medical administration services in Japan. The company’s focus on raising employee productivity through the adoption of IT solutions allows it to provide more services without hiring more employees. This approach is essential in Japan because of the country’s aging society and labor scarcity, and we think this positions the company to continue to grow profitably.

Top Ten Holdings by Weight at April 30, 2021

Company

 

  

Sector

 

  

Country

 

  

%

 

       
Hoa Phat Group    Materials    Vietnam    4.3
       
Reply    Info Technology    Italy    3.0
       
STRATEC Biomedical    Health Care    Germany    2.6
       
Max Financial Services    Financials    India    2.5
       
RUBIS    Utilities    France    2.4
       
Abcam    Health Care    UK    2.2
       
Dechra Pharmaceuticals    Health Care    UK    2.2
       
Bechtle    Info Technology    Germany    2.2
       
Fuchs Petrolub    Materials    Germany    2.1
       
Tomra Systems    Industrials    Norway    2.1

Finally, we added Bankinter, a new Financials holding. This well-managed Spanish bank has been gaining share as the banking industry has consolidated in recent years. Tourism is an important industry in Spain. The prevalence of the virus in the country has been high, so Spain’s economy is poised for a big rebound as leisure travel, one pre-pandemic habit we expect to survive, resumes.

 

Please read the separate disclosures page for important information, including the risks of investing in the Portfolio.

 

 

 

 

17

 


Table of Contents

Emerging Markets Portfolio

Institutional Investors: HLMEX & HLEZX | Individual Investors: HLEMX

 

 

Portfolio Management Team

 

LOGO

 

Scott Crawshaw

Co-Lead Portfolio Manager

 

Craig Shaw, CFA

Co-Lead Portfolio Manager

 

Pradipta Chakrabortty

Portfolio Manager

 

Richard Schmidt, CFA

Portfolio Manager

The Institutional Emerging Markets Portfolio (Institutional Class and Institutional Class Z) and the Emerging Markets Portfolio (Advisor Class)—collectively, the “Portfolios”—are both managed in strict accordance with Harding Loevner’s Emerging Markets Equity strategy model portfolio. Therefore, the Portfolios have highly similar holdings and characteristics. We have provided a single commentary to cover both Portfolios. The specific performance and characteristics of each are presented separately in the tables that follow.

Performance Summary

For the Institutional Emerging Markets Portfolio, the Institutional Class rose 25.05% and Class Z rose 25.12% (net of fees and expenses). For the Emerging Markets Portfolio, the Advisor Class rose 24.97% (net of fees and expenses) in the six-month period ended April 30, 2021. The Portfolios’ benchmark, the MSCI Emerging Markets Index, rose 22.95% (net of source taxes).

Market Review

Stocks in Emerging Markets (EMs) rallied in the first half of the fiscal year as news late in 2020 that vaccines had demonstrated exceptional levels of efficacy in final trials provided the catalyst for upgrading of global growth expectations and renewal of interest in those markets and industries worst hit by the COVID-19 pandemic. This, in turn, also boosted EM currencies, with the majority making significant gains versus a persistently weak dollar. The prospect of a stronger, broader-based recovery combined with China’s continued economic health and anticipation of the Biden

Fund Facts at April 30, 2021

 

    
       
Sales Charge   None         
       
Number of Holdings   74         
       
Dividend Policy   Annual         
   
    Institutional Investors       

Individual Investors

     
Portfolio Assets   $6,768.7M    $4,569.7M
     
Turnover (5 Yr. Avg.)   19%    20%
     
    Inst Class   Inst Class Z    Advisor
     
Ticker   HLMEX   HLEZX    HLEMX
     
CUSIP   412295701   412295693    412295305
     
Inception Date   10/17/2005   3/5/2014    11/9/1998
     
Minimum Investment1   $500,000   $10,000,000     $5,000
     
Net Expense Ratio2   1.17%3   1.11%4      1.32%5
     
Gross Expense Ratio2   1.27%   1.19%     1.35%

1 Lower minimums available through certain brokerage firms; 2 As of the most recent Prospectus and based on the fiscal year end. 3 The Net Expense Ratio is shown net of Harding Loevner’s contractual agreement through February 28, 2022. Harding Loevner’s contractual agreement caps the net expense ratio at 1.17%. The Net Expense Ratio is applicable to investors. 4 The Net Expense Ratio is shown net of Harding Loevner’s contractual agreement through February 28, 2022. Harding Loevner’s contractual agreement caps the net expense ratio at the Portfolio’s contractual management fee. The Net Expense Ratio is applicable to investors. 5 The Net Expense Ratio is shown net of Harding Loevner’s contractual agreement. Harding Loevner’s contractual agreement caps the net expense ratio at 1.32%. The Net Expense Ratio is applicable to investors.

administration’s massive infrastructure plans also propelled commodity and Energy prices higher.

Latin America and emerging Europe were the strongest regions in the index, with EMs especially sensitive to commodity prices (e.g., Russia, South Africa, Brazil, Mexico) enjoying an especially strong bounce. Asia lagged mostly due to China, the largest EM, which was among the worst-performing markets despite keeping the virus under control and registering robust growth in both manufacturing and services. Concerns included tighter domestic borrowing conditions and continuing tensions with the US. Anti-trust actions against Chinese internet companies were another cause for concern. Although the fines levied by Chinese regulators against Tencent, Baidu, and JD.com for their monopolistic behavior were miniscule, Alibaba received a much larger (US$3 billion) punishment in April albeit one still modest in relation to the size of the company. Across the strait, Taiwan was among the strongest EMs, led by semiconductor stocks, especially TSMC, buoyed by the current global chip shortage.

Materials was the best-performing sector with the rise in commodity prices and signs of broader global economic expansion. In Financials, EM bank stocks, which were among those most battered by the virus during much of 2020, rose sharply. Stocks of companies that have benefited the most from the pandemic environment in the Information Technology (IT)

 

 

 

18

 

  


Table of Contents

Performance (% total return)

 

 
    For periods ended March 31, 2021     For periods ended April 30, 2021  
       
     1     3     5     10     Since Inception*     1     3     5     10     Since Inception*  
               
     Year     Years     Years     Years     Oct-05     Mar-14     Nov-98     Year     Years     Years     Years     Oct-05     Mar-14     Nov -98  
                             

Inst. Emerging Markets Portfolio – Inst. Class

    60.07       4.58       11.25       5.23       7.62                       49.65       6.28       11.35       4.99       7.68                  
                             

Inst. Emerging Markets Portfolio – Class Z

    60.29       4.74       11.47                     6.90               49.92       6.45       11.57                     7.05          
                             

Emerging Markets Portfolio – Advisor Class

    60.08       4.45       11.14       5.12                       11.14       49.62       6.15       11.22       4.88                       11.17  
                             

MSCI Emerging Markets Index

    58.39       6.48       12.07       3.65       7.45       7.08             48.71       7.51       12.50       3.59       7.58       7.36        

Returns are annualized for periods greater than 1 year. *Inception of Institutional Class, October 17, 2005. Inception of Class Z, March 5, 2014. Inception of the Advisor Class, November 9, 1998. Index performance prior to January 1, 2001 cannot be shown since it relies on back-filled data.

Performance data quoted represents past performance; past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance of the Portfolio may be lower or higher than the performance quoted. Performance data current to the most recent month end may be obtained by calling (877) 435-8105 or visiting www.hardingloevnerfunds.com.

 

sector also continued to enjoy strong gains, led by semiconductor and other hardware manufacturers. Consumer Discretionary was the only sector in the index to decline, weighed down by index heavyweight Alibaba and its regulatory woes.

Performance Attribution

The Portfolio outpaced the index in the first half of the fiscal year due to strong stocks in Consumer Staples, Energy, and Consumer Discretionary. Our underweight the latter lagging sector was also helpful.

In Staples, the re-mobilization of consumers in Latin America and EM Europe helped to revive the shares of three beverage businesses: UK-based Coca-Cola HBC, Mexico’s FEMSA, and Brazil’s Ambev. In Energy, higher oil prices boosted the shares of two Russian-based companies, Lukoil and oil and natural gas producer Novatek, as well as Tenaris, a high-end oil pipe manufacturer. All fared better than Brazil-based Petrobras, whose well-respected CEO was ousted by President Jair Bolsonaro due to disagreement over fuel prices. In Consumer Discretionary, strong holdings included duty-free retailer China Tourism Group Duty Free and Taiwan’s Eclat Textile, which reported that customers such as Under Armour have increased their sales forecasts for 2021. Our underweight versus the benchmark in embattled Alibaba also helped relative returns.

The Portfolio’s lack of holdings in the top-performing Materials sector was the main detractor this period.

By region, key positive contributors to relative returns were our overweights in Brazil and Mexico as well as the Portfolio’s off -benchmark investments in China-focused companies listed in Hong Kong. Hong Kong-listed power tool manufacturer Techtronic Industries has continued to gain share thanks to innovative new products, and semiconductor equipment manufacturer

ASM Pacific Technology is set to benefit from large-scale capital investment plans in the industry.

We lagged the index in Brazil where, in addition to Petrobras, shares of global industrial equipment producer WEG were down as investors grappled with the impact of rising commodity prices on the company’s margins. The Portfolio’s small weight in cash also dampened performance versus the index.

Perspective and Outlook

Even as humanity continues its determined battle to contain the coronavirus, the longer-term threat facing our species from climate change is capturing increasing attention. The shift to electric vehicles (EVs) undeniably represents a growth opportunity for investors, particularly in China given its massive addressable market and the government’s new commitment to achieve carbon neutrality by 2060. In recent years, a plethora of companies have sought to capitalize on EV growth in China, including foreign automakers, who have laid out aggressive plans to build out EV capabilities, many through partnerships and joint ventures with Chinese firms. The existence of a growing market, however, by no means guarantees that EV makers themselves will be solid long-term investments.

A major challenge for EV makers is the specter of even more competitors entering the scene. The legacy, ICE-based automobile industry has enjoyed high barriers to entry due to the massive fixed capital required to produce engines, giving rise to enormous economies of scale, and the fact that trust based on brand reputation is important in consumer purchase decisions. The manufacturing process for EVs is significantly less complex and key components can be outsourced, presenting a low barrier to entry, as evidenced by the growing number of consumer and technology brands developing their own EVs, including Apple, and China’s internet giant Baidu and smartphone maker Xiaomi.

 

 

 

 

19

 


Table of Contents

Amid the increasingly crowded field, achieving stand-alone dominance in EV manufacturing will likely require a company to achieve (and maintain) the automobile equivalent of the iPhone: a uniquely attractive combination of hardware, software, and aesthetics. Tesla has come as close as any company to hitting on all three, but whether its edge can prevail is an open question. The software domain would appear to provide the most scope for enduring differentiation, but we think a single EV-maker is less likely to win out here than a software/systems specialist, such as China’s Waymo or Baidu, that will partner with multiple manufacturers to achieve scale. Tesla has enviable first-mover advantage in hardware (including manufacturing cost efficiency) and some aspects of software, with its revered user interface. We think it’s likely, however, that as the diversity of customer preferences are revealed, others will challenge Tesla for leadership in certain areas, be it drive-ability, style, or entertainment.

We can only speculate about how the EV industry will ultimately shake out. This lack of fundamental foresight makes us wary of predicting long-term winners among today’s brands, though we will continue to watch for companies that offer sufficient quality characteristics and durable growth potential. In the meantime, we have chosen to gain exposure to the EV growth opportunity through other ways very much aligned with our focus on quality-growth companies. In common with all other industries, our goal with respect to EVs is to invest in firms that offer predictable growth in their core businesses augmented by new growth opportunities exploitable by farsighted management. Indeed, we already have three EV-related holdings that fit this something-old/something-new profile:

Hon Hai Precision

Hon Hai Precision, also known as Foxconn, is the world’s leading provider of electronics manufacturing services (EMS), producing such iconic products such as the iPhone, Amazon Kindle, and Sony PlayStation. With its expertise in both hardware and software, combined with its massive scale and powerful supply chain management, Hon Hai offers its clients unrivaled speed-to-market at large scale and low cost. Its assembly capabilities are augmented by its ability to make certain components, such as iPhone casings, itself, from scratch. This reduces Hon Hai’s costs and allows it to make larger investments in research and development than smaller competitors.

One of Hon Hai’s recent growth initiatives has been entering the automotive industry, specifically EVs. It already offers a thousand EV components and counts Tesla among its customers. Hon Hai is an attractive supplier to EV manufacturers because of its expertise in the production of light metal structural parts, its experience in managing complex supply chains, and its expertise in products that integrate software with hardware (Exhibit A: the iPhone). Hon Hai has already designed a chassis and mapped out a production schedule for new models for three brands in 2022. Hon Hai is also building its own hardware and software “open platform,” called MIH. With contributions from Hon Hai’s partners and third-party developers,

MIH promises EV-makers a way to reduce up-front development costs, shorten vehicle development time, and facilitate mass production. MIH has already attracted customers such as Chinese automaker Geely, Italy’s Fiat, and US-based Fisker. While it is still early days in EV at Hon Hai, it is targeting a 10% share of what it estimates will be a $500 billion market by 2025.

WEG

WEG is one of Brazil’s leading industrial companies, manufacturing a broad range of electrical equipment for the global market. WEG earns a majority of its revenues abroad and has been making considerable capital expenditures to bring the same high level of vertical integration it enjoys inside Brazil to its manufacturing plants in Mexico, China, and elsewhere. These investments should improve WEG’s cost structure, global market share, and margins. Against the backdrop of the rotten Brazilian economy of recent years, WEG has managed to grow consistently and generate high returns on capital.

WEG’s management has shown commendable foresight in steering the company towards growth opportunities in adjacent business.

Portfolio Positioning (%) at April 30, 2021

 

Country/Region

    

Institutional

HLMEX / HLEZX

 

 

    
Advisor
HLEMX
 
 
     Benchmark 1 
       

Brazil

     6.3        6.3        4.6  
       

China + Hong Kong2

     34.0        34.0        37.5  
       

India

     7.5        7.5        9.4  
       

Mexico

     5.0        5.0        1.7  
       

Russia

     7.7        7.7        3.0  
       

South Africa

     1.5        1.5        3.7  
       

South Korea

     9.2        9.2        13.4  
       

Taiwan

     11.5        11.6        14.6  
       

Small Emerging Markets3

     5.9        5.9        12.1  
       

Frontier Markets4

     1.7        1.7         
       

Developed Market Listed5

     7.3        7.4         
       

Cash

     2.3        2.2         
        

Sector

    
Institutional
HLMEX / HLEZX
 
 
    
Advisor
HLEMX
 
 
    
Benchmark

 
       

Comm Services

     9.3        9.3        11.7  
       

Consumer Discretionary

     16.2        16.2        17.4  
       

Consumer Staples

     9.2        9.3        5.5  
       

Energy

     5.0        5.0        4.7  
       

Financials

     21.9        21.9        17.9  
       

Health Care

     3.2        3.2        4.7  
       

Industrials

     8.6        8.6        4.4  
       

Information Technology

     22.8        22.8        21.2  
       

Materials

     0.0        0.0        8.6  
       

Real Estate

     0.0        0.0        2.0  
       

Utilities

     1.5        1.5        1.9  
       

Cash

     2.3        2.2         

1MSCI Emerging Markets Index; 2The Benchmark does not include Hong Kong; 3Includes the remaining emerging markets which, individually, comprise less than 5% of the index; 4Includes countries with less-developed markets outside the index; 5Includes emerging markets or frontier markets companies listed in developed markets, excluding Hong Kong.

 

 

 

20

 

  


Table of Contents

Its initiatives include developing electric traction systems for buses, trains, and other modes of transport. In 2019, WEG stepped up its activity in this segment by becoming a key part of the VW-coordinated “e-Consortium” focused on developing electrical mobility in Brazil. WEG supplies the powertrain system globally for all VW electric delivery trucks and also makes the motors to power the air conditioning and other auxiliary systems. WEG’s initiatives in electric mobility are currently just a small part of the company’s many climate-related growth opportunities. The company has a larger wind and solar energy business, for example, that includes manufacturing solar energy kits for home use that have been gaining popularity in many markets.

Silergy

A new holding this period is Silergy, a Taiwan-listed manufacturer of power-management integrated circuits (PMIC) used in a range of electronic equipment, from computer tablets to industrial robots. The company’s design and manufacturing platform is highly integrated: it operates its own chip fabrication (“fab”) facilities, which enables the company to stay a step ahead of competitors with more intelligent or efficient products. Silergy has steadily increased its share of the PMIC market and enjoyed about a 15% cumulative annual growth rate of revenues and profits over the last five years.

Silergy has been investing for years in R&D to produce PMICs suitable for automotive applications. The recent chip shortage has prompted automakers to expand their suppliers of PMICs, presenting an opportunity for Silergy to enter the highly competitive supply chain. Silergy’s automotive-related revenues will likely exceed 5% of sales in 2021 and could double next year. Management has been vocal about its attractive near-term opportunities in telematics, infotainment, advanced driver-assistance systems, and LED lighting.

Portfolio Highlights

In 2020 and the early weeks of 2021, shares of a small group of fast-growing companies posted exceptionally strong returns, even after these shares were already looking quite expensive. Starting in mid-February, many of the expensive growers suffered rising share price volatility and moderate to significant reversals. A spike in volatility can reflect rising controversy in the market’s interpretation of the investment thesis—perhaps in some cases there is less certainty over the path to profitable growth—but it could just as well be rising interest rate expectations that increase the discount demanded in the present for those rosy earnings projections.

High valuations can represent a significant risk to growth stocks and growth investors, risk that quickly multiplies if lofty growth expectations are not allied with fundamental quality providing the foundation for sustainable profit growth. We have avoided many of the highest flyers of 2020. The issue for us often comes down to the quality component of our process—we demand, among other markers of quality, a track record of profitability and cash

Top Ten Holdings by Weight at April 30, 2021

 

Company    Sector    Country     


Institutional

HLMEX /
HLEZX

 


 

    

Advisor

HLEMX

 

 

         

TSMC

   Info Technology    Taiwan      5.3        5.3  
         
Samsung Electronics    Info Technology    South Korea      4.8        5.1  
         
Tencent    Comm Services    China      4.7        4.7  
         
EPAM    Info Technology    US      3.9        4.6  
         
Alibaba    Cons
Discretionary
   China      3.0        3.9  
         
AIA Group    Financials    Hong Kong      2.7        2.7  
         
LG Household & Health Care    Cons Staples    South Korea      2.4        2.4  
         
Sberbank    Financials    Russia      2.2        2.2  
         
Tata Consultancy Services    Info Technology    India      2.2        2.2  
         
Techtronic Industries    Industrials    Hong Kong      2.2        2.2  

flow generation that we think is sustainable before we invest in a business. Many of 2020’s hot dots don’t meet those criteria. And a number that do are still trading at rarified valuations even after their recent loss in altitude, which eliminates them from consideration.

For our portfolio we continue to find high-quality growth companies beyond IT, e-commerce, and the other most obvious growth industries. One of our purchases this period is Country Garden Services (CGS), a leader in China’s consolidating property management industry. The country’s densely populated communities rely upon property managers to enhance their quality of living. CGS’s superior reputation for service—and its wide variety of offerings including housekeeping, babysitting, interior design, and even schooling—is helping it gain market share. It is also expanding into commercial property services. Our analyst foresees CGS achieving 29% annual sales growth over the next five years.

During this period, we also added to our position in Alibaba, taking advantage of its recent tussles with regulators. Despite the policy risks, the company’s e-commerce and explosively growing cloud-computing segments remain exceptionally strong, making its valuation look attractive, particularly compared to other high-growth North Asia EIT stocks.

 

 

 

 

21

 


Table of Contents

Chinese Equity Portfolio

Institutional Investors: HLMCX

 

 

Portfolio Management Team

 

LOGO

Pradipta Chakrabortty

Lead Portfolio Manager

Jingyi Li

Portfolio Manager

Wenting Shen, CFA

Portfolio Manager

Performance Summary

The Chinese Equity Portfolio was launched on December 16, 2020. The Institutional Class rose 7.20% (net of fees and expenses) since launch through April 30, 2021. The Portfolio’s benchmark, the MSCI China All Shares Index, rose 4.02% in this period (net of source taxes).

Market Review

China largely got the COVID-19 outbreak under control by June 2020, and in response its economy continued to pick up steam during the first half of the fiscal year. Business activities re-accelerated while stringent border controls stayed in place to maintain a COVID-19-free domestic environment. In January 2021, new cases were detected for the first time in months, but testing mandated by local governments and stay-in-place orders in a handful of cities proved effective in curtailing the outbreak. Because many migrant workers elected not to travel during the Chinese New Year, industrial production following the weeklong holiday resumed more quickly than in previous years, with industrial activity readings posting their 13th consecutive month of expansion.

In March 2021, China launched its 14th Five-Year Plan and its 2035 long-term plan. Policy discussions surrounding these plans have reemphasized past areas of priority such as technological innovation and domestic consumption, while continuing to press ahead with reforms of state-owned enterprises (SOEs) and financial markets. In a sign of how other priorities have moved up the focus list, officials revealed a surprising level of detail around a previous pledge to achieve peak carbon emissions by

Fund Facts at April 30, 2021

 

   
Total Net Assets    $4.2M
   
Sales Charge    None
   
Number of Holdings    37
   
Turnover (5 Yr. Avg.)   
   
Dividend Policy    Annual
   Institutional Class
   
Ticker    HLMCX
   
CUSIP    412295685
   
Inception Date    12/16/2020
   
Minimum Investment1    $100,000
   
Net Expense Ratio2    1.15%3
   
Gross Expense Ratio2    4.75%

1Lower minimums available through certain brokerage firms. 2As of the most recent Prospectus and based on expenses for the fiscal year end. The Net Expense Ratio is shown net of Harding Loevner’s contractual agreement through February 28, 2022. 3Harding Loevner’s contractual agreement caps the net expense ratio at 1.15%. The Net Expense Ratio is applicable to investors.

2030 and net carbon neutrality by 2060. Regarding actual policy changes, China also passed reforms to relieve the demographic pressures that have resulted in skilled labor shortages emerging in some cities by lifting urban residency (“hukou”) restrictions in Shandong and Jiangxi, two provinces that are home to nearly 150 million people. This makes rural migrants eligible for the social safety nets of the cities in which they already live and work, and is intended to attract their families and friends, as well as new graduates, to these cities.

Conversely, regulatory risk has risen for China’s leading internet companies, depressing sentiment towards their stocks as regulators in China took a harder line on anti-competitive practices. Although they issued only negligible penalties (the equivalent of US$75,000) for monopolistic behavior against Tencent, Baidu, and JD.com, a much larger fine of nearly US$3 billion was imposed on Alibaba for demanding exclusivity of some of its merchants. We see very little fundamental impact on Alibaba’s business prospects from this sanction. Accessing Alibaba’s massive customer base of robust spenders remains an attractive value proposition for the company’s participating merchants, and Alibaba’s management seems committed to invest in further lowering merchants’ operating cost on its platforms. The direct financial hit of the penalty to Alibaba’s earnings pales in importance compared to how it resolves the open-ended threat previously overhanging its shares—which look attractive today in our valuation models as many of Alibaba’s long-term initiatives, particularly in cloud services, are not adequately valued by the market.

 

 

 

22

 

  


Table of Contents

Performance (% total return)

 

     For periods ended March 31, 2021      For periods ended April 30, 2021  
   
     Calendar YTD      1 Year      Since Inception*      Calendar YTD      1 Year      Since Inception*  
   

Chinese Equity Portfolio – Institutional Class

     -0.57               4.40        2.10               7.20  
   

MSCI China All Shares Index

     -1.50               1.67        0.78               4.02  

Returns are annualized for periods greater than 1 year. *Inception date: December 16, 2020.

Performance data quoted represents past performance; past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance of the Portfolio may be lower or higher than the performance quoted. Performance data current to the most recent month end may be obtained by calling (877) 435-8105 or visiting www.hardingloevnerfunds.com.

 

Performance Attribution

The Portfolio’s outperformance was primarily due to strong holdings in Consumer Discretionary and Information Technology (IT) as well our overweights in Health Care and Industrials.

In Consumer Discretionary, duty-free shop operator China Tourism Group Duty Free rose as January’s COVID-19 uptick failed to dissuade travelers from flocking to tropical Hainan island to vacation. The company is benefitting from a recent increase in the quantity of Western luxury goods that can be brought from Hainan to the mainland duty-free, part of a multi-year initiative to incentivize spending domestically instead of in duty-free stores overseas.

We had broad-based positive stock selection in IT, where our holdings are primarily equipment and precision parts manufacturers such as ASM Pacific Technology (semiconductor equipment), Sunny Optical (optical components), and Silergy (electronic components). Shares of these companies performed well this period due to rising sales for their industrial customers in the automotive, smartphone, and semiconductor sectors.

Consumer Staples detracted from our performance as Foshan Haitian, a soy sauce and condiments producer, gave back some of its gains after a strong 2020. Our lack of Chinese bank holdings also hurt relative performance.

Perspective and Outlook

China has achieved a near-legendary transition from having an economy reliant on legacy-heavy industry and infrastructure investment to one defined by, among other facets, skilled labor, unprecedented internet connectivity, and rising incomes for a vast number of Chinese.1 This transition has been accompanied by a rise of consumer power, a significant portion of it expressed online. The figures are impressive—estimates place the size of China’s middle class between 400-700 million individuals; China is now the world’s biggest market for luxury goods, smartphones,

passenger cars, and beer, among many other products. It also comprises the majority of production for growing industries such as electric vehicles (EVs) and solar power. More than most other countries, China has increasingly identified innovation as a condition of growth and has pursued it through aggressive policies and private sector funding of R&D. The government continue to aid in the development of innovative, quality-growth businesses over a wider range of industries. Coupled with stock market reforms that have improved access to mainland companies, the result has been a vastly expanded opportunity set for foreign-based investors. More than 1,800 Chinese companies of US$1 billion in market capitalization or greater are now investable through the Shanghai and Shenzhen Stock Connect programs.

Most companies that we follow and rate in China have a strong competitive position within industries with favorable market dynamics. For example, larger companies, particularly internet and e-commerce-related enterprises, benefit from economies of scale in a colossal yet still rapidly growing domestic market. Because domestic rivalry is typically fierce, market leaders had to learn to evolve quickly. This for some has led to a virtuous circle: market growth provides strong free cash flow, which they can reinvest in R&D to improve product quality and customer experience, which strengthens their competitive position and their cash flow. The favorable dynamics extend beyond the industries that one expects to see in growth-oriented portfolios to areas like robotics, companies up and down the value chain in electric vehicles, and biomedical research, just to name a few of our favorite hunting grounds. This, in turn, contributes to a level of industry and sector diversification that we think is necessary to construct a portfolio of companies from a single country.

 

 

1Our China country specialists regularly stress the deep complexity of China’s economy, whose development, occurrent in staggered fashion across regions, has led to significant wealth disparity. At around US$10,000 GDP per capita nationally, China is now in the middle income bracket. But this belies a radical difference in prosperity. “Tier one” cities in mainland China (Beijing, Shanghai, Guangzhou, Shenzhen) have a combined population of nearly 80 million people and have ascended to high-income status, with per capita GDP of around US$22,000. Within Emerging Markets, these four cities enjoy GDP per capita that is exceeded only by Taiwan and South Korea.

 

 

 

 

23

 


Table of Contents

The investment approach for the Chinese Equity Portfolio is consistent with the other Portfolios offered by Harding, Loevner Funds, including our Emerging Markets (EM), International, and Global Equity Portfolios, each of which have been investing in China for over 20 years. We invest only in companies meeting, in our judgment, four criteria: they must possess a competitive advantage, generate sustainable superior long-term growth, have the financial strength to fund growth and withstand difficult conditions, and possess farsighted and dynamic management capable of exploiting these advantages for the benefit of shareholders. We identify investments based on the insights of our global industry specialists, with years of experience investing across multiple geographies and different stages of market maturity and product lifecycles, and our China specialists, who each bring formidable local expertise and knowledge. Our longer-term investment horizon should also provide a source of edge in the Chinese market, which even today remains heavily driven by retail investors with speculative inclinations, who often move as a herd, driving share prices far above or below fair value, creating (in the latter case) buying opportunities for fundamental investors like us.

Contemplating Investment Risks

One question that naturally arises when launching a China-focused Portfolio is how we approach the risks that accompany investing in this country. For Harding Loevner, the assessment of risk for any security, including Chinese securities, stems from our insistence on business quality as a condition of purchase. In not compromising our commitment to strong balance sheets in good times, we potentially lessen the risk of permanent losses relating to financial distress and can therefore place a higher degree of confidence in our estimates of long-term value. However, there are indeed some elements of company, quality, and industry specific to China that deserve focus. For example, relating to financial strength, some Chinese companies appear to be highly free-cash generative businesses, able to maintain robust cash balances despite their rapid growth—yet we have observed the occasional phenomenon of firms parking cash in opaque wealth management products issued by non-bank institutions.2 Another example of risk we evaluate while analyzing a company’s industry structure is whether sudden shifts in regulatory policy affect the bargaining power of buyers and suppliers.

The careful analysis of corporate governance is also of particular import as we scour the Chinese equity universe, especially for companies where government entities have significant ownership and presence in boards. In China, as elsewhere, our approach is focused on identifying signs of poor corporate governance that typically destroy shareholder value. If a potential problem surfaces, we contemplate and evaluate the risk of value destruction based on facts and circumstances. In such a large and diverse market, there are bound to be firms that are not up to the

 

 

2Part of the country’s shadow banking system, these products provide little transparency on underlying assets. Moreover, they are treated as off-balance sheet items and therefore, the institutions which manage them usually offer no implicit assumption of capital loss.

mark, but overall, the domestic Chinese equity market has been professionalized. A-share disclosure requirements are even more rigorous in certain areas than other major markets, including Hong Kong and the United States.3 Many Chinese businesses comport themselves in accordance with global audit standards, and all companies in our portfolio use a globally-recognized auditor.

Portfolio Highlights

The Chinese Equity Portfolio reflects the different dimensions of the country’s economic transition. Many of our portfolio companies target aspirational consumers, who increasingly expect high quality and sophisticated products and services, including in customized international travel (Trip.com Group), duty-free luxury goods (China Tourism Group), and online entertainment and social media (Tencent). However, China’s growth also rests on rising consumption across all segments of the population. Several holdings provide universal services, including Baidu in internet services, JD.com in online retail, and Foshan Haitian in branded soy sauce and condiments. Health Care also represents a potentially rich opportunity in this regard.

Portfolio Positioning (%) at April 30, 2021

 

Market

     Portfolio        Benchmark 1 
     

Mainland China + Hong Kong

     90.0        100.0  
     

Other Emerging Markets2

     6.3         
     

Cash

     3.7         

Sector

     Portfolio        Benchmark 1 
     

Comm Services

     14.1        14.1  
     

Consumer Discretionary

     29.1        25.1  
     

Consumer Staples

     5.6        9.2  
     

Energy

     0.0        1.3  
     

Financials

     4.0        15.7  
     

Health Care

     14.6        8.9  
     

Industrials

     18.2        7.5  
     

Information Technology

     9.3        8.3  
     

Materials

     0.0        4.5  
     

Real Estate

     0.0        3.4  
     

Utilities

     1.4        2.0  
     

Cash

     3.7         

1MSCI China All Shares Index; 2Includes countries listed in emerging markets excluding Mainland China and Hong Kong.

 

 

3For example, China requires both parent and consolidated financial statements, not just the consolidated statements unlike Hong Kong and the US. Additionally, mainland companies are required to furnish detailed cash flow statements quarterly for all companies whereas US and Hong Kong companies are not. The Shenzhen Stock Exchange also requires disclosing company visits to listed companies.

 

 

 

24

 

  


Table of Contents

Our largest overweight is in the Industrials sector, comprised of domestic leaders in China’s automation market. Over the past three decades, China has grown to become the “world’s factory,” with roughly 30% share of global manufacturing output today. It accounts for an even higher portion of world production in labor-intensive categories such as electronics and automobiles. China was able to establish manufacturing leads in these categories due in part to its sizable low-cost labor force, and also because entire supply chains with better logistical efficiency than elsewhere were created onshore thanks to supportive economic and regulatory policies, and substantial investment in what are now top-class transportation and broadband networks. However, the labor market has changed: wages have risen considerably, and that is set to continue as the number and proportion of working-age Chinese individuals peaked in 2015. Barring an unlikely opening to immigration, China will realize in the next few decades one of the largest drops in working age population of any country.

This prospect has spurred an increased emphasis on industrial automation. The density of robot use in China remains only 20% to 50% of levels in Japan, Korea, and Germany, which presents significant opportunities for Chinese automation companies to better meet the needs of a local market that had previously been underserved by global rivals. Shenzhen Inovance Technology is China’s largest producer of industrial automation control components. We think its customization strategy will actually be its biggest advantage over multinational rivals, as it funnels resources into developing products that better suit the needs of local industries like battery manufacturing that are much better represented in China than elsewhere. As the EV supply chain consolidates, strong secular EV demand combined with an expected shift to a more modular value chain, similar to that of smartphones, should help Inovance take further share of both EV powertrain components and the robots used to put the vehicles together. Another portfolio company, Haitian International, focuses on very large high-precision injection molding machines with better energy efficiency than competitors’ equipment. Its long-term growth will be propelled by capacity expansion and new product launches to meet increasing demand from domestic industries such as automobiles and home appliances.

It is worth noting that our Chinese Equity Portfolio has underweights in more cyclical areas of the market. The largest of these underweights is in Financials; we do not own any Chinese banks, as most do not meet our quality hurdle. Nor do we own stocks in the Materials and Energy sectors, where we prefer businesses favorably positioned at the lower end of global cost curves. We have yet to discover commodity-oriented companies in China meeting that criterion.

Top Ten Holdings by Weight at April 30, 2021

 

Company    Sector    Market    %
       
Alibaba    Cons Discretionary    Mainland China    10.9

Tencent

   Comm Services    Mainland China    7.1
       
China Tourism Group Duty Free    Cons Discretionary    Mainland China    4.5
       
WuXi Biologics    Health Care    Mainland China    4.2
       
AirTAC    Industrials    Taiwan    4.1
       
WuXi AppTec    Health Care    Mainland China    4.0
       
Techtronic Industries    Industrials    Hong Kong    3.5
       
Haitian International    Industrials    Mainland China    3.3
       
AIA Group    Financials    Hong Kong    3.1
       
Wuliangye Yibin    Cons Staples    Mainland China    2.9

 

 

 

 

Please read the separate disclosures page for important information, including the risks of investing in the Portfolio.

 

 

 

 

25

 


Table of Contents

Frontier Emerging Markets Portfolio

Institutional Investors: HLFMX & HLFFX | Individual Investors: HLMOX

 

 

Portfolio Management Team

 

LOGO

Pradipta Chakrabortty

Co-Lead Portfolio Manager

Babatunde Ojo, CFA

Co-Lead Portfolio Manager

Performance Summary

For the Frontier Emerging Markets Portfolio, the Institutional Class I gained 16.76%, the Institutional Class II gained 16.96% and the Advisor Class gained 16.44% (net of fees and expenses) in the six-month period ended April 30, 2021. The Portfolio’s benchmark the MSCI Frontier Emerging Markets Index, gained 10.22% (net of source taxes).

Market Review

Frontier Emerging Markets (FEM) rose, gaining 10% during the six-month period ended April 30, 2021. The period was turbulent, beginning with an escalation in the global pandemic towards the end of 2020, followed by vaccine breakthroughs that gave investors concrete hope for normalization in 2021, ultimately ending with a reversal of this rebound in January. Optimism over the clinical trial success of vaccines that initially lifted FEMs’ performance in late 2020 flagged as it became apparent just how much FEM countries (with a few exceptions, like the United Arab Emirates) would lag in their access to, and ability to roll out, the vaccines to their populations. These concerns were then amplified by new waves of COVID-19 infections and the emergence of even more contagious and deadly variants of the virus, prompting further mobility restrictions and business disruptions.

Companies that benefited from the pandemic and the abrupt shift to remote work and commerce, many of them within Information Technology (IT) and Health Care, far outpaced more cyclical sectors such as Financials and Consumer Discretionary, which nonetheless also finished in positive territory. Energy, however,

Fund Facts at April 30, 2021

 

 
       
Total Net Assets    $236.7M        
       
Sales Charge    None        
       
Number of Holdings    58        
       
Turnover (5 Yr. Avg.)    29%        
       
Dividend Policy    Annual        
 
  

Institutional Investors

  Individual Investors
   
   Inst Class I   Inst Class II   Investor Class
       
Ticker    HLFMX   HLFFX   HLMOX
       
CUSIP    412295867   412295735   412295859
       
Inception Date    5/27/2008   3/1/2017   12/31/2010
       
Minimum Investment1    $100,000   $10,000,000   $5,000
       
Net Expense Ratio2    1.68%3   1.35%4   2.00%5
       
Gross Expense Ratio2    1.68%   1.60%   2.12%

1Lower minimums available through certain brokerage firms. 2As of the most recent Prospectus and based on expenses for the fiscal year end. 3Harding Loevner has contractually agreed to cap the expense ratio at 1.75% through February 28, 2022. The expense ratio (without cap) is applicable to investors. 4The Net Expense Ratio is shown net of Harding Loevner’s contractual agreement through February 28, 2022. Harding Loevner’s contractual agreement caps the expense ratio at 1.35%. The Net Expense Ratio is applicable to investors. 5The Net Expense Ratio is shown net of Harding Loevner’s contractual agreement through February 28, 2022. Harding Loevner’s contractual agreement caps the expense ratio at 2.00%. The Net Expense Ratio is applicable to investors.

was the best-performing sector as global oil prices continued to climb amid continued production constraints imposed by OPEC+ and expectations of improved economic growth. Materials also outperformed, with mining companies buoyed by China’s surging demand for industrial metals as well as the Biden administration’s plans for a massive infrastructure spend. Industrials and Consumer Staples lagged, finishing down for the period.

Geographically, Europe performed best, led by Kazakhstan, thanks to Halyk Savings Bank, which reported strong earnings due to a strengthened competitive position within its market, a result of the company’s good asset quality, and its progress on several digital initiatives.

Latin America was among the period’s top performers due to a significant year-end rise in commodity prices. Colombia, an oil exporter, did especially well, as the rise in Brent crude price sparked a stock market rally and boosted the value of the Colombian peso against the US dollar.

The Middle East was the poorest-performing region, as the Lebanese market (which accounts for less than 1% of the index and was not represented in our portfolio) collapsed after prolonged political uncertainty and fiscal distress. The country has been grappling with a debt crisis for many years and eventually defaulted on its foreign debt obligations in March 2020.

 

 

 

26

 

  


Table of Contents

Performance (% total return)

 

 

                             
                                                
            For periods ended March 31, 2021                    For periods ended April 30, 2021         
     1      3      5      10      Since Inception*      1      3      5      10      Since Inception*  
      Year      Years      Years      Years      May-08      Mar-17      Dec-10      Year      Years      Years      Years      May-08      Mar-17      Dec-10  

Frontier EM Portfolio – Inst Class I

     44.23        -4.56        3.22        1.56        -0.87                          35.34        -2.89        2.95        1.50        -0.64                    

Frontier EM Portfolio – Inst Class II

     44.67        -4.30                               2.88                 35.93        -2.62                               3.58           

Frontier EM Portfolio – Investor Class

     43.72        -4.88        2.83        1.17                          0.72        35.06        -3.24        2.58        1.13                          1.00  

MSCI Frontier EM Index

     33.58        -4.29        2.46        1.45               1.70        0.75        26.27        -3.37        2.34        1.38               2.17        0.95  

Returns are annualized for periods greater than 1 year. *Inception of the Institutional Class I, May 27, 2008. Inception of the Institutional Class II, March 1, 2017. Inception of the Investor Class, December 31, 2010. Index performance prior to December 2, 2008 cannot be shown since it relies on back-filled data.

Performance data quoted represents past performance; past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance of the Portfolio may be lower or higher than the performance quoted. Performance data current to the most recent month end may be obtained by calling (877) 435-8105 or visiting www.hardingloevnerfunds.com.

 

Performance Attribution

By sector, strong stock selection in IT was a significant contributor. Among our top performers was UAE-based payment processor Network International. Although the company’s payment processing business for tourists visiting the UAE is still only about half what it was before COVID-19, its domestic UAE revenues have recovered to pre-pandemic levels and the company’s new CEO Nandan Mer voiced optimism about processing fee levels projected for 2021. EPAM (based in the US but with large operations in Belarus and other FEMs), which saw all of its customer segments grow in 2020, also contributed to our performance. Its life sciences and health care segment saw the biggest gain, but even the travel and consumer segment managed modest growth, with demand from its retail and e-commerce clients offsetting the slump in tourism-related businesses.

Strong stocks in Financials also helped, especially Halyk, Bancolombia, and Philippine-based Security Bank. At Bancolombia, strong cost control and better fee income from non-lending sources (such as debit and credit cards, insurance, trust, brokerage, and investment banking) offset still-rising loan provisioning. Excess capital leaves the bank well cushioned to absorb further credit losses. Similarly, at Security Bank, asset quality pressure remains, but the bank has imposed stricter underwriting standards that should protect it going forward. Additionally, its growth is supported by the Philippines government’s new infrastructure initiative.

Our stocks in Real Estate were among the top detractors, primarily due to the impact of fresh government-mandated lockdowns on Kuwait mall operator Mabanee. Stock selection in Energy also hurt relative performance. Most investors failed to see synergies arising from a decision by Colombian state-owned oil company Ecopetrol to acquire a controlling stake in state-owned electric utility ISA.

 

By region, Asian holdings benefited the portfolio, especially Vietnam-based steel producer Hoa Phat Group. Billet sales remained strong due to continued high levels of exports to China and other Asian markets. The Gulf States also contributed. UAE-based food and beverage producer Agthia rallied following its proposal to acquire several packaged foods companies with strong distribution in the UAE and neighboring Kuwait and Jordan.

Stock selection was weak in frontier Europe, particularly Polish video game maker CD Projekt. The company was hacked, delaying fixes for troubling bugs in its recent launch of Cyberpunk 2077.

Perspective and Outlook

Way back at the start of the 2010s, equity investors found much to like about FEMs. Young populations and rapidly modernizing societies seemed to offer the perfect nutrients for robust economic growth of the kind that was in short supply in many more developed parts of the world in the wake of the global financial crisis (GFC). And, for the next several years, FEM investors were not disappointed. From the third quarter of 2009 through third quarter 2014, frontier and small emerging markets roughly matched the performance of the US-led resurgence in developed markets (DMs), and they handily beat traditional emerging markets (EMs) by an average of seven percentage points a year. However, since FEMs’ September 2014 absolute peak there has been a complete reversal, with EMs outperforming FEMs by seven percentage points annually. FEMs’ underperformance of DMs has been even greater: an average of 10 percentage points a year.

Six years ago, it would have been hard to imagine the succession of crises about to batter FEMs emanating from without. First was the commodity price shock in the latter part of 2014. When the US shale boom led to oversupply in the global oil market and the Saudi-led oil cartel responded with a price war to maintain

 

 

 

 

27

 


Table of Contents

its market share, the price of crude plunged a staggering 68% between June 2014 and December 2015. This led to a deep economic recession in the oil-dependent countries—Colombia, Kazakhstan, Nigeria, and the Gulf states—which together accounted for 45% of the MSCI FEM Index at the start of the period.

A second major crisis occurred only a couple of years into recovery from the commodity shock. The triggers were the US Federal Reserve’s aggressive rate hikes and reduction of its financial asset purchase program, as well as escalating trade tensions between the US and China. This combination dealt another blow to FEM currencies, as nearly every floating currency fell against the US dollar.

A third set of challenges came from the churn in the FEM index itself. Over the past six years, MSCI made numerous changes to the index by promoting countries with large weights to EM status and eliminating them from the benchmark. The re-volving door stirred consternation among investors, many of whom came to view the FEM index as overly concentrated and a dumping ground for markets “not good enough” for EM status, contributing to record foreign investor outflows and compounding the fall in FEM stock prices.

Finally came the COVID-19 pandemic, and in particular, its impact on FEM banks. Financial institutions’ leveraged exposures to their domestic economies meant that many banks were placed in a difficult position as whole sectors shut down and governments suspended borrowers’ loan repayment obligations in a frantic attempt to keep businesses afloat. The damage to banks was felt across the frontier and emerging markets, and with Financials representing the largest (41% prior to the November Kuwait upgrade) share of any sector in the FEM index, the impact on the entire asset category was especially acute.

Given this dreary sequence of developments and more than a half-decade of underperformance, investors can be forgiven if they are tempted to give up on FEMs. But this could be “rearview-mirror investing” of the worst sort. We have always said that investing in FEMs requires patience and is only suited for those with a very long time-horizon. In the context of FEMs’ decades-long emergence, we believe the past six years should be viewed as a rutted detour, not a dead end, because the strong fundamentals identified at the start of the 2010s are, if anything, even stronger today. FEMs now account for a third of the world population, but only 6% of the global economy and only the tiniest fraction (less than 1%) of global equity capital markets. In other words, there is lots of room for these markets to begin to catch up. FEM governments are increasingly investing in social and physical infrastructure and implementing other sensible policies to support the growth of the private sector. These are among the reasons why the International Monetary Fund projects that frontier economies will continue to grow faster than their emerging and developed counterparts in the medium-term.

 

We expect strong economic growth will translate into corporate earnings growth and, ultimately, higher share prices. Some of the biggest improvement will take place among the highest-quality members of the Financials sector, whose superior financial strength compared to competitors and increased market share coming out of the COVID-19 crisis position them to benefit disproportionately from FEMs’ recovery and growth in the years ahead. We are encouraged by the records of the high-quality banks in our Portfolio (Halyk being a prime example), which corroborates our philosophy when it comes to investing in FEM banks. The thesis for us has always been simple. We only invest in high-quality banks capable of success across economic cycles. High-quality FEM institutions like Halyk have a number of advantages, including a strong balance sheet, a well-established distribution network, and funding costs that enable them to at least keep up with, if not perform better than, lower-quality banks in good economic times—and to significantly outperform and gain market share during periods of economic crisis, such as Halyk throughout the COVID-19 pandemic. A strong balance sheet and competent management invariably allow these high-quality companies to emerge from crises with a superior competitive position, which further solidifies their dominance. The fact that some of the most

Portfolio Positioning (%) at April 30, 2021

 

Region    Portfolio      Benchmark1  

Africa

     20.3        17.5  

Asia

     38.8        45.7  

Europe

     11.1        10.6  

Gulf States

     5.6        4.4  

Latin America

     13.5        21.4  

Middle East

     0.0        0.4  

Developed Markets Listed2

     8.4         

Cash

     2.3         
Sector    Portfolio      Benchmark1  

Communication Services

     6.6        8.8  

Consumer Discretionary

     5.4        1.0  

Consumer Staples

     15.7        7.0  

Energy

     3.9        5.0  

Financials

     33.3        33.2  

Health Care

     6.1        2.2  

Industrials

     4.5        11.6  

Information Technology

     12.5        4.9  

Materials

     5.1        8.8  

Real Estate

     4.6        14.0  

Utilities

     0.0        3.5  

Cash

     2.3         

1MSCI Frontier Emerging Markets Index; 2Includes frontier or small emerging markets companies listed in developed markets.

 

 

 

28

 

  


Table of Contents

well-run and innovative of these companies are now training their advantages on seizing the mantle of digital leadership in their marketplaces is another, potentially even more encouraging, factor in their favor.

Beyond banks, we see bright prospects for selected companies across a range of industries, including consumer, technology, hospitality, and health care.

Portfolio Highlights

MSCI upgraded Kuwait from frontier to EM status in November 2020, resulting in the country’s removal from the MSCI FEM Index. With Kuwait having accounted for 20%, its removal left the index even more concentrated in the Philippines, which saw its weight jump seven percentage points to one third of the benchmark at the end of 2020. Our portfolio has a single country risk limit of 20%, guaranteeing that we will continue to be significantly underweight in the Philippines. Though such country ceilings bring higher tracking error, the trade-off to reduce overall portfolio risk is worth making. Indeed, we see country diversification as being especially important in FEMs, as a means to manage individual political and currency risks that are typically higher than those in DMs.

This risk regime has been helpful to our strategy over the past few quarters, during which the Philippines market badly underperformed other FEMs, largely due to the havoc COVID-19 has wreaked on its economy. In this densely populated country of over 7,600 islands, the efficient flow of goods and services can be challenging in the best of times. The country’s GDP shrank 9.5% in 2020 as COVID-19 cases remained stubbornly high despite extensive quarantine measures taken by the government. Such unforeseeable calamities are precisely the reason we have country ceilings in place.

Nevertheless, the Philippines economy and its corporate earnings will rebound at some point. We have been using the sell-off as an opportunity to add to our Philippine positions at cheaper valuations. We added to our position in Jollibee Foods, the country’s dominant quick-service restaurant chain, whose 60% local market share is complemented by sizeable businesses in the US, China, and throughout Southeast Asia. Its shares became cheap after it posted record losses because many of its locations in the Philippines, and elsewhere, temporarily closed or faced declining traffic. Management has since taken sensible actions to lift Jollibee out of crisis and position it for faster recovery post-pandemic. By the last quarter of 2020, Jollibee was already back to generating profits.

We also added to our position in Wilcon Depot, the leading home improvement big-box retailer in the Philippines. Like Jollibee, the company was severely impacted by the country’s lockdowns, but we expect earnings to pick back up this year with a cyclical recovery in the construction sector and recent cuts in mortgage interest rates. Management is rolling out new stores across the provinces while enhancing its e-commerce platform and logistics capabilities.

Top Ten Holdings by Weight at April 30, 2021      
Company    Sector    Country      %  

Hoa Phat Group

   Materials      Vietnam        4.9  

Globant

   Info Technology      Argentina        4.8  

EPAM Systems

   Info Technology      US        4.7  

Safaricom

   Comm Services      Kenya        4.5  

Commercial International Bank

   Financials      Egypt        4.0  

SM Prime Holdings

   Real Estate      Philippines        3.8  

Banca Transilvania

   Financials      Romania        3.8  

Vietnam Dairy Products

   Cons Staples      Vietnam        3.5  

Universal Robina

   Cons Staples      Philippines        3.2  

Halyk Savings Bank

   Financials      Kazakhstan        3.0  
 

 

 

 

29

 


Table of Contents

Global Equity Research Portfolio

Institutional Investors: HLRGX

 

 

Portfolio Management Team

 

LOGO

Moon Surana, CFA

Portfolio Manager

Andrew West, CFA

Portfolio Manager

Performance Summary

For the Global Equity Research Portfolio, the Institutional Class gained 26.05% in the six-month period ended April 30, 2021. The Portfolio’s benchmark, the MSCI All Country World Index, gained 28.29% (net of source taxes).

Market Review

Global stock markets increased in the six months ended April 30, as the rollout of several successful COVID-19 vaccines led to economic rebounds across the globe. All sectors and regions finished in positive territory for the period.

Despite an escalation in the global pandemic, the closing months of 2020 saw a dramatic rise in global stock markets in response to startlingly positive final-stage vaccine clinical trial results. Accelerated approvals gave investors further hope for some return to normal commerce in 2021, even as COVID-19 hospitalizations in the US and Europe soared.

In March, the IMF raised its global GDP growth forecast for 2021 to 6.0%. In the US, among the world’s early leaders in vaccination rates, retail sales climbed to the strongest level on record and restaurant bookings and the number of airline passengers, while still below pre-COVID-19 levels, continued to improve. The Biden administration passed a colossal US$1.9 trillion relief package, the third such stimulus measure since the pandemic began, sending direct payments to millions of Americans and extending unemployment insurance. In China, electricity generation and rail cargo volume rose substantially year over year, but consumer spending remained subdued despite much of daily life having

Fund Facts at April 30, 2021

 

Total Net Assets   

$9.3M

Sales Charge   

None

Number of Holdings   

309

Turnover (5 Yr. Avg.)   

Dividend Policy   

Annual

 
    

Institutional Investors

 
Ticker   

HLRGX

 
CUSIP   

412295792

 
Inception Date   

12/19/2016

 
Minimum Investment1   

$100,000

 
Net Expense Ratio2   

0.80%3

 
Gross Expense Ratio2   

2.04%

1Lower minimums available through certain brokerage firms; 2The Expense Ratios are as of the most recent Prospectus and are based on expenses for the most recent fiscal year end. The Net Expense Ratio is shown net of Harding Loevner’s contractual agreement through February 28, 2022. 3Harding Loevner’s contractual agreement caps the net expense ratio at 0.80%. The Net Expense Ratio is applicable to investors.

returned to normal. The recovery in Europe was even more uneven, amid the emergence of new more virulent virus strains and problems with its vaccine rollout extending or renewing lockdowns.

Better economic data coupled with seemingly unlimited central bank liquidity led to rising management confidence and a surge in mergers and acquisition activity (M&A). Company CEOs were not the only market participants infected with high confidence; investors became more sanguine as well. The growth of special-purpose acquisition companies (SPACs), a “backdoor” means of taking private companies public with minimal regulatory scrutiny, accounted for an unprecedented 25% of all US deals. Retail trading activity also rose sharply, with a record number of people opening online accounts, and option volumes rising dramatically. The speculative frenzy extended to initial public offerings (IPOs) in many markets, with shares of newly listed companies (many of them still loss-making) being met by strong institutional and retail demand.

As homebuyers and corporate treasurers alike raced to lock in low interest rates, bond yields rose, with the yield on the US 10-year reaching pre-pandemic levels in March. Commodity prices, particularly those linked with industrial activity such as iron ore and copper, jumped higher, while Brent crude rose to over US$60 per barrel.

 

 

 

30

 

  


Table of Contents
Performance (% total return)                        
                                  
     For periods ended March 31, 2021      For periods ended April 30, 2021  
     
     Calendar      1      3      Since      Calendar      1      3      Since  
      YTD      Year      Years      Inception*      YTD      Year      Year      Inception*  

Global Equity Research Portfolio – Institutional Class

     3.84        56.86        12.97        15.86        7.33        46.76        14.44        16.42  

MSCI All Country World Index

     4.57        54.60        12.07        13.59        9.14        45.74        13.32        14.44  

Returns are annualized for periods greater than 1 year. *Inception date: December 19, 2016.

Performance data quoted represents past performance; past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance of the Portfolio may be lower or higher than the performance quoted. Performance data current to the most recent month end may be obtained by calling (877) 435-8105 or visiting www.hardingloevnerfunds.com.

 

On a sector basis, Energy was the strongest performer, surging in lockstep with rising oil prices. Financials also performed strongly, aided by a steepening yield curve and surprisingly low credit defaults. Information Technology (IT) also outperformed despite heightened scrutiny from regulators in Europe, China, and the US. Less-cyclical sectors—Consumer Staples, Health Care, and Utilities—all underperformed for the period.

Viewed by geography, the eurozone outperformed as some of the countries hit hardest by the virus, such as Spain and Italy, began to recover. Canada was a big outperformer, helped by its large weighting in banks and Energy. In Europe outside the eurozone, the UK posted strong returns on the back of its expansive vaccination program. Japan significantly underperformed as the country instated a new, more stringent state of emergency in response to another virus wave. Emerging Markets (EMs) also underperformed as weakness in China due to its regulatory crackdowns on tech companies off set strong performance in Taiwan and Russia, where the global semiconductor shortage and the rise in the oil price helped the former’s IT and latter’s Energy companies, respectively.

Performance Attribution

The Portfolio underperformed as stocks of high-quality growing companies lagged the broader market. On a sector basis, weak stocks in Materials and Consumer Discretionary detracted the most during the period. In the former, shares of US-based gas and chemical company Air Products, a steady business that benefits from durable long-term contracts with customers, lagged the broader market as more cyclical stocks outperformed. In Consumer Discretionary, shares of Japanese gas appliances manufacturer Rinnai lagged as the price of raw inputs such have copper have continued to increase. The Portfolio’s overweight in Consumer Staples also detracted.

Strong stocks in Financials helped, particularly US-based Signature Bank. The bank benefitted from expectations of higher interest rates, as well as resilient credit and deposit growth throughout the period. US-based SVB Financial Group also

contributed; the bank has benefited from rising expectations for increased economic growth and higher interest rates. The Portfolio’s underweight in Utilities and overweight in Industrials also helped.

Viewed by geography, weak stocks in Japan detracted the most from relative performance. Shares of Unicharm, a manufacturer of hygiene and household cleaning products, declined in response to rising input costs (like oil) and a market style shift to stocks of more-cyclical companies. Stocks in the US also detracted, particularly household and personal care products manufacturer Church & Dwight, which modestly declined over an ebbing of pandemic stay-at-home-related tailwinds and rising inflationary pressures. The Portfolio’s overweight in Japan and EMs, as well as its cash weight during this period of strong equity returns, also dragged on relative performance.

Strong stocks in EMs contributed, especially Taiwanese electronics manufacturer Hon Hai Precision. Share rose on the back of agreements with a pair of Chinese carmakers (Byton and Zhejiang Geely Holding Group) to help manufacture electric vehicles. Stocks in Europe outside the eurozone were also helpful, particularly UK-based aviation services company Signature Aviation. Shares increased as the company was a subject of a bidding war, before being ultimately acquired by Global Infrastructure Partners.

Perspective and Outlook

For the best part of our 30-year existence we’ve invested in high-quality, growing companies. That means we understand only too well the slings and arrows of performance that the market occasionally hurls the way of our quality-focused portfolio. During the recovery from the prolonged bear market that followed the bursting of the tech bubble in 2000 we suffered one of our worst periods of relative performance. As the profit slump—at the time the deepest since the 1930s—dragged into its second year, the US Federal Reserve led other central banks in further rounds of cutting interest rates in a bid to spur a stronger recovery.

 

 

 

 

31

 


Table of Contents

Investors who had fled the securities of barely profitable or highly leveraged companies reconsidered their cautious stance. Companies that were priced as if they might be the next round of bankruptcies suddenly looked like probable survivors, and their share prices leapt higher as investors adjusted to the upgraded prognosis. As cyclical and financial risks receded, stocks of the most stable companies, with ultra-conservative balance sheets and resilient profit margins, no longer transfixed investors, whose eyes wandered to less pristine corporate stories in hopes of a bargain. Over the ensuing 24 months, stocks of companies in the lowest tiers of quality, derided as junk, trounced by double digits those in the top tiers.

Judging by the performance of the different quintiles of the market sorted by our proprietary quality rankings, the shift in market style that coincided with the early November release of vaccine efficacy results matches in many ways the pattern of 2003-2004, and then some. Whereas two decades ago it took over two years for the bottom quintile to outpace the top by 19 percentage points, this latest go-round has produced a 23 percentage point gap between the same two groups in just five months, with a mostly monotonic progression of performance down the tiers of quality: the worse you were, the better you did.

The earlier episode drove home the perils of being too risk-averse! While wallowing in the depths of a deep recession and long bear market, we took comfort from the resilience and reasonable valuation of the best companies and—despite the obvious chasm in relative valuations that had opened up between stocks of the best and the next-best, let alone the worst—ultimately lost sight of the opportunity cost of future returns from what we did not own.

Over the last couple of years, as valuations for high-quality and rapidly growing companies have risen steadily, we’ve had to make difficult trade-offs in attempting to balance our commitment to these company attributes against the prices their shares fetch. Historically our debate has mostly concerned the trade-off between valuation and growth, but in this nascent recovery from the pandemic, the real issue—at least as far as relative performance goes—has turned out to be related more to trading off valuation against quality. Growth, in contrast to quality, has not been a particularly good predictive factor recently: only the fastest growth quintile (sorted by our growth metric) has seriously lagged the index, while the other 80% of the market matched or bettered the market’s average performance since the beginning of November.

Although both high quality and faster growth have become highly priced in recent times, we’ve made no attempt to predict either inflation or interest rates, despite recognizing how these inputs have an immediate impact on stock valuations through their influence on discount rates. Considering such attempts a fool’s errand, we prefer instead to focus on discerning

the enduring characteristics of companies themselves—characteristics that tend to persist across business cycles and political eras.

Our investment process is designed to give analysts the freedom, with few exceptions, to “go anywhere,” and locate the best businesses even in out-of-favor industries or countries. By keeping our opportunity set broad, always on the lookout for companies with strong competitive positions and secular growth tailwinds, the goal is to continuously furnish portfolio managers with sufficient raw materials from which to assemble diversified and differentiated portfolios of high-quality growing businesses. Our risk guidelines, including our portfolio limits on countries, sectors, and single companies, limit the worst of those inclinations, and we alter those limits only rarely and with great deliberation. In other words, don’t expect us to follow the current trend of some growth and momentum-oriented investors and to jettison our single holding limits to amass larger stakes in our favorite companies.

 

Portfolio Positioning (%) at April 30, 2021

 

  
Country/Region    Portfolio      Benchmark1  

Canada

     1.1        2.8  

Emerging Markets

     21.6        12.8  

Europe EMU

     13.2        8.6  

Europe ex-EMU

     10.0        7.9  

Frontier Markets2

     0.0         

Japan

     8.9        6.2  

Middle East

     0.0        0.2  

Pacific ex-Japan

     3.2        3.1  

US

     40.7        58.4  

Cash

     1.3         
Sector    Portfolio      Benchmark1  

Comm Services

     5.1        9.6  

Consumer Discretionary

     12.0        12.8  

Consumer Staples

     10.4        6.9  

Energy

     3.3        3.3  

Financials

     12.5        14.3  

Health Care

     15.2        11.3  

Industrials

     16.4        9.9  

Information Technology

     18.6        21.4  

Materials

     4.0        5.1  

Real Estate

     0.3        2.6  

Utilities

     0.9        2.8  

Cash

     1.3         

1MSCI All Country World Index; 2Includes countries with less-developed markets outside the index.

 

 

 

32

 

  


Table of Contents

Portfolio Highlights

The Global Equity Research Portfolio’s holdings are directly determined by analysts’ recommendations among Harding

Loevner’s collection of researched companies. During the six-month period ended April 30, 2021, our analysts recommended buying 57 companies and selling 41. Owing to recent analyst promotions and the ongoing expansion of our small cap coverage, the number of small companies in the Portfolio’s opportunity set has meaningfully increased in recent quarters. We ended the six-month period with 309 holdings in the Portfolio. In terms of our exposure to different sectors, our exposure to Financials, Energy, and IT increased the most while exposure to Industrials, Materials, and Health Care decreased. By region, our exposure to the US decreased the most while exposure to the eurozone increased the most.

Insofar as the relative valuations of many of our buy-rated small-cap stocks have resembled those of some of the most stretched areas of the broader market, this increase in small-cap holdings exacerbated our concerns about portfolio valuation risk and led us to implement new portfolio construction rules to manage it. Companies below US$5 billion in market cap are now allowed in the Portfolio only if they exhibit cheap relative valuations. We use our proprietary value rankings for this purpose, getting rid of the most-expensive half of our small cap companies among the pool of analyst-recommended stocks, while retaining or purchasing cheaper ones. We also made additions and trims to holdings as part of a new emphasis on reducing the valuation risk of our large-company holdings. The net impact of these changes was that the Portfolio now looks quite a bit less expensive than previously.

In Financials, we made net trims in the Portfolio, however strong performance increased the Portfolio weight. India-based HDFC Bank and HDFC Corp, and Indonesia-based Bank Rakyat were sold after the analyst downgraded them on valuation concerns. In Energy, we made net additions. Schlumberger, a US-based oil services company, was purchased as recovering energy prices made the analyst more optimistic about future performance. We also took the opportunity to add to Netherlands-based Vopak and Pakistan’s Oil & Gas Development Company after weakness.

Purchases and sales in IT were relatively balanced, but strong performance increased exposure. We made several new purchases including the Spanish travel technology company Amadeus and Argentina-based enterprise-level IT services leader Globant after our analysts upgraded these stocks. Amadeus has underperformed relative to the steep fall-off in on travel during the pandemic, but we expect the business to recover and believe the valuation is attractive enough to wait. In the case of Globant, we’ve increased our revenue growth forecast due to increasing demand from enterprises for digital transformation and used a recent pullback in the price of expensive tech stocks as an opportunity to act. We added to Hon Hai Precision, Cisco, US-based business and IT consulting firm Cognizant, and AAC Technologies, a Chinese manufacturer of miniaturized acoustic components, due to cheap relative valuation.

Top Ten Holdings by Weight at April 30, 2021   
Company    Sector   Country    %

UnitedHealth Group

   Health Care   US    1.2

Alphabet

   Comm Services   US    1.1

Cisco

   Info Technology   US    1.1

Cognizant Technology

   Info Technology   US    1.1

JPMorgan Chase

   Financials   US    1.1

Vertex Pharmaceuticals

   Health Care   US    1.0

AbbVie

   Health Care   US    1.0

Microsoft

   Info Technology   US    1.0

RGA

   Financials   US    1.0

MasterCard

   Info Technology   US    0.9

In Industrials, we made several sales and trims due to valuation concerns. These included the Japanese b2b e-commerce platform MonotaRO, Brazilian electric equipment manufacturer WEG, China-based automatic controls producer Shenzhen Inovance, and Honeywell, among others.

In Health Care, purchases and sales were mostly balanced, but poor performance saw the weight in the Portfolio decrease. We sold Switzerland-based Roche as our analyst expects more competition for its legacy oncology products from biosimilars. On the other hand, we purchased German lab equipment supplier Sartorius after a very strong year that saw its products play a key role in COVID-19 vaccine manufacturing. We also added several small cap companies: Swiss dental implant maker Straumann, UK monoclonal antibodies supplier Abiomed, and Penumbra, a US-based medical device company specializing in the treatment of strokes.

In the US our exposure decreased after several sales and trims. Kansas City Southern railroad and Tiffany were sold in the face of what appeared at the time to be imminent mergers (LVMH’s indeed completed its takeover of Tiffany in January). We also sold several companies, such as US-based industrial automation company Rockwell, due to valuation. First Republic Bank and Signature Bank were trimmed after strong outperformance left them looking relatively expensive.

Our exposure to the eurozone increased from the purchase of several smaller cap holdings. We also had some upgrades of existing companies and new companies added to our research universe.

Please read the separate disclosures page for important information, including the risks of investing in the Portfolio.

 

 

 

 

33

 


Table of Contents

International Equity Research Portfolio

Institutional Investors: HLIRX & HLMZX

 

 

Portfolio Management Team

 

LOGO

Moon Surana, CFA

Portfolio Manager

Andrew West, CFA

Portfolio Manager

Performance Summary

For the International Equity Research Portfolio, the Institutional Class gained 24.60% (net of fees and expenses) in the six-month period ended April 30, 2021. The Portfolio’s benchmark the MSCI All Country World ex-US Index, gained 27.41% (net of source taxes).

Market Review

International stock markets increased in the six months ended April 30, as the rollout of several successful COVID-19 vaccines led to economic rebounds across the globe. All sectors and regions finished in positive territory for the period.

The closing months of 2020 saw a dramatic rise in global stock markets, despite an escalation in the global pandemic. The starting gun for the run-up was Pfizer’s announcement of better-than-expected results for its COVID-19 vaccine trials and was followed in rapid fire by positive reports from Moderna, AstraZeneca, and Sinopharm. Accelerated approvals gave investors further hope for some return to normal commerce in 2021, even as COVID-19 hospitalizations in the US and Europe soared.

In 2021, signs of a global economic rebound multiplied as the vaccination efforts began in earnest. In March, the IMF raised its global GDP growth forecast for 2021 to 6.0%. In the US, among the world’s leaders in vaccination rates, retail sales climbed to the strongest level on record and restaurant bookings and the number of airline passengers, while still below pre-COVID-19 levels, continued to improve. The Biden administration passed a colossal US$1.9 trillion relief package, the third such stimulus measure since the pandemic began, sending direct payments to millions

Fund Facts at April 30, 2021

 

  
     
Total Net Assets   $15.4M     
     
Sales Charge   None     
     
Number of Holdings   223     
     
Turnover (5 Yr. Avg.)   46%     
     
Dividend Policy   Annual     
 
    Institutional Investors
   
    Inst Class    Inst Class Z
   
Ticker   HLIRX    HLMZX
   
CUSIP   412295826    412295743
   
Inception Date   12/17/2015   
   
Minimum Investment1   $100,000    $10,000,000
   
Net Expense Ratio2   0.75%3    0.75%3
   
Gross Expense Ratio2   1.40%    1.81%

1Lower minimums available through certain brokerage firms; 2As of the most relent Prospectus and based on expenses for the most recent fiscal year end. 3The Net Expense Ratio is shown net of Harding Loevner’s contractual agreement through February 28, 2022. Harding Loevner’s contractual agreement caps the net expense ratio at 0.75%. The Net Expense Ratio is applicable to investors.

of Americans and extending unemployment insurance. In China, electricity generation and rail cargo volume rose substantially year over year, but consumer spending remained subdued despite much of daily life having returned to normal. The recovery in Europe was even more uneven, amid the emergence of new more virulent virus strains and problems with its vaccine rollout extending or renewing lockdowns.

Better economic data coupled with seemingly unlimited central bank liquidity led to rising management confidence and a surge in mergers and acquisition activity (M&A). Company CEO’s were not the only market participants infected with high confidence; investors became more sanguine as well. The growth of special-purpose acquisition companies (SPACs), a “backdoor” means of taking private companies public with minimal regulatory scrutiny, accounted for an unprecedented 25% of all US deals. Retail trading activity also rose sharply, with a record number of people opening online accounts, and option volumes rising dramatically. The speculative frenzy extended to initial public offerings (IPOs) in many markets, with shares of newly listed companies (many of them still loss-making) being met by strong institutional and retail demand.

As homebuyers and corporate treasurers alike raced to lock in low interest rates, bond yields rose, with the yield on the US 10-year reaching pre-pandemic levels in March. Commodity prices, particularly those linked with industrial activity such as iron ore and copper, jumped higher, while Brent crude rose to over US$60 per barrel.

 

 

 

34

 

  


Table of Contents

Performance (% total return)

                       
     For periods ended March 31, 2021      For periods ended April 30, 2021
   
     1 Year    3 Years    5 Years    Since Inception*      1 Year    3 Years    5 Years    Since Inception*
                 

Intl Equity Research Portfolio – Institutional Class

   53.06    7.41    11.43      11.36      45.86    8.58    11.58    11.77
   

MSCI All Country World Ex-US Index

   49.41    6.51    9.76      9.27      42.98    6.98    9.83    9.71

Returns are annualized for periods greater than 1 year. *Inception date: December 17, 2015.

Performance data quoted represents past performance; past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance of the Portfolio may be lower or higher than the performance quoted. Performance data current to the most recent month end may be obtained by calling (877) 435-8105 or visiting www.hardingloevnerfunds.com.

 

On a sector basis, Energy was the strongest performer, surging in lockstep with rising oil prices. Financials also performed strongly, aided by a steepening yield curve and surprisingly low credit defaults. Shares of Information Technology (IT) companies also outpaced the index despite facing heightened scrutiny from regulators in Europe, China, and the US. Less-cyclical sectors—Consumer Staples, Health Care, and Utilities—all underperformed for the period.

Viewed by geography, the eurozone outperformed as some of the countries hit hardest by the virus, such as Spain and Italy, began to recover. Canada was a big outperformer, helped by its large weighting in banks and Energy. In Europe outside the eurozone, the UK posted strong returns on the back of its expansive vaccination program. Japan significantly underperformed as the country instated a new, more stringent state of emergency in response to another virus wave. Emerging Markets (EMs) also underperformed as weakness in China due to its regulatory crackdowns on tech companies offset strong performance in Taiwan and Russia, where the global semiconductor shortage and the rise in the oil price helped the former’s IT and latter’s Energy companies, respectively.

Performance Attribution

The Portfolio underperformed as stocks of high-quality, fast-growing companies lagged the broader market in the six-month period. The main detractors from relative returns were weak stocks in Materials and IT as well our overweight to the lagging Consumer Staples sector. Good stocks in Financials and Industrials along with the Portfolio’s underweight in Communications Services were helpful.

In Materials, German flavors-and-fragrance maker Symrise experienced slower organic sales growth in its beverage and sweets segments, and Danish industrial enzyme producer Novozymes reported an overall decline in organic growth. Another Danish company, natural food ingredients producer Chr. Hansen,

gave back some of the strong stock returns it generated in 2020. In IT, our underweight to Taiwan-based semiconductor manufacturer TSMC detracted; its stock soared on news that its rival Intel was experiencing production delays of its next-generation chip.

In Financials, our EM banking holdings, such as Bancolombia and Spain’s BBVA and Banco Santander, performed particularly well. With economic activity picking up, manufacturers everywhere are seeing more orders, but our Industrials holdings Techtronic Industries, a Hong Kong-based power-tool manufacturer, and Komatsu, a Japanese earth-moving equipment maker, were standouts. Steady investment by Techtronic in R&D has paid off in a series of successful products launches, while at Komatsu economic recovery has spurred a rebound in demand for its construction equipment.

Regionally, our holdings in Japan detracted most from relative returns. Shares of Unicharm, a Japanese manufacturer of hygiene and household cleaning products, declined in response to the rising costs of inputs (such as oil) and the market’s style shift favoring stocks of more-cyclical companies. Poor stocks in the eurozone also dragged on performance versus the index, notably Symrise.

Investments in Pacific ex-Japan were a large positive contributor to relative returns. Two banks in Singapore, DBS Group and OCBC Bank, outperformed after announcing better-than-expected fourth-quarter results. Both banks saw their loan books improving with fewer loans subject to a government-mandated loan-repayment moratorium. DBS has also seen growth in its wealth management business and credit card volume, leading to increased fee income.

Perspective and Outlook

For the best part of our 30-year existence we’ve invested in high-quality, growing companies. That means we understand only too well the slings and arrows of performance that the market

 

 

 

 

35

 


Table of Contents

occasionally hurls the way of our quality-focused portfolio. During the recovery from the prolonged bear market that followed the bursting of the tech bubble in 2000, we suffered one of our worst periods of relative performance. As the profit slump—at the time the deepest since the 1930s—dragged into its second year, the US Federal Reserve led other central banks in further rounds of cutting interest rates in a bid to spur a stronger recovery. Investors who had fled the securities of barely profitable or highly leveraged companies re-considered their cautious stance. Companies that were priced as if they might be the next round of bankruptcies suddenly looked like probable survivors, and their share prices leapt higher as investors adjusted to the upgraded prognosis. As cyclical and financial risks receded, stocks of the most stable companies, with ultra-conservative balance sheets and resilient profit margins, no longer transfixed investors, whose eyes wandered to less-pristine corporate stories in hopes of a bargain. Over the ensuing 24 months, stocks of companies in the lowest tiers of quality, derided as junk, trounced by double digits those in the top tiers.

Judging by the performance of the different quintiles of the market sorted by our proprietary quality rankings, the shift in market style that coincided with the early November release of vaccine efficacy results matches in many ways the pattern of 2003-2004, and then some. Whereas two decades ago it took over two years for the bottom quintile to outpace the top by thirteen percentage points, this latest go-round has produced a 21 percentage point gap between the same two groups in just five months, with a mostly monotonic progression of performance down the tiers of quality: the worse you were, the better you did.

The earlier episode drove home the perils of being too risk-averse! While wallowing in the depths of a deep recession and long bear market, we took comfort from the resilience and reasonable valuation of the best companies and—despite the obvious chasm in relative valuations that had opened up between stocks of the best and the next-best, let alone the worst—ultimately lost sight of the opportunity cost of future returns from what we did not own.

Over the last couple of years, as valuations for high-quality and rapidly growing companies have risen steadily, we’ve had to make difficult trade-offs in attempting to balance our commitment to these company attributes against the prices their shares fetch. Historically our debate has mostly concerned the trade-off between valuation and growth, but in this nascent recovery from the pandemic, the real issue—at least as far as relative performance goes—has turned out to be related more to trading off valuation against quality. Growth, in contrast to quality, has not been a particularly good predictive factor recently: only the fastest growth quintile (sorted by our growth metric) has seriously lagged the index, while the other 80% of the market matched or bettered the market’s average performance since the beginning of November.

Although both high quality and faster growth have become highly priced in recent times, we’ve made no attempt to predict either inflation or interest rates, despite recognizing how these inputs

have an immediate impact on stock valuations through their influence on discount rates. Considering such attempts a fool’s errand, we prefer instead to focus on discerning the enduring characteristics of companies themselves—characteristics that tend to persist across business cycles and political eras.

Our investment process is designed to give analysts the freedom, with few exceptions, to “go anywhere,” and locate the best businesses even in out-of-favor industries or countries. By keeping our opportunity set broad, always on the lookout for companies with strong competitive positions and secular growth tailwinds, the goal is to continuously furnish portfolio managers with sufficient raw materials from which to assemble diversified and differentiated portfolios of high-quality growing businesses. Our risk guidelines, including our portfolio limits on countries, sectors, and single companies, limit the worst of those inclinations, and we alter those limits only rarely and with great deliberation. In other words, don’t expect us to follow the current trend of some growth- and momentum-oriented investors and to jettison our single holding limits to amass larger stakes in our favorite companies.

 

Portfolio Positioning (%) at April 30, 2021

 

  

Country/Region

     Portfolio      Benchmark1
     

Canada

     1.6      6.8
     

Emerging Markets

     31.9      30.8
     

Europe EMU

     23.8      20.8
     

Europe ex-EMU

     20.4      19.0
     

Frontier Markets2

     0.0     
     

Japan

     15.3      14.8
     

Middle East

     0.0      0.4
     

Pacific ex-Japan

     6.1      7.4
     

Cash

     0.9     
     

Sector

     Portfolio      Benchmark1
     

Communication Services

     5.1      7.1
     

Consumer Discretionary

     12.2      13.5
     

Consumer Staples

     11.7      8.4
     

Energy

     4.1      4.4
     

Financials

     15.5      18.9
     

Health Care

     10.2      8.9
     

Industrials

     18.9      11.8
     

Information Technology

     13.4      12.8
     

Materials

     5.8      8.5
     

Real Estate

     0.7      2.6
     

Utilities

     1.5      3.1
     

Cash

     0.9     

1MSCI All Country World ex-US Index; 2Includes countries with less-developed markets outside the index.

 

 

 

36

 

  


Table of Contents

Portfolio Highlights

The International Equity Research Portfolio’s holdings are directly determined by analysts’ recommendations among Harding Loevner’s collection of researched companies. During the six-month period ended April 30, 2021, our analysts recommended buying 46 companies and selling 33. One of our associate analysts, Samuel Hosseini, was promoted to analyst, making his recommended purchases, including a number of small cap companies, newly eligible for the Portfolio. Owing to his and other recent promotions and the ongoing expansion of our small cap coverage, the number of international small companies in the Portfolio’s opportunity set has meaningfully increased in recent quarters. We ended the six-month period with 223 holdings in the Portfolio.

Our exposure to IT increased as a result of several new purchases, including a handful of small cap companies that newly became eligible for the strategy: Germany-based Nemetschek, a niche software supplier to the construction and media and entertainment industries; Taiwan-based semiconductor manufacturer Chipbond Technology; and China-based Sangfor Technologies, an enterprise cloud and network security vendor.

In Communication Services, we bought French market research and consulting firm Ipsos, Russian internet search firm Yandex, Cheil Worldwide (a South Korean marketing company affiliated with Samsung Electronics), and Scout24. The latter operates a leading real estate platform in Germany where agents, landlords, and individual sellers can list and display their properties for sale or rent. (Think of it as a mashup of Realtor.com, Apartments.com, and Craigslist.) The company is a dominant player with over 70% market share and enjoys a strong network effect.

In Health Care, we sold Grifols, a Spanish producer of blood plasma-based products, after the stock outperformed and the valuation looked less compelling to our analyst. We also sold Switzerland-based Roche, as our analyst expects more competition for its legacy oncology products from biosimilars. Analysts recommended Health Care purchases as well, including Italian-based diagnostics company DiaSorin. This business should continue to get a boost from strong demand for COVID-19-related tests.

By region, our exposure to the EMU increased the most during the six-month period while exposure to EMs shrank the most. Our increased investments in the EMU was largely the result of purchasing newly eligible smaller-cap holdings such as Nemetschek and Germany-based IT consultancy Bechtle. We also had some analyst upgrades of larger-cap companies, including Amadeus, an airline-reservation-management software business headquartered in Spain. The spread of effective vaccines has lifted both the outlook for a rebound in travel and Amadeus’s performance relative to the rest of IT. In EM, the number of upgrades and downgrades were balanced during the quarter, but we also made several trims due to high relative valuation,

Top Ten Holdings by Weight at April 30, 2021

 

  
Company    Sector   Country    %
       
Banco Santander    Financials   Spain    1.2
       
DBS Group    Financials   Singapore    1.2
       
OCBC Bank    Financials   Singapore    1.1
       
Brenntag    Industrials   Germany    1.1
       
Hakuhodo    Comm Services   Japan    1.1
       
Rio Tinto    Materials   UK    1.1
       
SE Banken    Financials   Sweden    1.1
       
Kubota    Industrials   Japan    1.0
       
BHP    Materials   Australia    1.0
       
BMW    Cons Discretionary   Germany    1.0

including Shenzhen Inovance, China’s largest producer of industrial automation control components and Naver, a South Korean social media company.

 

 

 

 

37

 


Table of Contents

Emerging Markets Research Portfolio

Institutional Investors: HLREX

 

 

Portfolio Management Team

 

LOGO

Moon Surana CFA

Portfolio Manager

Andrew West, CFA

Portfolio Manager

Performance Summary

For the Emerging Markets Equity Research Portfolio, the Institutional Class rose 22.17% (net of fees and expenses) in the six-month period ended April 30, 2021. The Portfolio’s benchmark, the MSCI Emerging + Frontier Markets Index, rose 22.87% (net of source taxes).

Market Review

Stocks in Emerging Markets (EMs) rallied in the first half of the fiscal year as news late in 2020 that vaccines had demonstrated exceptional levels of efficacy in final trials provided the catalyst for upgrading of global growth expectations and renewal of interest in those markets and industries worst hit by the COVID-19 pandemic. This, in turn, also boosted EM currencies, with the majority making significant gains versus a persistently weak dollar. The prospect of a stronger, broader-based recovery combined with China’s continued economic health and anticipation of the Biden administration’s massive infrastructure plans also propelled commodity and energy prices higher.

Latin America and emerging Europe were the strongest regions in the index, with EMs especially sensitive to commodity prices (e.g., Russia, South Africa, Brazil, Mexico) enjoying an especially strong bounce. Asia lagged mostly due to China, the largest EM, which was among the worst-performing markets despite keeping the virus under control and registering robust growth in both manufacturing and services. Concerns included tighter domestic borrowing conditions, and continuing tensions with the US. Antitrust actions against Chinese internet companies were another cause for concern. Although the fines levied by Chinese regulators

Fund Facts at April 30, 2021

 

   
Total Net Assets   $9.0M
   
Sales Charge   None
   
Number of Holdings   131
   
Turnover (5 Year Average)  
   
Dividend Policy   Annual
 
  Institutional Investors
 
  Institutional Class
   
Ticker   HLREX
   
CUSIP   412295776
   
Inception Date   12/19/2016
   
Minimum Investment1   $100,000
   
Net Expense Ratio2   1.15%3
   
Gross Expense Ratio2   2.40%

1Lower minimums available through certain brokerage firms; 2The Expense Ratios are are as of the most recent Prospectus and are based on expenses for the most recent fiscal year end. The Net Expense Ratio is shown net of Harding Loevner’s contractual agreement through February 28, 2022. 3Harding Loevner’s contractual agreement caps the Net Expense Ratio at 1.15%. The Net Expense Ratio is applicable to investors.

against Tencent, Baidu, and JD.com for their monopolistic behavior were miniscule, Alibaba received a much larger (US$3 billion) punishment in April albeit one still modest in relation to the size of the company. Across the strait, Taiwan was among the strongest EMs, led by semiconductor stocks, especially TSMC, buoyed by the current global chip shortage.

Materials was the best-performing sector with the rise in commodity prices and signs of broader global economic expansion. In Financials, EM bank stocks, which were among those most battered by the virus during much of 2020, rose sharply. Stocks of companies that have benefited the most from the pandemic environment in the Information Technology (IT) sector also continued to enjoy strong gains, led by semiconductor and other hardware manufacturers. Consumer Discretionary was the only sector in the index to decline, weighed down by index heavyweight Alibaba and its regulatory woes.

Performance Attribution

The Portfolio modestly underperformed the index in the first half of the fiscal year largely due to holdings in IT. Shares of Taiwanese mobile-device lens manufacturer Largan Precision were pressured by continued dampened demand due to the COVID-19 outbreak and the US sanctions on Chinese smartphone maker Huawei (a large customer). The impact of the global chip shortage on smartphone production has also been a concern. Another

 

 

 

38

 

  


Table of Contents

Performance (% total return)

 

     For periods ended March 31, 2021      For periods ended April 30, 2021  
   
      1 Year      3 Years      Since Inception*      1 Year      3 Years      Since Inception*  
   

Emerging Markets Research Portfolio – Institutional Class

     57.64        5.68        12.67        46.01        6.85        12.59  
   

MSCI Emerging + Frontier Markets Index

     58.09        6.35        13.21        48.55        7.42        13.59  

Returns are annualized for periods greater than 1 year. *Inception date: December 19, 2016.

Performance data quoted represents past performance; past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance of the Portfolio may be lower or higher than the performance quoted. Performance data current to the most recent month end may be obtained by calling (877) 435-8105 or visiting www.hardingloevnerfunds.com.

 

smartphone-component manufacturer, AAC Technologies, was a detractor on worries about rising competition in its core business making speakers and microphones. Relative returns were also hurt by the Portfolio’s underweights to IT and the top-performing Materials sector and an overweight in Consumer Staples.

Strong stocks in Consumer Staples and Consumer Discretionary were helpful, as was our underweight in the latter. In Staples, the re-mobilization of consumers in Latin America helped to revive the shares of two beverage businesses: Mexico’s FEMSA and Brazil’s Ambev. In Discretionary, duty-free retailer China Tourism Group Duty Free has enjoyed strong sales growth for its stores on the resort island of Hainan.

By geography, the key detractors included South Korean consumer-products company LG Household & Health Care, a Consumer Staples stock that lagged its local tech-heavy market. In India, shares of Hero Motocorp were hurt by concerns about the impact on automobile demand of the country’s intensifying new wave of COVID-19 cases. The Portfolio’s cash also dampened performance versus the index. Good stocks (FEMSA) and an overweight in Mexico were helpful.

Perspective and Outlook

Even as humanity continues its determined battle to contain the coronavirus, the longer-term threat facing our species from climate change is capturing increasing attention. The shift to electric vehicles (EVs) undeniably represents a growth opportunity for investors, particularly in China given its massive addressable market and the government’s new commitment to achieve carbon neutrality by 2060. In recent years, a plethora of companies have sought to capitalize on EV growth in China, including foreign automakers, who have laid out aggressive plans to build out EV capabilities, many through partnerships and joint ventures with Chinese firms. The existence of a growing market, however, by no means guarantees that EV makers themselves will be solid long-term investments.

A major challenge for EV makers is the specter of even more competitors entering the scene. The legacy, ICE-based automobile industry has enjoyed high barriers to entry due to the massive fixed capital required to produce engines, giving rise to enormous economies of scale, and the fact that trust based on brand reputation is important in consumer purchase decisions. The manufacturing process for EVs is significantly less complex and key components can be outsourced, presenting a low barrier to entry, as evidenced by the growing number of consumer and technology brands developing their own EVs, including Apple, and China’s internet giant Baidu and smartphone maker Xiaomi.

Amid the increasingly crowded field, achieving stand-alone dominance in EV manufacturing will likely require a company to achieve (and maintain) the automobile equivalent of the iPhone: a uniquely attractive combination of hardware, software, and aesthetics. Tesla has come as close as any company to hitting on all three, but whether its edge can prevail is an open question. The software domain would appear to provide the most scope for enduring differentiation, but we think a single EV-maker is less likely to win out here than a software/systems specialist, such as China’s Waymo or Baidu, that will partner with multiple manufacturers to achieve scale.

Tesla has enviable first-mover advantage in hardware and some aspects of software, with its revered user interface. We think it’s likely, however, that as the diversity of customer preferences are revealed, others will challenge Tesla for leadership in certain areas, be it drive-ability, style, or entertainment.

We can only speculate about how the EV industry will ultimately shake out. This lack of fundamental foresight makes us wary of predicting long-term winners among today’s brands, though we will continue to watch for companies that offer sufficient quality characteristics and durable growth potential. In the meantime, we have chosen to gain exposure to the EV growth opportunity through other ways very much aligned with our focus on quality-growth companies. In common with all other industries, our goal with respect to EVs is to invest in firms that offer predictable growth in their core businesses augmented by new growth opportunities

 

 

 

 

39

 


Table of Contents

exploitable by farsighted management. Indeed, we already have three EV-related holdings that fit this something-old/ something-new profile:

Hon Hai Precision

Hon Hai Precision, also known as Foxconn, is the world’s leading provider of electronics manufacturing services (EMS), producing such iconic products such as the iPhone, Kindle, and PlayStation. With its expertise in hardware and software, combined with its massive scale and powerful supply chain management, Hon Hai offers its clients unrivaled speed-to-market at large scale and low cost. Its assembly capabilities are augmented by its ability to make certain components, such as iPhone casings, itself, from scratch. This reduces Hon Hai’s costs and allows it to make larger investments in research and development than smaller competitors.

One of Hon Hai’s recent growth initiatives has been entering the automotive industry, specifically EVs. It already offers a thousand EV components and counts Tesla among its customers. Hon Hai is an attractive supplier to EV manufacturers because of its expertise in the production of light metal structural parts, its experience in managing complex supply chains, and its expertise in products that integrate software with hardware (Exhibit A: the iPhone). Hon Hai has already designed a chassis and mapped out a production schedule for new models for three brands in 2022. Hon Hai is also building its own hardware and software “open platform,” called MIH. With contributions from Hon Hai’s partners and third-party developers, MIH promises EV-makers a way to reduce up-front development costs, shorten vehicle development time, and facilitate mass production. MIH has already attracted customers such as Chinese automaker Geely, Italy’s Fiat, and US-based Fisker. While it is still early days in EV at Hon Hai, it is targeting a 10% share of what it estimates will be a US$500 billion market by 2025.

WEG

WEG is one of Brazil’s leading industrial companies, manufacturing a broad range of electrical equipment for the global market. WEG earns most of its revenues abroad and has been making considerable capital expenditures to bring the same high level of vertical integration it enjoys inside Brazil to its manufacturing plants in Mexico, China, and elsewhere. These investments should improve WEG’s cost structure, global market share, and margins. Against the backdrop of the rotten Brazilian economy of recent years, WEG has managed to grow consistently and generate high returns on capital.

WEG’s management has shown commendable foresight in steering the company towards growth opportunities in adjacent business. Its initiatives include developing electric traction systems for buses, trains, and other modes of transport. In 2019, WEG stepped up its activity in this segment

by becoming a key part of the VW-coordinated “e-Consortium” focused on developing electrical mobility in Brazil. WEG supplies the powertrain system globally for all VW electric delivery trucks and also makes the motors to power the air conditioning and other auxiliary systems. WEG’s initiatives in electric mobility are currently just a small part of the company’s many climate-related growth opportunities. The company has a larger wind and solar energy business, for example, that includes manufacturing solar energy kits for home use that have been gaining popularity in many markets.

Silergy

A new holding this period is Silergy, a Taiwan-listed manufacturer of power-management integrated circuits (PMIC) used in a range of electronics, from computer tablets to industrial robots. The company’s design and manufacturing platform is highly integrated: it operates its own chip fabrication (“fab”) facilities, which enables the company to stay a step ahead of competitors. The company has steadily increased its share of the PMIC market and enjoyed about

 

Portfolio Positioning (%) at April 30, 2021

 

  

Country/Region

     Portfolio        Benchmark 1 
     

Brazil

     5.1        4.6  
     

China + Hong Kong2

     37.2        37.2  
     

India

     4.6        9.3  
     

Mexico

     5.5        1.7  
     

Russia

     4.3        3.0  
     

South Africa

     1.0        3.7  
     

South Korea

     8.4        13.3  
     

Taiwan

     8.5        14.4  
     

Small Emerging Markets3

     18.5        11.9  
     

Frontier Markets4

     5.8        0.9  
     

Cash

     1.1         
     

Sector

     Portfolio        Benchmark 1 
     

Communication Services

     9.4        11.7  
     

Consumer Discretionary

     16.5        17.2  
     

Consumer Staples

     14.9        5.6  
     

Energy

     5.8        4.7  
     

Financials

     20.6        18.1  
     

Health Care

     6.2        4.7  
     

Industrials

     6.5        4.4  
     

Information Technology

     13.8        21.0  
     

Materials

     2.3        8.6  
     

Real Estate

     1.2        2.1  
     

Utilities

     1.7        1.9  
     

Cash

     1.1         

1MSCI Emerging + Frontier Markets Index; 2The Emerging Markets Research Portfolio’s end weight in China at April 30, 2021 is 37.2% and Hong Kong is 0.0%. The Benchmark does not include Hong Kong; 3Includes the remaining emerging markets which, individually, comprise less than 5% of the index; 4Includes emerging markets or frontier markets companies listed in developed markets.

 

 

 

40

 

  


Table of Contents

a 15% cumulative annual growth rate of revenues and profits over the last five years.

Silergy has been investing for years in R&D to produce PMICs suitable for automotive applications. The recent chip shortage has prompted automakers to expand their suppliers of PMICs, presenting an opportunity for Silergy to enter the highly competitive supply chain. Silergy’s automotive-related revenues will likely exceed 5% of sales in 2021 and could double next year. Management has been vocal about its attractive near-term opportunities in telematics, infotainment, advanced driver-assistance systems, and LED lighting.

Portfolio Highlights

The Emerging Markets Equity Research Portfolio’s holdings are directly determined by analysts’ recommendations among Harding Loevner’s collection of researched companies. During the six-month period ended April 30, 2021, our analysts recommended buying 23 companies and selling 17. One of our associate analysts, Samuel Hosseini, was promoted to analyst, making his recommended purchases, including a number of small cap companies, newly eligible for the Portfolio. Owing to this and other recent promotions and the ongoing expansion of our small cap coverage, the number of emerging markets small companies in the Portfolio’s opportunity set has increased in recent quarters. We ended the six-month period with 131 holdings in the Portfolio, an increase of eight from the beginning, driven by upgrades and new companies added to our research universe. In this period portfolio exposure to the Energy and Health Care sectors increased the most, while exposure to Consumer Staples fell the most. By country, exposure to China and small emerging markets increased the most while exposure to India fell.

Insofar as the relative valuations of many of our buy-rated small-cap stocks have resembled those of some of the most stretched areas of the broader market, we decided to implement new portfolio construction rules to manage this valuation risk. Companies below US$3 billion in market cap are now allowed in the Portfolio only if they exhibit cheap relative valuations. We use our proprietary value rankings for this purpose, getting rid of the most-expensive half of our small cap companies among the pool of analyst-recommended stocks, while retaining or purchasing cheaper ones. We also made additions and trims to holdings as part of a new emphasis on reducing the valuation risk of our large-company holdings. The net impact of these changes was that the Portfolio now looks quite a bit less expensive than previously.

In Energy, we added to several companies that had cheap valuations and improving prospects due to rising oil prices. These included Russia-based oil giant Lukoil, Colombian integrated oil and gas company Ecopetrol, and Romanian natural gas producer Romgaz.

In Health Care, we purchased Mouwasat Medical Services, which owns a portfolio of high-quality hospitals in Saudi Arabia that

Top Ten Holdings by Weight at April 30, 2021

 

 

Company

 

 

Sector

 

 

Country

 

   

 

%

 

 

 

       
Walmart de México   Cons Staples   Mexico     2.1  
       
Midea Group   Cons Discretionary   China     2.0  
       
CSPC Pharmaceutical Group   Health Care   China     2.0  
       
FEMSA   Cons Staples   Mexico     2.0  
       
Samsung Electronics   Info Technology   South Korea     2.0  
       
Gree Electric   Cons Discretionary   China     2.0  
       
Hon Hai Precision   Info Technology   Taiwan     2.0  
       
TSMC   Info Technology   Taiwan     1.9  
       
NCSoft   Comm Services   South Korea     1.9  
       
Ping An Insurance   Financials   China     1.8  

are the preferred health care option for many of the country’s largest employers. The company has been gaining market share from overcrowded and inefficient government hospitals and is well positioned to benefit from Saudi health care spending that is projected to grow from US$46 billion in 2019 to US$160 billion by 2031. We also added to China’s CSPC Pharmaceutical Group, whose shares look attractively valued relative to those of other Chinese companies. CSPC manufactures and distributes pharmaceutical products and invests heavily in R&D, supporting a strong pipeline of innovative treatments.

We reduced exposure to Consumer Staples, including trimming Godrej, an Indian personal and household care company, and Amorepacific, a South Korean cosmetics company, due to relatively expensive valuations.

We increased our exposure to China through additions to CSPC Pharmaceutical, Gree Electric, Ping An Insurance, home-appliance manufacturer Midea, online job-search platform 51job, and AAC Technologies. Our analysts’ fair value estimates indicated that all looked cheap on relative valuation. We also made several new purchases in China including Baidu, China’s leading internet search operator, after shares fells along with the general sell-off in Chinese IT sparked by increased regulatory pressures. Given Baidu’s business fundamentals remained strong, our analyst saw this as a good chance to buy at a reasonable valuation. We also made purchases of several new Chinese companies that were added to our coverage: YonYou Network Technology, a software developer and distributor; Country Garden Services, a property management company; Sangfor, a cybersecurity software and cloud computing provider; and Hefei Meyer, an optical inspection and sorting systems maker. The latter is one of the first companies recommended by Lee Gao, a new China analyst hired at the end of 2020 who is helping expand our coverage with more companies that meet our high-quality, durable-growth criteria.

The Portfolio’s weight in India fell due to a number of sales and trims due to valuation concerns, including HDFC Bank and its parent HDFC Corp. We also trimmed Godrej, Asian Paints, and IT consulting firm Tata Consultancy.

 

 

 

 

41

 


Table of Contents

Disclosures

The Portfolios invest in foreign securities, which will involve greater volatility and political, economic, and currency risks and differences in accounting methods. They also invest in emerging markets, which involve unique risks, such as exposure to economies less diverse and mature than the US or other more established foreign markets. Economic and political instability may cause larger price changes in emerging markets securities than other foreign securities.

Investments in small- and mid-cap companies involve additional risks such as limited liquidity and greater volatility.

Diversification does not guarantee a profit or prevent a loss in a declining market.

Long-term earnings growth and earnings per share growth are not a forecast of the Portfolios’ future performance.

The value of securities may fluctuate in response to various factors including, but not limited to, public health risks; these may be magnified if conditions and events adversely impact the global economy.

Companies held in the Portfolios during the first half of the fiscal year appear in bold type; only the first reference to a particular holding appears in bold. The Portfolios are actively managed; therefore holdings shown may not be current. Portfolio holdings and top ten holdings should not be considered recommendations to buy or sell any security. Please refer to the Portfolios of Investments in this report for complete Portfolio holdings. Current and future Portfolio holdings are subject to risk.

While the Portfolios have no sales charge, management fees and other expenses still apply. Please see the Prospectus for further details.

Sector & Geographic Exposure data is sourced from: Northern Trust, Harding Loevner Funds Portfolios, and MSCI Barra.

Expense Ratios: Differences may exist between the commentary data and similar information reported in the financial statements due to timing differences. Unless otherwise stated, the expense ratios presented are shown as of the most recent Prospectus date, February 28, 2021.

Five year average turnover data is calculated using a simple average of annual turnover figures for the past five fiscal years. These annual turnover figures utilize purchase, sales, and market value data which is not reflective of adjustments required pursuant to Generally Accepted Accounting Principles (GAAP). Accordingly, differences may exist between this data and similar information reported in the financial statements.

Quasar Distributors, LLC, Distributor.

Index Definitions

 

 

The MSCI All Country World Index is a free float-adjusted market capitalization index that is designed to measure equity market performance in the global developed and emerging markets. The Index consists of 49 developed and emerging market countries. Net dividends reinvested.

The MSCI All Country World ex-US Index is a free float-adjusted market capitalization index that is designed to measure equity market performance in the global developed and emerging markets, excluding the US. The Index consists of 48 developed and emerging market countries. Net dividends reinvested.

The MSCI All Country World ex-US Small Cap Index is a free-float market capitalization index that is designed to measure small cap developed and emerging market equity performance. The Index consists of 48 developed and emerging markets countries and targets companies within a market

capitalization range of USD 94-14,460 million (as of March 31, 2020) in terms of the companies’ full market capitalization. Net dividends reinvested.

The MSCI Emerging Markets Index is a free float-adjusted market capitalization index that is designed to measure equity market performance in the global emerging markets. The Index consists of 26 emerging market countries. Net dividends reinvested.

The MSCI China All Shares Index is a free float-adjusted market capitalization index that is designed to reflect an opportunity set capturing large and mid-cap China share classes listed in Hong Kong, Shanghai, Shenzhen, and outside of China.

The MSCI Emerging + Frontier Markets Index is a free float-adjusted market capitalization index that is designed to measure equity market performance in the global emerging markets and frontier markets. The Index consists of 26 emerging markets countries and 28 frontier markets countries. Net dividends reinvested.

The MSCI Frontier Emerging Markets Index is a free float-adjusted market capitalization index designed to measure equity market performance in all countries from the MSCI Frontier Markets Index and the lower size spectrum of the MSCI Emerging Markets Index. The Index consists of 28 frontier markets and 6 emerging markets. Net dividends reinvested.

The S&P 500 Index is an unmanaged index commonly used to measure performance of US stocks.

You cannot invest directly in these Indexes.

Term Definitions

 

 

Alpha is a measure a measure of risk-adjusted return.

Basis points are a common measurement used chiefly for interest rates and other percentages in finance. A basis point is one hundredth of one percent.

Dividend yield is the annual dividends per share divided by current price per share, expressed as a percent.

Economies of scale is the cost advantage that arises with increased output of a product.

Gross Domestic Product (GDP) is the monetary value of all finished goods and services produced within a country’s borders in a specific time period (usually calculated on an annual basis).

Market Capitalization is the total dollar market value of all of a company’s outstanding shares.

Return on Capital (ROC) is a calculation used to assess a company’s efficiency at allocating the capital under its control to profitable investments.

Sharpe Ratio is the return over the risk-free rate per unit of risk.

Tracking Error is a measure of how closely a portfolio follows the index to which it is benchmarked.

Turnover is calculated by dividing the lesser of Purchases or Sales by Average Capital.

 

 

 

42

 

  


Table of Contents

LOGO

 

Global Equity Portfolio    Institutional Emerging Markets Portfolio    Global Equity Research Portfolio
International Equity Portfolio    Emerging Markets Portfolio    International Equity Research Portfolio
International Small Companies Portfolio    Frontier Emerging Markets Portfolio    Emerging Markets Research Portfolio
Chinese Equity Portfolio      


Table of Contents

Harding, Loevner Funds, Inc.

 

Table of Contents

 

 

Expense Example

       2

Portfolio of Investments

       4

Global Equity Portfolio

       4

International Equity Portfolio

       7

International Small Companies Portfolio

       10

Institutional Emerging Markets Portfolio

       13

Emerging Markets Portfolio

       16

Frontier Emerging Markets Portfolio

       19

Global Equity Research Portfolio

       22

International Equity Research Portfolio

       30

Emerging Markets Research Portfolio

       36

Chinese Equity Portfolio

       41

Statements of Assets and Liabilities

       43

Statements of Operations

       46

Statements of Changes in Net Assets

       48

Financial Highlights

       52

Notes to Financial Statements

       56

Approval of Investment Advisory Agreement

       70

Results of Special Meeting of Shareholders

       72

Liquidity Risk Management Program

       73

Supplemental Information

       74

Directors and Principal Officers

       75

For use only when preceded or accompanied by a prospectus. Read the prospectus carefully before you invest or send money.    


Table of Contents

Harding, Loevner Funds, Inc.

 

Expense Example

April 30, 2021 (unaudited)

 

As a shareholder of a Harding Loevner Portfolio, you incur ongoing costs, including management fees; to the extent applicable, distribution (12b-1) fees and/or shareholder services fees; and other fund expenses. The following examples are intended to help you understand your ongoing costs (in dollars and cents) of investing in a Portfolio and to compare these costs with the ongoing costs of investing in other mutual funds.

The examples are based on an investment of $1,000 invested at the beginning of a six month period and held through the period ended April 30, 2021.

Actual Expenses

The first line under each Portfolio in the table below provides information about actual account values and actual expenses. You may use the information in this line, together with the amount you invested, to estimate the expenses that you paid over the period. Simply divide your account value by $1,000 (for example, an $8,600 account value divided by $1,000 = 8.6), then multiply the result by the number in the first line for your Portfolio under the heading entitled “Expenses Paid During Period” to estimate the expenses you paid on your account during this period.

Hypothetical Example for Comparison Purposes

The second line under each Portfolio in the table below provides information about hypothetical account values and hypothetical expenses based on the Portfolio’s actual expense ratio and an assumed rate of return of 5% per year before expenses, which is not the Portfolio’s actual return. The hypothetical account values and expenses may not be used to estimate the actual ending account balance or expenses you paid for the period. You may use this information to compare the ongoing costs of investing in your Portfolio and other funds. To do so, compare this 5% hypothetical example with the 5% hypothetical examples that appear in the shareholder reports of the other funds. Please note that the expenses shown in the table are meant to highlight your ongoing costs only. Therefore, the second line under each Portfolio in the table is useful in comparing ongoing costs only, and will not help you determine the relative total costs of owning different funds.

 

Portfolio     

Beginning
Account Value
November 1,

2020

     Ending
Account Value
April 30, 2021
     Annualized
Expense Ratio
  

Expenses Paid

During Period*
(November 1, 2020 to
April 30, 2021)

Global Equity Portfolio — Institutional Class

                         

Actual

         $1,000.00          $1,240.50          0.89 %        $4.94

Hypothetical (5% annual return before expenses)

         1,000.00          1,020.38          0.89        4.46

Global Equity Portfolio — Institutional Class Z

                         

Actual

         1,000.00          1,240.80          0.80        4.44

Hypothetical (5% annual return before expenses)

         1,000.00          1,020.83          0.80        4.01

Global Equity Portfolio — Advisor Class

                         

Actual

         1,000.00          1,239.00          1.10        6.11

Hypothetical (5% annual return before expenses)

         1,000.00          1,019.34          1.10        5.51

International Equity Portfolio — Institutional Class

                         

Actual

         1,000.00          1,242.60          0.80        4.45

Hypothetical (5% annual return before expenses)

         1,000.00          1,020.83          0.80        4.01

International Equity Portfolio — Institutional Class Z

                         

Actual

         1,000.00          1,243.00          0.72        4.00

Hypothetical (5% annual return before expenses)

         1,000.00          1,021.22          0.72        3.61

International Equity Portfolio — Investor Class

                         

Actual

         1,000.00          1,241.10          1.12        6.22

Hypothetical (5% annual return before expenses)

         1,000.00          1,019.24          1.12        5.61

International Small Companies Portfolio — Institutional Class

                         

Actual

         1,000.00          1,222.90          1.15        6.34

Hypothetical (5% annual return before expenses)

         1,000.00          1,019.09          1.15        5.76

* Expenses are calculated using each Portfolio’s annualized expense ratio (as disclosed in the table), multiplied by the average account value for the period, multiplied by the number of days in the period (181 days), and divided by the number of days in the year (365 days).

 

2


Table of Contents

Harding, Loevner Funds, Inc.

 

Expense Example (continued)

April 30, 2021 (unaudited)

 

 

Portfolio     

Beginning
Account Value
November 1,

2020

     Ending
Account Value
April 30, 2021
     Annualized
Expense Ratio
  

Expenses Paid

During Period*

(November 1, 2020 to
April 30, 2021)

International Small Companies Portfolio — Investor Class

                         

Actual

         $1,000.00          $1,221.60          1.40 %        $7.71

Hypothetical (5% annual return before expenses)

         1,000.00          1,017.85          1.40        7.00

Institutional Emerging Markets Portfolio — Institutional Class

                         

Actual

         1,000.00          1,250.50          1.17        6.53

Hypothetical (5% annual return before expenses)

         1,000.00          1,018.99          1.17        5.86

Institutional Emerging Markets Portfolio — Institutional Class Z

                         

Actual

         1,000.00          1,251.20          1.11        6.20

Hypothetical (5% annual return before expenses)

         1,000.00          1,019.29          1.11        5.56

Emerging Markets Portfolio — Advisor Class

                         

Actual

         1,000.00          1,249.70          1.32        7.36

Hypothetical (5% annual return before expenses)

         1,000.00          1,018.25          1.32        6.61

Frontier Emerging Markets Portfolio — Institutional Class I

                         

Actual

         1,000.00          1,167.60          1.60        8.60

Hypothetical (5% annual return before expenses)

         1,000.00          1,016.86          1.60        8.00

Frontier Emerging Markets Portfolio — Institutional Class II

                         

Actual

         1,000.00          1,169.60          1.35        7.26

Hypothetical (5% annual return before expenses)

         1,000.00          1,018.10          1.35        6.76

Frontier Emerging Markets Portfolio — Investor Class

                         

Actual

         1,000.00          1,164.40          2.00        10.73

Hypothetical (5% annual return before expenses)

         1,000.00          1,014.88          2.00        9.99

Global Equity Research Portfolio — Institutional Class

                         

Actual

         1,000.00          1,260.50          0.80        4.48

Hypothetical (5% annual return before expenses)

         1,000.00          1,020.83          0.80        4.01

International Equity Research Portfolio — Institutional Class

                         

Actual

         1,000.00          1,246.00          0.75        4.18

Hypothetical (5% annual return before expenses)

         1,000.00          1,021.08          0.75        3.76

Emerging Markets Research Portfolio — Institutional Class

                         

Actual

         1,000.00          1,221.70          1.15        6.33

Hypothetical (5% annual return before expenses)

         1,000.00          1,019.09          1.15        5.76

Chinese Equity Portfolio — Institutional Class

                         

Actual

         1,000.00          1,072.00          1.15        4.41

Hypothetical (5% annual return before expenses)

         1,000.00          1,019.08          1.15        5.76

* Expenses are calculated using each Portfolio’s annualized expense ratio (as disclosed in the table), multiplied by the average account value for the period, multiplied by the number of days in the period (181 days), and divided by the number of days in the year (365 days).

 

3


Table of Contents

Harding, Loevner Funds, Inc.

 

Global Equity Portfolio

Portfolio of Investments

April 30, 2021 (unaudited)

 

 

     Shares      Value  
COMMON STOCKS - 98.6%              

Australia - 0.5%

     

Xero Ltd. (Software & Services)*†

     84,288        $9,135,784  

Brazil - 1.0%

     

B3 SA - Brasil Bolsa Balcao (Diversified Financials)

     1,761,200        16,697,527  

China - 8.5%

     

Alibaba Group Holding Ltd. (Retailing)*†

     628,520        18,156,412  

Country Garden Services Holdings Co., Ltd. (Commercial & Professional Services)†

     2,605,000        27,223,519  

ENN Energy Holdings Ltd. (Utilities)†

     516,000        8,784,984  

NetEase Inc. (Media & Entertainment)†

     871,900        19,503,107  

Tencent Holdings Ltd. (Media & Entertainment)†

     317,300        25,375,452  

Trip.com Group Ltd. (Retailing)*

     232,052        9,195,148  

Trip.com Group Ltd. - ADR (Retailing)*

     232,052        9,068,592  

Wuxi Biologics Cayman Inc. (Pharmaceuticals, Biotechnology & Life Sciences)*^†

     2,030,000        28,474,400  
        145,781,614  

Denmark - 0.8%

     

Genmab A/S (Pharmaceuticals, Biotechnology & Life Sciences)*†

     37,319        13,767,998  

Finland - 0.9%

     

Neste OYJ (Energy)†

     260,476        15,804,198  

France - 2.2%

     

L’Oreal SA (Household & Personal Products)†

     42,109        17,293,762  

Schneider Electric SE (Capital Goods)†

     123,526        19,749,570  
        37,043,332  

Germany - 1.3%

     

TeamViewer AG (Software & Services)*^†

     463,308        22,031,586  

Hong Kong - 1.2%

     

AIA Group Ltd. (Insurance)†

     1,604,405        20,395,789  

India - 1.2%

     

HDFC Bank Ltd. - ADR (Banks)*

     304,039        21,367,861  

Indonesia - 1.1%

     

Bank Central Asia Tbk PT (Banks)†

     8,191,454        18,122,944  

 

     Shares      Value  
COMMON STOCKS - 98.6%     (continued)         

Japan - 3.2%

     

Chugai Pharmaceutical Co., Ltd. (Pharmaceuticals, Biotechnology & Life Sciences)†

     340,300        $12,786,203  

Keyence Corp. (Technology Hardware &
Equipment)†

     30,204        14,526,437  

MISUMI Group Inc. (Capital Goods)†

     224,000        6,315,366  

Sysmex Corp. (Health Care Equipment & Services)†

     202,565        20,257,550  
        53,885,556  

Netherlands - 2.4%

     

Adyen NV (Software & Services)*^†

     7,439        18,266,614  

ASML Holding NV, Reg S (Semiconductors & Semiconductor Equipment)

     34,809        22,559,713  
        40,826,327  

Poland - 0.9%

     

CD Projekt SA (Media & Entertainment)*†

     323,001        14,815,516  

Singapore - 1.2%

     

DBS Group Holdings Ltd. (Banks)†

     892,683        20,076,044  

South Korea - 1.1%

     

Samsung Electronics Co., Ltd. - GDR, Reg S (Technology Hardware & Equipment)†

     10,623        19,329,278  

Sweden - 1.6%

     

Atlas Copco AB, Class A (Capital Goods)†

     290,406        17,604,235  

Epiroc AB, Class A (Capital Goods)†

     427,261        9,263,245  
        26,867,480  

Switzerland - 2.9%

     

Alcon Inc. (Health Care Equipment & Services)*

     261,238        19,705,183  

Roche Holding AG, Genusschein (Pharmaceuticals, Biotechnology & Life Sciences)†

     59,583        19,412,708  

VAT Group AG (Capital Goods)^†

     36,954        10,584,067  
        49,701,958  

Taiwan - 1.1%

     

Taiwan Semiconductor Manufacturing Co., Ltd. (Semiconductors & Semiconductor Equipment)†

     569,000        12,330,122  
 

 

See Notes to Financial Statements

 

4


Table of Contents

Harding, Loevner Funds, Inc.

 

Global Equity Portfolio

Portfolio of Investments (continued)

April 30, 2021 (unaudited)

 

 

     Shares      Value  
COMMON STOCKS - 98.6%    (continued)              

Taiwan - 1.1%    (continued)

     

Taiwan Semiconductor Manufacturing Co., Ltd. - Sponsored ADR (Semiconductors & Semiconductor Equipment)

     61,071        $7,129,428  
        19,459,550  

United Kingdom - 1.6%

     

Abcam plc (Pharmaceuticals, Biotechnology & Life Sciences)*†

     962,912        20,396,383  

Spirax-Sarco Engineering plc (Capital Goods)†

     47,680        7,778,456  
        28,174,839  

United States - 63.9%

     

Accenture plc, Class A (Software & Services)

     62,697        18,180,249  

Adobe Inc. (Software & Services)*

     62,247        31,642,640  

Align Technology Inc. (Health Care Equipment & Services)*

     50,552        30,105,233  

Alphabet Inc., Class A (Media & Entertainment)*

     25,812        60,748,542  

Amazon.com Inc. (Retailing)*

     15,847        54,948,205  

AMETEK Inc. (Capital Goods)

     129,235        17,437,678  

Apple Inc. (Technology Hardware & Equipment)

     133,698        17,575,939  

CME Group Inc. (Diversified Financials)

     201,343        40,669,273  

Danaher Corp. (Health Care Equipment & Services)

     63,424        16,105,891  

Deere & Co. (Capital Goods)

     126,536        46,925,876  

eBay Inc. (Retailing)

     420,402        23,454,228  

Edwards Lifesciences Corp. (Health Care Equipment & Services)*

     181,171        17,305,454  

EPAM Systems Inc. (Software & Services)*

     56,088        25,674,282  

Estee Lauder Cos., Inc., Class A (Household & Personal Products)

     64,150        20,130,270  

Etsy Inc. (Retailing)*

     92,385        18,365,214  

Facebook Inc., Class A (Media & Entertainment)*

     135,705        44,114,981  

First Republic Bank (Banks)

     346,495        63,491,744  

Illumina Inc. (Pharmaceuticals, Biotechnology & Life Sciences)*

     115,740        45,467,300  

Intuitive Surgical Inc. (Health Care Equipment & Services)*

     19,688        17,030,120  

IQVIA Holdings Inc. (Pharmaceuticals, Biotechnology & Life Sciences)*

     67,749        15,900,013  
     Shares      Value  
COMMON STOCKS - 98.6% (continued)         

United States - 63.9%    (continued)

     

Mastercard Inc., Class A (Software & Services)

     41,660        $15,916,620  

Microsoft Corp. (Software & Services)

     139,857        35,269,138  

NIKE Inc., Class B (Consumer Durables & Apparel)

     239,993        31,827,872  

NVIDIA Corp. (Semiconductors & Semiconductor Equipment)

     35,051        21,043,919  

PayPal Holdings Inc. (Software & Services)*

     170,618        44,751,395  

Roper Technologies Inc. (Capital Goods)

     32,871        14,674,929  

salesforce.com Inc. (Software & Services)*

     73,112        16,839,156  

Schlumberger NV (Energy)

     752,330        20,350,526  

SVB Financial Group (Banks)*

     114,114        65,253,809  

Synopsys Inc. (Software & Services)*

     82,904        20,482,262  

Thermo Fisher Scientific Inc. (Pharmaceuticals, Biotechnology & Life Sciences)

     47,853        22,501,916  

Trade Desk Inc., Class A (Software & Services)*

     23,840        17,386,750  

Tradeweb Markets Inc., Class A (Diversified Financials)

     242,415        19,703,491  

UnitedHealth Group Inc. (Health Care Equipment & Services)

     49,272        19,649,674  

Verisk Analytics Inc. (Commercial & Professional Services)

     74,358        13,994,176  

Vertex Pharmaceuticals Inc. (Pharmaceuticals, Biotechnology & Life Sciences)*

     162,867        35,537,579  

VF Corp. (Consumer Durables & Apparel)

     180,894        15,857,168  

Walt Disney Co. (Media & Entertainment)*

     97,367        18,112,209  

Workday Inc., Class A (Software & Services)*

     67,991        16,793,777  
                1,091,219,498  

Total Common Stocks (Cost $1,175,290,111)

 

     $1,684,504,679  
            
SHORT TERM INVESTMENTS - 0.7%              

Northern Institutional Funds - Treasury Portfolio (Premier Shares), 0.01% (Money Market Funds)

     11,641,172        11,641,172  
 

 

See Notes to Financial Statements

 

5


Table of Contents

Harding, Loevner Funds, Inc.

 

Global Equity Portfolio

Portfolio of Investments (continued)

April 30, 2021 (unaudited)

 

 

     Shares      Value  
SHORT TERM INVESTMENTS - 0.7%    (continued)         

Total Short Term Investments (Cost $11,641,172)

 

     $11,641,172  
            

Total Investments - 99.3%

                 

(Cost $1,186,931,283)

              $1,696,145,851  

Other Assets Less Liabilities - 0.7%

              12,213,831  

Net Assets - 100.0%

              $1,708,359,682  

Summary of Abbreviations

 

ADR

American Depositary Receipt

GDR

Global Depositary Receipt

Reg S

Security sold outside United States without registration under the Securities Act of 1933.

 

*

Non-income producing security.

Investment categorized as level 2 security as disclosed in Note 2 of the Notes to Financial Statements.

^

Security exempt from registration pursuant to Rule 144A of the Securities Act of 1933. These securities, which represent 4.6% of net assets as of April 30, 2021, are considered liquid and may be resold in transactions exempt from registration, normally to qualified buyers.

 

Industry       
Percentage of
Net Assets
 
 

Banks

       11.0 %

Capital Goods

       8.8

Commercial & Professional Services

       2.4

Consumer Durables & Apparel

       2.8

Diversified Financials

       4.5

Energy

       2.1

Health Care Equipment & Services

       8.2

Household & Personal Products

       2.2

Insurance

       1.2

Media & Entertainment

       10.7

Pharmaceuticals, Biotechnology & Life Sciences

       12.6

Retailing

       7.8

Semiconductors & Semiconductor Equipment

       3.7

Software & Services

       17.1

Technology Hardware & Equipment

       3.0

Utilities

       0.5

Money Market Fund

       0.7

Total Investments

       99.3

Other Assets Less Liabilities

       0.7

Net Assets

       100.0 %
 

 

See Notes to Financial Statements

 

6


Table of Contents

Harding, Loevner Funds, Inc.

 

International Equity Portfolio

Portfolio of Investments

April 30, 2021 (unaudited)

 

 

     Shares      Value  
COMMON STOCKS - 93.7%              

Australia - 3.0%

     

BHP Group Ltd. - Sponsored ADR (Materials)

     8,309,798        $604,620,903  

Brazil - 1.0%

     

Ambev SA - ADR (Food Beverage & Tobacco)

     75,457,476        209,771,783  

Canada - 1.9%

     

Alimentation Couche-Tard Inc., Class B (Food & Staples Retailing)

     5,637,300        191,021,067  

Canadian National Railway Co. (Transportation)

     1,811,376        194,994,627  
        386,015,694  

China - 7.5%

     

Alibaba Group Holding Ltd. - Sponsored ADR (Retailing)*

     1,396,255        322,465,092  

CSPC Pharmaceutical Group Ltd. (Pharmaceuticals, Biotechnology & Life Sciences)†

     161,690,000        200,060,779  

ENN Energy Holdings Ltd. (Utilities)†

     11,602,000        197,525,942  

Ping An Insurance Group Co. of China Ltd., Class H (Insurance)†

     25,369,500        277,186,211  

Tencent Holdings Ltd. (Media & Entertainment)†

     6,711,000        536,699,212  
        1,533,937,236  

Denmark - 1.0%

     

Novozymes A/S, Class B (Materials)†

     2,811,959        200,026,486  

France - 8.1%

     

Air Liquide SA (Materials)†

     1,144,768        192,813,818  

Dassault Systemes SE (Software &
Services)†

     1,158,181        268,600,622  

L’Oreal SA (Household & Personal
Products)†

     1,618,234        664,593,192  

Schneider Electric SE (Capital Goods)†

     3,316,274        530,212,141  
        1,656,219,773  

Germany - 9.5%

     

Allianz SE, Reg S (Insurance)†

     1,993,788        518,713,011  

Infineon Technologies AG (Semiconductors & Semiconductor Equipment)†

     20,712,463        836,437,709  

SAP SE - Sponsored ADR (Software & Services)

     2,172,176        303,974,309  

Symrise AG (Materials)†

     2,244,605        289,899,868  
        1,949,024,897  

Hong Kong - 3.2%

     

AIA Group Ltd. (Insurance)†

     51,300,074        652,145,490  

India - 2.7%

     

HDFC Bank Ltd. - ADR (Banks)*

     3,593,245        252,533,259  
     Shares      Value  
COMMON STOCKS - 93.7% (continued)         

India - 2.7% (continued)

     

ICICI Bank Ltd. - Sponsored ADR (Banks)*

     18,134,554        $295,593,230  
        548,126,489  

Indonesia - 0.9%

     

Telkom Indonesia Persero Tbk PT (Telecommunication Services)†

     863,876,711        190,977,646  

Israel - 1.2%

     

Check Point Software Technologies Ltd. (Software & Services)*

     2,121,208        247,778,307  

Japan - 12.9%

     

Chugai Pharmaceutical Co., Ltd. (Pharmaceuticals, Biotechnology & Life Sciences)†

     8,063,700        302,980,023  

FANUC Corp. (Capital Goods)†

     813,500        187,561,173  

Keyence Corp. (Technology Hardware & Equipment)†

     847,654        407,674,213  

Komatsu Ltd. (Capital Goods)†

     9,897,900        290,513,402  

Kubota Corp. (Capital Goods)†

     15,601,600        367,080,657  

Nitori Holdings Co., Ltd. (Retailing)†

     1,012,700        181,500,496  

Shionogi & Co., Ltd. (Pharmaceuticals, Biotechnology & Life Sciences)†

     4,687,700        246,612,755  

Sysmex Corp. (Health Care Equipment & Services)†

     2,856,907        285,705,513  

Unicharm Corp. (Household & Personal Products)†

     9,470,700        367,029,560  
        2,636,657,792  

Mexico - 1.0%

     

Fomento Economico Mexicano SAB de CV - Sponsored ADR (Food Beverage & Tobacco)

     2,756,297        213,613,018  

Netherlands - 3.1%

     

Adyen NV (Software & Services)*^†

     258,864        635,645,758  

Russia - 2.4%

     

LUKOIL PJSC - Sponsored ADR (Energy)

     4,195,472        324,058,257  

Yandex NV, Class A (Media &
Entertainment)*

     2,558,460        167,707,053  
        491,765,310  

Singapore - 2.4%

     

DBS Group Holdings Ltd. (Banks)†

     21,821,008        490,744,769  

South Korea - 1.9%

     

Samsung Electronics Co., Ltd. - GDR, Reg S (Technology Hardware & Equipment)†

     207,896        378,281,053  
 

 

See Notes to Financial Statements

 

7


Table of Contents

Harding, Loevner Funds, Inc.

 

International Equity Portfolio

Portfolio of Investments (continued)

April 30, 2021 (unaudited)

 

 

     Shares      Value  
COMMON STOCKS - 93.7% (continued)         

Spain - 1.3%

     

Banco Bilbao Vizcaya Argentaria SA
(Banks)*†

     47,251,374        $264,762,848  

Sweden - 7.4%

     

Alfa Laval AB (Capital Goods)†

     9,040,116        307,013,919  

Atlas Copco AB, Class A (Capital Goods)†

     11,963,400        725,214,003  

Epiroc AB, Class A (Capital Goods)†

     13,888,114        301,101,683  

Skandinaviska Enskilda Banken AB, Class A (Banks)†

     14,290,925        183,369,164  
        1,516,698,769  

Switzerland - 10.1%

     

Alcon Inc. (Health Care Equipment & Services)*

     3,947,339        297,747,781  

Lonza Group AG, Reg S (Pharmaceuticals, Biotechnology & Life Sciences)†

     633,076        402,846,709  

Nestle SA - Sponsored ADR (Food Beverage & Tobacco)

     3,263,965        390,141,736  

Roche Holding AG, Genusschein (Pharmaceuticals, Biotechnology & Life Sciences)†

     1,559,219        508,008,386  

SGS SA, Reg S (Commercial & Professional Services)†

     59,686        176,778,449  

Sonova Holding AG, Reg S (Health Care Equipment & Services)*†

     961,686        284,660,501  
        2,060,183,562  

Taiwan - 3.7%

     

Taiwan Semiconductor Manufacturing Co., Ltd. - Sponsored ADR (Semiconductors & Semiconductor Equipment)

     6,468,244        755,102,805  

United Kingdom - 6.5%

     

Diageo plc (Food Beverage & Tobacco)†

     4,925,120        221,093,017  

Rio Tinto plc (Materials)†

     5,525,335        464,356,939  

Royal Dutch Shell plc, Class B (Energy)†

     12,751,393        228,316,913  

Standard Chartered plc (Banks)†

     21,467,594        154,085,826  

Unilever plc (Household & Personal Products)†

     4,308,809        252,644,846  
        1,320,497,541  

United States - 1.0%

     

Linde plc (Materials)†

     742,389        212,579,777  

Total Common Stocks (Cost $11,920,132,533)

 

     $19,155,177,706  
     Shares      Value  
PREFERRED STOCKS - 3.9%              

Brazil - 1.3%

     

Itau Unibanco Holding SA - Sponsored ADR, 0.62% (Banks)+

     52,334,093        $261,670,465  

Germany - 0.5%

     

FUCHS PETROLUB SE, 2.26%
(Materials)+†

     1,891,182        100,930,529  

South Korea - 2.1%

     

Samsung Electronics Co., Ltd. - GDR, Reg S, 1.94% (Technology Hardware & Equipment)+†

     259,535        428,923,489  

Total Preferred Stocks (Cost $461,921,002)

 

     $791,524,483  
     
SHORT TERM INVESTMENTS - 2.2%         

Northern Institutional Funds - Treasury Portfolio (Premier Shares), 0.01% (Money Market Funds)

     459,610,526        459,610,526  

Total Short Term Investments (Cost $459,610,526)

 

     $459,610,526  
     

Total Investments - 99.8%

                 

(Cost $12,841,664,061)

              $20,406,312,715  

Other Assets Less Liabilities - 0.2%

              33,373,449  

Net Assets - 100.0%

              $20,439,686,164  

Summary of Abbreviations

 

ADR

American Depositary Receipt

GDR

Global Depositary Receipt

Reg S

Security sold outside United States without registration under the Securities Act of 1933.

 

*

Non-income producing security.

Investment categorized as level 2 security as disclosed in Note 2 of the Notes to Financial Statements.

^

Security exempt from registration pursuant to Rule 144A of the Securities Act of 1933. These securities, which represent 3.1% of net assets as of April 30, 2021, are considered liquid and may be resold in transactions exempt from registration, normally to qualified buyers.

+

Current yield is disclosed. Dividends are calculated based on a percentage of the issuer’s net income.

 

 

See Notes to Financial Statements

 

8


Table of Contents

Harding, Loevner Funds, Inc.

 

International Equity Portfolio

Portfolio of Investments (continued)

April 30, 2021 (unaudited)

 

 

Industry       
Percentage of
Net Assets
 
 

Banks

       9.3 %

Capital Goods

       13.3

Commercial & Professional Services

       0.9

Energy

       2.7

Food & Staples Retailing

       0.9

Food Beverage & Tobacco

       5.1

Health Care Equipment & Services

       4.2

Household & Personal Products

       6.3

Insurance

       7.1

Materials

       10.1

Media & Entertainment

       3.4

Pharmaceuticals, Biotechnology & Life Sciences

       8.1

Retailing

       2.5

Semiconductors & Semiconductor Equipment

       7.8

Software & Services

       7.1

Technology Hardware & Equipment

       5.9

Telecommunication Services

       0.9

Transportation

       1.0

Utilities

       1.0

Money Market Fund

       2.2

Total Investments

       99.8

Other Assets Less Liabilities

       0.2

Net Assets

       100.0 %
 

 

See Notes to Financial Statements

 

9


Table of Contents

Harding, Loevner Funds, Inc.

 

International Small Companies Portfolio

Portfolio of Investments

April 30, 2021 (unaudited)

 

 

     Shares      Value  
COMMON STOCKS - 97.0%              

Argentina - 1.8%

     

Globant SA (Software & Services)*

     39,941        $9,153,678  

Bangladesh - 0.7%

     

Square Pharmaceuticals Ltd. (Pharmaceuticals, Biotechnology & Life Sciences)†

     1,568,474        3,913,610  

Canada - 1.9%

     

Kinaxis Inc. (Software & Services)*

     75,300        9,712,453  

China - 1.6%

     

Haitian International Holdings Ltd. (Capital Goods)†

     2,046,000        8,327,720  

Denmark - 0.7%

     

SimCorp A/S (Software & Services)†

     26,902        3,552,574  

Egypt - 1.5%

     

Edita Food Industries SAE (Food Beverage & Tobacco)†

     9,388,776        4,418,640  

Integrated Diagnostics Holdings plc (Health Care Equipment & Services)^†

     3,055,449        3,574,067  
        7,992,707  

Finland - 2.3%

     

Nokian Renkaat OYJ (Automobiles &
Components)†

     80,690        3,004,704  

Vaisala OYJ, Class A (Technology Hardware & Equipment)†

     208,178        8,721,133  
        11,725,837  

France - 5.2%

     

Alten SA (Software & Services)*†

     84,632        10,589,617  

LISI (Capital Goods)*†

     123,630        3,990,448  

Rubis SCA (Utilities)†

     260,618        12,233,061  
        26,813,126  

Germany - 9.1%

     

Bechtle AG (Software & Services)†

     55,506        11,313,443  

FUCHS PETROLUB SE (Materials)†

     247,967        10,747,801  

KWS Saat SE & Co. KGaA (Food Beverage & Tobacco)†

     84,093        7,479,500  

Pfeiffer Vacuum Technology AG (Capital Goods)†

     21,529        4,176,432  

STRATEC SE (Health Care Equipment &
Services)†

     96,525        13,679,176  
        47,396,352  

Hong Kong - 0.7%

     

ASM Pacific Technology Ltd. (Semiconductors & Semiconductor Equipment)†

     240,100        3,627,067  
     Shares      Value  
COMMON STOCKS - 97.0% (continued)         

India - 3.2%

     

Max Financial Services Ltd. (Insurance)*†

     1,082,412        $13,065,253  

SH Kelkar & Co., Ltd. (Materials)^†

     1,792,487        3,340,817  
        16,406,070  

Indonesia - 2.2%

     

Sarana Menara Nusantara Tbk PT (Telecommunication Services)†

     75,638,300        5,960,453  

Tower Bersama Infrastructure Tbk PT (Telecommunication Services)†

     27,382,400        5,283,746  
        11,244,199  

Israel - 1.5%

     

CyberArk Software Ltd. (Software & Services)*

     55,388        7,782,014  

Italy - 3.0%

     

Reply SpA (Software & Services)†

     113,708        15,444,271  

Japan - 12.0%

     

ABC-Mart Inc. (Retailing)†

     28,300        1,513,452  

Ariake Japan Co., Ltd. (Food Beverage & Tobacco)†

     139,600        8,099,271  

BML Inc. (Health Care Equipment & Services)†

     114,200        3,957,637  

Cosmos Pharmaceutical Corp. (Food & Staples Retailing)†

     44,500        6,382,906  

Infomart Corp. (Software & Services)†

     743,800        6,982,076  

JCU Corp. (Materials)†

     164,200        5,772,513  

MISUMI Group Inc. (Capital Goods)†

     69,400        1,956,636  

Nihon M&A Center Inc. (Commercial & Professional Services)†

     112,200        2,934,633  

Pigeon Corp. (Household & Personal Products)†

     33,800        1,146,249  

Rinnai Corp. (Consumer Durables & Apparel)†

     14,900        1,497,607  

Rohto Pharmaceutical Co., Ltd. (Household & Personal Products)†

     100,100        2,568,310  

SMS Co., Ltd. (Commercial & Professional Services)†

     289,100        7,898,755  

Solasto Corp. (Health Care Equipment & Services)†

     259,400        3,376,669  

Stanley Electric Co., Ltd. (Automobiles & Components)†

     289,700        8,301,961  
        62,388,675  

Kuwait - 0.9%

     

Mabanee Co. KPSC (Real Estate)†

     1,913,387        4,436,938  
 

 

See Notes to Financial Statements

 

10


Table of Contents

Harding, Loevner Funds, Inc.

 

International Small Companies Portfolio

Portfolio of Investments (continued)

April 30, 2021 (unaudited)

 

 

     Shares      Value  
COMMON STOCKS - 97.0% (continued)         

Lithuania - 1.4%

     

Siauliu Bankas AB (Banks)†

     10,562,104        $7,477,446  

Malaysia - 1.4%

     

Dialog Group Bhd. (Energy)†

     5,193,340        3,851,620  

TIME dotCom Bhd. (Telecommunication
Services)†

     1,042,700        3,530,886  
        7,382,506  

Mexico - 2.0%

     

Grupo Herdez SAB de CV (Food Beverage & Tobacco)

     2,552,238        5,368,557  

Megacable Holdings SAB de CV (Media & Entertainment)

     1,319,000        4,825,546  
        10,194,103  

Netherlands - 1.0%

     

ASM International NV (Semiconductors & Semiconductor Equipment)†

     17,166        5,222,699  

Norway - 2.1%

     

Tomra Systems ASA (Commercial & Professional Services)†

     212,995        10,679,031  

Peru - 1.0%

     

Alicorp SAA (Food Beverage & Tobacco)

     1,144,581        2,086,445  

Ferreycorp SAA (Capital Goods)

     6,538,194        3,178,241  
        5,264,686  

Philippines - 0.2%

     

Security Bank Corp. (Banks)†

     341,640        818,965  

Romania - 0.3%

     

Societatea Nationala de Gaze Naturale ROMGAZ SA (Energy)†

     228,007        1,811,316  

Saudi Arabia - 1.0%

     

Jarir Marketing Co. (Retailing)†

     99,962        5,305,343  

South Africa - 0.6%

     

Clicks Group Ltd. (Food & Staples Retailing)†

     86,974        1,451,767  

Discovery Ltd. (Insurance)*†

     198,408        1,806,742  
        3,258,509  

South Korea - 0.2%

     

Cheil Worldwide Inc. (Media & Entertainment)†

     65,335        1,287,652  

Spain - 0.9%

     

Bankinter SA (Banks)†

     631,827        3,462,728  

Linea Directa Aseguradora SA Cia de Seguros y Reaseguros (Insurance)*

     631,827        1,238,171  
        4,700,899  

Sweden - 3.6%

     

Intrum AB (Commercial & Professional Services)†

     207,116        7,133,241  
     Shares      Value  
COMMON STOCKS - 97.0% (continued)         

Sweden - 3.6% (continued)

     

Paradox Interactive AB (Media & Entertainment)†

     374,191        $8,761,278  

Thule Group AB (Consumer Durables & Apparel)^†

     65,512        2,983,516  
        18,878,035  

Switzerland - 3.6%

     

Bossard Holding AG, Class A, Reg S (Capital
Goods)†

     28,587        6,869,900  

LEM Holding SA, Reg S (Technology Hardware & Equipment)†

     4,178        7,822,793  

VAT Group AG (Capital Goods)^†

     14,336        4,106,002  
        18,798,695  

Taiwan - 3.4%

     

Advantech Co., Ltd. (Technology Hardware & Equipment)†

     223,645        2,839,461  

Chipbond Technology Corp. (Semiconductors & Semiconductor Equipment)†

     2,345,700        6,474,376  

Eclat Textile Co., Ltd. (Consumer Durables & Apparel)†

     148,909        2,867,305  

Silergy Corp. (Semiconductors & Semiconductor Equipment)†

     52,000        5,509,360  
        17,690,502  

Ukraine - 0.8%

     

Kernel Holding SA (Food Beverage & Tobacco)†

     303,203        4,077,523  

United Arab Emirates - 0.9%

     

Agthia Group PJSC (Food Beverage & Tobacco)†

     2,869,592        4,919,509  

United Kingdom - 19.2%

     

Abcam plc (Pharmaceuticals, Biotechnology & Life Sciences)*†

     546,302        11,571,758  

Bank of Georgia Group plc (Banks)*†

     169,770        2,396,459  

Clarkson plc (Transportation)†

     144,805        6,069,191  

Cranswick plc (Food Beverage & Tobacco)†

     79,949        4,117,845  

Dechra Pharmaceuticals plc (Pharmaceuticals, Biotechnology & Life Sciences)†

     206,392        11,495,730  

Diploma plc (Capital Goods)†

     264,139        10,469,069  

EMIS Group plc (Health Care Equipment &
Services)†

     414,940        7,024,435  

HomeServe plc (Commercial & Professional
Services)†

     269,900        4,076,689  

Keywords Studios plc (Software & Services)*†

     283,932        10,616,837  

Network International Holdings plc (Software & Services)*^†

     1,360,246        7,887,680  
 

 

See Notes to Financial Statements

 

11


Table of Contents

Harding, Loevner Funds, Inc.

 

International Small Companies Portfolio

Portfolio of Investments (continued)

April 30, 2021 (unaudited)

 

 

     Shares      Value  
COMMON STOCKS - 97.0% (continued)         

United Kingdom - 19.2% (continued)

     

Rathbone Brothers plc (Diversified Financials)†

     152,318        $3,558,751  

Rightmove plc (Media & Entertainment)†

     502,301        4,258,501  

Senior plc (Capital Goods)*†

     5,625,729        8,420,502  

YouGov plc (Media & Entertainment)†

     534,544        7,824,774  
        99,788,221  

United States - 0.8%

     

Core Laboratories NV (Energy)

     97,738        2,754,257  

Sensata Technologies Holding plc (Capital Goods)*

     24,173        1,395,749  
        4,150,006  

Vietnam - 4.3%

     

Hoa Phat Group JSC (Materials)†

     8,948,601        22,462,753  

Total Common Stocks (Cost $350,883,660)

 

     $504,085,690  
     
SHORT TERM INVESTMENTS - 3.1%         

Northern Institutional Funds - Treasury Portfolio (Premier Shares), 0.01% (Money Market Funds)

     16,277,399        16,277,399  

Total Short Term Investments (Cost $16,277,399)

 

     $16,277,399  
     

Total Investments - 100.1%

                 

(Cost $367,161,059)

              $520,363,089  

Liabilities Less Other Assets - (0.1)%

              (520,161

Net Assets - 100.0%

              $519,842,928  

Summary of Abbreviations

 

Reg S

Security sold outside United States without registration under the Securities Act of 1933.

 

*

Non-income producing security.

Investment categorized as level 2 security as disclosed in Note 2 of the Notes to Financial Statements.

^

Security exempt from registration pursuant to Rule 144A of the Securities Act of 1933. These securities, which represent 4.2% of net assets as of April 30, 2021, are considered liquid and may be resold in transactions exempt from registration, normally to qualified buyers.

 

Industry       
Percentage of
Net Assets
 
 

Automobiles & Components

       2.2 %

Banks

       2.7

Capital Goods

       10.2

Commercial & Professional Services

       6.3

Consumer Durables & Apparel

       1.4

Diversified Financials

       0.7

Energy

       1.6

Food & Staples Retailing

       1.5

Food Beverage & Tobacco

       7.8

Health Care Equipment & Services

       6.1

Household & Personal Products

       0.7

Insurance

       3.1

Materials

       8.1

Media & Entertainment

       5.2

Pharmaceuticals, Biotechnology & Life Sciences

       5.2

Real Estate

       0.9

Retailing

       1.3

Semiconductors & Semiconductor Equipment

       4.0

Software & Services

       17.9

Technology Hardware & Equipment

       3.7

Telecommunication Services

       2.8

Transportation

       1.2

Utilities

       2.4

Money Market Fund

       3.1

Total Investments

       100.1

Liabilities Less Other Assets

       (0.1 )

Net Assets

       100.0 %
 

 

See Notes to Financial Statements

 

12


Table of Contents

Harding, Loevner Funds, Inc.

 

Institutional Emerging Markets Portfolio

Portfolio of Investments

April 30, 2021 (unaudited)

 

 

     Shares      Value  
COMMON STOCKS - 94.7%              

Brazil - 4.2%

     

Ambev SA - ADR (Food Beverage & Tobacco)

     21,817,090        $60,651,510  

B3 SA - Brasil Bolsa Balcao (Diversified Financials)

     5,173,800        49,051,592  

Cia Brasileira de Distribuicao - ADR (Food & Staples Retailing)

     1,301,993        9,660,788  

Localiza Rent a Car SA (Transportation)*

     5,631,570        66,661,749  

Lojas Renner SA (Retailing)

     3,797,000        28,239,578  

Sendas Distribuidora SA ADR (Food & Staples Retailing)

     186,635        2,749,134  

Ultrapar Participacoes SA (Energy)

     6,647,078        25,831,834  

WEG SA (Capital Goods)

     6,477,892        41,750,536  
        284,596,721  

Chile - 0.3%

     

Banco Santander Chile - ADR (Banks)

     822,558        18,293,690  

China - 26.9%

     

51job Inc. - ADR (Commercial & Professional Services)*

     600,939        36,987,795  

Alibaba Group Holding Ltd. (Retailing)*†

     7,049,816        203,652,011  

Alibaba Group Holding Ltd. - Sponsored ADR (Retailing)*

     458,552        105,902,584  

Autohome Inc. - ADR (Media & Entertainment)

     253,134        23,473,116  

Baidu Inc. - Sponsored ADR (Media & Entertainment)*

     150,488        31,652,141  

Baidu Inc., Class A (Media & Entertainment)*

     1,203,904        31,896,423  

China Tourism Group Duty Free Corp., Ltd., Class A (Retailing)†

     1,491,200        71,507,646  

Country Garden Services Holdings Co., Ltd. (Commercial & Professional Services)†

     3,613,504        37,762,877  

CSPC Pharmaceutical Group Ltd. (Pharmaceuticals, Biotechnology & Life Sciences)†

     69,720,080        86,265,406  

ENN Energy Holdings Ltd. (Utilities)†

     6,066,200        103,278,044  

Fuyao Glass Industry Group Co., Ltd., Class H (Automobiles & Components)^†

     11,644,200        67,440,015  

Hefei Meiya Optoelectronic Technology Inc., Class A (Capital Goods)†

     1,188,781        8,793,764  

Jiangsu Hengrui Medicine Co., Ltd., Class A (Pharmaceuticals, Biotechnology & Life Sciences)†

     2,084,100        27,037,380  
     Shares      Value  
COMMON STOCKS - 94.7%     (continued)         

China - 26.9% (continued)

     

Midea Group Co., Ltd., Class A (Consumer Durables & Apparel)†

     9,468,264        $117,115,997  

New Oriental Education & Technology Group Inc. (Consumer Services)*†

     3,100,888        47,664,429  

New Oriental Education & Technology Group Inc. - Sponsored ADR (Consumer Services)*

     3,100,888        47,319,551  

Ping An Insurance Group Co. of China Ltd., Class H (Insurance)†

     9,967,000        108,899,071  

Sangfor Technologies Inc., Class A (Software & Services)†

     836,327        35,298,294  

SF Holding Co., Ltd., Class A (Transportation)†

     3,104,800        30,840,248  

Shenzhou International Group Holdings Ltd. (Consumer Durables & Apparel)†

     3,875,000        84,783,089  

Sino Biopharmaceutical Ltd. (Pharmaceuticals, Biotechnology & Life Sciences)†

     24,174,135        25,999,540  

Sunny Optical Technology Group Co., Ltd. (Technology Hardware & Equipment)†

     3,331,700        80,393,483  

Tencent Holdings Ltd. (Media & Entertainment)†

     3,969,500        317,453,065  

Wuxi Biologics Cayman Inc. (Pharmaceuticals, Biotechnology & Life Sciences)*^†

     5,584,500        78,332,654  

ZTO Express Cayman Inc. - ADR (Transportation)

     423,746        13,627,671  
        1,823,376,294  

Czech Republic - 0.6%

     

Komercni banka AS (Banks)*†

     1,291,362        39,150,507  

Egypt - 0.5%

     

Commercial International Bank Egypt SAE - GDR, Reg S (Banks)†

     9,204,702        33,629,964  

Hong Kong - 7.1%

     

AIA Group Ltd. (Insurance)†

     14,260,615        181,286,205  

ASM Pacific Technology Ltd. (Semiconductors & Semiconductor Equipment)†

     3,253,069        49,142,442  

Sands China Ltd. (Consumer Services)*†

     21,236,538        100,667,391  

Techtronic Industries Co., Ltd.

     

(Capital Goods)†

     8,100,301        146,532,824  
        477,628,862  

India - 7.5%

     

HDFC Bank Ltd. - ADR (Banks)*

     1,045,316        73,464,808  
 

See Notes to Financial Statements

 

 

13


Table of Contents

Harding, Loevner Funds, Inc.

 

Institutional Emerging Markets Portfolio

Portfolio of Investments (continued)

April 30, 2021 (unaudited)

 

 

     Shares      Value  
COMMON STOCKS - 94.7%     (continued)              

India - 7.5% (continued)

     

Housing Development Finance Corp., Ltd. (Banks)†

     4,456,419        $145,427,491  

Kotak Mahindra Bank Ltd. (Banks)*†

     3,641,835        85,933,634  

Maruti Suzuki India Ltd. (Automobiles & Components)†

     653,591        56,940,512  

Tata Consultancy Services Ltd. (Software & Services)†

     3,587,285        146,898,937  
        508,665,382  

Indonesia - 2.4%

     

Astra International Tbk PT (Automobiles & Components)†

     81,489,200        30,931,543  

Bank Central Asia Tbk PT (Banks)†

     26,086,533        57,714,391  

Bank Rakyat Indonesia Persero Tbk PT (Banks)†

     261,964,400        73,373,413  
        162,019,347  

Italy - 0.8%

     

Tenaris SA - ADR (Energy)

     2,393,000        51,162,340  

Kenya - 1.2%

     

East African Breweries Ltd. (Food Beverage & Tobacco)*†

     6,241,665        9,823,224  

Safaricom plc (Telecommunication Services)†

     197,381,427        73,850,816  
        83,674,040  

Mexico - 4.9%

     

Fomento Economico Mexicano SAB de CV - Sponsored ADR (Food Beverage & Tobacco)

     1,033,418        80,089,895  

Grupo Aeroportuario del Sureste SAB de CV-ADR (Transportation)*

     345,148        58,709,675  

Grupo Financiero Banorte SAB de CV, Series O (Banks)

     17,037,500        96,933,004  

Wal-Mart de Mexico SAB de CV (Food & Staples Retailing)

     30,444,300        99,657,478  
        335,390,052  

Panama - 0.5%

     

Copa Holdings SA, Class A

     

(Transportation)*

     373,246        32,285,779  

Peru - 0.3%

     

Credicorp Ltd. (Banks)

     147,601        17,623,559  

Poland - 0.4%

     

CD Projekt SA (Media & Entertainment)*†

     585,625        26,861,640  

Russia - 7.7%

     

LUKOIL PJSC - Sponsored ADR (Energy)

     1,645,116        127,068,760  
     Shares      Value  
COMMON STOCKS - 94.7%     (continued)              

Russia - 7.7% (continued)

     

Novatek PJSC - Sponsored GDR, Reg S
(Energy)†

     742,568        $133,637,198  

Sberbank of Russia PJSC - Sponsored ADR (Banks)†

     9,401,387        147,919,824  

Yandex NV, Class A (Media & Entertainment)*

     1,750,420        114,740,031  
        523,365,813  

South Africa - 1.5%

     

Discovery Ltd. (Insurance)*†

     6,272,907        57,122,304  

Standard Bank Group Ltd. (Banks)†

     5,416,809        44,053,291  
        101,175,595  

South Korea - 8.9%

     

Amorepacific Corp. (Household & Personal Products)†

     278,574        67,659,508  

Coway Co., Ltd. (Consumer Durables &
Apparel)†

     684,474        41,135,034  

LG Household & Health Care Ltd. (Household & Personal Products)†

     116,821        161,384,654  

NCSoft Corp. (Media & Entertainment)†

     9,896        7,368,070  

Samsung Electronics Co., Ltd. - GDR, Reg S (Technology Hardware & Equipment)†

     176,940        321,954,485  
        599,501,751  

Taiwan - 11.5%

     

Airtac International Group (Capital Goods)†

     2,531,000        107,799,789  

Eclat Textile Co., Ltd. (Consumer Durables & Apparel)†

     4,952,031        95,353,415  

Hon Hai Precision Industry Co., Ltd. (Technology Hardware & Equipment)†

     26,755,031        111,993,558  

Largan Precision Co., Ltd. (Technology Hardware & Equipment)†

     556,000        61,738,434  

Silergy Corp. (Semiconductors & Semiconductor Equipment)†

     440,122        46,630,588  

Taiwan Semiconductor Manufacturing Co., Ltd. (Semiconductors & Semiconductor
Equipment)†

     16,548,277        358,598,017  
        782,113,801  

Thailand - 0.9%

     

Siam Commercial Bank pcl, Reg S (Banks)†

     18,847,570        63,556,639  

United Kingdom - 2.7%

     

Bank of Georgia Group plc (Banks)*†

     713,964        10,078,253  

Coca-Cola HBC AG - CDI (Food Beverage & Tobacco)*†

     3,865,479        133,657,162  

 

 

 

See Notes to Financial Statements

 

14


Table of Contents

Harding, Loevner Funds, Inc.

 

Institutional Emerging Markets Portfolio

Portfolio of Investments (continued)

April 30, 2021 (unaudited)

 

 

     Shares      Value  
COMMON STOCKS - 94.7% (continued)              

United Kingdom - 2.7% (continued)

     

Network International Holdings plc (Software & Services)*^†

     6,772,466        $39,271,608  
        183,007,023  

United States - 3.9%

     

EPAM Systems Inc. (Software & Services)*

     576,132        263,724,423  

Total Common Stocks (Cost $4,034,178,582)

 

     $6,410,803,222  
            
PREFERRED STOCKS - 3.0%              

Brazil-2.1%

     

Banco Bradesco SA - ADR (Banks)*

     17,712,577        77,049,711  

Itau Unibanco Holding SA - Sponsored ADR, 0.62% (Banks)+

     13,062,207        65,311,035  
        142,360,746  

Colombia - 0.6%

     

Bancolombia SA - Sponsored ADR, 0.88% (Banks)+

     1,281,616        38,358,767  

South Korea - 0.3%

     

Samsung Electronics Co., Ltd. - GDR, Reg S, 1.94% (Technology Hardware & Equipment)+†

     14,808        24,472,611  

Total Preferred Stocks (Cost $192,850,216)

 

     $205,192,124  
            
SHORT TERM INVESTMENTS - 2.4%              

Northern Institutional Funds - Treasury Portfolio (Premier Shares), 0.01% (Money Market Funds)

     161,952,653        161,952,653  

Total Short Term Investments (Cost $161,952,653)

 

     $161,952,653  
            

Total Investments - 100.1%

 

        

(Cost $4,388,981,451)

              $6,777,947,999  

Liabilities Less Other Assets - (0.1)%

              (9,262,753

Net Assets - 100.0%

 

     $6,768,685,246  

Summary of Abbreviations

 

ADR

American Depositary Receipt

CDI

Chess Depositary Interest

GDR

Global Depositary Receipt

Reg S

Security sold outside United States without registration under the Securities Act of 1933.

 

*

Non-income producing security.

Investment categorized as level 2 security as disclosed in Note 2 of the Notes to Financial Statements.

^

Security exempt from registration pursuant to Rule 144A of the Securities Act of 1933. These securities, which represent 2.7% of net assets as of April 30, 2021, are considered liquid and may be resold in transactions exempt from registration, normally to qualified buyers.

+

Current yield is disclosed. Dividends are calculated based on a percentage of the issuer’s net income.

 

Industry       
Percentage of
Net Assets
 
 

Automobiles & Components

       2.3 %

Banks

       16.1

Capital Goods

       4.5

Commercial & Professional Services

       1.1

Consumer Durables & Apparel

       5.0

Consumer Services

       2.9

Diversified Financials

       0.7

Energy

       5.0

Food & Staples Retailing

       1.6

Food Beverage & Tobacco

       4.2

Household & Personal Products

       3.4

Insurance

       5.1

Media & Entertainment

       8.2

Pharmaceuticals, Biotechnology & Life Sciences

       3.2

Retailing

       6.0

Semiconductors & Semiconductor Equipment

       6.7

Software & Services

       7.2

Technology Hardware & Equipment

       8.9

Telecommunication Services

       1.1

Transportation

       3.0

Utilities

       1.5

Money Market Fund

       2.4

Total Investments

       100.1

Liabilities Less Other Assets

       (0.1 )

Net Assets

       100.0 %
 

 

See Notes to Financial Statements

 

15


Table of Contents

Harding, Loevner Funds, Inc.

 

Emerging Markets Portfolio

Portfolio of Investments

April 30, 2021 (unaudited)

 

 

     Shares      Value  
COMMON STOCKS - 94.8%              

Brazil - 4.2%

     

Ambev SA - ADR (Food Beverage & Tobacco)

     14,743,509        $40,986,955  

B3 SA - Brasil Bolsa Balcao (Diversified Financials)

     3,496,300        33,147,605  

Cia Brasileira de Distribuicao - ADR (Food & Staples Retailing)

     900,934        6,684,930  

Localiza Rent a Car SA (Transportation)*

     3,805,755        45,049,299  

Lojas Renner SA (Retailing)

     2,565,900        19,083,469  

Sendas Distribuidora SA ADR (Food & Staples Retailing)

     129,157        1,902,483  

Ultrapar Participacoes SA (Energy)

     4,491,900        17,456,395  

WEG SA (Capital Goods)

     4,377,660        28,214,372  
        192,525,508  

Chile - 0.3%

     

Banco Santander Chile - ADR (Banks)

     555,867        12,362,482  

China - 27.0%

     

51job Inc. - ADR (Commercial & Professional Services)*

     406,102        24,995,578  

Alibaba Group Holding Ltd. (Retailing)*†

     4,764,064        137,622,204  

Alibaba Group Holding Ltd. - Sponsored ADR (Retailing)*

     309,879        71,566,555  

Autohome Inc. - ADR (Media & Entertainment)

     171,062        15,862,579  

Baidu Inc. - Sponsored ADR (Media & Entertainment)*

     101,696        21,389,720  

Baidu Inc., Class A (Media & Entertainment)*

     813,576        21,555,012  

China Tourism Group Duty Free Corp., Ltd., Class A (Retailing)†

     1,007,700        48,322,327  

Country Garden Services Holdings Co., Ltd. (Commercial & Professional Services)†

     2,454,000        25,645,495  

CSPC Pharmaceutical Group Ltd. (Pharmaceuticals, Biotechnology & Life Sciences)†

     47,114,560        58,295,353  

ENN Energy Holdings Ltd. (Utilities)†

     4,099,700        69,798,061  

Fuyao Glass Industry Group Co., Ltd., Class H (Automobiles & Components)^†

     7,868,900        45,574,512  

Hefei Meiya Optoelectronic Technology Inc., Class A (Capital Goods)†

     805,934        5,961,731  

Jiangsu Hengrui Medicine Co., Ltd., Class A (Pharmaceuticals, Biotechnology & Life Sciences)†

     1,408,400        18,271,410  
     Shares      Value  
COMMON STOCKS - 94.8%     (continued)              

China - 27.0% (continued)

     

Midea Group Co., Ltd., Class A (Consumer Durables & Apparel)†

     6,398,368        $79,143,468  

New Oriental Education & Technology Group Inc. (Consumer Services)*†

     2,095,512        32,210,574  

New Oriental Education & Technology Group Inc. - Sponsored ADR (Consumer Services)*

     2,095,512        31,977,513  

Ping An Insurance Group Co. of China Ltd., Class H (Insurance)†

     6,735,500        73,591,822  

Sangfor Technologies Inc., Class A (Software & Services)†

     566,326        23,902,542  

SF Holding Co., Ltd., Class A (Transportation)†

     2,098,200        20,841,603  

Shenzhou International Group Holdings Ltd. (Consumer Durables & Apparel)†

     2,619,000        57,302,429  

Sino Biopharmaceutical Ltd. (Pharmaceuticals, Biotechnology & Life Sciences)†

     16,336,182        17,569,738  

Sunny Optical Technology Group Co., Ltd. (Technology Hardware & Equipment)†

     2,251,500        54,328,399  

Tencent Holdings Ltd. (Media & Entertainment)†

     2,682,500        214,527,736  

Wuxi Biologics Cayman Inc. (Pharmaceuticals, Biotechnology & Life Sciences)*^†

     3,762,500        52,775,828  

ZTO Express Cayman Inc. - ADR (Transportation)

     286,358        9,209,273  
        1,232,241,462  

Czech Republic - 0.6%

     

Komercni banka AS (Banks)*†

     872,674        26,457,050  

Egypt - 0.5%

     

Commercial International Bank Egypt SAE - GDR, Reg S (Banks)†

     6,220,335        22,726,389  

Hong Kong - 7.1%

     

AIA Group Ltd. (Insurance)†

     9,636,989        122,508,964  

ASM Pacific Technology Ltd. (Semiconductors & Semiconductor Equipment)†

     2,198,323        33,208,936  

Sands China Ltd. (Consumer Services)*†

     14,351,344        68,029,561  

Techtronic Industries Co., Ltd. (Capital Goods)†

     5,474,000        99,023,564  
        322,771,025  

India - 7.5%

     

HDFC Bank Ltd. - ADR (Banks)*

     706,401        49,645,862  
 

See Notes to Financial Statements

 

 

16


Table of Contents

Harding, Loevner Funds, Inc.

 

Emerging Markets Portfolio

Portfolio of Investments (continued)

April 30, 2021 (unaudited)

 

 

     Shares      Value  
COMMON STOCKS - 94.8% (continued)         

India - 7.5% (continued)

     

Housing Development Finance Corp., Ltd. (Banks)†

     3,011,550        $98,276,702  

Kotak Mahindra Bank Ltd. (Banks)*†

     2,461,072        58,072,060  

Maruti Suzuki India Ltd. (Automobiles & Components)†

     441,683        38,479,196  

Tata Consultancy Services Ltd. (Software & Services)†

     2,424,208        99,271,058  
        343,744,878  

Indonesia - 2.4%

     

Astra International Tbk PT (Automobiles & Components)†

     55,068,600        20,902,853  

Bank Central Asia Tbk PT (Banks)†

     17,628,710        39,002,127  

Bank Rakyat Indonesia Persero

     

Tbk PT (Banks)†

     177,029,790        49,584,141  
        109,489,121  

Italy - 0.7%

     

Tenaris SA - ADR (Energy)

     1,617,137        34,574,389  

Kenya - 1.2%

     

East African Breweries Ltd. (Food Beverage & Tobacco)*†

     4,217,950        6,638,272  

Safaricom plc (Telecommunication Services)†

     133,386,001        49,906,747  
        56,545,019  

Mexico - 5.0%

     

Fomento Economico Mexicano SAB de CV - Sponsored ADR (Food Beverage & Tobacco)

     698,361        54,122,978  

Grupo Aeroportuario del Sureste SAB de CV-ADR (Transportation)*

     233,243        39,674,634  

Grupo Financiero Banorte SAB de CV, Series O (Banks)

     11,513,640        65,505,603  

Wal-Mart de Mexico SAB de CV (Food & Staples Retailing)

     20,573,600        67,346,370  
        226,649,585  

Panama - 0.5%

     

Copa Holdings SA, Class A (Transportation)*

     252,231        21,817,982  

Peru - 0.3%

     

Credicorp Ltd. (Banks)

     99,751        11,910,270  

Poland - 0.4%

     

CD Projekt SA (Media & Entertainment)*†

     395,752        18,152,483  

Russia - 7.7%

     

LUKOIL PJSC - Sponsored ADR (Energy)

     1,111,733        85,870,257  
     Shares      Value  
COMMON STOCKS - 94.8%     (continued)         

Russia - 7.7% (continued)

     

Novatek PJSC - Sponsored GDR, Reg S
(Energy)†

     501,811        $90,309,057  

Sberbank of Russia PJSC - Sponsored ADR (Banks)†

     6,353,250        99,960,955  

Yandex NV, Class A (Media & Entertainment)*

     1,182,895        77,538,767  
        353,679,036  

South Africa - 1.5%

     

Discovery Ltd. (Insurance)*†

     4,239,092        38,601,991  

Standard Bank Group Ltd. (Banks)†

     3,660,560        29,770,242  
        68,372,233  

South Korea - 8.8%

     

Amorepacific Corp. (Household & Personal Products)†

     188,254        45,722,763  

Coway Co., Ltd. (Consumer Durables &
Apparel)†

     462,552        27,798,123  

LG Household & Health Care Ltd. (Household & Personal Products)†

     78,945        109,060,113  

NCSoft Corp. (Media & Entertainment)†

     6,001        4,468,047  

Samsung Electronics Co., Ltd. - GDR, Reg S (Technology Hardware & Equipment)†

     119,572        217,569,468  
        404,618,514  

Taiwan - 11.6%

     

Airtac International Group (Capital Goods)†

     1,711,000        72,874,531  

Eclat Textile Co., Ltd. (Consumer Durables & Apparel)†

     3,346,216        64,432,780  

Hon Hai Precision Industry Co., Ltd. (Technology Hardware & Equipment)†

     18,080,136        75,681,421  

Largan Precision Co., Ltd. (Technology Hardware & Equipment)†

     376,001        41,751,283  

Silergy Corp. (Semiconductors & Semiconductor Equipment)†

     297,000        31,466,922  

Taiwan Semiconductor Manufacturing Co., Ltd. (Semiconductors & Semiconductor
Equipment)†

     11,182,637        242,325,618  
        528,532,555  

Thailand - 0.9%

     

Siam Commercial Bank pcl, Reg S (Banks)†

     12,736,800        42,950,269  

United Kingdom - 2.7%

     

Bank of Georgia Group plc (Banks)*†

     489,812        6,914,143  

Coca-Cola HBC AG - CDI (Food Beverage & Tobacco)*†

     2,612,205        90,322,546  
 

 

See Notes to Financial Statements

 

17


Table of Contents

Harding, Loevner Funds, Inc.

 

Emerging Markets Portfolio

Portfolio of Investments (continued)

April 30, 2021 (unaudited)

 

 

     Shares      Value  
COMMON STOCKS - 94.8% (continued)         

United Kingdom - 2.7% (continued)

     

Network International Holdings plc (Software & Services)*^†

     4,576,684        $26,538,892  
        123,775,581  

United States - 3.9%

     

EPAM Systems Inc. (Software & Services)*

     389,338        178,219,469  

Total Common Stocks (Cost $2,527,467,116)

 

     $4,332,115,300  
  
PREFERRED STOCKS - 3.0%         

Brazil - 2.1%

     

Banco Bradesco SA - ADR (Banks)*

     11,969,770        52,068,499  

Itau Unibanco Holding SA - Sponsored ADR, 0.62% (Banks)+

     8,827,152        44,135,760  
        96,204,259  

Colombia - 0.6%

     

Bancolombia SA - Sponsored ADR, 0.88% (Banks)+

     866,088        25,922,014  

South Korea - 0.3%

     

Samsung Electronics Co., Ltd. - GDR, Reg S, 1.94% (Technology Hardware & Equipment)+†

     10,007        16,538,183  

Total Preferred Stocks (Cost $113,876,461)

 

     $138,664,456  
  
SHORT TERM INVESTMENTS - 2.4%         

Northern Institutional Funds - Treasury Portfolio (Premier Shares), 0.01% (Money Market Funds)

     108,829,058        108,829,058  

Total Short Term Investments (Cost $108,829,058)

 

     $108,829,058  
                   

Total Investments - 100.2%

                 

(Cost $2,750,172,635)

              $4,579,608,814  

Liabilities Less Other Assets - (0.2)%

              (9,906,899

Net Assets - 100.0%

              $4,569,701,915  

Summary of Abbreviations

 

ADR

American Depositary Receipt

CDI

Chess Depositary Interest

GDR

Global Depositary Receipt

Reg S

Security sold outside United States without registration under the Securities Act of 1933.

 

*

Non-income producing security.

Investment categorized as level 2 security as disclosed in Note 2 of the Notes to Financial Statements.

^

Security exempt from registration pursuant to Rule 144A of the Securities Act of 1933. These securities, which represent 2.7% of net assets as of April 30, 2021, are considered liquid and may be resold in transactions exempt from registration, normally to qualified buyers.

+

Current yield is disclosed. Dividends are calculated based on a percentage of the issuer’s net income.

 

Industry       
Percentage of
Net Assets
 
 

Automobiles & Components

       2.3 %

Banks

       16.1

Capital Goods

       4.5

Commercial & Professional Services

       1.1

Consumer Durables & Apparel

       5.0

Consumer Services

       2.9

Diversified Financials

       0.7

Energy

       5.0

Food & Staples Retailing

       1.7

Food Beverage & Tobacco

       4.2

Household & Personal Products

       3.4

Insurance

       5.1

Media & Entertainment

       8.2

Pharmaceuticals, Biotechnology & Life Sciences

       3.2

Retailing

       6.0

Semiconductors & Semiconductor Equipment

       6.7

Software & Services

       7.2

Technology Hardware & Equipment

       8.9

Telecommunication Services

       1.1

Transportation

       3.0

Utilities

       1.5

Money Market Fund

       2.4

Total Investments

       100.2

Liabilities Less Other Assets

       (0.2 )

Net Assets

       100.0 %
 

 

See Notes to Financial Statements

 

18


Table of Contents

Harding, Loevner Funds, Inc.

 

Frontier Emerging Markets Portfolio

Portfolio of Investments

April 30, 2021 (unaudited)

 

 

     Shares      Value  
COMMON STOCKS - 95.1%              

Argentina - 4.8%

     

Globant SA (Software & Services)*

     49,471        $11,337,764  

Bangladesh - 2.7%

     

GrameenPhone Ltd. (Telecommunication Services)†

     186,026        743,870  

Square Pharmaceuticals Ltd. (Pharmaceuticals, Biotechnology & Life Sciences)†

     2,234,726        5,576,021  
        6,319,891  

Colombia - 3.3%

     

Cementos Argos SA - Sponsored ADR (Materials)#†

     45,446        310,578  

Ecopetrol SA - Sponsored ADR (Energy)

     549,815        6,504,311  

Grupo Nutresa SA (Food Beverage & Tobacco)

     158,287        906,713  
        7,721,602  

Croatia - 0.2%

     

Ericsson Nikola Tesla (Technology Hardware & Equipment)†

     2,209        580,579  

Egypt - 5.9%

     

Commercial International Bank Egypt SAE - GDR, Reg S (Banks)†

     2,607,476        9,526,579  

Edita Food Industries SAE (Food Beverage & Tobacco)†

     2,861,162        1,346,549  

Integrated Diagnostics Holdings plc (Health Care Equipment & Services)^†

     2,676,247        3,130,501  
        14,003,629  

Iceland - 1.4%

     

Marel HF (Capital Goods)^†

     449,060        3,217,641  

Indonesia - 2.5%

     

Bank Central Asia Tbk PT (Banks)†

     2,676,300        5,921,102  

Kazakhstan - 3.0%

     

Halyk Savings Bank of Kazakhstan JSC - GDR, Reg S (Banks)†

     502,422        7,194,863  

Kenya - 6.3%

     

East African Breweries Ltd. (Food Beverage &
Tobacco)*†

     805,000        1,266,921  

Equity Group Holdings plc (Banks)*†

     8,666,700        3,145,869  

Safaricom plc (Telecommunication Services)†

     28,270,250        10,577,393  
        14,990,183  
     Shares      Value  
COMMON STOCKS - 95.1%     (continued)              

Morocco - 2.7%

     

Maroc Telecom (Telecommunication Services)†

     196,549        $3,031,848  

Societe d’Exploitation des Ports (Transportation)†

     135,684        3,458,024  
        6,489,872  

Nigeria - 5.3%

     

Guaranty Trust Bank plc (Banks)†

     48,903,727        3,601,146  

Nestle Nigeria plc (Food Beverage & Tobacco)

     1,394,492        4,844,474  

Nigerian Breweries plc (Food Beverage & Tobacco)†

     1,270,573        170,342  

Zenith Bank plc (Banks)†

     71,417,980        3,887,650  
        12,503,612  

Pakistan - 0.8%

     

MCB Bank Ltd. (Banks)†

     1,504,300        1,589,444  

Oil & Gas Development Co., Ltd. (Energy)†

     607,900        359,973  
        1,949,417  

Peru - 2.9%

     

Alicorp SAA (Food Beverage & Tobacco)

     958,751        1,747,697  

Cementos Pacasmayo SAA,

     

Class C (Materials)

     261,456        376,449  

Credicorp Ltd. (Banks)

     39,445        4,709,733  
        6,833,879  

Philippines - 18.9%

     

Bank of the Philippine Islands (Banks)†

     3,096,944        5,325,964  

BDO Unibank Inc. (Banks)†

     1,483,168        3,175,486  

International Container Terminal Services Inc. (Transportation)†

     952,280        2,570,382  

Jollibee Foods Corp. (Consumer Services)†

     673,530        2,461,968  

Robinsons Retail Holdings Inc. (Food & Staples Retailing)†

     2,106,240        2,296,477  

Security Bank Corp. (Banks)†

     2,395,260        5,741,813  

SM Prime Holdings Inc. (Real Estate)†

     12,726,900        9,101,421  

Universal Robina Corp. (Food Beverage &
Tobacco)†

     2,702,730        7,688,647  

Wilcon Depot Inc. (Retailing)†

     17,607,500        6,426,954  
        44,789,112  

Poland - 0.6%

     

CD Projekt SA (Media & Entertainment)*†

     28,665        1,314,816  

Romania - 4.7%

     

Banca Transilvania SA (Banks)†

     14,607,396        8,879,077  
 

 

See Notes to Financial Statements

 

19


Table of Contents

Harding, Loevner Funds, Inc.

 

Frontier Emerging Markets Portfolio

Portfolio of Investments (continued)

April 30, 2021 (unaudited)

 

 

     Shares      Value  
COMMON STOCKS - 95.1%     (continued)         

Romania - 4.7%     (continued)

     

Societatea Nationala de Gaze Naturale ROMGAZ SA (Energy)†

     283,879        $2,255,170  
        11,134,247  

Saudi Arabia - 3.0%

     

Bupa Arabia for Cooperative Insurance Co. (Insurance)*†

     52,236        1,609,807  

Jarir Marketing Co. (Retailing)†

     46,491        2,467,445  

Mouwasat Medical Services Co. (Health Care Equipment & Services)†

     63,032        2,978,690  
        7,055,942  

Slovenia - 1.2%

     

Krka dd Novo mesto (Pharmaceuticals, Biotechnology & Life Sciences)†

     22,507        2,827,226  

Sri Lanka - 0.3%

     

Commercial Bank of Ceylon plc (Banks)†

     341,348        139,490  

John Keells Holdings plc (Capital Goods)†

     656,614        468,770  
        608,260  

Thailand - 0.6%

     

Home Product Center pcl, Reg S (Retailing)†

     3,264,994        1,478,488  

United Arab Emirates - 2.6%

     

Agthia Group PJSC (Food Beverage & Tobacco)†

     2,605,169        4,466,194  

Emaar Properties PJSC (Real Estate)†

     1,680,355        1,701,997  
        6,168,191  

United Kingdom - 3.7%

     

Bank of Georgia Group plc (Banks)*†

     88,288        1,246,266  

Network International Holdings plc (Software & Services)*^†

     1,114,569        6,463,069  

TBC Bank Group plc (Banks)*†

     71,914        967,516  
        8,676,851  

United States - 4.7%

     

EPAM Systems Inc. (Software & Services)*

     24,268        11,108,677  

Vietnam - 13.0%

     

Bank for Foreign Trade of Vietnam JSC (Banks)†

     1,408,010        6,110,587  

Hoa Phat Group JSC (Materials)†

     4,581,576        11,500,659  

Sai Gon Cargo Service Corp. (Transportation)†

     162,720        887,174  

Saigon Beer Alcohol Beverage Corp. (Food Beverage & Tobacco)†

     561,510        4,076,052  
     Shares      Value  
COMMON STOCKS - 95.1%     (continued)         

Vietnam - 13.0%     (continued)

     

Vietnam Dairy Products JSC (Food Beverage & Tobacco)†

     2,043,194        $8,263,542  
                30,838,014  

Total Common Stocks (Cost $179,305,026)

 

     $225,063,858  

PREFERRED STOCKS - 2.6%

     

Colombia - 2.6%

     

Bancolombia SA - Sponsored ADR, 0.88%
(Banks)+

     205,201        6,141,666  

Total Preferred Stocks (Cost $6,344,876)

 

     $6,141,666  
  
SHORT TERM INVESTMENTS - 1.4%  

Northern Institutional Funds - Treasury Portfolio (Premier Shares), 0.01% (Money Market Funds)

     3,338,540        3,338,540  

Total Short Term Investments (Cost $3,338,540)

 

     $3,338,540  
                   

Total Investments - 99.1%

 

        

(Cost $188,988,442)

 

     $234,544,064  

Other Assets Less Liabilities - 0.9%

              2,118,780  

Net Assets - 100.0%

 

     $236,662,844  

Summary of Abbreviations

 

ADR

American Depositary Receipt

 

GDR

Global Depositary Receipt

 

Reg S

Security sold outside United States without registration under the Securities Act of 1933.

 

*

Non-income producing security.

 

Investment categorized as level 2 security as disclosed in Note 2 of the Notes to Financial Statements.

 

#

Security valued at fair value as determined in good faith under policies and procedures established by and under the supervision of the Portfolio’s Board of Directors as disclosed in Note 2 of the Notes to Financial Statements.

 

^

Security exempt from registration pursuant to Rule 144A of the Securities Act of 1933. These securities, which represent 5.4% of net assets as of April 30, 2021, are considered liquid and may be resold in transactions exempt from registration, normally to qualified buyers.

 

+

Current yield is disclosed. Dividends are calculated based on a percentage of the issuer’s net income.

 

 

See Notes to Financial Statements

 

20


Table of Contents

Harding, Loevner Funds, Inc.

 

Frontier Emerging Markets Portfolio

Portfolio of Investments (continued)

April 30, 2021 (continued)

 

 

Industry       
Percentage of
Net Assets
 
 

Banks

       32.7 %

Capital Goods

       1.6

Consumer Services

       1.0

Energy

       3.8

Food & Staples Retailing

       1.0

Food Beverage & Tobacco

       14.7

Health Care Equipment & Services

       2.6

Insurance

       0.7

Materials

       5.1

Media & Entertainment

       0.6

Pharmaceuticals, Biotechnology & Life Sciences

       3.5

Real Estate

       4.6

Retailing

       4.4

Software & Services

       12.2

Technology Hardware & Equipment

       0.2

Telecommunication Services

       6.1

Transportation

       2.9

Money Market Fund

       1.4

Total Investments

       99.1

Other Assets Less Liabilities

       0.9

Net Assets

       100.0 %
 

 

See Notes to Financial Statements

 

21


Table of Contents

Harding, Loevner Funds, Inc.

 

Global Equity Research Portfolio

Portfolio of Investments

April 30, 2021 (unaudited)

 

 

     Shares      Value  
COMMON STOCKS - 97.1%              

Argentina - 0.1%

     

Globant SA (Software & Services)*

     58        $13,292  

Australia - 0.4%

     

BHP Group Ltd. (Materials)†

     676        24,573  

Cochlear Ltd. (Health Care Equipment & Services)†

     83        14,206  
        38,779  

Brazil - 1.0%

     

Ambev SA - ADR (Food Beverage & Tobacco)

     7,484        20,806  

B3 SA - Brasil Bolsa Balcao (Diversified Financials)

     1,000        9,481  

Cia Brasileira de Distribuicao - ADR (Food & Staples Retailing)

     2,433        18,053  

Localiza Rent a Car SA (Transportation)*

     1,100        13,021  

Raia Drogasil SA (Food & Staples Retailing)*

     2,500        12,104  

Ultrapar Participacoes SA - Sponsored ADR (Energy)

     2,681        10,402  

WEG SA (Capital Goods)

     1,600        10,312  
        94,179  

Canada - 1.0%

     

Alimentation Couche-Tard Inc. (Food & Staples Retailing)

     1,600        54,359  

Imperial Oil Ltd. (Energy)

     1,500        43,323  
        97,682  

Chile - 0.3%

     

Banco Santander Chile - ADR (Banks)

     1,149        25,554  

China - 8.4%

     

51job Inc. - ADR (Commercial & Professional Services)*

     150        9,233  

AAC Technologies Holdings Inc. (Technology Hardware & Equipment)†

     5,670        31,399  

Alibaba Group Holding Ltd. (Retailing)*†

     440        12,711  

Autohome Inc. - ADR (Media & Entertainment)

     143        13,260  

Baidu Inc., Class A (Media & Entertainment)*

     500        13,247  

China Merchants Bank Co., Ltd., Class A (Banks)†

     1,900        15,458  

China Tourism Group Duty Free Corp., Ltd., Class A (Retailing)†

     500        23,977  

Country Garden Services Holdings Co., Ltd. (Commercial & Professional Services)†

     2,000        20,901  
     Shares      Value  
COMMON STOCKS - 97.1%     (continued)              

China - 8.4% (continued)

     

CSPC Pharmaceutical Group Ltd. (Pharmaceuticals, Biotechnology & Life Sciences)†

     15,360        $19,005  

ENN Energy Holdings Ltd. (Utilities)†

     2,000        34,050  

Fuyao Glass Industry Group Co., Ltd., Class H (Automobiles & Components)^†

     3,600        20,850  

Glodon Co., Ltd., Class A (Software & Services)†

     2,000        22,466  

Gree Electric Appliances Inc. of Zhuhai, Class A (Consumer Durables & Apparel)†

     1,200        11,097  

Haitian International Holdings Ltd. (Capital Goods)†

     4,000        16,281  

Hangzhou Tigermed Consulting Co., Ltd., Class A (Pharmaceuticals, Biotechnology & Life Sciences)†

     700        16,888  

Inner Mongolia Yili Industrial Group Co., Ltd., Class A (Food Beverage & Tobacco)†

     2,600        16,436  

JD.com Inc., Class A (Retailing)*†

     414        15,993  

Jiangsu Expressway Co., Ltd., Class H (Transportation)†

     56,000        65,904  

Jiangsu Hengrui Medicine Co., Ltd., Class A (Pharmaceuticals, Biotechnology & Life Sciences)†

     840        10,897  

Jiangsu Yanghe Brewery Joint-Stock Co., Ltd., Class A (Food Beverage & Tobacco)†

     600        17,880  

Kweichow Moutai Co., Ltd., Class A (Food Beverage & Tobacco)†

     100        30,942  

Meituan, Class B (Retailing)*^†

     300        11,422  

Midea Group Co., Ltd., Class A (Consumer Durables & Apparel)†

     1,200        14,843  

NetEase Inc. - ADR (Media & Entertainment)

     205        22,972  

New Oriental Education & Technology Group Inc. (Consumer Services)*†

     1,100        16,908  

Ping An Insurance Group Co. of China Ltd., Class A (Insurance)†

     1,100        12,313  

Sangfor Technologies Inc., Class A (Software & Services)†

     400        16,883  

SF Holding Co., Ltd., Class A (Transportation)†

     1,900        18,873  
 

 

See Notes to Financial Statements

 

22


Table of Contents

Harding, Loevner Funds, Inc.

 

Global Equity Research Portfolio

Portfolio of Investments (continued)

April 30, 2021 (unaudited)

 

 

     Shares      Value  
COMMON STOCKS - 97.1%     (continued)         

China - 8.4%     (continued)

     

Shanghai International Airport Co., Ltd., Class A (Transportation)†

     1,000        $7,586  

Shenzhen Inovance Technology Co., Ltd., Class A (Capital Goods)†

     900        12,427  

Shenzhou International Group Holdings Ltd. (Consumer Durables & Apparel)†

     1,000        21,880  

Sino Biopharmaceutical Ltd. (Pharmaceuticals, Biotechnology & Life Sciences)†

     13,500        14,519  

Songcheng Performance Development Co., Ltd., Class A (Consumer Services)†

     4,200        14,085  

Sunny Optical Technology Group Co., Ltd. (Technology Hardware & Equipment)†

     600        14,478  

Suofeiya Home Collection Co., Ltd., Class A (Consumer Durables & Apparel)†

     4,000        17,985  

TAL Education Group - ADR (Consumer Services)*

     254        14,465  

Tencent Holdings Ltd. (Media & Entertainment)†

     200        15,995  

TravelSky Technology Ltd., Class H (Software & Services)†

     5,000        10,946  

Trip.com Group Ltd. (Retailing)*

     514        20,367  

Wuliangye Yibin Co., Ltd., Class A (Food Beverage & Tobacco)†

     500        21,991  

WuXi AppTec Co., Ltd., Class A (Pharmaceuticals, Biotechnology & Life Sciences)†

     572        13,992  

Wuxi Biologics Cayman Inc. (Pharmaceuticals, Biotechnology & Life Sciences)*^†

     1,500        21,040  

Yonyou Network Technology Co., Ltd., Class A (Software & Services)†

     1,700        8,680  
        783,525  

Colombia - 0.3%

     

Ecopetrol SA - Sponsored ADR (Energy)

     800        9,464  

Grupo Nutresa SA (Food Beverage & Tobacco)

     2,782        15,936  
        25,400  

Czech Republic - 0.2%

     

Komercni banka AS (Banks)*†

     493        14,946  
     Shares      Value  
COMMON STOCKS - 97.1%     (continued)         

Denmark - 1.2%

     

Chr Hansen Holding A/S (Materials)*†

     129        $11,853  

Coloplast A/S, Class B (Health Care Equipment & Services)†

     193        31,935  

Genmab A/S (Pharmaceuticals, Biotechnology & Life Sciences)*†

     39        14,388  

Novozymes A/S, Class B (Materials)†

     732        52,070  
        110,246  

Egypt - 0.2%

     

Commercial International Bank Egypt SAE - GDR, Reg S (Banks)†

     4,564        16,675  

Finland - 0.4%

     

Kone OYJ, Class B (Capital Goods)†

     211        16,581  

Neste OYJ (Energy)†

     314        19,052  
        35,633  

France - 3.9%

     

Air Liquide SA (Materials)†

     330        55,582  

Dassault Systemes SE (Software & Services)†

     130        30,149  

IPSOS (Media & Entertainment)†

     1,082        45,058  

Kering SA (Consumer Durables & Apparel)†

     26        20,828  

LISI (Capital Goods)*†

     1,514        48,868  

L’Oreal SA (Household & Personal Products)†

     49        20,124  

Rubis SCA (Utilities)†

     1,135        53,275  

Safran SA (Capital Goods)*†

     327        48,806  

Sartorius Stedim Biotech (Pharmaceuticals, Biotechnology & Life Sciences)†

     41        18,838  

Schneider Electric SE (Capital Goods)†

     159        25,421  
        366,949  

Germany - 4.1%

     

adidas AG (Consumer Durables & Apparel)*†

     60        18,528  

Allianz SE, Reg S (Insurance)†

     230        59,838  

Bayerische Motoren Werke AG (Automobiles & Components)†

     778        77,982  

Bechtle AG (Software & Services)†

     82        16,713  

Brenntag AG (Capital Goods)†

     257        23,077  

Carl Zeiss Meditec AG (Bearer) (Health Care Equipment & Services)†

     134        23,604  

FUCHS PETROLUB SE (Materials)†

     375        16,254  
 

 

See Notes to Financial Statements

 

23


Table of Contents

Harding, Loevner Funds, Inc.

 

Global Equity Research Portfolio

Portfolio of Investments (continued)

April 30, 2021 (unaudited)

 

 

     Shares      Value  
COMMON STOCKS - 97.1%     (continued)         

Germany - 4.1%     (continued)

     

Infineon Technologies AG (Semiconductors & Semiconductor Equipment)†

     438        $17,688  

KWS Saat SE & Co. KGaA (Food Beverage & Tobacco)†

     393        34,955  

Nemetschek SE (Software & Services)†

     246        18,335  

SAP SE - Sponsored ADR (Software & Services)

     110        15,393  

Scout24 AG (Media & Entertainment)^†

     235        19,575  

Symrise AG (Materials)†

     160        20,665  

TeamViewer AG (Software & Services)*^†

     366        17,404  
        380,011  

Hong Kong - 1.3%

     

AIA Group Ltd. (Insurance)†

     1,600        20,340  

ASM Pacific Technology Ltd. (Semiconductors & Semiconductor Equipment)†

     1,800        27,192  

Sands China Ltd. (Consumer Services)*†

     6,400        30,338  

Techtronic Industries Co., Ltd. (Capital Goods)†

     2,500        45,224  
        123,094  

India - 1.4%

     

Asian Paints Ltd. (Materials)†

     460        15,723  

Dabur India Ltd. (Household & Personal Products)†

     1,812        13,159  

Godrej Consumer Products Ltd. (Household & Personal Products)*†

     1,225        11,424  

Hero MotoCorp Ltd. (Automobiles & Components)†

     419        15,943  

ICICI Bank Ltd. - Sponsored ADR (Banks)*

     1,034        16,854  

Kotak Mahindra Bank Ltd. (Banks)*†

     608        14,347  

Pidilite Industries Ltd. (Materials)*†

     572        13,999  

Tata Consultancy Services Ltd. (Software & Services)†

     741        30,344  
        131,793  

Indonesia - 0.3%

     

Astra International Tbk PT (Automobiles &
Components)†

     33,400        12,678  

Unilever Indonesia Tbk PT (Household & Personal Products)†

     38,500        15,989  
                28,667  

Italy - 0.8%

     

Amplifon SpA (Health Care Equipment & Services)*†

     439        18,532  

 

     Shares      Value  
COMMON STOCKS - 97.1%     (continued)         

Italy - 0.8%     (continued)

     

DiaSorin SpA (Health Care Equipment & Services)†

     82        $13,924  

FinecoBank Banca Fineco SpA (Banks)*†

     1,194        20,601  

Reply SpA (Software & Services)†

     131        17,793  
        70,850  

Japan - 8.9%

     

ABC-Mart Inc. (Retailing)†

     700        37,435  

Benefit One Inc. (Commercial & Professional Services)†

     1,000        25,115  

BML Inc. (Health Care Equipment & Services)†

     1,100        38,121  

Chugai Pharmaceutical Co., Ltd. (Pharmaceuticals, Biotechnology & Life Sciences)†

     600        22,544  

Cosmos Pharmaceutical Corp. (Food & Staples Retailing)†

     300        43,031  

FANUC Corp. (Capital Goods)†

     100        23,056  

Fast Retailing Co., Ltd. (Retailing)†

     20        16,430  

Hakuhodo DY Holdings Inc. (Media & Entertainment)†

     3,100        52,254  

Kakaku.com Inc. (Media & Entertainment)†

     500        13,597  

Keyence Corp. (Technology Hardware & Equipment)†

     46        22,123  

Kobayashi Pharmaceutical Co., Ltd. (Household & Personal Products)†

     150        13,389  

Komatsu Ltd. (Capital Goods)†

     900        26,416  

Kubota Corp. (Capital Goods)†

     2,600        61,174  

M3 Inc. (Health Care Equipment & Services)†

     300        20,749  

Makita Corp. (Capital Goods)†

     1,200        53,982  

MISUMI Group Inc. (Capital Goods)†

     700        19,735  

Nitori Holdings Co., Ltd. (Retailing)†

     400        71,690  

Nomura Research Institute Ltd. (Software & Services)†

     890        27,347  

Rinnai Corp. (Consumer Durables & Apparel)†

     540        54,276  

Shimano Inc. (Consumer Durables & Apparel)†

     80        18,303  

Shionogi & Co., Ltd. (Pharmaceuticals, Biotechnology & Life Sciences)†

     300        15,782  

Shiseido Co., Ltd. (Household & Personal Products)†

     300        21,773  

SMC Corp. (Capital Goods)†

     40        23,239  

Stanley Electric Co., Ltd. (Automobiles & Components)†

     500        14,329  
 

 

See Notes to Financial Statements

 

24


Table of Contents

Harding, Loevner Funds, Inc.

 

Global Equity Research Portfolio

Portfolio of Investments (continued)

April 30, 2021 (unaudited)

 

 

     Shares      Value  
COMMON STOCKS - 97.1%     (continued)         

Japan - 8.9%     (continued)

     

Sugi Holdings Co., Ltd. (Food & Staples Retailing)†

     500        $38,401  

Sysmex Corp. (Health Care Equipment & Services)†

     200        20,001  

Unicharm Corp. (Household & Personal Products)†

     900        34,879  
        829,171  

Mexico - 1.0%

     

Fomento Economico Mexicano SAB de CV - Sponsored ADR (Food Beverage & Tobacco)

     192        14,880  

Grupo Financiero Banorte SAB de CV, Series O (Banks)

     3,300        18,775  

Wal-Mart de Mexico SAB de CV (Food & Staples Retailing)

     18,700        61,213  
        94,868  

Netherlands - 1.4%

     

Adyen NV (Software & Services)*^†

     8        19,644  

ASML Holding NV, Reg S (Semiconductors & Semiconductor Equipment)

     90        58,329  

Koninklijke Vopak NV (Energy)†

     653        29,913  

Prosus NV (Retailing)*†

     166        18,000  
        125,886  

Norway - 0.2%

     

Tomra Systems ASA (Commercial & Professional Services)†

     375        18,802  

Pakistan - 0.4%

     

MCB Bank Ltd. (Banks)†

     10,800        11,411  

Oil & Gas Development Co., Ltd. (Energy)†

     48,700        28,838  
        40,249  

Peru - 0.3%

     

Alicorp SAA (Food Beverage & Tobacco)

     9,290        16,935  

Credicorp Ltd. (Banks)

     55        6,567  
        23,502  

Philippines - 1.1%

     

Bank of the Philippine Islands (Banks)†

     12,490        21,480  

BDO Unibank Inc. (Banks)†

     10,070        21,560  

International Container Terminal Services Inc. (Transportation)†

     4,970        13,415  

Robinsons Retail Holdings Inc. (Food & Staples Retailing)†

     10,510        11,459  

Security Bank Corp. (Banks)†

     4,340        10,404  

SM Prime Holdings Inc. (Real Estate)†

     12,800        9,154  
     Shares    Value
COMMON STOCKS - 97.1%     (continued)     

Philippines - 1.1%     (continued)

         

Universal Robina Corp. (Food Beverage & Tobacco)†

       6,400      $ 18,206
            105,678

Poland - 0.2%

         

ING Bank Slaski SA (Banks)*†

       426        19,474

Russia - 0.8%

         

LUKOIL PJSC - Sponsored ADR (Energy)

       278        21,473

Novatek PJSC - Sponsored GDR,

         

Reg S (Energy)†

       89        16,017

Sberbank of Russia PJSC - Sponsored ADR (Banks)†

       1,278        20,108

Yandex NV, Class A (Media & Entertainment)*

       188        12,323
            69,921

Saudi Arabia - 0.9%

         

Al Rajhi Bank (Banks)†

       631        16,635

Jarir Marketing Co. (Retailing)†

       252        13,374

Saudi National Bank (Banks)*†

       3,383        51,244
            81,253

Singapore - 1.5%

         

DBS Group Holdings Ltd. (Banks)†

       2,418        54,380

Oversea-Chinese Banking Corp., Ltd. (Banks)†

       9,103        83,494
            137,874

South Africa - 0.2%

         

Discovery Ltd. (Insurance)*†

       1,831        16,673

South Korea - 1.0%

         

Amorepacific Corp. (Household & Personal Products)†

       79        19,188

Cheil Worldwide Inc. (Media & Entertainment)†

       1,001        19,728

Coway Co., Ltd. (Consumer Durables & Apparel)†

       184        11,058

LG Household & Health Care Ltd. (Household & Personal Products)†

       9        12,433

NAVER Corp. (Media & Entertainment)†

       55        17,723

NCSoft Corp. (Media & Entertainment)†

       18        13,402
            93,532

Spain - 1.8%

         

Amadeus IT Group SA (Software & Services)*†

       248        16,888

Banco Bilbao Vizcaya Argentaria SA (Banks)*†

       6,148        34,449

Banco Santander SA - Sponsored ADR (Banks)*

       14,529        55,356

Bankinter SA (Banks)†

       8,132        44,567
 

 

See Notes to Financial Statements

 

25


Table of Contents

Harding, Loevner Funds, Inc.

 

Global Equity Research Portfolio

Portfolio of Investments (continued)

April 30, 2021 (unaudited)

 

 

     Shares      Value  
COMMON STOCKS - 97.1%     (continued)         

Spain - 1.8%     (continued)

     

Linea Directa Aseguradora SA Cia de Seguros y Reaseguros (Insurance)*

     8,132        $15,936  
        167,196  

Sweden - 2.4%

     

Alfa Laval AB (Capital Goods)†

     887        30,124  

Assa Abloy AB, Class B (Capital Goods)†

     664        18,933  

Atlas Copco AB, Class A (Capital Goods)†

     544        32,977  

Epiroc AB, Class A (Capital Goods)†

     1,467        31,805  

Evolution Gaming Group AB (Consumer Services)^†

     112        22,129  

Hexagon AB, Class B (Technology Hardware & Equipment)†

     270        25,749  

Intrum AB (Commercial & Professional Services)†

     1,097        37,782  

Skandinaviska Enskilda Banken AB, Class A (Banks)†

     1,670        21,428  
        220,927  

Switzerland - 2.5%

     

Alcon Inc. (Health Care Equipment & Services)*

     661        49,859  

Cie Financiere Richemont SA, Class A, Reg S (Consumer Durables & Apparel)†

     244        25,037  

Lonza Group AG, Reg S (Pharmaceuticals, Biotechnology & Life Sciences)†

     60        38,180  

SGS SA, Reg S (Commercial & Professional Services)†

     8        23,694  

Sonova Holding AG, Reg S (Health Care Equipment & Services)*†

     68        20,128  

Straumann Holding AG, Reg S (Health Care Equipment & Services)†

     15        21,512  

Temenos AG, Reg S (Software & Services)†

     98        14,402  

VAT Group AG (Capital Goods)^†

     96        27,496  

Vifor Pharma AG (Pharmaceuticals, Biotechnology & Life Sciences)†

     91        13,118  
        233,426  

Taiwan - 2.3%

     

Advantech Co., Ltd. (Technology Hardware & Equipment)†

     999        12,683  

Airtac International Group (Capital Goods)†

     400        17,037  
     Shares      Value  
COMMON STOCKS - 97.1%     (continued)         

Taiwan - 2.3%     (continued)

     

Chipbond Technology Corp. (Semiconductors & Semiconductor Equipment)†

     14,000        $38,641  

Hon Hai Precision Industry Co., Ltd. (Technology Hardware & Equipment)†

     17,000        71,160  

Largan Precision Co., Ltd. (Technology Hardware & Equipment)†

     100        11,104  

Silergy Corp. (Semiconductors & Semiconductor Equipment)†

     200        21,190  

Taiwan Semiconductor Manufacturing Co., Ltd. (Semiconductors & Semiconductor Equipment)†

     2,000        43,340  
        215,155  

Thailand - 0.2%

     

Siam Commercial Bank pcl, Reg S (Banks)†

     6,200        20,907  

Turkey - 0.1%

     

BIM Birlesik Magazalar AS (Food & Staples Retailing)†

     1,226        9,622  

United Arab Emirates - 0.2%

     

Emaar Properties PJSC (Real Estate)†

     18,834        19,077  

United Kingdom - 3.7%

     

Abcam plc (Pharmaceuticals, Biotechnology & Life Sciences)*†

     970        20,547  

Clarkson plc (Transportation)†

     506        21,208  

Coca-Cola HBC AG - CDI (Food Beverage & Tobacco)*†

     751        25,968  

Compass Group plc (Consumer Services)*†

     967        20,992  

Dechra Pharmaceuticals plc (Pharmaceuticals, Biotechnology & Life Sciences)†

     780        43,445  

Grafton Group plc (Capital Goods)†

     2,919        48,079  

Halma plc (Technology Hardware & Equipment)†

     511        18,260  

HomeServe plc (Commercial & Professional Services)†

     977        14,757  

Intertek Group plc (Commercial & Professional Services)†

     242        20,509  

Reckitt Benckiser Group plc (Household & Personal Products)†

     152        13,549  

Rio Tinto plc (Materials)†

     225        18,909  

Royal Dutch Shell plc, Class B - Sponsored ADR (Energy)

     790        28,290  

Spirax-Sarco Engineering plc (Capital Goods)†

     154        25,123  
 

 

See Notes to Financial Statements

 

26


Table of Contents

Harding, Loevner Funds, Inc.

 

Global Equity Research Portfolio

Portfolio of Investments (continued)

April 30, 2021 (unaudited)

 

 

     Shares      Value  
COMMON STOCKS - 97.1%     (continued)         

United Kingdom - 3.7%     (continued)

     

Standard Chartered plc (Banks)†

     3,634        $26,083  
        345,719  

United States - 40.7%

     

Abbott Laboratories (Health Care Equipment & Services)

     390        46,831  

AbbVie Inc. (Pharmaceuticals, Biotechnology & Life Sciences)

     847        94,440  

ABIOMED Inc. (Health Care Equipment & Services)*

     55        17,640  

Accenture plc, Class A (Software & Services)

     70        20,298  

Adobe Inc. (Software & Services)*

     90        45,751  

Air Products and Chemicals Inc. (Materials)

     253        72,985  

Allegion plc (Capital Goods)

     570        76,597  

Alphabet Inc., Class A (Media & Entertainment)*

     45        105,907  

Amazon.com Inc. (Retailing)*

     14        48,544  

AMETEK Inc. (Capital Goods)

     147        19,835  

Amphenol Corp., Class A (Technology Hardware & Equipment)

     288        19,394  

ANSYS Inc. (Software & Services)*

     78        28,521  

Apple Inc. (Technology Hardware & Equipment)

     260        34,180  

Atlassian Corp. plc, Class A (Software & Services)*

     117        27,794  

Automatic Data Processing Inc. (Software & Services)

     418        78,162  

BorgWarner Inc. (Automobiles & Components)

     919        44,645  

Church & Dwight Co., Inc. (Household & Personal Products)

     787        67,477  

Cisco Systems Inc. (Technology Hardware & Equipment)

     1,988        101,209  

CME Group Inc. (Diversified Financials)

     88        17,775  

Cognex Corp. (Technology Hardware & Equipment)

     230        19,808  

Cognizant Technology Solutions Corp., Class A (Software & Services)

     1,240        99,696  

Colgate-Palmolive Co. (Household & Personal Products)

     825        66,577  

Costco Wholesale Corp. (Food & Staples Retailing)

     49        18,232  

Danaher Corp. (Health Care Equipment & Services)

     80        20,315  

Deere & Co. (Capital Goods)

     200        74,170  

Domino’s Pizza Inc. (Consumer Services)

     137        57,861  
     Shares    Value
COMMON STOCKS - 97.1%     (continued)     

United States - 40.7%     (continued)

         

eBay Inc. (Retailing)

       1,273      $ 71,021

Ecolab Inc. (Materials)

       84        18,826

Edwards Lifesciences Corp. (Health Care Equipment & Services)*

       212        20,250

Emerson Electric Co. (Capital Goods)

       666        60,266

EnerSys (Capital Goods)

       200        18,316

EPAM Systems Inc. (Software & Services)*

       59        27,007

Estee Lauder Cos., Inc., Class A (Household & Personal Products)

       73        22,907

Etsy Inc. (Retailing)*

       183        36,379

Exxon Mobil Corp. (Energy)

       1,474        84,372

Facebook Inc., Class A (Media & Entertainment)*

       270        87,772

First Republic Bank (Banks)

       119        21,806

Gartner Inc. (Software & Services)*

       100        19,588

Guidewire Software Inc. (Software & Services)*

       152        16,038

Healthcare Services Group Inc. (Commercial & Professional Services)

       622        18,629

HEICO Corp. (Capital Goods)

       290        40,832

Honeywell International Inc. (Capital Goods)

       314        70,035

IDEXX Laboratories Inc. (Health Care Equipment & Services)*

       70        38,429

Illumina Inc. (Pharmaceuticals, Biotechnology & Life Sciences)*

       60        23,570

Intuitive Surgical Inc. (Health Care Equipment & Services)*

       21        18,165

IPG Photonics Corp. (Technology Hardware & Equipment)*

       95        20,625

IQVIA Holdings Inc. (Pharmaceuticals, Biotechnology & Life Sciences)*

       100        23,469

Johnson & Johnson (Pharmaceuticals, Biotechnology & Life Sciences)

       501        81,528

JPMorgan Chase & Co. (Banks)

       641        98,592

Linde plc (Materials)†

       169        48,392

Mastercard Inc., Class A (Software & Services)

       230        87,874

McDonald’s Corp. (Consumer Services)

       85        20,067

 

 

 

See Notes to Financial Statements

 

27


Table of Contents

Harding, Loevner Funds, Inc.

 

Global Equity Research Portfolio

Portfolio of Investments (continued)

April 30, 2021 (unaudited)

 

 

     Shares      Value  
COMMON STOCKS - 97.1% (continued)         

United States - 40.7% (continued)

     

Merck & Co., Inc. (Pharmaceuticals, Biotechnology & Life Sciences)

     734        $54,683  

Mettler-Toledo International Inc. (Pharmaceuticals, Biotechnology & Life Sciences)*

     19        24,953  

Microsoft Corp. (Software & Services)

     363        91,541  

Neurocrine Biosciences Inc. (Pharmaceuticals, Biotechnology & Life Sciences)*

     445        42,048  

NIKE Inc., Class B (Consumer Durables & Apparel)

     156        20,689  

Ollie’s Bargain Outlet Holdings Inc. (Retailing)*

     255        23,529  

Palo Alto Networks Inc. (Software & Services)*

     52        18,376  

PayPal Holdings Inc. (Software & Services)*

     161        42,229  

Penumbra Inc. (Health Care Equipment & Services)*

     62        18,971  

Planet Fitness Inc., Class A (Consumer Services)*

     203        17,050  

Procter & Gamble Co. (Household & Personal Products)

     532        70,979  

Reinsurance Group of America Inc. (Insurance)

     697        90,979  

Republic Services Inc. (Commercial & Professional Services)

     185        19,665  

ResMed Inc. (Health Care Equipment & Services)

     81        15,226  

Rollins Inc. (Commercial & Professional Services)

     1,132        42,201  

Roper Technologies Inc. (Capital Goods)

     47        20,983  

salesforce.com Inc. (Software & Services)*

     130        29,942  

Schlumberger NV (Energy)

     698        18,881  

Sensata Technologies Holding plc (Capital Goods)*

     328        18,939  

ServiceNow Inc. (Software & Services)*

     54        27,344  

Signature Bank (Banks)

     150        37,726  

Starbucks Corp. (Consumer Services)

     578        66,175  

Stryker Corp. (Health Care Equipment & Services)

     73        19,172  

SVB Financial Group (Banks)*

     102        58,327  

Synopsys Inc. (Software & Services)*

     269        66,459  
     Shares      Value  
COMMON STOCKS - 97.1% (continued)         

United States - 40.7% (continued)

     

Texas Instruments Inc. (Semiconductors & Semiconductor Equipment)

     115        $20,759  

Thermo Fisher Scientific Inc. (Pharmaceuticals, Biotechnology & Life Sciences)

     60        28,214  

UnitedHealth Group Inc. (Health Care Equipment & Services)

     276        110,069  

Verisk Analytics Inc. (Commercial & Professional Services)

     249        46,862  

Vertex Pharmaceuticals Inc. (Pharmaceuticals, Biotechnology & Life Sciences)*

     433        94,481  

Visa Inc., Class A (Software & Services)

     76        17,751  

Walt Disney Co. (Media & Entertainment)*

     98        18,230  

Workday Inc., Class A (Software & Services)*

     140        34,580  

Zoetis Inc. (Pharmaceuticals, Biotechnology & Life Sciences)

     261        45,161  
                3,792,573  

Total Common Stocks (Cost $6,431,516)

 

     $9,038,760  
  
PREFERRED STOCKS - 1.6%              

Brazil - 0.3%

     

Banco Bradesco SA - ADR (Banks)*

     3,143        13,671  

Itau Unibanco Holding SA - Sponsored ADR, 0.62% (Banks)+

     3,374        16,870  
        30,541  

Colombia - 0.1%

     

Bancolombia SA - Sponsored .ADR, 0.88% (Banks)+

     360        10,775  

Germany - 0.9%

     

Henkel AG & Co. KGaA, 1.95% (Household & Personal Products)+†

     547        62,828  

Sartorius AG, 0.16% (Health Care Equipment &
Services)+†

     33        18,617  
        81,445  

 

 

 

See Notes to Financial Statements

 

28


Table of Contents

Harding, Loevner Funds, Inc.

 

Global Equity Research Portfolio

Portfolio of Investments (continued)

April 30, 2021 (unaudited)

 

 

     Shares      Value  
PREFERRED STOCKS - 1.6%     (continued)         

South Korea - 0.3%

     

Samsung Electronics Co., Ltd. - GDR, Reg S, 1.94% (Technology Hardware & Equipment)+†

     17        $28,095  

Total Preferred Stocks (Cost $132,228)

 

     $150,856  
                   

SHORT TERM INVESTMENTS - 1.3%

 

        

Northern Institutional Funds - Treasury Portfolio (Premier Shares), 0.01% (Money Market Funds)

     121,664        121,664  

Total Short Term Investments (Cost $121,664)

 

     $121,664  
                   

Total Investments - 100.0%

                 

(Cost $6,685,408)

              $9,311,280  

Other Assets Less Liabilities - 0.0%

              269  

Net Assets - 100.0%

 

     $9,311,549  

Summary of Abbreviations

 

ADR

American Depositary Receipt

 

CDI

Chess Depositary Interest

 

GDR

Global Depositary Receipt

 

Reg S

Security sold outside United States without registration under the Securities Act of 1933.

 

*

Non-income producing security.

 

Investment categorized as level 2 security as disclosed in Note 2 of the Notes to Financial Statements.

 

^

Security exempt from registration pursuant to Rule 144A of the Securities Act of 1933. These securities, which represent 1.7% of net assets as of April 30, 2021, are considered liquid and may be resold in transactions exempt from registration, normally to qualified buyers.

 

+

Current yield is disclosed. Dividends are calculated based on a percentage of the issuer’s net income.

 

Industry       
Percentage of
Net Assets
 
 

Automobiles & Components

       2.0 %

Banks

       9.9

Capital Goods

       11.7

Commercial & Professional Services

       3.2

Consumer Durables & Apparel

       2.5

Consumer Services

       3.0

Diversified Financials

       0.3

Energy

       3.3

Food & Staples Retailing

       2.9

Food Beverage & Tobacco

       2.5

Health Care Equipment & Services

       6.6

Household & Personal Products

       5.0

Insurance

       2.3

Materials

       4.0

Media & Entertainment

       5.1

Pharmaceuticals, Biotechnology & Life Sciences

       8.6

Real Estate

       0.3

Retailing

       4.5

Semiconductors & Semiconductor Equipment

       2.4

Software & Services

       11.6

Technology Hardware & Equipment

       4.6

Transportation

       1.5

Utilities

       0.9

Money Market Fund

       1.3

Total Investments

       100.0

Other Assets Less Liabilities

       0.0

Net Assets

       100.0 %
 

 

See Notes to Financial Statements

 

29


Table of Contents

Harding, Loevner Funds, Inc.

 

International Equity Research Portfolio

Portfolio of Investments

April 30, 2021 (unaudited)

 

 

 

     Shares      Value  
COMMON STOCKS - 96.6%              

Argentina - 0.2%

     

Globant SA (Software & Services)*

     164        $37,586  

Australia - 1.5%

     

BHP Group Ltd. (Materials)†

     4,296        156,161  

Cochlear Ltd. (Health Care Equipment & Services)†

     451        77,191  
        233,352  

Brazil - 1.7%

     

Ambev SA - ADR (Food Beverage & Tobacco)

     13,956        38,798  

B3 SA - Brasil Bolsa Balcao (Diversified Financials)

     2,900        27,494  

Cia Brasileira de Distribuicao - ADR (Food & Staples Retailing)

     6,733        49,959  

Localiza Rent a Car SA (Transportation)*

     3,100        36,695  

Raia Drogasil SA (Food & Staples Retailing)*

     7,000        33,891  

Ultrapar Participacoes SA - Sponsored ADR (Energy)

     10,307        39,991  

WEG SA (Capital Goods)

     6,200        39,960  
        266,788  

Canada - 1.6%

     

Alimentation Couche-Tard Inc.

     

(Food & Staples Retailing)

     3,800        129,104  

Imperial Oil Ltd. (Energy)

     4,200        121,303  
        250,407  

Chile - 0.4%

     

Banco Santander Chile - ADR (Banks)

     2,474        55,022  

China - 11.9%

     

51job Inc. - ADR (Commercial & Professional Services)*

     694        42,716  

AAC Technologies Holdings Inc. (Technology Hardware & Equipment)†

     5,000        27,689  

Alibaba Group Holding Ltd. (Retailing)*†

     1,344        38,825  

Autohome Inc. - ADR (Media & Entertainment)

     422        39,132  

Baidu Inc., Class A (Media & Entertainment)*

     1,350        35,767  

China Merchants Bank Co., Ltd., Class A (Banks)†

     5,300        43,118  

China Tourism Group Duty Free Corp., Ltd., Class A (Retailing)†

     800        38,362  

Country Garden Services Holdings Co., Ltd. (Commercial & Professional Services)†

     5,000        52,252  
     Shares      Value  
COMMON STOCKS - 96.6% (continued)         

China - 11.9% (continued)

     

CSPC Pharmaceutical Group Ltd. (Pharmaceuticals, Biotechnology & Life Sciences)†

     39,600        $48,998  

ENN Energy Holdings Ltd. (Utilities)†

     4,300        73,208  

Fuyao Glass Industry Group Co., Ltd., Class H (Automobiles & Components)^†

     4,400        25,484  

Glodon Co., Ltd., Class A (Software & Services)†

     3,480        39,091  

Gree Electric Appliances Inc. of Zhuhai, Class A (Consumer Durables & Apparel)†

     3,300        30,516  

Haitian International Holdings Ltd. (Capital Goods)†

     14,400        58,612  

Hangzhou Tigermed Consulting Co., Ltd., Class A (Pharmaceuticals, Biotechnology & Life Sciences)† Inner Mongolia Yili Industrial Group Co., Ltd., Class A (Food Beverage & Tobacco)†

    
1,400
10,700
 
 
    
33,776
67,640
 
 

JD.com Inc., Class A (Retailing)*†

     1,176        45,429  

Jiangsu Expressway Co., Ltd., Class H (Transportation)†

     32,000        37,660  

Jiangsu Hengrui Medicine Co., Ltd., Class A (Pharmaceuticals, Biotechnology & Life Sciences)†

     2,720        35,287  

Jiangsu Yanghe Brewery Joint-Stock Co., Ltd., Class A (Food Beverage & Tobacco)†

     1,800        53,641  

Kweichow Moutai Co., Ltd., Class A (Food Beverage & Tobacco)†

     100        30,942  

Meituan, Class B (Retailing)*^†

     900        34,267  

Midea Group Co., Ltd., Class A (Consumer Durables & Apparel)†

     3,400        42,056  

NetEase Inc. - ADR (Media & Entertainment)

     610        68,357  

New Oriental Education & Technology Group Inc. (Consumer Services)*†

     2,490        38,274  

Ping An Insurance Group Co. of China Ltd., Class A (Insurance)†

     3,300        36,939  

Sangfor Technologies Inc., Class A (Software & Services)†

     1,100        46,427  

SF Holding Co., Ltd., Class A (Transportation)†

     3,800        37,746  
 

 

See Notes to Financial Statements

 

30


Table of Contents

Harding, Loevner Funds, Inc.

 

International Equity Research Portfolio

Portfolio of Investments (continued)

April 30, 2021 (unaudited)

 

 

     Shares      Value  
COMMON STOCKS - 96.6% (continued)              

China - 11.9% (continued)

     

Shanghai International Airport Co., Ltd., Class A (Transportation)†

     2,900        $21,998  

Shenzhen Inovance Technology Co., Ltd., Class A (Capital Goods)†

     2,700        37,282  

Shenzhou International Group Holdings Ltd. (Consumer Durables & Apparel)†

     2,000        43,759  

Sino Biopharmaceutical Ltd. (Pharmaceuticals, Biotechnology & Life Sciences)†

     36,500        39,256  

Songcheng Performance Development Co., Ltd., Class A (Consumer Services)†

     11,800        39,573  

Sunny Optical Technology Group Co., Ltd. (Technology Hardware & Equipment)†

     1,700        41,021  

Suofeiya Home Collection Co., Ltd., Class A (Consumer Durables & Apparel)†

     11,600        52,157  

TAL Education Group - ADR (Consumer Services)*

     702        39,979  

Tencent Holdings Ltd. (Media & Entertainment)†

     600        47,984  

TravelSky Technology Ltd., Class H (Software & Services)†

     14,000        30,648  

Trip.com Group Ltd. (Retailing)*

     1,251        49,571  

Wuliangye Yibin Co., Ltd., Class A (Food Beverage & Tobacco)†

     1,300        57,177  

WuXi AppTec Co., Ltd., Class A (Pharmaceuticals, Biotechnology & Life Sciences)†

     2,492        60,956  

Wuxi Biologics Cayman Inc. (Pharmaceuticals, Biotechnology & Life Sciences)*^†

     3,000        42,080  

Yonyou Network Technology Co., Ltd., Class A (Software & Services)†

     4,700        23,997  
        1,829,649  

Colombia - 0.6%

     

Ecopetrol SA - Sponsored ADR (Energy)

     3,713        43,925  

Grupo Nutresa SA (Food Beverage & Tobacco)

     7,328        41,977  
        85,902  

Czech Republic - 0.3%

     

Komercni banka AS (Banks)*†

     1,394        42,262  
     Shares      Value  
COMMON STOCKS - 96.6%   (continued)              

Denmark - 1.5%

     

Chr Hansen Holding A/S (Materials)*†

     741        $68,088  

Coloplast A/S, Class B (Health Care Equipment & Services)†

     399        66,020  

Genmab A/S (Pharmaceuticals, Biotechnology & Life Sciences)*†

     133        49,067  

Novozymes A/S, Class B (Materials)†

     598        42,538  
        225,713  

Egypt - 0.6%

     

Commercial International Bank Egypt SAE - GDR, Reg S (Banks)†

     25,199        92,066  

Finland - 0.6%

     

Kone OYJ, Class B (Capital Goods)†

     601        47,229  

Neste OYJ (Energy)†

     665        40,348  
        87,577  

France - 6.0%

     

Air Liquide SA (Materials)†

     763        128,512  

Dassault Systemes SE (Software & Services)†

     195        45,224  

IPSOS (Media & Entertainment)†

     2,319        96,571  

Kering SA (Consumer Durables & Apparel)†

     111        88,917  

LISI (Capital Goods)*†

     3,247        104,805  

L’Oreal SA (Household & Personal Products)†

     100        41,069  

Rubis SCA (Utilities)†

     3,302        154,991  

Safran SA (Capital Goods)*†

     590        88,059  

Sartorius Stedim Biotech (Pharmaceuticals, Biotechnology & Life Sciences)†

     103        47,325  

Schneider Electric SE (Capital Goods)†

     778        124,388  
        919,861  

Germany - 8.7%

     

adidas AG (Consumer Durables & Apparel)*†

     99        30,572  

Allianz SE, Reg S (Insurance)†

     560        145,692  

Bayerische Motoren Werke AG (Automobiles & Components)†

     1,550        155,363  

Bechtle AG (Software & Services)†

     421        85,810  

Brenntag AG (Capital Goods)†

     1,927        173,030  

Carl Zeiss Meditec AG (Bearer) (Health Care Equipment & Services)†

     256        45,094  

FUCHS PETROLUB SE (Materials)†

     2,618        113,474  
 

 

See Notes to Financial Statements

 

31


Table of Contents

Harding, Loevner Funds, Inc.

 

International Equity Research Portfolio

Portfolio of Investments (continued)

April 30, 2021 (unaudited)

 

 

     Shares      Value  
COMMON STOCKS - 96.6% (continued)              

Germany - 8.7% (continued)

     

Infineon Technologies AG (Semiconductors & Semiconductor Equipment)†

     1,274        $51,448  

KWS Saat SE & Co. KGaA (Food Beverage & Tobacco)†

     828        73,645  

Nemetschek SE (Software & Services)†

     528        39,352  

SAP SE - Sponsored ADR (Software & Services)

     757        105,935  

Scout24 AG (Media & Entertainment)^†

     1,202        100,124  

Symrise AG (Materials)†

     987        127,475  

TeamViewer AG (Software & Services)*^†

     1,870        88,924  
        1,335,938  

Hong Kong - 2.3%

     

AIA Group Ltd. (Insurance)†

     9,200        116,954  

ASM Pacific Technology Ltd. (Semiconductors & Semiconductor Equipment)†

     10,100        152,575  

Sands China Ltd. (Consumer Services)*† Techtronic Industries Co., Ltd.

     8,800        41,715  

(Capital Goods)†

     2,500        45,224  
        356,468  

India - 2.2%

     

Asian Paints Ltd. (Materials)† Dabur India Ltd. (Household &

     998        34,112  

Personal Products)†

     5,182        37,633  

Godrej Consumer Products Ltd. (Household & Personal Products)*†

     3,680        34,320  

Hero MotoCorp Ltd. (Automobiles & Components)†

     1,194        45,430  

ICICI Bank Ltd. - Sponsored ADR (Banks)*

     3,149        51,329  

Kotak Mahindra Bank Ltd. (Banks)*†

     1,697        40,043  

Pidilite Industries Ltd. (Materials)*†

     2,251        55,092  

Tata Consultancy Services Ltd. (Software & Services)†

     1,001        40,991  
        338,950  

Indonesia - 0.4%

     

Astra International Tbk PT (Automobiles & Components)†

     122,700        46,574  

Unilever Indonesia Tbk PT (Household & Personal Products)†

     53,600        22,261  
        68,835  

Italy - 1.8%

     

Amplifon SpA (Health Care Equipment & Services)*†

     927        39,133  

 

     Shares      Value  
COMMON STOCKS - 96.6% (continued)              

Italy - 1.8% (continued)

     

DiaSorin SpA (Health Care Equipment & Services)†

     281        $47,715  

FinecoBank Banca Fineco SpA (Banks)*†

     2,153        37,148  

Reply SpA (Software & Services)†

     1,107        150,357  
        274,353  

Japan - 15.3%

     

ABC-Mart Inc. (Retailing)† Benefit One Inc. (Commercial &

     1,840        98,401  

Professional Services)†

     2,200        55,254  

BML Inc. (Health Care Equipment & Services)†

     2,300        79,707  

Chugai Pharmaceutical Co., Ltd. (Pharmaceuticals, Biotechnology & Life Sciences)†

     2,600        97,691  

Cosmos Pharmaceutical Corp. (Food & Staples Retailing)†

     600        86,062  

FANUC Corp. (Capital Goods)†

     350        80,696  

Fast Retailing Co., Ltd. (Retailing)†

     40        32,860  

Hakuhodo DY Holdings Inc. (Media & Entertainment)†

     9,990        168,392  

Kakaku.com Inc. (Media & Entertainment)†

     2,900        78,862  

Keyence Corp. (Technology Hardware & Equipment)†

     100        48,094  

Kobayashi Pharmaceutical Co., Ltd. (Household & Personal Products)†

     800        71,407  

Komatsu Ltd. (Capital Goods)†

     5,040        147,929  

Kubota Corp. (Capital Goods)†

     6,700        157,640  

M3 Inc. (Health Care Equipment & Services)†

     500        34,582  

Makita Corp. (Capital Goods)†

     2,400        107,965  

MISUMI Group Inc. (Capital Goods)†

     2,200        62,026  

Nitori Holdings Co., Ltd. (Retailing)†

     800        143,380  

Nomura Research Institute Ltd. (Software & Services)†

     1,106        33,984  

Rinnai Corp. (Consumer Durables & Apparel)†

     1,200        120,613  

Shimano Inc. (Consumer Durables & Apparel)†

     170        38,893  

Shionogi & Co., Ltd. (Pharmaceuticals, Biotechnology & Life Sciences)†

     700        36,826  

Shiseido Co., Ltd. (Household & Personal Products)†

     600        43,547  

SMC Corp. (Capital Goods)†

     160        92,954  

Stanley Electric Co., Ltd. (Automobiles & Components)†

     4,815        137,984  
 

 

See Notes to Financial Statements

 

32


Table of Contents

Harding, Loevner Funds, Inc.

 

International Equity Research Portfolio

Portfolio of Investments (continued)

April 30, 2021 (unaudited)

 

 

     Shares    Value
COMMON STOCKS - 96.6% (continued)          

Japan - 15.3% (continued)

         

Sugi Holdings Co., Ltd. (Food & Staples Retailing)†

       1,755      $ 134,786

Sysmex Corp. (Health Care Equipment & Services)†

       500        50,003

Unicharm Corp. (Household & Personal Products)†

       2,800        108,512
            2,349,050

Mexico - 1.3%

         

Fomento Economico Mexicano SAB de CV - Sponsored ADR (Food Beverage & Tobacco)

       692        53,630

Grupo Financiero Banorte SAB de CV, Series O (Banks)

       9,600        54,618

Wal-Mart de Mexico SAB de CV

         

(Food & Staples Retailing)

       26,600        87,074
            195,322

Netherlands - 2.5%

         

Adyen NV (Software & Services)*^†

       18        44,199

ASML Holding NV, Reg S (Semiconductors & Semiconductor Equipment)

       212        137,397

Koninklijke Vopak NV (Energy)†

       2,669        122,264

Prosus NV (Retailing)*†

       757        82,082
            385,942

Norway - 0.3%

         

Tomra Systems ASA (Commercial & Professional Services)†

       804        40,311

Pakistan - 0.4%

         

MCB Bank Ltd. (Banks)†

       32,100        33,917

Oil & Gas Development Co., Ltd. (Energy)†

       47,100        27,890
            61,807

Peru - 0.3%

         

Alicorp SAA (Food Beverage & Tobacco)

       17,978        32,772

Credicorp Ltd. (Banks)

       159        18,984
            51,756

Philippines - 2.0%

         

Bank of the Philippine Islands (Banks)†

       27,440        47,190

BDO Unibank Inc. (Banks)†

       18,870        40,401

International Container Terminal Services Inc. (Transportation)†

       14,190        38,301

Robinsons Retail Holdings Inc. (Food & Staples Retailing)†

       39,680        43,264

Security Bank Corp. (Banks)†

       19,210        46,049

SM Prime Holdings Inc. (Real Estate)†

       83,300        59,571

 

     Shares      Value  
COMMON STOCKS - 96.6% (continued)              

Philippines - 2.0% (continued)

     

Universal Robina Corp. (Food Beverage & Tobacco)†

     9,040        $25,717  
        300,493  

Poland - 0.3%

     

ING Bank Slaski SA (Banks)*†

     980        44,800  

Russia - 1.1%

     

LUKOIL PJSC - Sponsored ADR (Energy)

     603        46,576  

Novatek PJSC - Sponsored GDR, Reg S (Energy)†

     190        34,194  

Sberbank of Russia PJSC - Sponsored ADR (Banks)†

     3,389        53,322  

Yandex NV, Class A (Media & Entertainment)*

     541        35,462  
        169,554  

Saudi Arabia - 1.0%

     

Al Rajhi Bank (Banks)†

     1,801        47,479  

Jarir Marketing Co. (Retailing)†

     724        38,425  

Saudi National Bank (Banks)*†

     4,522        68,497  
        154,401  

Singapore - 2.3%

     

DBS Group Holdings Ltd. (Banks)†

     7,914        177,982  

Oversea-Chinese Banking Corp., Ltd. (Banks)†

     19,084        175,041  
        353,023  

South Africa - 0.2%

     

Discovery Ltd. (Insurance)*†

     4,148        37,772  

South Korea - 1.6%

     

Amorepacific Corp. (Household & Personal Products)†

     223        54,162  

Cheil Worldwide Inc. (Media & Entertainment)†

     2,148        42,334  

Coway Co., Ltd. (Consumer Durables & Apparel)†

     524        31,491  

LG Household & Health Care Ltd. (Household & Personal Products)†

     29        40,062  

NAVER Corp. (Media & Entertainment)†

     111        35,769  

NCSoft Corp. (Media & Entertainment)†

     48        35,738  
        239,556  

Spain - 2.9%

     

Amadeus IT Group SA (Software & Services)*†

     528        35,955  

Banco Bilbao Vizcaya Argentaria SA (Banks)*†

     18,242        102,215  

Banco Santander SA - Sponsored ADR (Banks)*

     48,713        185,596  

Bankinter SA (Banks)†

     16,713        91,596  
 

 

See Notes to Financial Statements

 

33


Table of Contents

Harding, Loevner Funds, Inc.

 

International Equity Research Portfolio

Portfolio of Investments (continued)

April 30, 2021 (unaudited)

 

 

     Shares      Value  
COMMON STOCKS - 96.6% (continued)              

Spain - 2.9% (continued)

     

Linea Directa Aseguradora SA Cia de Seguros y Reaseguros (Insurance)*

     16,713        $32,752  
        448,114  

Sweden - 5.5%

     

Alfa Laval AB (Capital Goods)†

     3,916        132,993  

Assa Abloy AB, Class B (Capital Goods)†

     5,185        147,840  

Atlas Copco AB, Class A (Capital Goods)†

     998        60,498  

Epiroc AB, Class A (Capital Goods)†

     5,368        116,381  

Evolution Gaming Group AB (Consumer Services)^†

     230        45,444  

Hexagon AB, Class B (Technology Hardware & Equipment)†

     1,069        101,947  

Intrum AB (Commercial & Professional Services)†

     2,391        82,348  

Skandinaviska Enskilda Banken AB, Class A (Banks)†

     12,667        162,532  
        849,983  

Switzerland - 5.0%

     

Alcon Inc. (Health Care Equipment & Services)*

     1,961        147,918  

Cie Financiere Richemont SA, Class A, Reg S (Consumer Durables & Apparel)†

     1,343        137,807  

Lonza Group AG, Reg S (Pharmaceuticals, Biotechnology & Life Sciences)†

     123        78,269  

SGS SA, Reg S (Commercial & Professional Services)†

     25        74,045  

Sonova Holding AG, Reg S (Health Care Equipment & Services)*†

     140        41,440  

Straumann Holding AG, Reg S (Health Care Equipment & Services)†

     31        44,457  

Temenos AG, Reg S (Software & Services)†

     306        44,971  

VAT Group AG (Capital Goods)^†

     207        59,287  

Vifor Pharma AG (Pharmaceuticals, Biotechnology & Life Sciences)†

     983        141,704  
        769,898  

Taiwan - 3.2%

     

Advantech Co., Ltd. (Technology Hardware & Equipment)†

     6,998        88,849  

Airtac International Group (Capital Goods)†

     1,000        42,592  

 

     Shares      Value  
COMMON STOCKS - 96.6% (continued)              

Taiwan - 3.2% (continued)

     

Chipbond Technology Corp. (Semiconductors & Semiconductor Equipment)†

     21,000        $57,962  

Hon Hai Precision Industry Co., Ltd. (Technology Hardware & Equipment)†

     31,000        129,762  

Largan Precision Co., Ltd. (Technology Hardware & Equipment)†

     300        33,312  

Silergy Corp. (Semiconductors & Semiconductor Equipment)†

     500        52,975  

Taiwan Semiconductor Manufacturing Co., Ltd. (Semiconductors & Semiconductor Equipment)†

     4,000        86,679  
        492,131  

Thailand - 0.4%

     

Siam Commercial Bank pcl, Reg S(Banks)†

     16,000        53,954  

Turkey - 0.2%

     

BIM Birlesik Magazalar AS (Food & Staples Retailing)†

     4,402        34,550  

United Arab Emirates - 0.3%

     

Emaar Properties PJSC (Real Estate)†

     49,936        50,579  

United Kingdom - 8.2%

     

Abcam plc (Pharmaceuticals, Biotechnology & Life Sciences)*†

     1,734        36,730  

Clarkson plc (Transportation)†

     2,170        90,951  

Coca-Cola HBC AG - CDI (Food Beverage & Tobacco)*†

     1,189        41,112  

Compass Group plc (Consumer Services)*†

     1,938        42,070  

Dechra Pharmaceuticals plc (Pharmaceuticals, Biotechnology & Life Sciences)†

     2,000        111,397  

Grafton Group plc (Capital Goods)†

     6,261        103,126  

Halma plc (Technology Hardware & Equipment)†

     2,597        92,802  

HomeServe plc (Commercial & Professional Services)†

     9,991        150,909  

Intertek Group plc (Commercial & Professional Services)†

     804        68,136  

Reckitt Benckiser Group plc (Household & Personal Products)†

     777        69,260  

Rio Tinto plc (Materials)†

     1,986        166,906  

Royal Dutch Shell plc, Class B - Sponsored ADR (Energy)

     4,189        150,008  

Spirax-Sarco Engineering plc (Capital Goods)†

     248        40,458  
 

 

See Notes to Financial Statements

 

34


Table of Contents

Harding, Loevner Funds, Inc.

 

International Equity Research Portfolio

Portfolio of Investments (continued)

April 30, 2021 (unaudited)

 

 

     Shares      Value  
COMMON STOCKS - 96.6% (continued)              

United Kingdom - 8.2% (continued)

     

Standard Chartered plc (Banks)†

     12,421        $89,153  
        1,253,018  
                   

Total Common Stocks (Cost $11,116,301)

              $14,836,743  

PREFERRED STOCKS - 2.5%

     

Brazil - 0.5%

     

Banco Bradesco SA - ADR (Banks)*

     9,420        40,978  

Itau Unibanco Holding SA - Sponsored ADR, 0.62% (Banks)+

     7,362        36,811  
        77,789  

Colombia - 0.3%

     

Bancolombia SA - Sponsored ADR, 0.88%
(Banks)+

     1,501        44,925  

Germany - 1.3%

     

Henkel AG & Co. KGaA, 1.95% (Household & Personal Products)+†

     1,348        154,831  

Sartorius AG, 0.16% (Health Care Equipment & Services)+†

     70        39,491  
        194,322  

South Korea - 0.4%

     

Samsung Electronics Co., Ltd. - GDR, Reg S, 1.94% (Technology Hardware & Equipment)+†

     42        69,412  

Total Preferred Stocks (Cost $327,160)

              $386,448  
     
SHORT TERM INVESTMENTS - 0.8%              

Northern Institutional Funds - Treasury Portfolio (Premier Shares), 0.01% (Money Market Funds)

     117,852        117,852  

Total Short Term Investments (Cost $117,852)

 

     $117,852  
            

Total Investments - 99.9%

                 

(Cost $11,561,313)

              $15,341,043  

Other Assets Less Liabilities - 0.1%

              13,013  

Net Assets - 100.0%

              $15,354,056  

Summary of Abbreviations

 

ADR

American Depositary Receipt

 

CDI

Chess Depositary Interest

 

GDR

Global Depositary Receipt

 

Reg S

Security sold outside United States without registration under the Securities Act of 1933.

 

*

Non-income producing security.

Investment categorized as level 2 security as disclosed in Note 2 of the Notes to Financial Statements.

^

Security exempt from registration pursuant to Rule 144A of the Securities Act of 1933. These securities, which represent 2.9% of net assets as of April 30, 2021, are considered liquid and may be resold in transactions exempt from registration, normally to qualified buyers.

+

Current yield is disclosed. Dividends are calculated based on a percentage of the issuer’s net income.

 

Industry       
Percentage of
Net Assets
 
 

Automobiles & Components

       2.7 %

Banks

       12.9

Capital Goods

       13.5

Commercial & Professional Services

       3.7

Consumer Durables & Apparel

       4.0

Consumer Services

       1.6

Diversified Financials

       0.2

Energy

       4.1

Food & Staples Retailing

       3.9

Food Beverage & Tobacco

       3.4

Health Care Equipment & Services

       4.6

Household & Personal Products

       4.4

Insurance

       2.4

Materials

       5.8

Media & Entertainment

       5.1

Pharmaceuticals, Biotechnology & Life Sciences

       5.6

Real Estate

       0.7

Retailing

       3.9

Semiconductors & Semiconductor Equipment

       3.5

Software & Services

       5.8

Technology Hardware & Equipment

       4.1

Transportation

       1.7

Utilities

       1.5

Money Market Fund

       0.8

Total Investments

       99.9

Other Assets Less Liabilities

       0.1

Net Assets

       100.0 %
 

 

See Notes to Financial Statements

 

35


Table of Contents

Harding, Loevner Funds, Inc.

 

Emerging Markets Research Portfolio

Portfolio of Investments

April 30, 2021 (unaudited)

 

 

     Shares      Value  
COMMON STOCKS - 95.0%              

Argentina - 0.5%

     

Globant SA (Software & Services)*

     196        $44,919  

Bangladesh - 0.5%

     

GrameenPhone Ltd. (Telecommunication Services)†

     5,493        21,965  

Square Pharmaceuticals Ltd. (Pharmaceuticals, Biotechnology & Life Sciences)†

     10,847        27,065  
        49,030  

Brazil - 3.6%

     

Ambev SA - ADR (Food Beverage & Tobacco)

     20,505        57,004  

B3 SA - Brasil Bolsa Balcao (Diversified Financials)

     3,300        31,286  

Cia Brasileira de Distribuicao - ADR (Food & Staples Retailing)

     8,181        60,703  

Localiza Rent a Car SA (Transportation)*

     3,800        44,981  

Raia Drogasil SA (Food & Staples Retailing)*

     8,000        38,733  

Ultrapar Participacoes SA - Sponsored ADR (Energy)

     11,420        44,310  

WEG SA (Capital Goods)

     7,200        46,404  
        323,421  

Chile - 1.1%

     

Banco Santander Chile - ADR (Banks)

     4,331        96,321  

China - 37.2%

     

51job Inc. - ADR (Commercial & Professional Services)*

     721        44,378  

AAC Technologies Holdings Inc. (Technology Hardware & Equipment)†

     17,000        94,142  

Alibaba Group Holding Ltd. (Retailing)*†

     4,016        116,013  

Autohome Inc. - ADR (Media & Entertainment)

     442        40,987  

Baidu Inc., Class A (Media & Entertainment)*

     3,200        84,781  

China Merchants Bank Co., Ltd., Class A (Banks)†

     12,200        99,254  

China Tourism Group Duty Free Corp., Ltd., Class A (Retailing)†

     1,700        81,520  

Country Garden Services Holdings Co., Ltd. (Commercial & Professional Services)†

     5,000        52,252  

CSPC Pharmaceutical Group Ltd. (Pharmaceuticals, Biotechnology & Life Sciences)†

     146,080        180,746  
     Shares      Value  
COMMON STOCKS - 95.0%    (continued)              

China - 37.2%    (continued)

     

ENN Energy Holdings Ltd. (Utilities)†

     9,000        $153,227  

Fuyao Glass Industry Group Co., Ltd., Class H (Automobiles & Components)^†

     8,400        48,651  

Glodon Co., Ltd., Class A (Software & Services)†

     3,400        38,192  

Gree Electric Appliances Inc. of Zhuhai, Class A (Consumer Durables & Apparel)†

     19,300        178,471  

Haitian International Holdings Ltd. (Capital Goods)†

     15,000        61,054  

Hangzhou Tigermed Consulting Co., Ltd., Class A (Pharmaceuticals, Biotechnology & Life Sciences)†

     2,300        55,489  

Hefei Meiya Optoelectronic Technology Inc., Class A (Capital Goods)†

     3,700        27,370  

Inner Mongolia Yili Industrial Group Co., Ltd., Class A (Food Beverage & Tobacco)†

     11,300        71,433  

JD.com Inc., Class A (Retailing)*†

     3,302        127,556  

Jiangsu Expressway Co., Ltd., Class H (Transportation)†

     50,000        58,843  

Jiangsu Hengrui Medicine Co., Ltd., Class A (Pharmaceuticals, Biotechnology & Life Sciences)†

     5,400        70,055  

Jiangsu Yanghe Brewery Joint-Stock Co., Ltd., Class A (Food Beverage & Tobacco)†

     2,200        65,561  

Kweichow Moutai Co., Ltd., Class A (Food Beverage & Tobacco)†

     100        30,942  

Meituan, Class B (Retailing)*^†

     1,900        72,342  

Midea Group Co., Ltd., Class A (Consumer Durables & Apparel)†

     14,700        181,829  

NetEase Inc. - ADR (Media & Entertainment)

     1,395        156,324  

New Oriental Education & Technology Group Inc. (Consumer Services)*†

     2,610        40,119  

Ping An Insurance Group Co. of China Ltd., Class A (Insurance)†

     14,800        165,668  

Sangfor Technologies Inc., Class A (Software &
Services)†

     1,400        59,089  

SF Holding Co., Ltd., Class A (Transportation)†

     5,900        58,605  

Shanghai International Airport Co., Ltd., Class A (Transportation)†

     3,600        27,308  
 

 

See Notes to Financial Statements

 

36


Table of Contents

Harding, Loevner Funds, Inc.

 

Emerging Markets Research Portfolio

Portfolio of Investments (continued)

April 30, 2021 (unaudited)

 

 

     Shares      Value  
COMMON STOCKS - 95.0%    (continued)              

China - 37.2% (continued)

     

Shenzhen Inovance Technology Co., Ltd., Class A (Capital Goods)†

     3,200        $44,186  

Shenzhou International Group Holdings Ltd. (Consumer Durables & Apparel)†

     3,000        65,639  

Sino Biopharmaceutical Ltd. (Pharmaceuticals, Biotechnology & Life Sciences)†

     45,000        48,398  

Songcheng Performance Development Co., Ltd., Class A (Consumer Services)†

     14,000        46,951  

Sunny Optical Technology Group Co., Ltd. (Technology Hardware & Equipment)†

     2,000        48,260  

Suofeiya Home Collection Co., Ltd., Class A (Consumer Durables & Apparel)†

     13,700        61,599  

TAL Education Group - ADR (Consumer Services)*

     835        47,553  

Tencent Holdings Ltd. (Media & Entertainment)†

     1,900        151,949  

TravelSky Technology Ltd., Class H (Software & Services)†

     23,000        50,350  

Trip.com Group Ltd. (Retailing)*

     1,311        51,949  

Wuliangye Yibin Co., Ltd., Class A (Food Beverage & Tobacco)†

     1,100        48,380  

WuXi AppTec Co., Ltd., Class A (Pharmaceuticals, Biotechnology & Life Sciences)†

     2,856        69,860  

Wuxi Biologics Cayman Inc. (Pharmaceuticals, Biotechnology & Life Sciences)*^†

     3,000        42,080  

Yonyou Network Technology Co., Ltd., Class A (Software & Services)†

     5,500        28,082  
        3,347,437  

Colombia - 2.0%

     

Ecopetrol SA - Sponsored ADR (Energy)

     13,800        163,254  

Grupo Nutresa SA (Food Beverage & Tobacco)

     3,657        20,948  
        184,202  

Czech Republic - 0.8%

     

Komercni banka AS (Banks)*†

     2,407        72,973  

Egypt - 0.5%

     

Commercial International Bank Egypt SAE - GDR, Reg S (Banks)†

     11,703        42,758  
     Shares      Value  
COMMON STOCKS - 95.0%    (continued)              

India - 4.5%

     

Asian Paints Ltd. (Materials)†

     1,186        $40,538  

Dabur India Ltd. (Household & Personal Products)†

     6,102        44,315  

Godrej Consumer Products Ltd. (Household & Personal Products)*†

     2,406        22,438  

Hero MotoCorp Ltd. (Automobiles & Components)†

     2,039        77,582  

ICICI Bank Ltd. - Sponsored ADR (Banks)*

     4,150        67,645  

Kotak Mahindra Bank Ltd. (Banks)*†

     1,950        46,013  

Pidilite Industries Ltd. (Materials)*†

     2,034        49,781  

Tata Consultancy Services Ltd. (Software & Services)†

     1,502        61,507  
        409,819  

Indonesia - 1.0%

     

Astra International Tbk PT (Automobiles & Components)†

     116,400        44,183  

Unilever Indonesia Tbk PT (Household & Personal Products)†

     105,000        43,607  
        87,790  

Kazakhstan - 0.3%

     

Halyk Savings Bank of Kazakhstan JSC - GDR, Reg S(Banks)†

     1,610        23,056  

Kenya - 0.3%

     

Safaricom plc (Telecommunication Services)†

     62,300        23,310  

Malaysia - 0.5%

     

Dialog Group Bhd. (Energy)†

     63,800        47,317  

Mexico - 5.5%

     

Fomento Economico Mexicano SAB de CV - Sponsored ADR (Food Beverage & Tobacco)

     2,324        180,110  

Grupo Financiero Banorte SAB de CV, Series O (Banks)

     23,100        131,425  

Wal-Mart de Mexico SAB de CV (Food & Staples Retailing)

     57,000        186,586  
        498,121  

Morocco - 1.0%

     

Attijariwafa Bank (Banks)†

     1,345        64,639  

Maroc Telecom (Telecommunication Services)†

     1,491        22,999  
        87,638  
 

 

See Notes to Financial Statements

 

37


Table of Contents

Harding, Loevner Funds, Inc.

 

Emerging Markets Research Portfolio

Portfolio of Investments (continued)

April 30, 2021 (unaudited)

 

 

     Shares      Value  
COMMON STOCKS - 95.0%    (continued)         

Nigeria - 0.5%

     

Guaranty Trust Bank plc (Banks)†

     261,863        $19,283  

Zenith Bank plc (Banks)†

     414,394        22,558  
        41,841  

Pakistan - 0.4%

     

MCB Bank Ltd. (Banks)†

     17,600        18,596  

Oil & Gas Development Co., Ltd. (Energy)†

     27,700        16,403  
        34,999  

Peru - 0.6%

     

Alicorp SAA (Food Beverage & Tobacco)

     9,214        16,796  

Credicorp Ltd. (Banks)

     326        38,924  
        55,720  

Philippines - 3.9%

     

Bank of the Philippine Islands (Banks)†

     26,900        46,261  

BDO Unibank Inc. (Banks)†

     30,810        65,965  

International Container Terminal Services Inc. (Transportation)†

     24,950        67,345  

Jollibee Foods Corp. (Consumer Services)†

     6,330        23,138  

Robinsons Retail Holdings Inc. (Food & Staples Retailing)†

     24,910        27,160  

Security Bank Corp. (Banks)†

     10,700        25,650  

SM Prime Holdings Inc. (Real Estate)†

     72,700        51,990  

Universal Robina Corp. (Food Beverage & Tobacco)†

     15,950        45,374  
        352,883  

Poland - 0.3%

     

ING Bank Slaski SA (Banks)*†

     505        23,086  

Romania - 0.5%

     

Banca Transilvania SA (Banks)†

     35,213        21,404  

Societatea Nationala de Gaze Naturale ROMGAZ SA (Energy)†

     3,372        26,788  
        48,192  

Russia - 4.3%

     

LUKOIL PJSC - Sponsored ADR (Energy)

     1,778        137,333  

Novatek PJSC - Sponsored GDR, Reg S (Energy)†

     501        90,163  

Sberbank of Russia PJSC - Sponsored ADR (Banks)†

     7,465        117,453  

Yandex NV, Class A (Media & Entertainment)*

     643        42,148  
        387,097  

Saudi Arabia - 3.2%

     

Al Rajhi Bank (Banks)†

     2,128        56,099  
     Shares      Value  
COMMON STOCKS - 95.0%    (continued)         

Saudi Arabia - 3.2%    (continued)

     

Bupa Arabia for Cooperative Insurance Co. (Insurance)*†

     1,690        $52,082  

Jarir Marketing Co. (Retailing)†

     1,292        68,571  

Mouwasat Medical Services Co. (Health Care Equipment & Services)†

     471        22,258  

Saudi National Bank (Banks)*†

     5,813        88,052  
        287,062  

South Africa - 1.0%

     

Clicks Group Ltd. (Food & Staples Retailing)†

     1,322        22,067  

Discovery Ltd. (Insurance)*†

     7,600        69,207  
        91,274  

South Korea - 6.4%

     

Amorepacific Corp. (Household & Personal Products)†

     235        57,076  

Cheil Worldwide Inc. (Media & Entertainment)†

     3,865        76,173  

Coway Co., Ltd. (Consumer Durables & Apparel)†

     1,180        70,915  

LG Household & Health Care Ltd. (Household & Personal Products)†

     106        146,436  

NAVER Corp. (Media & Entertainment)†

     181        58,326  

NCSoft Corp. (Media & Entertainment)†

     228        169,757  
        578,683  

Taiwan - 8.5%

     

Advantech Co., Ltd. (Technology Hardware &
Equipment)†

     5,499        69,817  

Airtac International Group (Capital Goods)†

     1,200        51,110  

Chipbond Technology Corp. (Semiconductors & Semiconductor Equipment)†

     27,000        74,523  

Eclat Textile Co., Ltd. (Consumer Durables & Apparel)†

     4,000        77,022  

Hon Hai Precision Industry Co., Ltd. (Technology Hardware & Equipment)†

     42,000        175,807  

Largan Precision Co., Ltd. (Technology Hardware & Equipment)†

     700        77,728  

Silergy Corp. (Semiconductors & Semiconductor Equipment)†

     600        63,570  

Taiwan Semiconductor Manufacturing Co., Ltd. (Semiconductors & Semiconductor Equipment)†

     8,000        173,358  
        762,935  
 

 

See Notes to Financial Statements

 

38


Table of Contents

Harding, Loevner Funds, Inc.

 

Emerging Markets Research Portfolio

Portfolio of Investments (continued)

April 30, 2021 (unaudited)

 

 

     Shares      Value  
COMMON STOCKS - 95.0%    (continued)         

Thailand - 1.7%

     

Bumrungrad Hospital pcl, Reg S (Health Care Equipment & Services)†

     10,600        $45,617  

Siam Commercial Bank pcl, Reg S (Banks)†

     32,000        107,908  
        153,525  

Turkey - 1.0%

     

BIM Birlesik Magazalar AS (Food & Staples Retailing)†

     11,148        87,497  

United Arab Emirates - 0.6%

     

Emaar Properties PJSC (Real Estate)†

     53,031        53,714  

Vietnam - 2.8%

     

Bank for Foreign Trade of Vietnam JSC (Banks)†

     15,240        66,140  

Hoa Phat Group JSC (Materials)†

     46,716        117,266  

Saigon Beer Alcohol Beverage Corp. (Food Beverage & Tobacco)†

     2,320        16,841  

Vietnam Dairy Products JSC (Food Beverage & Tobacco)†

     11,810        47,765  
                248,012  

Total Common Stocks (Cost $6,894,111)

 

     $8,544,632  
  
PREFERRED STOCKS - 3.9%              

Brazil - 1.5%

     

Banco Bradesco SA - ADR (Banks)*

     21,930        95,394  

Itau Unibanco Holding SA - Sponsored ADR, 0.62% (Banks)+

     8,370        41,850  
        137,244  

Colombia - 0.4%

     

Bancolombia SA - Sponsored ADR, 0.88% (Banks)+

     1,139        34,090  

South Korea - 2.0%

     

Samsung Electronics Co., Ltd. - GDR, Reg S, 1.94% (Technology Hardware & Equipment)+†

     108        178,488  

Total Preferred Stocks (Cost $281,879)

              $349,822  
     Shares      Value  
SHORT TERM INVESTMENTS - 0.3%         

Northern Institutional Funds - Treasury Portfolio (Premier Shares), 0.01% (Money Market Funds)

     27,953        27,953  

Total Short Term Investments (Cost $27,953)

 

     $27,953  
            

Total Investments - 99.2%

                 

(Cost $7,203,943)

              $8,922,407  

Other Assets Less Liabilities - 0.8%

              74,280  

Net Assets - 100.0%

              $8,996,687  

Summary of Abbreviations

 

ADR

American Depositary Receipt

 

GDR

Global Depositary Receipt

 

Reg S

Security sold outside United States without registration under the Securities Act of 1933.

 

*

Non-income producing security.

Investment categorized as level 2 security as disclosed in Note 2 of the Notes to Financial Statements.

^

Security exempt from registration pursuant to Rule 144A of the Securities Act of 1933. These securities, which represent 1.8% of net assets as of April 30, 2021, are considered liquid and may be resold in transactions exempt from registration, normally to qualified buyers.

+

Current yield is disclosed. Dividends are calculated based on a percentage of the issuer’s net income.

 

 

See Notes to Financial Statements

 

39


Table of Contents

Harding, Loevner Funds, Inc.

 

Emerging Markets Research Portfolio

Portfolio of Investments (continued)

April 30, 2021 (unaudited)

 

 

Industry       
Percentage of
Net Assets
 
 

Automobiles & Components

       1.9 %

Banks

       17.0

Capital Goods

       2.6

Commercial & Professional Services

       1.1

Consumer Durables & Apparel

       7.1

Consumer Services

       1.7

Diversified Financials

       0.3

Energy

       5.8

Food & Staples Retailing

       4.7

Food Beverage & Tobacco

       6.7

Health Care Equipment & Services

       0.7

Household & Personal Products

       3.5

Insurance

       3.2

Materials

       2.3

Media & Entertainment

       8.7

Pharmaceuticals, Biotechnology & Life Sciences

       5.5

Real Estate

       1.2

Retailing

       5.7

Semiconductors & Semiconductor Equipment

       3.5

Software & Services

       3.1

Technology Hardware & Equipment

       7.2

Telecommunication Services

       0.8

Transportation

       2.9

Utilities

       1.7

Money Market Fund

       0.3

Total Investments

       99.2

Other Assets Less Liabilities

       0.8

Net Assets

       100.0 %
 

 

See Notes to Financial Statements

 

40


Table of Contents

Harding, Loevner Funds, Inc.

 

Chinese Equity Portfolio

Portfolio of Investments

April 30, 2021 (unaudited)

 

 

     Shares      Value  
COMMON STOCKS - 96.3%              

China - 83.5%

     

Alibaba Group Holding Ltd. (Retailing)*†

     15,700        $453,535  

Autohome Inc. - ADR (Media & Entertainment)

     1,123        104,136  

Baidu Inc., Class A (Media & Entertainment)*

     3,408        90,292  

China Tourism Group Duty Free Corp., Ltd., Class A (Retailing)†

     3,900        187,017  

Country Garden Services Holdings Co., Ltd. (Commercial & Professional Services)†

     8,000        83,604  

CSPC Pharmaceutical Group Ltd. (Pharmaceuticals, Biotechnology & Life Sciences)†

     70,000        86,612  

ENN Energy Holdings Ltd. (Utilities)†

     3,500        59,588  

Foshan Haitian Flavouring & Food Co., Ltd., Class A (Food Beverage & Tobacco)†

     2,300        60,126  

Gree Electric Appliances Inc. of Zhuhai, Class A (Consumer Durables & Apparel)†

     9,000        83,225  

Haitian International Holdings Ltd. (Capital Goods)†

     34,040        138,551  

Hangzhou Tigermed Consulting Co., Ltd., Class A (Pharmaceuticals, Biotechnology & Life Sciences)†

     4,200        101,328  

Hefei Meiya Optoelectronic Technology Inc., Class A (Capital Goods)†

     2,400        17,754  

Inner Mongolia Yili Industrial Group Co., Ltd., Class A (Food Beverage & Tobacco)†

     8,600        54,365  

JD.com Inc., Class A (Retailing)*†

     2,500        96,575  

Jiangsu Hengrui Medicine Co., Ltd., Class A (Pharmaceuticals, Biotechnology & Life Sciences)†

     5,700        73,947  

Midea Group Co., Ltd., Class A (Consumer Durables & Apparel)†

     7,900        97,718  

NetEase Inc. (Media & Entertainment)†

     4,300        96,185  

New Oriental Education & Technology Group Inc. (Consumer Services)*†

     4,243        65,220  

Ping An Insurance Group Co. of China Ltd., Class H (Insurance)†

     3,500        38,241  

Sangfor Technologies Inc., Class A (Software & Services)†

     829        34,989  
     Shares      Value  
COMMON STOCKS - 96.3% (continued)              

China - 83.5% (continued)

     

SF Holding Co., Ltd., Class A (Transportation)†

     9,300        $92,378  

Shanghai International Airport Co., Ltd., Class A (Transportation)†

     6,200        47,031  

Shenzhen Inovance Technology Co., Ltd., Class A (Capital Goods)†

     4,400        60,755  

Shenzhou International Group Holdings Ltd. (Consumer Durables & Apparel)†

     4,200        91,894  

Sunny Optical Technology Group Co., Ltd. (Technology Hardware & Equipment)†

     4,600        110,997  

Suofeiya Home Collection Co., Ltd., Class A (Consumer Durables & Apparel)†

     16,600        74,639  

Tencent Holdings Ltd. (Media & Entertainment)†

     3,700        295,900  

TravelSky Technology Ltd., Class H (Software & Services)†

     46,000        100,700  

Trip.com Group Ltd. (Retailing)*

     1,496        59,279  

Wuliangye Yibin Co., Ltd., Class A (Food Beverage & Tobacco)†

     2,700        118,751  

WuXi AppTec Co., Ltd., Class A (Pharmaceuticals, Biotechnology & Life Sciences)†

     6,800        166,333  

Wuxi Biologics Cayman Inc. (Pharmaceuticals, Biotechnology & Life Sciences)*^†

     12,500        175,335  

Yonyou Network Technology Co., Ltd., Class A (Software & Services)†

     9,300        47,483  
        3,464,483  

Hong Kong - 6.5%

     

AIA Group Ltd. (Insurance)†

     10,000        127,124  

Techtronic Industries Co., Ltd. (Capital Goods)†

     8,000        144,718  
        271,842  

Taiwan - 6.3%

     

Airtac International Group (Capital Goods)†

     4,000        170,367  

Silergy Corp. (Semiconductors & Semiconductor Equipment)†

     850        90,057  
                260,424  

Total Common Stocks (Cost $3,769,207)

              $3,996,749  
 

 

See Notes to Financial Statements

 

41


Table of Contents

Harding, Loevner Funds, Inc.

 

Chinese Equity Portfolio

Portfolio of Investments

April 30, 2021 (unaudited)

 

 

     Shares      Value  
SHORT TERM INVESTMENTS - 1.0%         

Northern Institutional Funds - Treasury Portfolio (Premier Shares), 0.01% (Money Market Funds)

     40,719        $40,719  

Total Short Term Investments (Cost $40,719)

 

     $40,719  
            

Total Investments - 97.3%

                 

(Cost $3,809,926)

              $4,037,468  

Other Assets Less Liabilities - 2.7%

              113,437  

Net Assets - 100.0%

              $4,150,905  

Summary of Abbreviations

 

ADR

American Depositary Receipt

 

*

Non-income producing security.

Investment categorized as level 2 security as disclosed in Note 2 of the Notes to Financial Statements.

^

Security exempt from registration pursuant to Rule 144A of the Securities Act of 1933. These securities, which represent 4.2% of net assets as of April 30, 2021, are considered liquid and may be resold in transactions exempt from registration, normally to qualified buyers.

 

Industry       
Percentage of
Net Assets
 
 

Capital Goods

       12.8 %

Commercial & Professional Services

       2.0

Consumer Durables & Apparel

       8.4

Consumer Services

       1.6

Food Beverage & Tobacco

       5.6

Insurance

       4.0

Media & Entertainment

       14.1

Pharmaceuticals, Biotechnology & Life Sciences

       14.5

Retailing

       19.2

Semiconductors & Semiconductor Equipment

       2.2

Software & Services

       4.4

Technology Hardware & Equipment

       2.7

Transportation

       3.4

Utilities

       1.4

Money Market Fund

       1.0

Total Investments

       97.3

Other Assets Less Liabilities

       2.7

Net Assets

       100.0 %
 

 

See Notes to Financial Statements

 

42


Table of Contents

Harding, Loevner Funds, Inc.

 

Statements of Assets and Liabilities

April 30, 2021 (Unaudited)

 

 

     

Global

Equity

Portfolio

    

International

Equity

Portfolio

    

International

Small

Companies

Portfolio

 
     

ASSETS:

        

Investments (cost $1,186,931,283, $12,841,664,061 and $367,161,059, respectively)

     $1,696,145,851        $20,406,312,715        $520,363,089  

Dividends and interest receivable

     970,922        39,428,957        1,096,885  

Foreign currency (cost $0, $0 and $697,729, respectively)

                   697,266  

Receivable for investments sold

     25,005,432                

Receivable for Fund shares sold

     1,533,445        26,639,295        832,182  

Tax reclaims receivable

     428,248        24,383,320        239,133  

Prepaid expenses

     350,125        4,615,151        144,849  

Total Assets:

     1,724,434,023        20,501,379,438        523,373,404  
     

LIABILITIES:

        

Payable to Investment Adviser

     (1,048,342      (11,186,849      (414,745

Payable for investments purchased

     (1,470,272      (18,885,489      (2,363,090

Payable for Fund shares redeemed

     (12,777,191      (21,883,149      (91,487

Payable for directors’ fees and expenses

     (8,475      (110,892      (2,488

Payable for distribution fees

            (231,820      (27,261

Deferred capital gains tax

                   (373,104

Other liabilities

     (770,061      (9,395,075      (258,301

Total Liabilities

     (16,074,341      (61,693,274      (3,530,476

Net Assets

     $1,708,359,682        $20,439,686,164        $519,842,928  
     

ANALYSIS OF NET ASSETS:

        

Paid in capital

     $986,746,714        $13,086,674,493        $369,716,322  

Distributable earnings

     721,612,968        7,353,011,671        150,126,606  

Net Assets

     $1,708,359,682        $20,439,686,164        $519,842,928  
     

Net Assets:

        

Institutional Class

     $1,270,944,223        $17,285,845,700        $473,402,458  

Institutional Class Z

     379,732,225        2,776,252,376         

Investor Class

            377,588,088        46,440,470  

Advisor Class

     57,683,234                

Total Shares Outstanding:

        

Institutional Class (500,000,000, 700,000,000 and 500,000,000, respectively, $.001 par value shares authorized)

     25,561,333        589,919,398        22,609,189  

Institutional Class Z (200,000,000, 300,000,000 and —, respectively, $.001 par value shares authorized)

     7,637,053        94,770,895         

Investor Class (—, 100,000,000 and 400,000,000, respectively, $.001 par value shares authorized)

            12,896,142        2,243,808  

Advisor Class (400,000,000, — and —, respectively, $.001 par value shares authorized)

     1,161,461                

Net Asset Value, Offering Price and Redemption Price Per Share:

        

Institutional Class

     $49.72        $29.30        $20.94  

Institutional Class Z

     49.72        29.29         

Investor Class

            29.28        20.70  

Advisor Class

     49.66                

See Notes to Financial Statements

 

43


Table of Contents

Harding, Loevner Funds, Inc.

 

Statements of Assets and Liabilities (continued)

April 30, 2021 (Unaudited)

 

 

     

Institutional

Emerging

Markets

Portfolio

    

Emerging

Markets

Portfolio

    

Frontier

Emerging

Markets

Portfolio

 
     

ASSETS:

        

Investments (cost $4,388,981,451, $2,750,172,635 and $188,988,442, respectively)

     $6,777,947,999        $4,579,608,814        $234,544,064  

Dividends and interest receivable

     8,501,080        5,753,687        1,211,291  

Foreign currency (cost $0, $0 and $1,518,232, respectively)

                   1,492,588  

Receivable for investments sold

     8,689,737        5,872,385        1,134,782  

Receivable for Fund shares sold

     4,586,078        3,685,628        42,165  

Tax reclaims receivable

     53,353        36,131         

Prepaid expenses

     2,241,036        2,081,637        79,404  

Total Assets:

     6,802,019,283        4,597,038,282        238,504,294  
     

LIABILITIES:

        

Payable to Investment Adviser

     (6,140,026      (4,210,783      (262,432

Payable for investments purchased

     (8,167,421      (5,002,554      (658,159

Payable for Fund shares redeemed

     (6,097,656      (8,072,647      (120,218

Payable for directors’ fees and expenses

     (36,491      (24,844      (1,297

Payable for distribution fees

                   (16,492

Deferred capital gains tax

     (9,238,937      (5,875,020      (599,697

Other liabilities

     (3,653,506      (4,150,519      (183,155

Total Liabilities

     (33,334,037      (27,336,367      (1,841,450

Net Assets

     $6,768,685,246        $4,569,701,915        $236,662,844  
     

ANALYSIS OF NET ASSETS:

        

Paid in capital

     $4,503,418,317        $2,670,330,867        $311,464,618  

Distributable earnings

     2,265,266,929        1,899,371,048        (74,801,774

Net Assets

     $6,768,685,246        $4,569,701,915        $236,662,844  
     

Net Assets:

        

Institutional Class

     $5,921,810,680        $—        $—  

Institutional Class I

                   89,488,739  

Institutional Class II

                   136,700,826  

Institutional Class Z

     846,874,566                

Investor Class

                   10,473,279  

Advisor Class

            4,569,701,915         

Total Shares Outstanding:

        

Institutional Class (500,000,000, — and —, respectively, $.001 par value shares authorized)

     223,933,677                

Institutional Class I (—, — and 400,000,000, respectively, $.001 par value shares authorized)

                   11,252,356  

Institutional Class II (—, — and 200,000,000, respectively, $.001 par value shares authorized)

                   17,103,883  

Institutional Class Z (500,000,000, — and —, respectively, $.001 par value shares authorized)

     31,963,072                

Investor Class (—, — and 400,000,000, respectively, $.001 par value shares authorized)

                   1,322,134  

Advisor Class (—, 500,000,000 and —, respectively, $.001 par value shares authorized)

            66,136,069         

Net Asset Value, Offering Price and Redemption Price Per Share:

        

Institutional Class

     $26.44        $—        $—  

Institutional Class I

                   7.95  

Institutional Class II

                   7.99  

Institutional Class Z

     26.50                

Investor Class

                   7.92  

Advisor Class

            69.10         

 

See Notes to Financial Statements

 

44


Table of Contents

Harding, Loevner Funds, Inc.

 

Statements of Assets and Liabilities (continued)

April 30, 2021 (Unaudited)

 

 

     

Global

Equity

Research

Portfolio

    

International

Equity

Research

Portfolio

    

Emerging

Markets

Research

Portfolio

    

Chinese

Equity

Portfolio

 

ASSETS:

           

Investments (cost $6,685,408, $11,561,313, $7,203,943 and $3,809,926, respectively)

     $9,311,280        $15,341,043        $8,922,407        $4,037,468  

Dividends and interest receivable

     14,624        31,211        15,700        678  

Foreign currency (cost $0, $0, $23,627 and $7,277, respectively)

                   23,098        7,276  

Receivable for investments sold

     2,410        11,208        55,610         

Receivable for Fund shares sold

            6,297                

Tax reclaims receivable

     2,242        11,100        10         

Capital gain tax refund receivable

     243        185        1,699         

Prepaid offering fees

                          102,658  

Prepaid expenses

     21,164        18,673        20,544        30,600  

Total Assets:

     9,351,963        15,419,717        9,039,068        4,178,680  
       

LIABILITIES:

           

Payable to Investment Adviser

     (5,320      (8,788      (7,397      (3,210

Payable for directors’ fees and expenses

     (39      (70      (40      (79

Payable to Custodian

     (81      (237              

Deferred capital gains tax

     (3,744      (8,961      (14,143       

Other liabilities

     (31,230      (47,605      (20,801      (24,486

Total Liabilities

     (40,414      (65,661      (42,381      (27,775

Net Assets

     $9,311,549        $15,354,056        $8,996,687        $4,150,905  
       

ANALYSIS OF NET ASSETS:

           

Paid in capital

     $6,115,186        $10,683,195        $6,895,304        $3,915,500  

Distributable earnings

     3,196,363        4,670,861        2,101,383        235,405  

Net Assets

     $9,311,549        $15,354,056        $8,996,687        $4,150,905  
       

Net Assets:

           

Institutional Class

     $9,311,549        $15,354,056        $8,996,687        $4,150,905  

Total Shares Outstanding:

           

Institutional Class (400,000,000, 400,000,000, 400,000,000 and 500,000,000, respectively, $.001 par value shares authorized)

     594,183        1,061,915        667,566        386,982  

Net Asset Value, Offering Price and Redemption Price Per Share:

           

Institutional Class

     $15.67        $14.46        $13.48        $10.73  

 

See Notes to Financial Statements

 

45


Table of Contents

Harding, Loevner Funds, Inc.

 

Statements of Operations

Six Months Ended April 30, 2021 (unaudited)

 

 

     

Global

Equity

Portfolio

    

International

Equity

Portfolio

    

International

Small

Companies

Portfolio

    

Institutional

Emerging

Markets

Portfolio

    

Emerging

Markets

Portfolio

 
         

INVESTMENT INCOME

              

Dividends (net of foreign withholding taxes of $319,167, $21,434,682, $259,450, $5,582,965 and $4,283,914, respectively)

     $5,305,617        $180,585,594        $2,997,538        $35,933,997        $23,892,766  

Total investment income

     5,305,617        180,585,594        2,997,538        35,933,997        23,892,766  
         

EXPENSES

              

Investment advisory fees (Note 3)

     5,976,830        64,696,944        2,256,889        36,392,854        24,915,335  

Administration fees (Note 3)

     254,560        3,019,590        74,922        1,023,067        696,645  

Distribution fees, Investor Class

            463,668        55,560                

Custody and accounting fees (Note 3)

     96,160        937,838        79,174        833,513        588,641  

Directors’ fees and expenses

     21,693        256,672        5,804        85,775        58,732  

Transfer agent fees and expenses (Note 3)

     4,971        260,501        2,783        30,872        275,101  

Printing and postage fees

     24,729        445,669        10,860        173,804        180,059  

State registration filing fees

     29,234        45,461        15,929        24,105        17,221  

Professional fees

     51,774        205,843        34,413        85,488        70,320  

Shareholder servicing fees (Note 3)

     576,805        6,845,320        160,744        2,600,379        3,209,074  

Compliance and Treasurer officers’ fees and expenses (Note 3)

     1,871        22,131        501        7,384        5,051  

Other fees and expenses

     36,209        410,520        12,714        138,405        106,668  

Total Expenses

     7,074,836        77,610,157        2,710,293        41,395,646        30,122,847  

Less Waiver of investment advisory fee and/or reimbursement of other operating expenses (Note 3)

     (13,326             (59,551      (3,210,199      (672,075

Net expenses

     7,061,510        77,610,157        2,650,742        38,185,447        29,450,772  

Net investment income (loss)

     (1,755,893      102,975,437        346,796        (2,251,450      (5,558,006
         

REALIZED AND UNREALIZED GAIN (LOSS)

              

Net realized gain (loss)

              

Investment transactions

     221,253,453        325,650,912        7,297,285        180,309,322        175,408,912  

Foreign currency transactions

     (279,100      283,803        (11,227      24,319        60,086  

Net realized gain

     220,974,353        325,934,715        7,286,058        180,333,641        175,468,998  

Change in unrealized appreciation (depreciation)

              

Investments (net of increase (decrease) in deferred foreign taxes of $—,

$—, $(375,777), $(6,047,852) and $(4,156,197), respectively)

     114,320,370        3,507,934,555        78,507,816        1,195,114,091        759,187,632  

Translation of assets and liabilities denominated in foreign currencies

     13,009        7,238        5,050        31,881        22,244  

Net change in unrealized appreciation

     114,333,379        3,507,941,793        78,512,866        1,195,145,972        759,209,876  

Net realized and unrealized gain

     335,307,732        3,833,876,508        85,798,924        1,375,479,613        934,678,874  
         

NET INCREASE IN NET ASSETS RESULTING FROM OPERATIONS

     $333,551,839        $3,936,851,945        $86,145,720        $1,373,228,163        $929,120,868  

 

See Notes to Financial Statements

 

46


Table of Contents

Harding, Loevner Funds, Inc.

 

Statements of Operations (continued)

Six Months Ended April 30, 2021 (unaudited)

 

 

      Frontier
Emerging
Markets
Portfolio
     Global
Equity
Research
Portfolio
     International
Equity
Research
Portfolio
     Emerging
Markets
Research
Portfolio
     Chinese
Equity
Portfolio(1)
 
         

INVESTMENT INCOME

              

Dividends (net of foreign withholding taxes of $302,293, $4,347, $12,541, $11,571 and $123, respectively)

     $3,127,532        $56,250        $102,957        $67,006        $8,781  

Total investment income

     3,127,532        56,250        102,957        67,006        8,781  
         

EXPENSES

              

Investment advisory fees (Note 3)

     1,517,365        30,340        51,395        43,637        13,522  

Administration fees (Note 3)

     39,802        6,303        7,235        6,312        4,335  

Distribution fees, Investor Class

     13,613                              

Custody and accounting fees (Note 3)

     90,831        4,517        14,779        6,916        4,431  

Directors’ fees and expenses

     2,994        120        203        122        103  

Transfer agent fees and expenses (Note 3)

     2,472        239        289        249        239  

Printing and postage fees

     6,033        100        189        99        833  

State registration filing fees

     22,737        10,130        9,231        10,199        7,525  

Professional fees

     21,332        19,079        18,804        20,857        11,910  

Shareholder servicing fees (Note 3)

     37,550               6,598                

Compliance and Treasurer officers’ fees and expenses (Note 3)

     259        10        17        10        10  

Offering fees

                                 49,665  

Other fees and expenses

     10,416        2,122        2,205        2,063        1,707  

Total Expenses

     1,765,404        72,960        110,945        90,464        94,280  

Less Waiver of investment advisory fee and/or reimbursement of other operating expenses (Note 3)

     (109,803      (38,287      (55,880      (40,282      (77,922

Net expenses

     1,655,601        34,673        55,065        50,182        16,358  

Net investment income (loss)

     1,471,931        21,577        47,892        16,824        (7,577
         

REALIZED AND UNREALIZED GAIN (LOSS)

              

Net realized gain (loss)

              

Investment transactions

     8,502,710        563,839        988,533        433,974        16,532  

Foreign currency transactions

     (24,891      72        (354      (1,018      (1,090

Net realized gain

     8,477,819        563,911        988,179        432,956        15,442  

Change in unrealized appreciation (depreciation)

              

Investments (net of increase (decrease) in deferred foreign taxes of $(91,730), $(645), $706, $(8,902) and $—, respectively)

     23,873,877        1,338,558        2,026,802        1,180,325        227,542  

Translation of assets and liabilities denominated in foreign currencies

     (28,813      (14             (390      (2

Net change in unrealized appreciation

     23,845,064        1,338,544        2,026,802        1,179,935        227,540  

Net realized and unrealized gain

     32,322,883        1,902,455        3,014,981        1,612,891        242,982  
         

NET INCREASE IN NET ASSETS RESULTING FROM OPERATIONS

     $33,794,814        $1,924,032        $3,062,873        $1,629,715        $235,405  

(1) For the period from December 16, 2020 (commencement of operations) through April 30, 2021.

 

See Notes to Financial Statements

 

47


Table of Contents

Harding, Loevner Funds, Inc.

 

Statements of Changes in Net Assets

For the Six Months Ended April 30, 2021 (unaudited) and the Fiscal Year Ended October 31, 2020

 

 

    

Global Equity

Portfolio

   

International Equity

Portfolio

    International Small Companies
Portfolio
 
     2021     2020     2021     2020     2021     2020  

INCREASE (DECREASE) IN NET ASSETS FROM OPERATIONS

              

Net investment income (loss)

     $(1,755,893     $(1,352,788     $102,975,437       $159,954,853       $346,796       $1,559,394  

Net realized gain (loss) on investments and foreign currency transactions

     220,974,353       110,956,573       325,934,715       (443,646,886     7,286,058       (4,067,129

Net change in unrealized appreciation on investments and translation of assets and liabilities denominated in foreign currencies

     114,333,379       72,903,102       3,507,941,793       1,117,466,328       78,512,866       35,452,939  

Net increase in net assets resulting from operations

     333,551,839       182,506,887       3,936,851,945       833,774,295       86,145,720       32,945,204  

DISTRIBUTIONS TO SHAREHOLDERS:

              

Institutional Class

     (65,209,713     (4,316,797     (123,781,067     (230,105,321     (609,751     (1,807,612

Institutional Class Z

     (17,916,242     (1,747,501     (21,728,233     (34,291,239            

Investor Class

                 (1,685,706     (5,139,836     (12,869     (315,070

Advisor Class

     (3,368,857     (135,973                        

Total distributions to shareholders

     (86,494,812     (6,200,271     (147,195,006     (269,536,396     (622,620     (2,122,682

TRANSACTIONS IN SHARES OF COMMON STOCK

              

Institutional Class

     41,070,160       243,439,192       485,609,948       (630,807,060     59,440,016       36,814,201  

Institutional Class Z

     38,799,043       7,571,877       100,535,051       135,625,446              

Investor Class

                 (35,706,783     (70,443,766     (1,982,601     (20,120,767

Advisor Class

     (4,739,929     (3,444,298                        

Net Increase (Decrease) in net assets from portfolio share transactions

     75,129,274       247,566,771       550,438,216       (565,625,380     57,457,415       16,693,434  

NET INCREASE (DECREASE) IN NET ASSETS

     322,186,301       423,873,387       4,340,095,155       (1,387,481     142,980,515       47,515,956  

NET ASSETS

              

At beginning of period

     1,386,173,381       962,299,994       16,099,591,009       16,100,978,490       376,862,413       329,346,457  

At end of period

     $1,708,359,682       $1,386,173,381       $20,439,686,164       $16,099,591,009       $519,842,928       $376,862,413  

See Notes to Financial Statements

 

48


Table of Contents

Harding, Loevner Funds, Inc.

 

Statements of Changes in Net Assets (continued)

For the Six Months Ended April 30, 2021 (unaudited) and the Fiscal Year Ended October 31, 2020

 

 

    

Institutional Emerging Markets

Portfolio

    Emerging Markets
Portfolio
    Frontier Emerging Markets
Portfolio
 
     2021     2020     2021     2020     2021     2020  

INCREASE (DECREASE) IN NET ASSETS FROM OPERATIONS

              

Net investment income (loss)

     $(2,251,450     $32,486,504       $(5,558,006     $19,174,342       $1,471,931       $3,878,583  

Net realized gain (loss) on investments and foreign currency transactions

     180,333,641       (73,626,689     175,468,998       (40,331,776     8,477,819       (831,046

Net change in unrealized appreciation (depreciation) on investments and translation of assets and liabilities denominated in foreign currencies

     1,195,145,972       110,468,671       759,209,876       21,905,626       23,845,064       (33,493,549

Net increase (decrease) in net assets resulting from operations

     1,373,228,163       69,328,486       929,120,868       748,192       33,794,814       (30,446,012

DISTRIBUTIONS TO SHAREHOLDERS:

              

Institutional Class

     (23,061,824     (76,149,087                        

Institutional Class I

                             (1,305,371     (2,815,425

Institutional Class II

                         (2,278,483     (2,717,575

Institutional Class Z

     (3,583,856     (9,138,400                        

Investor Class

                             (146,249     (292,150

Advisor Class

                 (14,604,730     (63,406,861            

Total distributions to shareholders

     (26,645,680     (85,287,487     (14,604,730     (63,406,861     (3,730,103     (5,825,150

TRANSACTIONS IN SHARES OF COMMON STOCK

              

Institutional Class

     (117,132,768     (12,857,492                        

Institutional Class I

                         5,096,324       (51,623,798

Institutional Class II

                             2,277,287       2,717,575  

Institutional Class Z

     64,896,513       80,529,077                          

Investor Class

                             (1,389,832     (8,252,656

Advisor Class

                 (84,023,458     (472,445,897            

Net Increase (Decrease) in net assets from portfolio share transactions

     (52,236,255     67,671,585       (84,023,458     (472,445,897     5,983,779       (57,158,879

NET INCREASE (DECREASE) IN NET ASSETS

     1,294,346,228       51,712,584       830,492,680       (535,104,566     36,048,490       (93,430,041

NET ASSETS

              

At beginning of period

     5,474,339,018       5,422,626,434       3,739,209,235       4,274,313,801       200,614,354       294,044,395  

At end of period

     $6,768,685,246       $5,474,339,018       $4,569,701,915       $3,739,209,235       $236,662,844       $200,614,354  

 

See Notes to Financial Statements

 

49


Table of Contents

Harding, Loevner Funds, Inc.

 

Statements of Changes in Net Assets (continued)

For the Six Months Ended April 30, 2021 (unaudited) and the Fiscal Year Ended October 31, 2020

 

 

     Global Equity Research
Portfolio
    International Equity
Research Portfolio
    Emerging Markets
Research Portfolio
 
     2021     2020     2021     2020     2021     2020  

INCREASE (DECREASE) IN NET ASSETS FROM OPERATIONS

              

Net investment income

     $21,577       $55,729       $47,892       $214,094       $16,824       $58,056  

Net realized gain on investments and foreign currency transactions

     563,911       162,841       988,179       198,640       432,956       46,259  

Net change in unrealized appreciation on investments and translation of assets and liabilities denominated in foreign currencies

     1,338,544       273,547       2,026,802       163,973       1,179,935       58,967  

Net increase in net assets resulting from operations

     1,924,032       492,117       3,062,873       576,707       1,629,715       163,282  

DISTRIBUTIONS TO SHAREHOLDERS:

              

Institutional Class

     (217,846     (379,881     (489,632     (374,600     (134,267     (299,717

Total distributions to shareholders

     (217,846     (379,881     (489,632     (374,600     (134,267     (299,717

TRANSACTIONS IN SHARES OF COMMON STOCK

              

Institutional Class

     218,347       379,881       286,813       (7,165,689     134,267       305,718  

Net Increase (Decrease) in net assets from portfolio share transactions

     218,347       379,881       286,813       (7,165,689     134,267       305,718  

NET INCREASE (DECREASE) IN NET ASSETS

     1,924,533       492,117       2,860,054       (6,963,582     1,629,715       169,283  

NET ASSETS

              

At beginning of period

     7,387,016       6,894,899       12,494,002       19,457,584       7,366,972       7,197,689  

At end of period

     $9,311,549       $7,387,016       $15,354,056       $12,494,002       $8,996,687       $7,366,972  

 

See Notes to Financial Statements

 

50


Table of Contents

Harding, Loevner Funds, Inc.

 

Statements of Changes in Net Assets (continued)

For the Six Months Ended April 30, 2021 (unaudited) and the Fiscal Year Ended October 31, 2020

 

 

     Chinese Equity
Portfolio(1)
 
     2021  

INCREASE (DECREASE) IN NET ASSETS FROM OPERATIONS

  

Net investment loss

     $(7,577

Net realized gain on investments and foreign currency transactions

     15,442  

Net change in unrealized appreciation on investments and translation of assets and liabilities denominated in foreign currencies

     227,540  

Net increase in net assets resulting from operations

     235,405  

DISTRIBUTIONS TO SHAREHOLDERS:

  

Institutional Class

      

Total distributions to shareholders

      

TRANSACTIONS IN SHARES OF COMMON STOCK

  

Institutional Class

     3,915,500  

Net Increase in net assets from portfolio share transactions

     3,915,500  

NET INCREASE IN NET ASSETS

     4,150,905  

NET ASSETS

  

Beginning of period

      

End of period

     $4,150,905  

 

(1)

For the period from December 16, 2020 (commencement of operations) through April 30, 2021.

 

See Notes to Financial Statements

 

51


Table of Contents

Harding, Loevner Funds, Inc.

 

Financial Highlights

For the Six Months Ended April 30, 2021 (unaudited) and the Fiscal Year Ended October 31

 

 

           

INCREASE (DECREASE) IN

NET ASSETS FROM

OPERATIONS:

    

DISTRIBUTIONS TO

SHAREHOLDERS FROM:

                  RATIOS/SUPPLEMENTAL DATA:        
    

Net asset

value,

beginning

of period

    

Net

investment

income

(loss)(1)

    

Net

realized

and

unrealized

gain (loss)

on

investments

and

foreign

currency-

related

transactions

    

Net

increase

(decrease)

from

investment

operations

    

Net

investment

income

    

Net

realized

gain

from
investments

    

Total

distributions

    

Net

asset

value,

end

of
period

    

Total

Return

   

Net assets,

end of period

(000’s)

    

Expenses

to average

net assets

   

Expenses

to average

net assets

(net of fees

waived/

reimbursed)

   

Net

investment

income to

average

net assets

   

Portfolio

turnover

rate

 

Global Equity Portfolio–Institutional Class

 

04/30/21

     $42.41        $(0.05      $10.00        $9.95        $ —        $(2.64      $(2.64      $49.72        24.05 (A)     $1,270,944        0.89 (B)     0.89 (B)     (0.23 )(B)     41 (A)

10/31/20

     35.38        (0.06      7.33        7.27        (0.24             (0.24      42.41        20.63       1,043,741        0.92       0.92       (0.15     63  

10/31/19

     35.68        0.09        3.45        3.54        (0.12      (3.72      (3.84      35.38        11.86       684,764        0.93       0.93       0.28       39  

10/31/18

     40.84        0.13        (0.13             (0.14      (5.02      (5.16      35.68        (0.35     619,347        0.94       0.94       0.34       42  

10/31/17

     32.53        0.09        8.74        8.83        (0.13      (0.39      (0.52      40.84        27.58       790,097        0.93       0.93       0.25       33  

10/31/16

     32.44        0.13        0.92        1.05        (0.12      (0.84      (0.96      32.53        3.43       779,020        0.92       0.92       0.42       24  

Global Equity Portfolio–Institutional Class Z

 

04/30/21

     42.39        (0.03      10.00        9.97               (2.64      (2.64      49.72        24.08 (A)      379,732        0.81 (B)      0.80 (B)      (0.14 )(B)      41 (A) 

10/31/20

     35.36        (0.02      7.31        7.29        (0.26             (0.26      42.39        20.76       289,320        0.85       0.84       (0.05     63  

10/31/19

     35.67        0.11        3.44        3.55        (0.14      (3.72      (3.86      35.36        11.89       229,355        0.88       0.88       0.32       39  

10/31/18

     40.84        0.17        (0.15      0.02        (0.17      (5.02      (5.19      35.67        (0.26     140,359        0.91       0.90       0.43       42  

10/31/17(2)(3)

     39.33        (0.01      1.52        1.51                             40.84        3.80 (A)      46,493        1.21 (B)      0.90 (B)      (0.05 )(B)      33 (A) 

Global Equity Portfolio–Advisor Class

 

04/30/21

     42.41        (0.11      10.00        9.89               (2.64      (2.64      49.66        23.90 (A)      57,684        1.10 (B)      1.10 (B)      (0.45 )(B)      41 (A) 

10/31/20

     35.30        (0.12      7.33        7.21        (0.10             (0.10      42.41        20.47       53,112        1.11       1.11       (0.32     63  

10/31/19

     35.60        0.03        3.43        3.46        (0.04      (3.72      (3.76      35.30        11.60       48,181        1.12       1.12       0.09       39  

10/31/18

     40.78        0.07        (0.15      (0.08      (0.08      (5.02      (5.10      35.60        (0.57     90,567        1.14       1.14       0.18       42  

10/31/17

     32.47        0.01        8.73        8.74        (0.04      (0.39      (0.43      40.78        27.28       75,244        1.14       1.14       0.02       33  

10/31/16

     32.38        0.05        0.91        0.96        (0.03      (0.84      (0.87      32.47        3.12       56,698        1.19       1.19       0.15       24  

International Equity Portfolio–Institutional Class

 

04/30/21

     23.76        0.15        5.60        5.75        (0.21             (0.21      29.30        24.26 (A)      17,285,846        0.80 (B)      0.80 (B)      1.05 (B)      7 (A) 

10/31/20

     22.72        0.23        1.19        1.42        (0.38             (0.38      23.76        6.25       13,596,900        0.81       0.81       1.01       17  

10/31/19

     20.74        0.29        1.98        2.27        (0.29             (0.29      22.72        11.19       13,766,876        0.81       0.81       1.35       30  

10/31/18

     22.64        0.31        (1.83      (1.52      (0.20      (0.18      (0.38      20.74        (6.86     11,995,592        0.81       0.81       1.34       10  

10/31/17

     18.37        0.23        4.22        4.45        (0.18             (0.18      22.64        24.47       11,107,736        0.82       0.82       1.22       12  

10/31/16

     17.69        0.21        0.64        0.85        (0.17             (0.17      18.37        4.91       6,354,810        0.84       0.84       1.20       22  

International Equity Portfolio–Institutional Class Z

 

04/30/21

     23.76        0.16        5.60        5.76        (0.23             (0.23      29.29        24.30 (A)      2,776,252        0.72 (B)      0.72 (B)      1.13 (B)      7 (A) 

10/31/20

     22.72        0.25        1.18        1.43        (0.39             (0.39      23.76        6.32       2,165,343        0.73       0.73       1.08       17  

10/31/19

     20.75        0.30        1.98        2.28        (0.31             (0.31      22.72        11.29       1,938,763        0.75       0.75       1.42       30  

10/31/18

     22.64        0.40        (1.90      (1.50      (0.21      (0.18      (0.39      20.75        (6.79     1,342,804        0.74       0.74       1.77       10  

10/31/17(3)(4)

     21.35        0.02        1.27        1.29                             22.64        6.00 (A)      166,923        0.99 (B)      0.80 (B)      0.33       12 (A) 

International Equity Portfolio–Investor Class

 

04/30/21

     23.70        0.10        5.61        5.71        (0.13             (0.13      29.28        24.11 (A)      377,588        1.12 (B)      1.12 (B)      0.71 (B)      7 (A) 

10/31/20

     22.66        0.16        1.18        1.34        (0.30             (0.30      23.70        5.91       337,348        1.13       1.13       0.69       17  

10/31/19

     20.65        0.22        1.98        2.20        (0.19             (0.19      22.66        10.79       395,339        1.13       1.13       1.03       30  

10/31/18

     22.55        0.21        (1.80      (1.59      (0.13      (0.18      (0.31      20.65        (7.16     411,712        1.14       1.14       0.92       10  

10/31/17

     18.30        0.19        4.18        4.37        (0.12             (0.12      22.55        24.04       644,243        1.14       1.14       0.95       12  

10/31/16

     17.62        0.14        0.66        0.80        (0.12             (0.12      18.30        4.63       433,765        1.15       1.15       0.83       22  

 

(A)

Not Annualized.

(B)

Annualized.

(1)

Net investment income per share was calculated using the average shares outstanding method.

(2)

For the period from August 1, 2017 (commencement of class operations) through October 31, 2017.

(3)

All per share amounts and net asset values have been adjusted as a result of the reverse share split effected after the close of business on December 1, 2017.

(4)

For the period from July 17, 2017 (commencement of operations) through October 31, 2017.

See Notes to Financial Statements

 

52


Table of Contents

Harding, Loevner Funds, Inc.

 

Financial Highlights (continued)

For the Six Months Ended April 30, 2021 (unaudited) and the Fiscal Year Ended October 31

 

 

           

INCREASE (DECREASE) IN

NET ASSETS FROM

OPERATIONS:

    

DISTRIBUTIONS TO

SHAREHOLDERS FROM:

                  RATIOS/SUPPLEMENTAL DATA:        
    

Net asset

value,

beginning

of period

    

Net

investment

income

(loss)(1)

    

Net

realized

and

unrealized

gain (loss)

on

investments

and

foreign

currency-

related

transactions

    

Net

increase

(decrease)

from

investment

operations

    

Net

investment

income

    

Net

realized

gain

from

investments

    

Total

distributions

    

Net

asset

value,

end

of

period

    

Total

Return

   

Net assets,

end of period

(000’s)

    

Expenses

to average

net assets

   

Expenses

to average

net assets

(net of fees

waived/

reimbursed)

   

Net

investment

income to

average

net assets

   

Portfolio

turnover

rate

 

International Small Companies Portfolio–Institutional Class

 

04/30/21

     $17.14        $0.02        $3.81        $3.83        $(0.03      $ —        $(0.03      $20.94        22.29 (A)     $473,402        1.17 (B)     1.15 (B)     0.18 (B)     5 (A)

10/31/20

     15.64        0.08        1.53        1.61        (0.11             (0.11      17.14        10.34       337,166        1.34       1.15       0.50       30  

10/31/19

     15.29        0.12        1.24        1.36        (0.13      (0.88      (1.01      15.64        10.14       272,252        1.38       1.15       0.78       37  

10/31/18

     16.67        0.13        (1.30      (1.17      (0.06      (0.15      (0.21      15.29        (7.15     151,283        1.39       1.15       0.75       52  

10/31/17

     13.72        0.11        3.41        3.52        (0.16      (0.41      (0.57      16.67        26.98       144,170        1.41       1.15       0.72       19  

10/31/16

     13.40        0.20        0.34        0.54        (0.09      (0.13      (0.22      13.72        4.15       62,785        1.60       1.25       1.51       49  

International Small Companies Portfolio–Investor Class

 

04/30/21

     16.94        (0.01      3.78        3.77        (0.01             (0.01      20.70        22.16 (A)      46,440        1.50 (B)      1.40 (B)      (0.11 )(B)      5 (A) 

10/31/20

     15.48        0.04        1.51        1.55        (0.09             (0.09      16.94        10.07       39,696        1.67       1.40       0.28       30  

10/31/19

     15.16        0.09        1.21        1.30        (0.10      (0.88      (0.98      15.48        9.82       57,095        1.70       1.40       0.63       37  

10/31/18

     16.55        0.10        (1.29      (1.19      (0.05      (0.15      (0.20      15.16        (7.35     57,912        1.75       1.40       0.58       52  

10/31/17

     13.64        0.05        3.42        3.47        (0.15      (0.41      (0.56      16.55        26.71       50,292        1.80       1.40       0.37       19  

10/31/16

     13.33        0.16        0.35        0.51        (0.07      (0.13      (0.20      13.64        3.92       44,363        1.90       1.50       1.18       49  

Institutional Emerging Markets Portfolio–Institutional Class (Formerly Class I)

 

04/30/21

     21.23        (0.01      5.32        5.31        (0.10             (0.10      26.44        25.05 (A)      5,921,811        1.27 (B)      1.17 (B)      (0.08 )(B)      7 (A) 

10/31/20

     21.25        0.12        0.19        0.31        (0.33             (0.33      21.23        1.38       4,847,707        1.28       1.28       0.59       23  

10/31/19

     18.43        0.24        2.76        3.00        (0.18             (0.18      21.25        16.43       4,864,702        1.27       1.27       1.18       17  

10/31/18

     21.94        0.19        (3.53      (3.34      (0.17             (0.17      18.43        (15.33     3,978,321        1.27       1.27       0.84       24  

10/31/17

     17.65        0.19        4.20        4.39        (0.10             (0.10      21.94        25.08       4,386,511        1.28       1.28       0.97       17  

10/31/16

     16.04        0.14        1.56        1.70        (0.09             (0.09      17.65        10.74       3,051,419        1.29       1.29       0.88       20  

Institutional Emerging Markets Portfolio–Institutional Class Z (Formerly Class II)

 

04/30/21

     21.28        (— )(2)       5.34        5.34        (0.12             (0.12      26.50        25.12 (A)      846,875        1.18 (B)      1.11 (B)      (0.01 )(B)      7 (A) 

10/31/20

     21.28        0.15        0.20        0.35        (0.35             (0.35      21.28        1.55       626,632        1.19       1.11       0.76       23  

10/31/19

     18.45        0.27        2.76        3.03        (0.20             (0.20      21.28        16.61       557,924        1.19       1.11       1.34       17  

10/31/18

     21.94        0.22        (3.52      (3.30      (0.19             (0.19      18.45        (15.21     391,583        1.20       1.11       1.00       24  

10/31/17(3)

     17.71        0.22        4.21        4.43        (0.20             (0.20      21.94        25.43       458,288        1.23       1.12       1.12       17  

10/31/16(3)

     16.14        0.16        1.59        1.75        (0.18             (0.18      17.71        11.06       381,031        1.24       1.13       0.96       20  

Emerging Markets Portfolio–Advisor Class

 

04/30/21

     55.48        (0.08      13.92        13.84        (0.22             (0.22      69.10        24.97 (A)      4,569,702        1.35 (B)      1.32 (B)      (0.25 )(B)      7 (A) 

10/31/20

     55.65        0.26        0.40        0.66        (0.83             (0.83      55.48        1.11       3,739,209        1.36       1.36       0.49       18  

10/31/19

     48.21        0.58        7.28        7.86        (0.42             (0.42      55.65        16.46       4,274,314        1.37       1.37       1.10       19  

10/31/18

     57.46        0.42        (9.24      (8.82      (0.40      (0.03      (0.43      48.21        (15.47     3,459,157        1.40       1.40       0.73       24  

10/31/17

     46.27        0.43        11.02        11.45        (0.26             (0.26      57.46        24.93       4,014,977        1.42       1.42       0.84       17  

10/31/16

     42.02        0.30        4.17        4.47        (0.22      (2)        (0.22      46.27        10.73       2,998,484        1.42       1.42       0.72       26  

 

(A)

Not Annualized.

(B)

Annualized.

(1)

Net investment income per share was calculated using the average shares outstanding method.

(2)

Amount was less than $0.005 per share.

(3)

All per share amounts and net asset values have been adjusted as a result of the reverse share split effected after the close of business on December 1, 2017.

 

See Notes to Financial Statements

 

53


Table of Contents

Harding, Loevner Funds, Inc.

 

Financial Highlights (continued)

For the Six Months Ended April 30, 2021 (unaudited) and the Fiscal Year Ended October 31

 

 

           

INCREASE (DECREASE) IN

NET ASSETS FROM

OPERATIONS:

    

DISTRIBUTIONS TO

SHAREHOLDERS FROM:

                  RATIOS/SUPPLEMENTAL DATA:        
    

Net asset

value,

beginning

of period

    

Net

investment

income

(loss)(1)

    

Net

realized

and

unrealized

gain (loss)

on

investments

and

foreign

currency-

related

transactions

    

Net

increase

(decrease)

from

investment

operations

    

Net

investment

income

    

Net

realized

gain

from

investments

    

Total

distributions

    

Net

asset

value,

end

of

period

    

Total

Return

   

Net assets,

end of period

(000’s)

    

Expenses

to average

net assets

   

Expenses

to average

net assets

(net of fees

waived/

reimbursed)

   

Net

investment

income to

average

net assets

   

Portfolio

turnover

rate

 

Frontier Emerging Markets Portfolio–Institutional Class I

 

04/30/21

     $6.92        $0.05        $1.11        $1.16        $(0.13      $ —        $(0.13      $7.95        16.76 (A)     $89,489        1.60 (B)     1.60 (B)     1.25 (B)     17 (A)

10/31/20

     7.80        0.10        (0.82      (0.72      (0.16             (0.16      6.92        (9.50     73,376        1.68       1.68       1.44       21  

10/31/19

     7.62        0.14        0.14        0.28        (0.10             (0.10      7.80        3.59       144,742        1.63       1.63       1.72       31  

10/31/18

     8.50        0.11        (0.82      (0.71      (0.17             (0.17      7.62        (8.47     220,367        1.62       1.62       1.24       20  

10/31/17

     7.35        0.05        1.17        1.22        (0.07             (0.07      8.50        16.82       266,844        1.71       1.71       0.69       28  

10/31/16

     7.62        0.10        (0.29      (0.19      (0.08             (0.08      7.35        (2.43     342,114        1.79       1.79       1.41       47  

Frontier Emerging Markets Portfolio–Institutional Class II

 

04/30/21

     6.95        0.05        1.13        1.18        (0.14             (0.14      7.99        16.96 (A)      136,701        1.51 (B)      1.35 (B)      1.40 (B)      17 (A) 

10/31/20

     7.82        0.14        (0.84      (0.70      (0.17             (0.17      6.95        (9.26     116,911        1.60       1.35       1.95       21  

10/31/19

     7.63        0.17        0.13        0.30        (0.11             (0.11      7.82        4.01       128,742        1.55       1.35       2.19       31  

10/31/18

     8.50        0.14        (0.83      (0.69      (0.18             (0.18      7.63        (8.31     163,794        1.56       1.35       1.51       20  

10/31/17(2)(3)

     7.43        0.08        0.99        1.07                             8.50        14.40 (A)      166,698        1.58 (B)      1.35 (B)      1.47 (B)      28 (A) 

Frontier Emerging Markets Portfolio–Investor Class

 

04/30/21

     6.88        0.02        1.12        1.14        (0.10             (0.10      7.92        16.44 (A)      10,473        2.05 (B)      2.00 (B)      0.66 (B)      17 (A) 

10/31/20

     7.75        0.08        (0.83      (0.75      (0.12             (0.12      6.88        (9.70     10,327        2.12       2.00       1.17       21  

10/31/19

     7.57        0.11        0.13        0.24        (0.06             (0.06      7.75        3.24       20,560        2.00       2.00       1.38       31  

10/31/18

     8.43        0.07        (0.79      (0.72      (0.14             (0.14      7.57        (8.75     25,388        2.06       2.00       0.87       20  

10/31/17

     7.28        0.04        1.15        1.19        (0.04             (0.04      8.43        16.40       30,981        2.13       2.00       0.48       28  

10/31/16

     7.55        0.07        (0.30      (0.23      (0.04             (0.04      7.28        (3.01     32,771        2.23       2.23       1.02       47  

Global Equity Research Portfolio–Institutional Class

 

04/30/21

     12.76        0.04        3.25        3.29        (0.09      (0.29      (0.38      15.67        26.05 (A)      9,312        1.68 (B)      0.80 (B)      0.50 (B)      22 (A) 

10/31/20

     12.57        0.10        0.78        0.88        (0.15      (0.54      (0.69      12.76        7.15       7,387        2.04       0.80       0.80       44  

10/31/19

     12.06        0.14        1.40        1.54        (0.09      (0.94      (1.03      12.57        14.36       6,895        1.96       0.83       1.18       44  

10/31/18

     12.23        0.10        0.23        0.33        (0.18      (0.32      (0.50      12.06        2.74       5,452        2.64       0.90       0.76       45  

10/31/17(4)

     10.00        0.08        2.15        2.23                             12.23        22.30 (A)      5,308        3.49 (B)      0.90 (B)      0.80 (B)      36 (A) 

International Equity Research Portfolio–Institutional Class

 

04/30/21

     12.01        0.05        2.87        2.92        (0.15      (0.32      (0.47      14.46        24.60 (A)      15,354        1.51 (B)      0.75 (B)      0.65 (B)      24 (A) 

10/31/20

     12.03        0.14        0.07        0.21        (0.14      (0.09      (0.23      12.01        1.73       12,494        1.40       0.75       1.20       51  

10/31/19

     11.59        0.18        1.17        1.35        (0.13      (0.78      (0.91      12.03        12.93       19,458        1.42       0.79       1.62       44  

10/31/18

     13.11        0.14        (0.93      (0.79      (0.14      (0.59      (0.73      11.59        (6.43     9,305        1.78       0.90       1.07       43  

10/31/17

     11.10        0.12        2.26        2.38        (0.17      (0.20      (0.37      13.11        22.26       9,479        2.26       0.90       0.99       55  

10/31/16(5)

     10.00        0.14        0.96        1.10                             11.10        11.00 (A)      6,244        3.54 (B)      0.90 (B)      1.51 (B)      33 (A) 

 

(A)

Not Annualized.

(B)

Annualized.

(1)

Net investment income per share was calculated using the average shares outstanding method.

(2)

For the period from March 1, 2017 (commencement of class operations) through October 31, 2017.

(3)

All per share amounts and net asset values have been adjusted as a result of the share dividend effected after the close of business on December 1, 2017.

(4)

For the period from December 19, 2016 (commencement of class operations) through October 31, 2017.

(5)

For the period from December 17, 2015 (commencement of class operations) through October 31, 2016.

 

See Notes to Financial Statements

 

54


Table of Contents

Harding, Loevner Funds, Inc.

 

Financial Highlights (continued)

For the Six Months Ended April 30, 2021 (unaudited) and the Fiscal Year Ended October 31

 

 

           

INCREASE (DECREASE) IN

NET ASSETS FROM

OPERATIONS:

    

DISTRIBUTIONS TO

SHAREHOLDERS FROM:

                  RATIOS/SUPPLEMENTAL DATA:        
    

Net asset

value,

beginning

of period

    

Net

investment

income

(loss)(1)

    

Net

realized

and

unrealized

gain (loss)

on

investments

and

foreign

currency-

related

transactions

    

Net

increase

(decrease)

from

investment

operations

    

Net

investment

income

    

Net

realized

gain

from

investments

    

Total

distributions

    

Net

asset

value,

end

of

period

    

Total

Return

   

Net assets,

end of period

(000’s)

    

Expenses

to average

net assets

   

Expenses

to average

net assets

(net of fees

waived/

reimbursed)

   

Net

investment

income to

average

net assets

   

Portfolio

turnover

rate

 

Emerging Markets Research Portfolio–Institutional Class

 

04/30/21

     $11.21        $0.03        $2.45        $2.48        $(0.08      $(0.13      $(0.21      $13.48        22.17 (A)     $8,997        2.07 (B)     1.15 (B)     0.39 (B)     24 (A)

10/31/20

     11.42        0.09        0.17        0.26        (0.14      (0.33      (0.47      11.21        2.19       7,367        2.40       1.15       0.83       67  

10/31/19

     10.82        0.15        1.35        1.50        (0.09      (0.81      (0.90      11.42        15.05       7,198        2.29       1.19       1.35       58  

10/31/18

     13.01        0.12        (1.34      (1.22      (0.23      (0.74      (0.97      10.82        (10.24     5,702        2.90       1.30       0.93       55  

10/31/17(2)

     10.00        0.10        2.91        3.01                             13.01        30.10 (A)      5,880        3.72 (B)      1.30 (B)      1.04 (B)      46 (A) 

Chinese Equity Portfolio–Institutional Class

 

04/30/21(3)

     10.00        (0.02      0.75        0.73                             10.73        7.20 (A)      4,151        6.62 (B)      1.15 (B)      (0.53 )(B)      5 (A) 

 

(A)

Not Annualized.

(B)

Annualized.

(1)

Net investment income per share was calculated using the average shares outstanding method.

(2)

For the period from December 19, 2016 (commencement of class operations) through October 31, 2017.

(3)

For the period from December 16, 2020 (commencement of operations) through April 30, 2021.

 

See Notes to Financial Statements

 

55


Table of Contents

Harding, Loevner Funds, Inc.

 

Notes to Financial Statements

April 30, 2021 (unaudited)

 

1. Organization

Harding, Loevner Funds, Inc. (the “Fund”) was organized as a Maryland corporation on July 31, 1996, and is registered under the Investment Company Act of 1940, as amended (the “1940 Act”), as an open-end management investment company. The Fund currently has nine separate diversified Portfolios and one non-diversified Portfolio, all of which were active as of April 30, 2021 (individually, a “Portfolio”, collectively, the “Portfolios”). The Fund is managed by Harding Loevner LP (the “Investment Adviser”).

 

Portfolio

  

Inception Date

  

Investment Objective

Global Equity Portfolio (“Global Equity”)

   Institutional Class: November 3, 2009 Institutional Class Z: August 1, 2017 Advisor Class: December 1, 1996    to seek long-term capital appreciation through investments in equity securities of companies based both inside and outside the United States

International Equity Portfolio (“International Equity”)

   Institutional Class: May 11, 1994* Institutional Class Z: July 17, 2017 Investor Class: September 30, 2005    to seek long-term capital appreciation through investments in equity securities of companies based outside the United States

International Small Companies Portfolio (“International Small Companies”)

   Institutional Class: June 30, 2011 Investor Class: March 26, 2007    to seek long-term capital appreciation through investments in equity securities of small companies based outside the United States

Institutional Emerging Markets Portfolio** (“Institutional Emerging Markets”)

   Institutional Class (Formerly Class I): October 17, 2005 Institutional Class Z (Formerly Class II): March 5, 2014    to seek long-term capital appreciation through investments in equity securities of companies based in emerging markets

Emerging Markets Portfolio** (“Emerging Markets”)

   Advisor Class: November 9, 1998    to seek long-term capital appreciation through investments in equity securities of companies based in emerging markets

Frontier Emerging Markets Portfolio (“Frontier Emerging Markets”)

   Institutional Class I: May 27, 2008 Institutional Class II: March 1, 2017 Investor Class: December 31, 2010    to seek long-term capital appreciation through investments in equity securities of companies based in frontier and smaller emerging markets

Global Equity Research Portfolio (“Global Equity Research”)

   Institutional Class: December 19, 2016    to seek long-term capital appreciation through investments in equity securities of companies based both inside and outside the United States

International Equity Research Portfolio (“International Equity Research”)

   Institutional Class: December 17, 2015    to seek long-term capital appreciation through investments in equity securities of companies based outside the United States

Emerging Markets Research Portfolio (“Emerging Markets Research”)

   Institutional Class: December 19, 2016    to seek long-term capital appreciation through investments in equity securities of companies based in emerging markets

Chinese Equity Portfolio (“Chinese Equity”)

   Institutional Class: December 16, 2020    to seek long-term capital appreciation through investments in equity securities of Chinese companies

* The International Equity Portfolio is the successor to the HLM International Equity Portfolio of AMT Capital Fund, Inc., pursuant to a reorganization that took place on October 31, 1996. Information for periods prior to October 31, 1996, is historical information for the predecessor portfolio.

** Effective March 1, 2019, the Institutional Emerging Markets and Emerging Markets Portfolios’ shares are generally available for purchase by new and existing shareholders, subject to certain limitations that may apply at the Fund’s discretion.

2. Summary of Significant Accounting Policies

The accounting policies of the Fund are in conformity with accounting principles generally accepted in the United States (“GAAP”) for investment companies. Accordingly, the Fund follows accounting and reporting guidance under Financial Accounting Standards Board (“FASB”) Accounting Standards Codification Topic 946, “Financial Services - Investment Companies”. The following is a summary of the Fund’s significant accounting policies:

 

56


Table of Contents

Harding, Loevner Funds, Inc.

 

Notes to Financial Statements (continued)

April 30, 2021 (unaudited)

 

2. Summary of Significant Accounting Policies (continued)

 

Estimates

The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts and disclosures in the financial statements. Actual results could differ from those estimates.

Valuation

The Board of Directors of the Fund (the “Board” or the “Directors”) has adopted procedures (“Procedures”) to govern the valuation of the securities held by each Portfolio of the Fund in accordance with the 1940 Act. The Procedures incorporate principles set forth in relevant pronouncements of the Securities and Exchange Commission (“SEC”) and its staff, including guidance on the obligations of the Portfolios and their Directors to determine, in good faith, the fair value of the Portfolios’ securities when market quotations are not readily available.

In determining a Portfolio’s net asset value per share (“NAV”), each equity security traded on a securities exchange, including the NASDAQ Stock Market, and over-the-counter securities, are first valued at the closing price on the exchange or market designated by the Fund’s accounting agent as the principal exchange (each, a “principal exchange”). The closing price provided by the Fund’s accounting agent for a principal exchange may differ from the price quoted elsewhere and may represent information such as last sales price, an official closing price, a closing auction price or other information, depending on exchange or market convention. Shares of open-end mutual funds including money market funds are valued at NAV. Such securities are typically categorized as “Level 1” pursuant to the hierarchy described below.

Since trading in many foreign securities is normally completed before the time at which a Portfolio calculates its NAV, the effect on the value of such securities held by a Portfolio of events that occur between the close of trading in the security and the time at which the Portfolio prices its securities would not be reflected in the Portfolio’s calculation of its NAV if foreign securities were generally valued at their closing prices. To address this issue, the Board has approved the daily use of independently provided quantitative models that may adjust the closing prices of certain foreign equity securities based on information that becomes available after the foreign market closes, through the application of an adjustment factor to such securities’ closing price. Adjustment factors may be greater than, less than, or equal to 1. Thus, use of these quantitative models could cause a Portfolio to value a security higher, lower or equal to its closing market price, which in turn could cause the Portfolio’s NAV per share to differ significantly from that which would have been calculated using closing market prices. The use of these quantitative models is also intended to decrease the opportunities for persons to engage in ‘‘time zone arbitrage,’’ i.e., trading intended to take advantage of stale closing prices in foreign markets that could affect the NAV of the Portfolios. Securities subjected to an adjustment factor due to the use of these quantitative models are not specifically designated on the Portfolios’ Portfolio of Investments as being “fair valued”. Securities with an adjustment factor greater than or less than 1, which are absent the use of significant unobservable inputs into their valuation, are categorized as “Level 2” and securities with an adjustment factor equal to 1, which are absent the use of significant unobservable inputs into their valuation, are categorized as “Level 1” pursuant to the hierarchy described below.

Any securities for which market quotations are not readily available or for which available prices are deemed unreliable are priced by the Investment Adviser at “fair value as determined in good faith”, in accordance with the Procedures. Such securities are identified on the Portfolios’ Portfolio of Investments as securities valued at “fair value as determined in good faith” and absent the use of significant unobservable inputs into their valuation, such securities would be categorized as “Level 2” pursuant to the hierarchy described below.

GAAP has established a hierarchy for NAV determination purposes in which various inputs are used in determining the value of each Portfolio’s assets or liabilities. GAAP defines fair value as the price that the Portfolio would receive upon selling an investment in a timely transaction to an independent buyer in the principal or most advantageous market of the investment. GAAP establishes a three-tier hierarchy to maximize the use of observable market data and minimize the use of unobservable inputs and to establish classification of fair value measurements for disclosure purposes. Inputs may be observable or unobservable and refer broadly to the assumptions that market participants would use in pricing the asset or liability including assumptions about risk. Such risks include the inherent risk in a particular valuation technique which is used to measure fair value. This may include the quantitative models and/or the inputs to the quantitative models used in the valuation technique described above. Observable inputs are inputs that reflect the assumptions market participants would use in pricing the asset or liability developed based on market data obtained from sources independent of the reporting entity. Unobservable inputs are inputs that reflect the reporting entity’s own assumptions about the assumptions market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The three-tier hierarchy of inputs is summarized in the three broad levels listed below.

 

57


Table of Contents

Harding, Loevner Funds, Inc.

 

Notes to Financial Statements (continued)

April 30, 2021 (unaudited)

 

2. Summary of Significant Accounting Policies (continued)

 

Level 1    unadjusted quoted prices in active markets for identical assets
Level 2    other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.)
Level 3    significant unobservable inputs (including the Portfolio’s own assumptions in determining the fair value of investments)

GAAP provides additional guidance for estimating fair value when the volume and level of activity for the asset or liability have significantly decreased as well as guidance on identifying circumstances that indicate when a transaction is not orderly.

The following is a summary of the Portfolios’ investments classified by Level 1, Level 2 and Level 3 and security type as of April 30, 2021. Please refer to each Portfolio’s Portfolio of Investments to view individual securities classified by industry type and country.

 

Portfolio    Unadjusted Quoted Prices
in Active Markets for
Identical Assets (Level 1)
   Other Significant
Observable Inputs
(Level 2)
   Significant
Unobservable Inputs
(Level 3)
   Total

Global Equity

                   

Common Stocks

     $ 1,196,942,950      $ 487,561,729      $      $ 1,684,504,679

Short Term Investments

       11,641,172                      11,641,172

Total Investments

     $ 1,208,584,122      $ 487,561,729      $      $ 1,696,145,851

International Equity

                   

Common Stocks

     $ 4,771,123,227      $  14,384,054,479      $      $  19,155,177,706

Preferred Stocks

       261,670,465        529,854,018               791,524,483

Short Term Investments

       459,610,526                      459,610,526

Total Investments

     $ 5,492,404,218      $ 14,913,908,497      $      $ 20,406,312,715

International Small Companies

                   

Common Stocks

     $ 47,495,111      $ 456,590,579      $      $ 504,085,690

Short Term Investments

       16,277,399                      16,277,399

Total Investments

     $ 63,772,510      $ 456,590,579      $      $ 520,363,089

Institutional Emerging Markets

                   

Common Stocks

     $ 1,609,209,444      $ 4,801,593,778      $      $ 6,410,803,222

Preferred Stocks

       180,719,513        24,472,611               205,192,124

Short Term Investments

       161,952,653                      161,952,653

Total Investments

     $ 1,951,881,610      $ 4,826,066,389      $      $ 6,777,947,999

Emerging Markets

                   

Common Stocks

     $ 1,087,670,801      $ 3,244,444,499      $      $ 4,332,115,300

Preferred Stocks

       122,126,273        16,538,183               138,664,456

Short Term Investments

       108,829,058                      108,829,058

Total Investments

     $ 1,318,626,132      $ 3,260,982,682      $      $ 4,579,608,814

Frontier Emerging Markets

                   

Common Stocks

     $ 41,535,818      $ 183,528,040      $      $ 225,063,858

Preferred Stocks

       6,141,666                      6,141,666

Short Term Investments

       3,338,540                      3,338,540

Total Investments

     $ 51,016,024      $ 183,528,040      $      $ 234,544,064

Global Equity Research

                   

Common Stocks

     $ 4,486,015      $ 4,552,745      $      $ 9,038,760

Preferred Stocks

       41,316        109,540               150,856

Short Term Investments

       121,664                      121,664

Total Investments

     $ 4,648,995      $ 4,662,285      $      $ 9,311,280

 

58


Table of Contents

Harding, Loevner Funds, Inc.

 

Notes to Financial Statements (continued)

April 30, 2021 (unaudited)

 

2. Summary of Significant Accounting Policies (continued)

 

Portfolio    Unadjusted Quoted Prices
in Active Markets for
Identical Assets (Level 1)
   Other Significant
Observable Inputs
(Level 2)
   Significant
Unobservable Inputs
(Level 3)
   Total

International Equity Research

                   

Common Stocks

     $ 2,111,278      $ 12,725,465      $      $ 14,836,743

Preferred Stocks

       122,714        263,734               386,448

Short Term Investments

       117,852                      117,852

Total Investments

     $ 2,351,844      $ 12,989,199      $      $ 15,341,043

Emerging Markets Research

                   

Common Stocks

     $ 1,875,802      $ 6,668,830      $      $ 8,544,632

Preferred Stocks

       171,334        178,488               349,822

Short Term Investments

       27,953                      27,953

Total Investments

     $ 2,075,089      $ 6,847,318      $      $ 8,922,407

Chinese Equity

                   

Common Stocks

     $ 253,707      $ 3,743,042      $      $ 3,996,749

Short Term Investments

       40,719                      40,719

Total Investments

     $ 294,426      $ 3,743,042      $      $ 4,037,468

As of April 30, 2021, there were no Level 3 investments held within the Portfolios.

Securities

For financial reporting purposes, all securities transactions are recorded on a trade date basis, as of the last business day in the reporting period. Throughout the reporting period, securities transactions are typically accounted for on a trade date – plus one business day basis. Interest income and expenses are recorded on an accrual basis. Dividend income is recorded on the ex-dividend date (except for certain foreign dividends that may be recorded as soon as the Portfolio is informed of such dividends). The Portfolios use the specific identification method for determining realized gains or losses from sales of securities.

Dividends to Shareholders

It is the policy of the Portfolios to declare dividends from net investment income annually. Net short-term and long-term capital gains distributions for the Portfolios, if any, are also normally distributed on an annual basis.

Dividends from net investment income and distributions from net realized gains from investment transactions have been determined in accordance with income tax regulations and may differ from net investment income and realized gains recorded by the Portfolios for financial reporting purposes. Differences result primarily from foreign currency transactions and timing differences related to recognition of income, and gains and losses from investment transactions. In general, to the extent that any differences, which are permanent in nature, result in over distributions to shareholders, the amount of the over distribution is reclassified within the capital accounts based on its federal tax basis treatment and may be reported as return of capital. Temporary differences do not require reclassification.

Currency Translation

Assets and liabilities denominated in foreign currencies and commitments under forward foreign currency exchange contracts are translated into U.S. dollars at the mean of the quoted bid and asked prices of such currencies against the U.S. dollar. Purchases and sales of the Portfolios’ securities are translated at the rates of exchange prevailing when such securities were acquired or sold. Income and expenses are translated at exchange rates prevailing when accrued. The Portfolios do not isolate that portion of the results of operations resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in market prices of securities held. Such fluctuations are included with the “Net realized gain (loss) on investment transactions” and “Change in unrealized appreciation (depreciation) on investments” on the Statements of Operations.

 

59


Table of Contents

Harding, Loevner Funds, Inc.

 

Notes to Financial Statements (continued)

April 30, 2021 (unaudited)

 

2. Summary of Significant Accounting Policies (continued)

 

Net realized gains and losses from foreign currency-related transactions arise from sales of foreign currency, currency gains or losses realized between the trade and settlement dates on securities transactions, and the difference between the amounts of dividends, interest, and foreign withholding taxes recorded on the Portfolios’ books, and the U.S. dollar equivalent of the amounts actually received or paid. Net unrealized appreciation or depreciation on translation of assets and liabilities denominated in foreign currencies arise from changes in the value of assets and liabilities other than investments in securities at the period end, resulting from changes in the exchange rates.

Expenses

Most expenses of the Fund can be directly attributed to a particular Portfolio. Expenses which cannot be directly attributed are apportioned among the Portfolios based upon relative net assets or other appropriate measures. If an expense is incurred at the Portfolio level, it is generally apportioned among the classes of that Portfolio based upon relative net assets of each respective class. Certain expenses are incurred at the class level and charged only to that particular class. These expenses may be class specific (i.e., distribution fees charged only to a particular class) or they may be identifiable to a particular class (i.e., the costs related to mailing shareholder reports to shareholders of a particular class).

Organization and Offering Fees

Costs incurred by the Chinese Equity Portfolio in connection with its organization were expensed as they were incurred. Costs related to the offering of shares were deferred and amortized on a straight line basis over the twelve-month period from the date of commencement of operations of the Portfolios.

Redemption Fees

Prior to February 28, 2020, the Fund had established fees on short-term redemptions to discourage frequent trading in Portfolio shares. Redemptions of Portfolio shares made within 90 days of purchase may have been subject to a redemption fee equal to 2% of the amount redeemed. For the year ended October 31, 2020 the Portfolios received the following redemption fees. These amounts are netted against “Payments for Shares Redeemed” in Note 7—Capital Share Transactions.

 

     Institutional
Class
  Institutional
Class I
   Institutional
Class II
Portfolio    Year Ended
October 31,
2020
  Year Ended
October 31,
2020
   Year Ended
October 31,
2020

Global Equity

     $ 18,908     $      $

International Equity

       132,379             

International Small Companies

       974             

Institutional Emerging Markets

       27,951 *             

Frontier Emerging Markets

             1,471       

* Formerly Class I

             
     Investor
Class
  Advisor
Class
   Institutional
Class Z
Portfolio    Year Ended
October 31,
2020
  Year Ended
October 31,
2020
   Year Ended
October 31,
2020

Global Equity

     $     $ 1,561      $

International Equity

       4,924              26

International Small Companies

       1,582             

Emerging Markets

             36,279       

Frontier Emerging Markets

       1,292             

 

60


Table of Contents

Harding, Loevner Funds, Inc.

 

Notes to Financial Statements (continued)

April 30, 2021 (unaudited)

 

2. Summary of Significant Accounting Policies (continued)

 

Indemnifications

Under the Fund’s organizational document, its officers and Board are indemnified against certain liability arising out of the performance of their duties to the Portfolios. In the normal course of business, the Fund may enter into contracts that contain a variety of representations or that provide indemnification for certain liabilities. The Fund’s maximum exposure under these arrangements is unknown, as this would involve future claims that may be made against the Fund that have not yet occurred. However, the Fund has not had prior claims or losses pursuant to these contracts and expects the risk of loss to be remote.

3. Transactions with Affiliates and Significant Agreements

The Board has approved investment advisory agreements with The Investment Adviser. Advisory fees are computed daily and paid monthly based on the average daily net assets of each Portfolio. The Investment Adviser has contractually agreed to reduce its fee and/or reimburse the Portfolios for other operating expenses to the extent that aggregate expenses, excluding certain non-operating expenses, exceed certain annual rates of the average daily net assets of each class.

The following annualized advisory fees and contractual expense limits were in effect for the period ended April 30, 2021. The advisory fees are charged at the Portfolio level as a whole and expense limitations are at the class specific level.

 

Portfolio   First $1 billion
of assets
  Next $1 billion
of assets
  Next $1 billion
of assets
  Over $3 billion
of assets
  Over $4 billion
of assets
  Over $5 billion
of assets
  Contractual Expense
Limit(a)

Global Equity–Institutional Class

      0.75%       0.73%       0.71%       0.69%       0.69%       0.69%       0.90%

Global Equity–Institutional Class Z

      0.75%       0.73%       0.71%       0.69%       0.69%       0.69%       0.80%

Global Equity–Advisor Class

      0.75%       0.73%       0.71%       0.69%       0.69%       0.69%       1.20%

International Equity–Institutional Class

      0.75%       0.73%       0.71%       0.69%       0.67%       0.65%       1.00%

International Equity–Institutional Class Z

      0.75%       0.73%       0.71%       0.69%       0.67%       0.65%       0.80%

International Equity–Investor Class

      0.75%       0.73%       0.71%       0.69%       0.67%       0.65%       1.25%

International Small Companies–Institutional Class(b)

      1.00%       1.00%       1.00%       1.00%       1.00%       1.00%       1.15%

International Small Companies–Investor Class(b)

      1.00%       1.00%       1.00%       1.00%       1.00%       1.00%       1.40%

Institutional Emerging Markets–Institutional Class(c)

      1.15%       1.13%       1.11%       1.09%       1.09%       1.09%       1.17% (d) 

Institutional Emerging Markets–Institutional Class Z(c)

      1.15%       1.13%       1.11%       1.09%       1.09%       1.09%       1.15% (d),(e) 

Emerging Markets–Advisor Class(f)

      1.15%       1.13%       1.11%       1.09%       1.09%       1.09%       1.32% (g) 

Frontier Emerging Markets–Institutional Class I

      1.35%       1.35%       1.35%       1.35%       1.35%       1.35%       1.75%

Frontier Emerging Markets–Institutional Class II

      1.35%       1.35%       1.35%       1.35%       1.35%       1.35%       1.35%

Frontier Emerging Markets–Investor Class

      1.35%       1.35%       1.35%       1.35%       1.35%       1.35%       2.00%

Global Equity Research–Institutional Class

      0.70%       0.70%       0.70%       0.70%       0.70%       0.70%       0.80%

International Equity Research–Institutional Class

      0.70%       0.70%       0.70%       0.70%       0.70%       0.70%       0.75%

Emerging Markets Research–Institutional Class

      1.00%       1.00%       1.00%       1.00%       1.00%       1.00%       1.15%

Chinese Equity–Institutional Class

      0.95%       0.95%       0.95%       0.95%       0.95%       0.95%       1.15%

 

(a)

Effective through February 28, 2022 for each Portfolio except Institutional Small Companies, Institutional Emerging Markets, and Emerging Markets.

 

(b)

Effective July 1, 2021, International Small Companies Contractual management fee will be reduced to 0.95% of all assets.

 

(c)

Effective July 1, 2021, Institutional Emerging Markets Portfolio contractual management fee will be reduced to 1.00% on the first $1 billion of assets, 0.98% on the next $1 billion of assets, 0.96% on the next $1 billion of assets, and 0.94% for assets over $3 billion.

 

(d)

Effective July 1, 2021, the Investment Adviser has contractually agreed to lower the expense cap for (i) the Institutional Emerging Markets Portfolio’s Institutional Class to 1.10% and (ii) the Institutional Emerging Markets Portfolio’s Institutional Class Z to 1.00% (regardless of fee tier). These expense cap changes are effective until February 28, 2023.

 

(e)

On first $1 Billion of assets.

 

(f)

Effective July 1, 2021, Emerging Markets Portfolio contractual management fee will be reduced to 1.00% on the first $1 billion of assets, 0.98% on the next $1 billion of assets, 0.96% on the next $1 billion of assets, and 0.94% for assets over $3 billion.

 

61


Table of Contents

Harding, Loevner Funds, Inc.

 

Notes to Financial Statements (continued)

April 30, 2021 (unaudited)

 

3. Transactions with Affiliates and Significant Agreements (continued)

 

(g)

Effective July 1, 2021 the Investment Adviser has contractually agreed to lower the expense cap for the Emerging Markets Portfolio’s Advisor Class to 1.30%. Expense cap change effective through February 28, 2023.

The Fund has an administration agreement with The Northern Trust Company (“Northern Trust”), which provides certain accounting, clerical and bookkeeping services, Blue Sky, corporate secretarial services and assistance in the preparation and filing of tax returns and reports to shareholders and the SEC.

Northern Trust also serves as custodian of each Portfolio’s securities and cash, transfer agent, dividend disbursing agent and agent in connection with any accumulation, open-account or similar plans provided to the shareholders of the Portfolios.

Foreside Management Services, LLC provides compliance support to the Fund’s Chief Compliance Officer. Fees paid pursuant to these services are shown as “Compliance and Treasurer officers’ fees and expenses” on the Statements of Operations.

The Fund has adopted an Amended Plan of Distribution pursuant to Rule 12b-1 under the 1940 Act (“Distribution Plan”). Under the Distribution Plan, the Investor Class of each of the International Equity, International Small Companies and Frontier Emerging Markets Portfolios may pay underwriters, distributors, dealers or brokers a fee at an annual rate of up to 0.25% of the average daily net assets of the Portfolio’s Investor Class shares for services or expenses arising in connection with activities primarily intended to result in the sale of Investor Class shares of the Portfolios or for Shareholder Services (defined below) consistent with those described under the Shareholder Servicing Plan.

The Fund, on behalf of the Portfolios, has agreements with various financial intermediaries and “mutual fund supermarkets”, under which customers of these intermediaries may purchase and hold Portfolio shares. These intermediaries assess fees in consideration for providing certain account maintenance, recordkeeping and transactional and other shareholder services (collectively, “Shareholder Services”). With the exception of Institutional Class Z, each Portfolio or class is authorized, pursuant to a Shareholder Servicing Plan, to pay to each intermediary an annual rate of up to 0.25% of its average daily net assets attributable to that intermediary (subject to the contractual expense limits described above) for such Shareholder Services. Because of the contractual expense limits on certain Portfolios’ fees and expenses, the Investment Adviser paid a portion of the Portfolios’ share of these fees during the period ended April 30, 2021. Such payments, if any, are included in the table above under the caption “Fees waived and/or reimbursed by the Investment Adviser”.

For the period ended April 30, 2021, the Investment Adviser waived and/or reimbursed the following amounts pursuant to the contractual expense limits described above:

 

Portfolio   Fees waived and/or reimbursed by the  Investment Adviser

Global Equity-Institutional Class Z

  $13,326

International Small Companies-Institutional Class

      36,228

International Small Companies-Investor Class

      23,323

Institutional Emerging Markets-Institutional Class

  2,931,115

Institutional Emerging Markets-Institutional Class Z

    279,084

Emerging Markets-Advisor Class

    672,075

Frontier Emerging Markets-Institutional Class II

    107,208

Frontier Emerging Markets-Investor Class

        2,595

Global Equity Research-Institutional Class

      38,287

International Equity Research-Institutional Class

      55,880

Emerging Markets Research-Institutional Class

      40,282

Chinese Equity-Institutional Class

      77,922

The Fund has an administration agreement with The Northern Trust Company (“Northern Trust”), which provides certain accounting, clerical and bookkeeping services, Blue Sky, corporate secretarial services and assistance in the preparation and filing of tax returns and reports to shareholders and the SEC.

Northern Trust also serves as custodian of each Portfolio’s securities and cash, transfer agent, dividend disbursing agent and agent in connection with any accumulation, open-account or similar plans provided to the shareholders of the Portfolios.

 

62


Table of Contents

Harding, Loevner Funds, Inc.

 

Notes to Financial Statements (continued)

April 30, 2021 (unaudited)

 

3. Transactions with Affiliates and Significant Agreements (continued)

 

Foreside Management Services, LLC provides compliance support to the Fund’s Chief Compliance Officer. Fees paid pursuant to these services are shown as “Compliance officers’ fees and expenses” on the Statements of Operations.

The Fund has adopted an Amended Plan of Distribution pursuant to Rule 12b-1 under the 1940 Act (“Distribution Plan”). Under the Distribution Plan, the Investor Class of each of the International Equity, International Small Companies and Frontier Emerging Markets Portfolios may pay underwriters, distributors, dealers or brokers a fee at an annual rate of up to 0.25% of the average daily net assets of the Portfolio’s Investor Class shares for services or expenses arising in connection with activities primarily intended to result in the sale of Investor Class shares of the Portfolios or for Shareholder Services (defined below) consistent with those described under the Shareholder Servicing Plan.

The Fund, on behalf of the Portfolios, has agreements with various financial intermediaries and “mutual fund supermarkets”, under which customers of these intermediaries may purchase and hold Portfolio shares. These intermediaries assess fees in consideration for providing certain account maintenance, recordkeeping and transactional and other shareholder services (collectively, “Shareholder Services”). With the exception of Institutional Class Z, each Portfolio or class is authorized, pursuant to a Shareholder Servicing Plan, to pay to each intermediary an annual rate of up to 0.25% of its average daily net assets attributable to that intermediary (subject to the contractual expense limits described above) for such Shareholder Services. Because of the contractual expense limits on certain Portfolios’ fees and expenses, the Investment Adviser paid a portion of the Portfolios’ share of these fees during the period ended April 30, 2021. Such payments, if any, are included in the table above under the caption “Fees waived and/or reimbursed by the Investment Adviser”.

A Portfolio may purchase securities from, or sell securities to, an affiliated fund provided the affiliation is due solely to having a common investment adviser, common officers, or common Directors. For the period ended April 30, 2021, no Portfolios engaged in purchases and/or sales of securities from an affiliated portfolio in compliance with Rule 17a-7 of the 1940 Act.

4. Class Specific Expenses

The class level expenses for the period ended April 30, 2021, were as follows for each Portfolio:

 

Portfolio    Distribution
Fees
   State Registration
Filing Fees
   Printing and
Postage Fees
   Transfer Agent
Fees and Expenses
   Shareholder
Servicing Fees

Global Equity–Institutional Class

         $      $  13,288      $   10,318      $  2,538      $ 506,565

Global Equity–Institutional Class Z

              8,864        3,677        731       

Global Equity–Advisor Class

              7,082        10,734        1,702        70,240

International Equity–Institutional Class

              23,748        374,434        240,026        6,597,190

International Equity–Institutional Class Z

              12,100        51,138        9,363       

International Equity–Investor Class

       463,668        9,613        20,097        11,112        248,130

International Small Companies–Institutional Class

              8,420        8,142        1,278        136,075

International Small Companies–Investor Class

       55,560        7,509        2,718        1,505        24,669

Institutional Emerging Markets–Institutional Class

              15,596        164,665        26,488        2,600,379

Institutional Emerging Markets–Institutional Class Z

              8,509        9,139        4,384       

Emerging Markets–Advsor Class

              17,221        180,059        275,101        3,209,774

Frontier Emerging Markets–Institutional Class I

              7,631        3,725        1,752        29,556

Frontier Emerging Markets–Institutional Class II

              8,245        1,351        164       

Frontier Emerging Markets–Investor Class

       13,613        6,861        957        556        7,994

Global Equity Research–Institutional Class

              10,130        100        239       

International Equity Research–Institutional Class

              9,231        189        289        6,598

Emerging Markets Research–Institutional Class

              10,199        99        249       

Chinese Equity–Institutional Class

              7,525        833        239       

5. Investment Transactions

Cost of purchases and proceeds from sales of investment securities, other than short-term investments, for the period ended April 30, 2021, were as follows for each Portfolio:

 

Portfolio    Purchase Cost of
Investment Securities
        Proceeds from Sales of
Investment Securities
    

Global Equity

     $ 652,425,470               $  639,253,201         

 

63


Table of Contents

Harding, Loevner Funds, Inc.

 

Notes to Financial Statements (continued)

April 30, 2021 (unaudited)

 

5. Investment Transactions (continued)

 

Portfolio    Purchase Cost of
Investment Securities
        Proceeds from Sales of
Investment Securities
    

International Equity

     $ 1,969,341,462          $  1,352,647,099    

International Small Companies

       78,681,309            21,414,932    

Institutional Emerging Markets

       447,959,367            587,187,854    

Emerging Markets

       303,781,721            447,203,295    

Frontier Emerging Markets

       36,568,608            36,482,017    

Global Equity Research

       1,829,970            1,823,284    

International Equity Research

       3,439,922            3,480,974    

Emerging Markets Research

       1,987,395            2,000,909    

Chinese Equity

       3,950,723                 198,066         

6. In-Kind Redemptions

During the period ended October 31, 2020, the Global Equity Portfolio delivered portfolio securities rather than cash in exchange for the redemption of shares for certain investors (in-kind redemptions). These investors received readily marketable securities that were valued on the redemption date using the same method employed in calculating the Portfolio’s NAV per share. The Global Equity Portfolio had in-kind redemptions of approximately $38,788,196. The redemption amounts are included in “Net increase (decrease) in net assets from portfolio share transactions” on the Statements of Changes in Net Assets. Net gain of approximately $17,420,766 on the securities resulting from such in-kind redemptions are included in “Net realized gain (loss) on investments and foreign currency transactions” in the Statements of Changes in Net Assets. For financial reporting purposes, these transactions are treated as sales of securities and the resulting gains and losses are recognized based on the market value of the securities on the date of the redemption. For tax purposes, no gains or losses are recognized.

7. Capital Share Transactions

Transactions in capital shares for the period ended April 30, 2021, were as follows for each Portfolio:

 

     

Shares

Sold

  

Proceeds

From

Shares Sold

   Shares From
Reinvested
Dividends
  

Reinvestment
of

Dividends

   Shares
Redeemed
 

Payments

for Shares
Redeemed

 

Net

Increase
(Decrease)

in Shares

 

Net

Increase
(Decrease) in
Net Assets

Global Equity

                                    

Institutional Class

       1,817,088      $ 86,049,910        1,350,884      $ 61,262,574        (2,216,683 )     $ (106,242,324 )       951,289     $ 41,070,160

Institutional Class Z

       1,127,003        54,338,406        296,046        13,419,766        (610,471 )       (28,959,129 )       812,578       38,799,043

Advisor Class

       183,726        8,728,427        72,150        3,270,573        (346,811 )       (16,738,929 )       (90,935 )       (4,739,929 )

International Equity

 

                               

Institutional Class

       77,925,873        2,207,658,867        3,415,990        94,725,399        (63,740,927 )       (1,816,774,318 )       17,600,936       485,609,948

Institutional Class Z

       13,330,586        378,219,244        756,652        20,966,814        (10,453,704 )       (298,651,007 )       3,633,534       100,535,051

Investor Class

       1,613,350        46,133,966        59,184        1,641,770        (3,008,564 )       (83,482,519 )       (1,336,030 )       (35,706,783 )

International Small Companies

 

                               

Institutional Class

       4,611,331        92,669,658        29,892        569,448        (1,697,658 )       (33,799,090 )       2,943,565       59,440,016

Investor Class

       102,328        1,987,113        661        12,455        (201,846 )       (3,982,169 )       (98,857 )       (1,982,601 )

Institutional Emerging Markets

 

                               

Institutional Class

       21,831,864        561,826,317        773,359        19,248,905        (27,034,993 )       (698,207,990 )       (4,429,770 )       (117,132,768 )

Institutional Class Z

       4,229,931        110,204,246        126,142        3,145,987        (1,844,890 )       (48,453,720 )       2,511,183       64,896,513

Emerging Markets

 

                               

Advisor Class

       6,649,521        449,540,569        203,161        13,223,729        (8,119,200 )       (546,787,756 )       (1,266,518 )       (84,023,458 )

Frontier Emerging Markets

 

                               

Institutional Class I

       2,653,809        20,802,677        132,190        1,028,440        (2,135,280 )       (16,734,793 )       650,719       5,096,324

Institutional Class II

                     291,739        2,277,287                    291,739       2,277,287

Investor Class

       80,474        621,578        17,809        138,195        (276,156 )       (2,149,605 )       (177,873 )       (1,389,832 )

Global Equity Research

 

                               

Institutional Class

       34        501        15,309        217,846                    15,343       218,347

 

64


Table of Contents

Harding, Loevner Funds, Inc.

 

Notes to Financial Statements (continued)

April 30, 2021 (unaudited)

 

7. Capital Share Transactions (continued)

 

     Shares
Sold
 

Proceeds
From

Shares Sold

  Shares From
Reinvested
Dividends
 

Reinvestment

of
Dividends

  Shares
Redeemed
  Payments
for Shares
Redeemed
  Net
Increase
(Decrease)
in Shares
  Net Increase
(Decrease)
in Net Assets

International Equity Research

                               

Institutional Class

      10,556     $ 148,353       36,323     $ 489,632       (25,186 )     $ (351,172 )       21,693     $ 286,813

Emerging Markets Research

                               

Institutional Class

                  10,515       134,267                   10,515       134,267

Chinese Equity

                               

Institutional Class

      386,982       3,915,500                               386,982       3,915,500

Transactions in capital shares for the year ended October 31, 2020, were as follows for each Portfolio:    

 

     Shares
Sold
 

Proceeds
From

Shares Sold

  Shares From
Reinvested
Dividends
  Reinvestment
of
Dividends
  Shares
Redeemed
  Payments
for Shares
Redeemed
 

Net

Increase
(Decrease)
in Shares

 

Net

Increase
(Decrease) in
Net Assets

Global Equity

                               

Institutional Class

      12,675,160     $ 516,679,441       99,937     $ 3,750,633       (7,521,201 )     $ (276,990,882 )       5,253,896     $ 243,439,192

Institutional Class Z

      1,214,016       46,104,062       34,033       1,275,910       (909,670 )       (39,808,095 )       338,379       7,571,877

Advisor Class

      324,320       12,635,875       3,494       131,272       (440,185 )       (16,211,445 )       (112,371 )       (3,444,298 )

International Equity

                               

Institutional Class

      186,458,188       4,129,832,968       7,739,005       182,950,087       (227,702,716 )       (4,943,590,115 )       (33,505,523 )       (630,807,060 )

Institutional Class Z

      27,006,575       623,067,400       1,367,636       32,317,240       (22,561,293 )       (519,759,194 )       5,812,918       135,625,446

Investor Class

      4,328,969       95,529,374       213,471       5,048,578       (7,754,318 )       (171,021,718 )       (3,211,878 )       (70,443,766 )

International Small Companies

 

                           

Institutional Class

      7,221,258       109,689,074       98,894       1,656,470       (5,059,225 )       (74,531,343 )       2,260,927       36,814,201

Investor Class

      609,402       9,503,676       18,570       308,083       (1,972,802 )       (29,932,526 )       (1,344,830 )       (20,120,767 )

Institutional Emerging Markets

 

                           

Institutional Class

      80,055,144       1,550,781,076       2,860,129       63,923,895       (83,498,478 )       (1,627,562,463 )       (583,205 )       (12,857,492 )

Institutional Class Z

      7,951,385       170,473,905       364,763       8,156,096       (5,085,941 )       (98,100,924 )       3,230,207       80,529,077

Emerging Markets

                               

Advisor Class

      16,535,208       833,799,789       963,746       56,465,950       (26,896,624 )       (1,362,711,636 )       (9,397,670 )       (472,445,897 )

Frontier Emerging Markets

 

                           

Institutional Class I

      4,237,438       28,199,937       272,401       2,132,906       (12,462,963 )       (81,956,641 )       (7,953,124 )       (51,623,798 )

Institutional Class II

                  346,188       2,717,575                   346,188       2,717,575

Investor Class

      573,612       3,560,115       35,821       279,761       (1,762,337 )       (12,092,532 )       (1,152,904 )       (8,252,656 )

Global Equity Research

 

                           

Institutional Class

                  30,488       379,881                   30,488       379,881

International Equity Research

 

                           

Institutional Class

      152,365       1,688,521       30,406       374,600       (760,187 )       (9,228,810 )       (577,416 )       (7,165,689 )

Emerging Markets Research

 

                           

Institutional Class

      660       6,001       25,882       299,717                   26,542       305,718

8. Income Tax

The cost of investments for federal income tax purposes and the components of net unrealized appreciation (depreciation) on investments at April 30, 2021, for each of the Portfolios were as follows:

 

Portfolio   

Gross

Unrealized
Appreciation

   Gross
Unrealized
Depreciation
  Net Unrealized
Appreciation /
(Depreciation)
   Cost

Global Equity

     $ 537,617,523      $  (28,402,955     $ 509,214,568      $ 1,186,931,283

International Equity

       7,798,644,766        (233,996,112 )       7,564,648,654        12,841,664,061

International Small Companies

       163,041,346        (9,874,395 )       153,166,951        367,196,138

 

65


Table of Contents

Harding, Loevner Funds, Inc.

 

Notes to Financial Statements (continued)

April 30, 2021 (unaudited)

 

8. Income Tax (continued)

 

Portfolio   

Gross

Unrealized
Appreciation

   Gross
Unrealized
Depreciation
  Net Unrealized
Appreciation /
(Depreciation)
   Cost

Institutional Emerging Markets

       2,554,232,598      $  (165,266,050     $  2,388,966,548      $  4,388,981,451

Emerging Markets

       1,920,237,430        (90,801,251 )       1,829,436,179        2,750,172,635

Frontier Emerging Markets

       62,596,635        (17,041,013 )       45,555,622        188,988,442

Global Equity Research

       2,785,961        (160,089 )       2,625,872        6,685,408

International Equity Research

       4,000,119        (220,389 )       3,779,730        11,561,313

Emerging Markets Research

       2,181,279        (462,815 )       1,718,464        7,203,943

Chinese Equity

       390,682        (163,140 )       227,542        3,809,926

It is the policy of each Portfolio of the Fund to qualify as a regulated investment company by complying with the applicable provisions of the Internal Revenue Code, and to make distributions of taxable income sufficient to relieve it from substantially all federal income and excise taxes; therefore, no federal income tax provision is required.

The Portfolios may be subject to taxes imposed by countries in which they invest. Such taxes are generally based on income and/or capital gains earned. Taxes are accrued based on net investment income, net realized gains and net unrealized appreciation as such income and/or gains are recorded. Taxes accrued on unrealized gains are reflected as a liability on the Statements of Assets and Liabilities under the caption “Deferred capital gains tax” and as a reduction in “Distributable earnings”. When assets subject to capital gains tax are sold, accrued taxes are relieved, and the actual amount of the taxes paid is reflected on the Statements of Operations as a reduction in “Net realized gain (loss) on Investment Transactions”. The Portfolios seek to recover a portion of foreign withholding taxes applied to income earned in jurisdictions where favorable treaty rates for US investors are available. The portion of such taxes believed to be recoverable is reflected as an asset on the Statements of Assets and Liabilities under the caption “Tax reclaims receivable”.

Management has performed an analysis of each Portfolio’s tax positions for the open tax years as of April 30, 2021, and has concluded that no provisions for income tax are required. The Portfolios’ federal tax returns for the prior three fiscal years (open tax years: October 31, 2018; October 31, 2019; October 31, 2020) remain subject to examination by the Portfolios’ major tax jurisdictions, which include the United States, the State of New Jersey and the State of Maryland. Management is not aware of any events that are reasonably possible to occur in the next twelve months that would result in the amounts of any unrecognized tax benefits significantly increasing or decreasing for the Portfolios. However, management’s conclusions regarding tax positions taken may be subject to review and adjustment at a later date based on factors including, but not limited to, new tax laws and accounting regulations and interpretations thereof.

The tax character of distributions paid during the fiscal years ended October 31, 2020 and 2019 were as follows:

 

     Distributions From
Portfolio   

Ordinary
Income

2020

   Long-Term
Capital Gains
2020
  

Ordinary
Income

2019

   Long-Term
Capital
Gains 2019

Global Equity

     $ 6,200,271      $      $ 5,039,201      $  84,041,831

International Equity

       269,536,396               191,998,952       

International Small Companies

       2,122,682               1,400,782        10,538,794

Institutional Emerging Markets

       85,287,487               42,525,477       

Emerging Markets

       63,406,861               29,768,361       

Frontier Emerging Markets

       5,825,150               4,881,573       

Global Equity Research

       83,862        296,019        231,465        283,521

International Equity Research

       232,264        142,336        306,053        507,992

Emerging Markets Research

       145,125        154,592        175,404        343,803

 

66


Table of Contents

Harding, Loevner Funds, Inc.

 

Notes to Financial Statements (continued)

April 30, 2021 (unaudited)

 

8. Income Tax (continued)

 

Under the Regulated Investment Company Modernization Act of 2010 (the “Act”), each Portfolio is permitted to carry forward capital losses incurred in taxable years beginning after the date of enactment for an unlimited period. Additionally, post-enactment capital loss carryforwards will retain their character as either short-term or long-term capital losses.

At October 31, 2020, capital losses incurred that will be carried forward indefinitely under provisions of the Act were as follows:

 

Portfolio    Short-Term
Capital Loss
Carryforward
  Long-Term
Capital Loss
Carryforward

International Equity

     $  (324,240,954 )     $  (231,889,974 )

International Small Companies

       (4,091,913 )       (620,403 )

Institutional Emerging Markets

       (47,899,513 )       (157,950,030 )

Emerging Markets

       (34,585,281 )       (2,166,831 )

Frontier Emerging Markets

       (20,318,737 )       (102,662,372 )

During the fiscal year ended October 31, 2020, the Global Equity and Frontier Emerging Markets Portfolios utilized $1,903,096 and $1,228,604, respectively, in capital loss carryforwards.

9. Foreign Exchange Contracts

The Portfolios do not generally hedge foreign currency exposure, however, the Portfolios may enter into forward foreign exchange contracts in order to hedge their exposure to changes in foreign currency exchange rates on their foreign portfolio holdings. Each Portfolio will conduct its currency transactions either on a spot (cash) basis at the rate prevailing in the currency exchange market, or by entering into forward contracts to purchase or sell currency. Foreign currency transactions entered into on the spot markets serve to pay for foreign investment purchases or to convert to dollars, the proceeds from foreign investment sales or dividend and interest receipts. The Portfolios will disclose open forward currency contracts, if any, on the Portfolios of Investments. The Portfolios do not separately disclose open spot market transactions on the Portfolios of Investments. Such realized gain (loss) and unrealized appreciation (depreciation) on spot market transactions is included in “Net realized gain (loss) on foreign currency transactions” and “Change in unrealized appreciation (depreciation) on translation of assets and liabilities denominated in foreign currencies”, respectively, on the Portfolios’ Statements of Operations. The Portfolios held no open forward currency contracts as of or during the period ended April 30, 2021.

10. Participation Notes

Each Portfolio may invest in participation notes. Participation notes are promissory notes that are designed to replicate the return of a particular underlying equity or debt security, currency or market. Participation notes are issued by banks or broker-dealers or their affiliates and allow a Portfolio to gain exposure to common stocks in markets where direct investment may not be allowed. Participation notes are generally traded over-the-counter. In addition to carrying the same risks associated with a direct investment in the underlying security, participation notes are subject to the risk that the broker-dealer or bank that issues them will not fulfill its contractual obligation to complete the transaction with a Portfolio. Participation notes constitute general unsecured contractual obligations of the banks or broker-dealers that issue them, and a Portfolio would be relying on the creditworthiness of such banks or broker-dealers and would have no rights under a participation note against the issuer(s) of the underlying security(ies). Participation notes may be more volatile and less liquid than other investments held by the Portfolios.

11. Concentration of Ownership

At April 30, 2021, the percentage of total shares outstanding held by record shareholders each owning 10% or greater of the aggregate shares outstanding of each Portfolio were as follows:

 

      No. of
Shareholders
   %
Ownership

Global Equity

       2        30.40 %*

International Equity

       2        26.19 %*

International Small Companies

       3        43.82 %*

Institutional Emerging Markets

       2        56.02 %*

Emerging Markets

       3        60.39 %*

Frontier Emerging Markets

       3        40.29 %*

 

67


Table of Contents

Harding, Loevner Funds, Inc.

 

Notes to Financial Statements (continued)

April 30, 2021 (unaudited)

 

11. Concentration of Ownership (continued)

 

      No. of
Shareholders
   %
Ownership

Global Equity Research

       2        83.34 %

International Equity Research

       3        70.10 %*

Emerging Markets Research

       2        73.42 %

Chinese Equity

       2        51.68 %

 

*

Includes omnibus positions of broker-dealers representing numerous shareholder accounts.

Investment activities of these shareholders may have a material effect on the Portfolios.

12. Concentration of Risk

Investing in securities of foreign issuers and currency transactions may involve certain considerations and risks not typically associated with investments in U.S. issuers. These risks include revaluation of currencies, adverse fluctuations in foreign currency values and possible adverse political, social and economic developments, including those particular to a specific industry, country or region, which could cause the securities and their markets to be less liquid and prices more volatile than those of comparable U.S. companies and U.S. government securities. These risks are greater with respect to securities of issuers located in emerging market countries in which the Portfolios are authorized to invest.

Frontier Emerging Markets is permitted to invest up to 35% of its total assets in companies in the same industry, if, at the time of investment, that industry represents 20% or more of the Portfolio’s benchmark index. During periods when the Portfolio has invested more than 25% of its total assets in companies in the same industry, it will operate as a concentrated portfolio and be subject to additional risks and greater volatility. Such additional risks include increased competition within the industry, or changes in legislation, or government regulations affecting the industry. The value of the Portfolio’s shares may be particularly vulnerable to factors affecting the banking industry, such as the availability and cost of capital funds, changes in interest rates, the rate of corporate and consumer debt defaults, extensive government regulation, and price competition. Such risks may be magnified with respect to securities of issuers in Frontier Emerging Markets. At April 30, 2021, the Portfolio’s investment in the Banking industry amounted to 32.96% of its total assets.

As a non-diversified fund, the Chinese Equity Portfolio has the ability to invest a larger percentage of its assets in the securities of a smaller number of issuers than a diversified fund. As a result, poor performance by a single issuer could adversely affect the Chinese Equity Portfolio’s performance more than if the Chinese Equity Portfolio were invested in a larger number of issuers.

13. Pandemic Risk

The outbreak of the novel coronavirus (“COVID-19”) and subsequent global pandemic began significantly impacting the U.S. and global financial markets and economies during the calendar quarter ended March 31, 2020. The worldwide spread of COVID-19 has created significant uncertainty in the global economy. The duration and extent of COVID-19 over the long-term cannot be reasonably estimated at this time. The ultimate impact of COVID-19 and the extent to which COVID-19 impacts the Funds’ normal course of business, results of operations, investments, and cash flows will depend on future developments, which are highly uncertain and difficult to predict. Management continues to monitor and evaluate this situation.

14. Line of Credit

The Fund has a $150 million line of credit agreement with Northern Trust. Borrowings are made solely to facilitate the handling of redemptions or unusual or unanticipated short-term cash requirements. Because several Portfolios participate and collateral requirements apply, there is no assurance that an individual Portfolio will have access to the entire $150 million at any particular time. Interest is charged to each Portfolio based on its borrowings at an amount above the Federal Funds rate, subject to a minimum rate. In addition, a facility fee is computed at an annual rate of 0.15% on the line of credit and is allocated among the Portfolios.

During the period ended April 30, 2021, the Funds did not have any borrowings under the line of credit agreement.

15. Subsequent Events

Subsequent events occurring after the date of this report have been evaluated for potential impact, for purposes of recognition or disclosure in the financial statements, through the date the report was issued.

 

68


Table of Contents

Harding, Loevner Funds, Inc.

 

Notes to Financial Statements (continued)

April 30, 2021 (unaudited)

 

15. Subsequent Events (continued)

 

As of July 1, 2021, the Investment Adviser has agreed to lower the contractual management fee and expense cap for certain Portfolios in the Fund. Please refer to the Investment Advisory Fee table in Note 3 for more detail.

 

69


Table of Contents

Harding, Loevner Funds, Inc.

 

Approval of Investment Advisory Agreement

(unaudited)

 

Approval of Investment Advisory Agreement

At a videoconference meeting of the board of directors (collectively, the “Board” or “Directors” and, each, a “Director”) of Harding, Loevner Funds, Inc. (the “Fund”) held on October 30, 2020 (the “Meeting”), the Board, including a majority of those directors who are not “interested persons” of the Fund (the “Independent Directors”), as defined in the Investment Company Act of 1940, as amended (the “1940 Act”), considered and approved the investment advisory agreement (the “New Portfolio Advisory Agreement”) between the Fund on behalf of a new series of the Fund, the Chinese Equity Portfolio (the “New Portfolio”), and Harding Loevner LP (“Harding Loevner”) for an initial two-year period. In considering the approval of the New Portfolio Advisory Agreement, the Board noted that the terms and conditions of the New Portfolio Advisory Agreement are substantially identical to the terms and conditions of the Investment Advisory Agreement, dated as of August 26, 2009, as amended (the “2009 Advisory Agreement”), between the Fund, on behalf of the Global Equity Portfolio, the International Equity Portfolio, the International Small Companies Portfolio, the Institutional Emerging Markets Portfolio (the “IEM Portfolio”), the Emerging Markets Portfolio (the “EM Portfolio”) and the Frontier Emerging Markets Portfolio (collectively, the “Traditional Portfolios”), and Harding Loevner, the Investment Advisory Agreement, dated as of December 17, 2015, as amended, between the Fund, on behalf of the International Equity Research Portfolio (the “IER Portfolio”) and Harding Loevner (the “IER Advisory Agreement”), and the Investment Advisory Agreement, dated as of December 19, 2017, as amended, between Harding Loevner and the Fund on behalf of the Global Equity Research Portfolio and Emerging Markets Research Portfolio (collectively, with the IER Portfolio, the “Research Portfolios,” and collectively, with the Traditional Portfolios, each a “Portfolio” and collectively, the “Legacy Portfolios”) amended (together with the 2009 Advisory Agreement and the IER Advisory Agreement, the “Legacy Advisory Agreements”). The Meeting was held via videoconference, with telephonic participation optional, in accordance with exemptive relief from certain in-person meeting requirements issued by the Securities and Exchange Commission in an exemptive order under Section 6(c) and Section 38(a) of the 1940 Act.

Prior to and during the Meeting, the Board received and assessed information regarding: (i) the qualifications of the portfolio managers primarily responsible for the day-to-day management of the New Portfolio; (ii) the investment strategy and portfolio construction approach to be implemented by Harding Loevner for the New Portfolio; (iii) Harding Loevner’s representations regarding the management fees of the peer funds of the New Portfolio with similar characteristics; (iv) Harding Loevner’s plans to position the New Portfolio in the marketplace relative to the Legacy Portfolios and peer mutual funds; and (v) the estimated costs associated with managing the New Portfolio and proposed fees payable to Harding Loevner under the New Portfolio Advisory Agreement relative to the costs and fees payable under the Legacy Advisory Agreements.

In addition, the Board considered, among other things, the following factors:

Nature, Extent and Quality of Services

The Board evaluated the information it deemed necessary to assess the nature, extent and quality of investment advisory services to be provided to the New Portfolio by Harding Loevner. The Board also considered the nature, extent and quality of: (i) the extensive non-advisory services to be provided to the New Portfolio by Harding Loevner, including portfolio trading; (ii) the resources to be devoted to the New Portfolio’s compliance policies and procedures; (iii) the resources to be devoted to the supervision of third-party service providers; and (iv) the quality and quantity of administrative and shareholder servicing. The Board considered Harding Loevner’s record of compliance with its compliance policies and procedures, as well as the qualifications, backgrounds and responsibilities of Harding Loevner’s management team and information regarding the members of the investment analyst and portfolio management teams for the New Portfolio. Based on these considerations, the Board concluded that it was satisfied with the nature, extent and quality of services to be provided to the New Portfolio under the New Portfolio Advisory Agreement.

Performance of Harding Loevner

Because the New Portfolio had not commenced operations, the Board considered, among other things, the Legacy Portfolios’ strong historical performance for multiple time periods compared against each Legacy Portfolio’s Morningstar Category and benchmark index. The Board noted the extensive review and analysis of the performance of the Legacy Portfolios conducted before and during the June 12, 2020 meeting (the “June Meeting”), when the Board approved the continuance of the Legacy Investment Advisory Agreements, pursuant to Section 15(c) of the 1940 Act. The Board noted with particular interest the historical performance of the IEM Portfolio and the EM Portfolio considered at the June Meeting and for interim periods through September 30, 2020, given the significance of Chinese stock selection to the performance of those portfolios. Further, the Board considered that the New Portfolio’s lead portfolio manager has served as co-lead portfolio manager of the Frontier Emerging Markets Portfolio since 2012 and as a portfolio manager for the IEM Portfolio and EM Portfolio since 2015, and that each member of the New Portfolio’s portfolio management team has deep experience investing in China. In addition, the Board took note that Harding Loevner has over 25 years of experience investing in China. Based on these considerations, the Board concluded that Harding Loevner had demonstrated the ability of its investment process to generate reasonable levels of positive absolute and relative performance.

 

70


Table of Contents

Harding, Loevner Funds, Inc.

 

Approval of Investment Advisory Agreement (continued)

(unaudited)

 

Costs of the Services and Profitability of Harding Loevner

In considering the New Portfolio’s profitability to Harding Loevner, the Board recognized that there was not yet profitability data to evaluate, but noted that profitability information would be provided after the New Portfolio commenced operations and, as with other new portfolios launched by Harding Loevner, the New Portfolio was not expected to be profitable to Harding Loevner initially. In evaluating Harding Loevner’s profitability, the Board recognized: (i) the significant resources that Harding Loevner is committing to the organization and management of the New Portfolio; (ii) the substantial business risk assumed in sponsoring the New Portfolio; and (iii) the proposed fee waiver for the New Portfolio. Further, the Board noted that the New Portfolio may not achieve profitability for some time. Based upon these considerations, the Board concluded that the profits Harding Loevner anticipates from managing the New Portfolio will not be excessive in light of the nature, extent and quality of the services to be provided to the New Portfolio.

Comparison of Fees and Services Provided by Harding Loevner

The Board considered the contractual advisory fees that are payable by the New Portfolio to Harding Loevner and the estimated actual investment advisory fees to be realized by Harding Loevner, taking into account the fee waiver and/or expense reimbursement arrangement for the New Portfolio. The Board also considered the fact that Harding Loevner’s fee waiver/expense reimbursement arrangement with the New Portfolio is not subject to recapture and that the proposed fee reductions are contractual in nature and may exceed the investment advisory fee for some time. The Board considered the fees payable to Harding Loevner by the New Portfolio compared to investment advisory fees payable to Harding Loevner by the Legacy Portfolios and the respective peer funds to the New Portfolio. Based on these considerations, the Board concluded that the investment advisory fee to be paid by the New Portfolio was not so disproportionately large that it could not have been the result of an arm’s length negotiation.

Economies of Scale

The Board considered whether there is potential for realization of economies of scale for the New Portfolio and whether material economies of scale would be shared with shareholders. The Board noted that the New Portfolio was not expected to raise a significant level of assets during the initial contract term and therefore was unlikely to realize material economies of scale.

Other Benefits

The Board considered other benefits to be derived by Harding Loevner from its relationship with the New Portfolio. In this regard, the Board noted that the only likely tangible material benefits from Harding Loevner’s relationship with the New Portfolio would be from: (i) the receipt of research products and services obtained through “soft dollars” in connection with New Portfolio brokerage transactions; and (ii) the enhancement of China research capabilities resulting from Harding Loevner’s increased investment in China research resources and talent. The Board also considered the extent to which Harding Loevner and its other clients, including the Legacy Portfolios, would benefit from receipt of research products and services through “soft dollars” and the enhancements to Harding Loevner’s China research capabilities. In light of the costs of providing investment management, administrative and other services to the New Portfolio, these other ancillary benefits that Harding Loevner may receive were considered reasonable.

In addition to the factors discussed above, the Board members noted that they had performed a comprehensive review of the services provided to the Legacy Portfolios by Harding Loevner under the Legacy Advisory Agreements during the June Meeting and had voted to renew at that time. The Board determined that the information they had considered in connection with the renewal of the Legacy Advisory Agreements at the June Meeting, as supplemented by relevant information provided during subsequent Board meetings, was applicable to their decision to approve the New Portfolio Advisory Agreement.

Following discussion, both in general session, and in executive session of the Independent Directors meeting alone with their legal counsel, the Board determined that it had received sufficient information to take action on the proposed resolutions approving the New Portfolio Advisory Agreement. The Board, including a majority of the Independent Directors, concluded with respect to the New Portfolio that Harding Loevner’s investment advisory fees were sufficiently supported by the Board’s review of the factors described above.

In light of all the foregoing, the Board, and separately, a majority of the Independent Directors, approved the New Portfolio Advisory Agreement with respect to the New Portfolio. The Board’s decision was based on all of the above-mentioned factors and their related conclusions, with no single factor or conclusion being determinative and with each director not necessarily attributing the same weight to each factor.

 

71


Table of Contents

Harding, Loevner Funds, Inc.

 

Results of Special Meeting of Shareholders

(unaudited)

 

Results of Special Meeting of Shareholders

The Fund held a Special Meeting of Shareholders on December 14, 2020 at 11:00 a.m. Eastern time. In light of public health concerns regarding the coronavirus pandemic, the Meeting was held in a virtual meeting format only. Shareholders elected Carolyn Ainslie, Jill R. Cuniff, Jason Lamin and Alexandra K. Lynn as Directors of the Fund. A total of 705,993,083 shares were represented at the meeting, constituting a quorum of 64.8%.

The results of the Special Meeting were as follows:

 

Nominee

   For    % Outstanding   % of Voted   Withheld    % Outstanding   % of Voted

Carolyn Ainslie

       698,907,090        64.13 %       99.00 %       7,085,993        0.65 %       1.00 %

Jill R. Cuniff

       700,075,743        64.24 %       99.16 %       5,917,339        0.54 %       0.84 %

Jason Lamin

       699,776,320        64.21 %       99.12 %       6,216,762        0.57 %       0.88 %

Alexandra K. Lynn

       699,708,284        64.20 %       99.11 %       6,284,798        0.58 %       0.89 %

 

72


Table of Contents

Harding, Loevner Funds, Inc.

 

Liquidity Risk Management Program

(unaudited)

 

Liquidity Risk Management Program

Pursuant to Rule 22e-4 under the Investment Company Act of 1940 (the “Liquidity Rule”), Harding, Loevner Funds, Inc. (the “Fund”) has adopted a liquidity risk management program (the “Program”) whose principal objectives include assessing, managing and periodically reviewing the liquidity risk of each series of the Fund (each, a “Portfolio” and together, the “Portfolios”), based on factors specific to the circumstances of each Portfolio.

The Board of Directors (the “Board”) of the Fund approved the Program and designated Harding Loevner LP as the administrator of the Program, acting through its Brokerage and Trading Advisory Committee (the “Administrator”). The Liquidity Rule and the Program require the Administrator to assess and review, at least annually, the liquidity risk of each Portfolio, and to consider whether any new or additional steps need to be taken or recommended to manage liquidity risk.

Pursuant to the Liquidity Rule, at the December 18, 2020 Board meeting, the Administrator provided the Board with an annual report that addressed the operation of the Program and assessed the adequacy and effectiveness of its implementation and any material changes to the Program (the “Liquidity Report”).

The Liquidity Report described the operation of the Program, including the process for categorizing portfolio securities into one of four liquidity categories, as defined in the Liquidity Rule, noting that the process is supervised by the Administrator. In addition, the Liquidity Report discussed the role of the Fund’s third-party liquidity classification data provider (the “Liquidity Data Provider”) in the classification process, including the techniques used and assumptions applied by the Liquidity Data Provider to analyze portfolio holdings and the quality and timeliness of the liquidity classification data provided to the Administrator by the Liquidity Data Provider.

The Liquidity Report then discussed the annual assessment and review of the Program undertaken by the Administrator. In its assessment and review of each Portfolio’s liquidity risk, the Administrator considered such information as it deemed appropriate, which included, among other factors:

•  The Portfolios’ investment strategies and liquidity of portfolio investments during both normal and reasonably foreseeable stressed conditions.

The Administrator reviewed the investment strategy and liquidity of each Portfolio during both normal and reasonably foreseeable stressed conditions, including whether each strategy involves a relatively more concentrated portfolio or large position sizes in particular issuers and whether, or to what extent, the investment strategy is appropriate for an open-end fund.

•  Short-term and long-term cash flow projections during both normal and reasonably foreseeable stressed conditions.

The Administrator reviewed the short- and long-term cash flow projections of each Portfolio during normal and reasonably foreseeable stressed conditions.

•  Holdings of cash and cash equivalents, as well as borrowing arrangements.

The Administrator reviewed holdings of cash and cash equivalents as well as borrowings, including the credit facility applicable to the Fund, the financial health of the institution providing the facility and the fact that the credit facility is shared among multiple Portfolios.

The Administrator’s consideration of the foregoing information among other factors, as part of its assessment and review of each Portfolio’s liquidity risk, suggested to the Administrator there would be sufficient cash to satisfy redemption requests under both normal conditions, and under reasonably foreseeable stressed conditions.

Finally, the Liquidity Report noted that the Fund had not adopted an highly liquid investment minimum (“HLIM”) because each Portfolio is invested primarily in highly liquid securities, and that the Administrator continues to believe, based on the composition of each Portfolio over the first year of the Program, that an HLIM is not needed.

The Liquidity Report concluded by stating that there were no material changes made to the Program since its inception, and that the Administrator had determined based on its assessment that the Program was effectively implemented and appropriately tailored to the nature and degree of the Fund’s liquidity risk, both under normal and reasonably foreseeable stressed conditions.

 

73


Table of Contents

Harding, Loevner Funds, Inc.

 

Supplemental Information

(unaudited)

 

Quarterly Portfolio Schedules of Investments

Each Portfolio files its complete portfolio of investments with the SEC for the first and third quarters of each fiscal year as an exhibit to its reports on Form N-PORT. The Portfolios’ Forms N-PORT are available on the SEC’s website at www.sec.gov. Additionally, they are available upon request by calling (877) 435-8105.

Proxy Voting Record

The Fund’s proxy voting record relating to the Portfolios’ securities during the most recent 12-month period ended June 30 is available on the Fund’s website at www.hardingloevnerfunds.com and on the SEC’s website at www.sec.gov, on Form N-PX.

Proxy Voting Policies and Procedures

The Fund’s proxy voting policies and procedures are included in Appendix B to the Fund’s Statement of Additional Information and is available without charge, upon request, by calling (877) 435-8105 or on the SEC’s website at www.sec.gov.

Additional Information

The Adviser updates Fact Sheets for the Portfolios each calendar quarter that are posted to the Fund’s website at www.hardingloevnerfunds.com. This information, along with the Adviser’s commentaries on its various strategies, is available without charge, upon request, by calling (877) 435-8105.

 

74


Table of Contents

Harding, Loevner Funds, Inc.

 

Directors and Principal Officers

(unaudited)

 

DIRECTORS AND PRINCIPAL OFFICERS OF THE FUNDS

David R. Loevner

Director and Chairman of the Board of Directors

Carolyn N. Ainslie

Director

Christine C. Carsman

Director Emeritus

Jill R. Cuniff

Director

R. Kelly Doherty

Director

Charles W. Freeman III

Director

Jason Lamin

Director

Alexandra K. Lynn

Director

Samuel R. Karetsky

Director Emeritus

Eric Rakowski

Director

Richard T. Reiter

President

Tracy L. Dotolo

Chief Financial Officer and Treasurer

Brian D. Simon

Chief Compliance Officer, Anti-Money Laundering Compliance Officer, and Assistant Secretary

Marcia Y. Lucas

Secretary

Aaron J. Bellish

Assistant Treasurer

Ryan Bowles

Assistant Treasurer

Derek A. Jewusiak

Assistant Treasurer

Lisa R. Price

Assistant Secretary

 

75


Table of Contents

 

 

 

 

 

This report is intended for shareholders of Harding, Loevner Funds, Inc. It may not be used as sales literature unless preceded or accompanied by the current Prospectus, which gives details about charges, expenses, investment objectives, risks and policies of the Portfolios.


Table of Contents

 

Client Name

Address Line 1

Address Line 2

City, State Zip

 

(877) 435-8105

www.hardingloevnerfunds.com


Table of Contents

Item 1. Reports to Stockholders (cont.).

 

(b)

The following is a copy of the notice transmitted to shareholders pursuant to Rule 30e-3 under the Investment Company Act of 1940 (17 CFR 270.30e-3) that contains disclosures specified by paragraph (c)(3) of that rule


Table of Contents

LOGO

Notice of Internet Availability of Shareholder Report(s) (/) .-1 0 I .-1 <I’ 0 1<1 0 w.~ eo o BROADRIDGE “ 0 FINANCIAL SOLUTIONS, INC. 0 0 ATTENTION: a 11:1 0 TEST PRINT 51 MERCEDES WAY EDGEWOOD, NY 11717 Jpd“liOdaiJWpeai-q~fS+IalefiOlSaAU~/A06“3aS“MMM :aia4 +Iodai Iap1o4aie4s pun~ 1en+nw e peai o+ M04 uiea1 •


Table of Contents

LOGO

rra1 HARDING g LOEVNER ID: Important Shareholder Report(s) Available Online and in Print by Request. Reports contain important information about your fund, including its portfolio holdings and financial statements. we encourage you to review your shareholder report(s) at the website(s) below: https://www.hardingloevner.com/ways-to-invest/us-mutual-funds/ Portfolio, Class Request a printed/email report at no charge and/or elect to receive paper reports in the future, by calling or visiting (otherwise you will not receive a paper/email report): 1-866-345-5954 www.FundReports.com Aim your mobile device camera here for more information    


Table of Contents

LOGO

 

Global Equity Portfolio    Institutional Emerging Markets Portfolio    Global Equity Research Portfolio
International Equity Portfolio    Emerging Markets Portfolio    International Equity Research Portfolio
International Small Companies Portfolio    Frontier Emerging Markets Portfolio    Emerging Markets Research Portfolio
Chinese Equity Portfolio      
           

The Prospectus, SAI, and the Fund’s annual and semi-annual reports are also available free of charge on Harding Loevner’s website at hardingloevnerfunds.com.

 

Reports and other information about the Fund are also available on the EDGAR database on the Commission’s

   Internet site at SEC.gov or by electronic request at the following e-mail address: publicinfo@sec.gov. A duplication fee will be applied to written requests and needs to be paid at the time your request is submitted.    As with all mutual funds, the Securities and Exchange Commission has not approved or disapproved these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.


Table of Contents

Harding Loevner Funds

Global equity investing for institutions is Harding Loevner’s exclusive focus. Through Harding Loevner Funds it offers distinct global strategies based on its quality-and-growth investment philosophy. It seeks to purchase shares of growing, financially strong, well-managed companies at favorable prices. Harding Loevner manages each of the Funds’ Portfolios according to a disciplined, research-based investment process. It identifies companies with sustainable competitive advantages and assesses the durability of their earnings growth by conducting in-depth fundamental research into global industries. In constructing portfolios, Harding Loevner diversifies carefully to limit risk.

Receive Investor Materials Electronically

Shareholders may sign up for electronic delivery of investor materials. By doing so, you will receive the information faster and help us reduce the impact on the environment of providing these materials. To enroll in electronic delivery,

 

  1.

Go to http://www.icsdelivery.com

 

  2.

Select the first letter of your brokerage firm’s name.

 

  3.

From the list that follows, select your brokerage firm. If your brokerage firm is not listed, electronic delivery may not be available. Please contact your brokerage firm.

 

  4.

Complete the information requested, including the e-mail address where you would like to receive notifications for electronic documents.

Your information will be kept confidential and will not be used for any purpose other than electronic delivery. If you change your mind, you can cancel electronic delivery at any time and revert to physical delivery of your materials. Just go to http://www. icsdelivery.com, perform the first three steps above, and follow the instructions for cancelling electronic delivery. If you have any questions, please contact your brokerage firm.

 

 

 

2

 

  


Table of Contents

Table of Contents

 

 

 

 

4

 

   Letter to Our Shareholders
       

 

6

 

   Global Equity Portfolio
            

 

10

 

   International Equity Portfolio
            

 

14

 

   International Small Companies Portfolio
            

 

18

 

   Emerging Markets Portfolio
            

 

22

 

   Chinese Equity Portfolio
            

 

26

 

   Frontier Emerging Markets Portfolio
       

 

30

 

   Global Equity Research Portfolio
            

 

34

 

   International Equity Research Portfolio
            

 

38

 

   Emerging Markets Research Portfolio

 

Contact

 

 

Harding, Loevner Funds, Inc.

c/o Northern Trust

Attn: Funds Center, Floor 38

333 South Wabash Avenue

Chicago, IL 60604

 

Phone: (877) 435-8105

Fax: (312) 267-3657

www.hardingloevnerfunds.com

  

Must be preceded or accompanied by a current Prospectus.

Quasar Distributors, LLC, Distributor

 

 

 

3

 


Table of Contents

Letter To Our Shareholders

April 30, 2021

 

 

LOGO

David Loevner, CFA, CIC

Chairman of the Funds and

Chief Executive Officer of the Adviser

Ferrill Roll, CFA

Chief Investment Officer of the Adviser

Simon Hallett, CFA

Vice Chairman of the Adviser

Last fall, in our Fiscal Year 2020 Annual Report and Commentary, we expressed some incredulity at “value” investing’s much ballyhooed demise. We had no unique insight to offer about the outlook for the value style other than noting that each prior reading of its last rites seemed to presage its roaring back to life. And, lo and behold, our October 31 missive presciently, if inadvertently, anticipated the turn in market style that coincided with the announcements of the first highly effective COVID-19 vaccines and the imminent change of US presidential administration.

Since November the “value” half of the MSCI All Country World Index has outperformed its “growth” counterpart by more than fifteen percentage points. More significant for us, however, has been the outperformance, by a country mile, of stocks of more leveraged, more cyclical, and less profitable companies relative to the stocks of higher-quality companies that are not so encumbered. The prospect of re-opening economies brightened the outlook for every business (save for the few that provide remote-working tools or home delivery), but it’s been the weakest companies—especially those that were severely challenged during the lockdowns—whose outlook has brightened the most. The Biden administration’s spending plans for consumer relief today and infrastructure tomorrow have further re-enlivened such companies’ prospects. Our portfolio managers, in varying degrees, had been leaning against the then-prevailing winds by resisting the pie-in-the-sky valuations of many of the fastest-growing companies, while maintaining exposure to growth businesses. A related, but separate, trade-off also vexed them: the one between rich valuation and business quality. Their struggle with those trade-offs is the subject of many of the reports that follow this letter.

Another area where we’ve leaned against the wind is in capping the exposure to China permitted in our Emerging Markets Portfolio. China’s market capitalization has swelled on the back of rising valuations and new issuance. Thanks to improved access for foreign investors, the Chinese market has secured a pre-eminent place in passive indices, and as many new companies have gone public it has also become more diversified. We anticipated the

broad outline of this evolution some years ago, adding analytical resources, expanding company coverage, and raising our self-imposed ceiling on maximum exposure to the country. In the spring of last year, as China’s stock market rebounded rapidly, reflecting the country’s early control of the virus when the rest of the world was still floundering, we resisted the loud calls (including from some of our own colleagues) to raise our ceiling further. We demurred because of our aversion to changing sensible constraints while they are actually binding. Constraints in risk guidelines are a form of pre-commitment, meant to gird our loins precisely when market momentum and FOMO conspire mightily to induce us to throw caution to the wind. That resistance proved well-considered in the latter part of 2020 when Chinese share prices tumbled even as other markets rose on positive vaccine news. The twin reminders of internal risks emanating from Chinese regulatory unpredictability and external ones from US congressional and executive actions drove home that, like any investment, Chinese stocks are not a one-way bet. Once the clamor for more Chinese risk-taking had subsided, and in recognition of China’s growing heft in the MSCI EM Index, we did relax our fixed limit on China at year end, but still constrain our portfolio managers to not exceed the country’s weight in the index.

More newsworthy, perhaps, in recognition of our growing success at finding Chinese companies with enviable growth prospects that also meet our business-quality standards, we launched a new, dedicated Chinese Equity Portfolio providing interested investors more concentrated exposure to Chinese stocks using our time-tested and battle-hardened investment philosophy and process. You’ll find that Portfolio’s first appearance later in this report as well.

An area where we find ourselves tilted in the direction of prevailing winds is that of scrutinizing Environmental, Societal, and Governance (ESG) risks and opportunities. Alongside our longstanding focus on the risks of poor corporate governance, we escalated our analysts’ assessment of the E and the S risks five years ago, incorporating checklists that require rigorous investigation into a common set of potential ESG-specific hazards. Since then, the winds have only blown harder, as we have continued to hone our skills in this area, a natural refinement of the search for long-term sustainable businesses that has been the aim of our high-quality, growth-oriented investment philosophy from the very start.

Last year, we heightened our efforts to assess the materiality of specific ESG-related risks to each industry. Using the processes we’ve developed, our analysts are continually probing the logic and consistency of their assessments of such risks. We’re also making sure those processes keep pace with rapidly evolving best practices, including expanding our capacity for engaging with issuers and for reporting to our own clients on the impact of our

 

 

 

4

 

  


Table of Contents

companies’ activities along dimensions such as carbon emissions or diversity, as well as on the results of our engagements with their managements.

As we continue sharpening our focus on ESG, our overarching goal is to deliver strong risk-adjusted returns. Instead of fleeing from any perceived ESG risk regardless of its materiality or the potential opportunity cost of avoiding it, we aim to assess all risks, including ESG risks, properly, identifying which are material and the time frames under which their consequences might be realized. In some instances, we may identify companies or entire industries that have become mispriced in a crowding of the market into fashionable ESG themes. By identifying the most material and persistent trends affecting industries, our analysts are capable of discerning which companies may become impaired, which embroiled in mounting regulation, and which, unheralded today, may thrive. Indeed, recognizing and exploiting such trends is exactly what we expect the best companies to do.

Leaning against the wind is part and parcel of contrarian investing, and any investor must diverge from the crowd in some way to have a chance to outperform. The art comes in judging when and where to diverge, and when simply to accept and appreciate the breeze at your back. We are grateful for your continued trust in Harding Loevner, as we make those judgments.

 

 

Sincerely,

 

LOGO   LOGO   LOGO
David R. Loevner, CFA, CIC   Ferrill D. Roll, CFA   Simon Hallett, CFA

Opinions expressed are those of Harding Loevner and are not intended to be forecasts of future events, a guarantee of future results, nor investment advice. Please read the separate disclosure page for important information, including the risks of investing in the Portfolios. Past performance is not a guarantee of future results.

 

 

 

5

 


Table of Contents

Global Equity Portfolio

Institutional Investors: HLMVX & HLGZX | Individual Investors: HLMGX

 

 

Portfolio Management Team

 

LOGO

 

Peter Baughan, CFA

Co-Lead Portfolio Manager

 

Jingyi Li

Co-Lead Portfolio Manager

 

LOGO

 

Scott Crawshaw

Portfolio Manager

 

Christopher Mack, CFA

Portfolio Manager

LOGO

 

Richard Schmidt, CFA

Portfolio Manager

Performance Summary

For the Global Equity Portfolio, the Institutional Class gained 24.05%, the Institutional Class Z gained 24.08%, and the Advisor Class gained 23.90% (net of fees and expenses) in the six-month period ended April 30, 2021. The Portfolio’s benchmark, the MSCI All Country World Index, gained 28.29% (net of source taxes).

Market Review

Global stock markets increased in the six months ended April 30, as the rollout of several successful COVID-19 vaccines led to economic rebounds across the globe. All sectors and regions finished in positive territory for the period.

The closing months of 2020 saw a dramatic rise in global stock markets, despite an escalation in the global pandemic. The starting gun for the run-up was Pfizer’s announcement of better-than-expected results for its COVID-19 vaccine trials and was followed in rapid fire by positive reports from Moderna, AstraZeneca, and Sinopharm. Accelerated approvals gave investors further hope for some return to normal commerce in 2021, even as COVID-19 hospitalizations in the US and Europe soared.

In 2021, signs of a global economic rebound multiplied as the vaccination efforts began in earnest. In March, the IMF raised its global GDP growth forecast for 2021 to 6.0%. In the US, among the world’s leaders in vaccination rates, retail sales climbed to the strongest level on record and restaurant bookings and the number of airline passengers, while still below pre-COVID-19 levels, continued to improve. The Biden administration passed a colossal US$1.9 trillion relief package, the third such stimulus measure

Fund Facts at April 30, 2021

 

  
     
Total Net Assets    $1,708.4M     
     
Sales Charge    None     
     
Number of Holdings    74     
     
Turnover (5 Year Average)    44%     
     
Dividend Policy    Annual     
   
    

Institutional Investors

   Individual Investors
   
    

Inst Class

  

Inst Class Z 

  

Advisor Class

       
Ticker   

HLMVX

   HLGZX     HLMGX
       
CUSIP   

412295602

   412295727     412295206
       
Inception Date   

11/3/2009

   8/1/2017     12/1/1996
       
Minimum Investment1   

$100,000

   $10,000,000     $5,000
       
Net Expense Ratio2   

0.88%3

   0.80%4      1.07%5
       
Gross Expense Ratio2   

0.88%

   0.83%     1.07%

1Lower minimums available through certain brokerage firms. 2As of the most recent Prospectus and based on expenses for the fiscal year end. 3Harding Loevner has contractually agreed to cap the expense ratio at 0.90% through February 28, 2022. The expense ratio (without cap) is applicable to investors. 4The Net Expense Ratio is shown net of Harding Loevner’s contractual agreement through February 28, 2022. Harding Loevner’s contractual agreement caps the expense ratio at 0.80%. The Net Expense Ratio is applicable to investors. 5Harding Loevner has contractually agreed to cap the expense ratio at 1.20% through February 28, 2022. The expense ratio (without cap) is applicable to investors.

since the pandemic began, sending direct payments to millions of Americans and extending unemployment insurance. In China, electricity generation and rail cargo volume rose substantially year over year, but consumer spending remained subdued despite much of daily life having returned to normal. The recovery in Europe was even more uneven, amid the emergence of new more virulent virus strains and problems with its vaccine rollout extending or renewing lockdowns.

Better economic data coupled with seemingly unlimited central bank liquidity led to rising management confidence and a surge in mergers and acquisition activity (M&A). Company CEOs were not the only market participants infected with high confidence; investors became more sanguine as well. The growth of special-purpose acquisition companies (SPACs), a “backdoor” means of taking private companies public with minimal regulatory scrutiny, accounted for an unprecedented 25% of all US deals. Retail trading activity also rose sharply, with a record number of people opening online accounts, and option volumes rising dramatically. The speculative frenzy extended to initial public offerings (IPOs) in many markets, with shares of newly listed companies (many of them still loss-making) being met by strong institutional and retail demand.

 

 

 

6

 

  


Table of Contents

Performance (% total return)

 

   
     For periods ended March 31, 2021      For periods ended April 30, 2021  
       
     1      3      5      10      Since Inception*      1      3      5      10      Since Inception*  
               
     Year      Years      Years      Years      Nov-09      Aug-17      Dec-96      Year      Years      Years      Years      Nov-09      Aug-17      Dec-96  
                             

Global Equity Portfolio – Inst Class

     58.35        14.15        16.34        11.29        11.86                          50.36        16.47        17.27        11.38        12.29                    
                             

Global Equity Portfolio – Inst Class Z

     58.47        14.22                               14.54                 50.49        16.55                               15.86           
                             

Global Equity Portfolio - Advisor Class

     58.08        13.92        16.09        11.03                          8.24        50.09        16.24        17.02        11.10                          8.45  
                             

MSCI All Country World Index

     54.60        12.07        13.21        9.15        10.14        11.74               45.74        13.32        13.85        9.17        10.47        12.74         

Returns are annualized for periods greater than 1 year. *Inception of the Institutional Class, November 3, 2009. Inception of the Institutional Class Z, August 1, 2017. Inception of the Advisor Class, December 1, 1996. Index performance prior to January 1, 2001 cannot be shown since it relies on back-filled data.

Performance data quoted represents past performance; past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance of the Portfolio may be lower or higher than the performance quoted. Performance data current to the most recent month end may be obtained by calling (877) 435-8105 or visiting www.hardingloevnerfunds.com.

 

As homebuyers and corporate treasurers alike raced to lock in low interest rates, bond yields rose, with the yield on the US 10-year reaching pre-pandemic levels in March. Commodity prices, particularly those linked with industrial activity such as iron ore and copper, jumped higher, while Brent crude rose to over US$60 per barrel.

On a sector basis, Energy was the strongest performer, surging in lockstep with rising oil prices. Financials also performed strongly, aided by a steepening yield curve and surprisingly low credit defaults. Information Technology (IT) also outperformed despite heightened scrutiny from regulators in Europe, China, and the US. Less-cyclical sectors—Consumer Staples, Health Care, and Utilities—all underperformed for the period.

Viewed by geography, the eurozone outperformed as some of the countries hit hardest by the virus, such as Spain and Italy, began to recover. Canada was a big outperformer, helped by its large weighting in banks and Energy. In Europe outside the eurozone, the UK posted strong returns on the back of its expansive vaccination program. Japan significantly underperformed as the country instated a new, more stringent state of emergency in response to another virus wave. Emerging Markets (EMs) also underperformed as weakness in China due to its regulatory crackdowns on tech companies offset strong performance in Taiwan and Russia, where the global semiconductor shortage and the rise in the oil price helped the former’s IT and latter’s Energy companies, respectively.

Performance Attribution

The Portfolio underperformed due to both negative sector allocation and stock selection. Weak stocks in Communication Services and Consumer Discretionary detracted the most during the period. In the former, shares of Polish video game producer CD Projekt were buffeted as the highly anticipated launch of its game Cyberpunk 2077 was marred by bugs and the company

fell victim to a ransomware attack. In Consumer Discretionary, shares of Chinese e-commerce company Alibaba declined following the company’s withdrawal of its planned IPO for its Ant Financial affiliate under pressure from banking regulators. Additionally, Alibaba was also put on notice about the potentially anti-competitive practices of its core e-commerce business. The Portfolio’s overweight in Health Care and underweight in Energy also detracted.

Strong stocks in Industrials helped, particularly agricultural equipment manufacturer John Deere. The company delivered strong earnings and raised its guidance for 2021. Sales of Deere’s tractors and combine harvesters have been underpinned by Chinese demand for agriculture products and by the rebound in the bioethanol market accompanying the jump in oil prices. The Portfolio’s underweight in Consumer Staples and Utilities and overweight in Financials also helped.

Viewed by geography, the Portfolio underperformed in every major market outside the US. Weak stocks in EMs (CD Projekt and Alibaba) detracted the most from relative performance. Stocks in Europe both inside and outside the eurozone also detracted, particularly Swiss drug manufacturer Lonza, which declined amid rising investor interest in more cyclical sectors. The Portfolio’s cash weight during this period of strong equity returns also dragged on relative performance.

Strong stocks in the US contributed, especially SVB Financial Group; the bank has benefited from rising expectations for increased economic growth and higher interest rates. Electronic payment services company PayPal was another strong performer as the company reported strong revenue, earnings, and new-user growth through the period. Additionally, the company launched its new service that enables customers to buy, hold, and sell cryptocurrencies. The Portfolio’s underweight in Japan was also a modest contributor during the period.

 

 

 

 

7

 


Table of Contents

Perspective and Outlook

For the best part of our 30-year existence we’ve invested in high-quality, growing companies. That means we understand only too well the slings and arrows of performance that the market occasionally hurls the way of our quality-focused portfolio. During the recovery from the prolonged bear market that followed the bursting of the tech bubble in 2000 we suffered one of our worst periods of relative performance. As the profit slump—at the time the deepest since the 1930s—dragged into its second year, the US Federal Reserve led other central banks in further rounds of cutting interest rates in a bid to spur a stronger recovery. Investors who had fled the securities of barely profitable or highly leveraged companies reconsidered their cautious stance. Companies that were priced as if they might be the next round of bankruptcies suddenly looked like probable survivors, and their share prices leapt higher as investors adjusted to the upgraded prognosis. As cyclical and financial risks receded, stocks of the most stable companies, with ultra-conservative balance sheets and resilient profit margins, no longer transfixed investors, whose eyes wandered to less pristine corporate stories in hopes of a bargain. Over the ensuing 24 months, stocks of companies in the lowest tiers of quality, derided as junk, trounced by double digits those in the top tiers.

Judging by the performance of the different quintiles of the market sorted by our proprietary quality rankings, the shift in market style that coincided with the early November release of vaccine efficacy results matches in many ways the pattern of 2003-2004, and then some. Whereas two decades ago it took over two years for the bottom quintile to outpace the top by 19 percentage points, this latest go-round has produced a 23 percentage point gap between the same two groups in just five months, with a mostly monotonic progression of performance down the tiers of quality: the worse you were, the better you did.

The earlier episode drove home the perils of being too risk-averse! While wallowing in the depths of a deep recession and long bear market, we took comfort from the resilience and reasonable valuation of the best companies and—despite the obvious chasm in relative valuations that had opened up between stocks of the best and the next-best, let alone the worst—ultimately lost sight of the opportunity cost of future returns from what we did not own.

Over the last couple of years, as valuations for high-quality and rapidly growing companies have risen steadily, we’ve had to make difficult trade-offs in attempting to balance our commitment to these company attributes against the prices their shares fetch. Historically our debate has mostly concerned the trade-off between valuation and growth, but in this nascent recovery from the pandemic, the real issue—at least as far as relative performance goes—has turned out to be related more to trading off valuation against quality. Growth,

in contrast to quality, has not been a particularly good predictive factor recently: only the fastest growth quintile (sorted by our growth metric) has seriously lagged the index, while the other 80% of the market matched or bettered the market’s average performance since the beginning of November.

Although both high quality and faster growth have become highly priced in recent times, we’ve made no attempt to predict either inflation or interest rates, despite recognizing how these inputs have an immediate impact on stock valuations through their influence on discount rates. Considering such attempts a fool’s errand, we prefer instead to focus on discerning the enduring characteristics of companies themselves—characteristics that tend to persist across business cycles and political eras.

Our investment process is designed to give analysts the freedom, with few exceptions, to “go anywhere,” and locate the best businesses even in out-of-favor industries or countries. By keeping our opportunity set broad, always on the lookout for companies with strong competitive positions and secular growth tailwinds, the goal is to continuously furnish portfolio managers with sufficient raw materials from which to assemble diversified and

Portfolio Positioning (%) at April 30, 2021

 

Country/Region    Portfolio      Benchmark1  
     

Canada

     0.0        2.8  
     

Emerging Markets

     15.0        12.8  
     

Europe EMU

     6.8        8.6  
     

Europe ex-EMU

     6.9        7.9  
     

Frontier Markets2

     0.0         
     

Japan

     3.1        6.2  
     

Middle East

     0.0        0.2  
     

Pacific ex-Japan

     2.9        3.1  
     

United States

     63.9        58.4  
     

Cash

     1.4         
Sector    Portfolio      Benchmark  
     

Comm Services

     10.7        9.6  
     

Consumer Discretionary

     10.6        12.8  
     

Consumer Staples

     2.2        6.9  
     

Energy

     2.1        3.3  
     

Financials

     16.7        14.3  
     

Health Care

     20.8        11.3  
     

Industrials

     11.2        9.9  
     

Information Technology

     23.8        21.4  
     

Materials

     0.0        5.1  
     

Real Estate

     0.0        2.6  
     

Utilities

     0.5        2.8  
     

Cash

     1.4         

1 MSCI All Country World Index; 2 Includes countries with less-developed markets outside the index.

 

 

 

8

 

  


Table of Contents

differentiated portfolios of high-quality growing businesses. Our risk guidelines, including our portfolio limits on countries, sectors, and single companies, limit the worst of those inclinations, and we alter those limits only rarely and with great deliberation. In other words, don’t expect us to follow the current trend of some growth and momentum-oriented investors and to jettison our single holding limits to amass larger stakes in our favorite companies.

Portfolio Highlights

We ended the period overweight to Health Care, IT, Financials, Industrials, Communication Services, and underweight to Consumer Staples, Consumer Discretionary, Energy, and Utilities. The Portfolio had no holdings in Materials or Real Estate.

Health Care remains the Portfolio’s largest overweight, boosted by the purchase of two new US-based holdings—Edwards Lifesciences and UnitedHealth Group—and one new Chinese holding—WuXi Biologics. We believe Edwards, whose SAPIEN valve is the most implanted heart valve in the world, can continue to grow revenue and earnings for the foreseeable future due to the shift from open-heart surgery to transcatheter aortic valve replacement. UnitedHealth is one of the largest diversified healthcare companies in the United States and is pioneering innovative payment systems and health care delivery methods that should allow it to maintain its status as the premier private insurer. Additionally, legislative risk impacting the company has appeared to decrease post-election. Wuxi has become the dominant company in China’s rapidly growing biopharmaceutical industry and is gaining significant traction outside China as well. As Wuxi’s capabilities increase, we believe the company will win more late-stage development projects given its innovative manufacturing strategy and lower cost, highly talented workforce.

While we continue to be overweight the Financials sector, we have shifted the composition away from a group of banks located in struggling emerging economies in favor of enlarged holdings of two US banks: SVB Financial Group and First Republic Bank. Both cater to lucrative niche markets and prioritize impeccable service as a means of growing through referrals from their affluent and contented clientele.

In Energy, we bought two new holdings: US-based Schlumberger and Finland-based Neste. Schlumberger’s management has continually invested, through good times and bad, to extend its technological lead in oil servicing. Its latest moves include improving its data analytics platform to enable customers to leverage their data for greater efficiencies and embarking on new clean energy ventures. Over the last two decades Neste has developed technology that turns used cooking oil and waste animal fats into transport fuel and cultivated the requisite network to source and collect the feedstock. Most biodiesel fuels utilize crop-based feedstocks such as palm oil, a commodity widely blamed for deforestation; Neste’s next-generation process suffers no such overhang. We expect regulators in Europe, as part of their efforts to mitigate climate

Top Ten Holdings by Weight at April 30, 2021
Company    Sector    Country    %
       
SVB Financial Group    Financials    US    3.8
       
First Republic Bank    Financials    US    3.7
       
Alphabet    Comm Services    US    3.6
       
Amazon.com    Cons Discretionary    US    3.2
       
John Deere    Industrials    US    2.7
       
Illumina    Health Care    US    2.7
       
PayPal    Info Technology    US    2.6
       
Facebook    Comm Services    US    2.6
       
CME Group    Financials    US    2.4
       
Vertex Pharmaceuticals    Health Care    US    2.1

change, to continually raise mandates for use of biofuels while simultaneously penalizing sources that emanate from palm oil, placing the company at the juncture of two powerful secular trends.

We sold two Industrials holdings—US-based prototype-manufacturing service provider Protolabs and Finnish elevator-maker Kone—as outperformance led shares to appear overvalued. In Financials, we sold our position in Brazilian bank Itaú Unibanco as the company has not behaved as anticipated in the face of commodity-led reflationary trends and higher interest rates in Brazil. We also sold our sole Materials holding, German flavors-and-fragrance maker Symrise, as we felt we were not being adequately compensated for the stock’s lack of liquidity.

 

Please read the separate disclosures page for important information, including the risks of investing in the Portfolio.

 

 

 

 

9

 


Table of Contents

International Equity Portfolio

Institutional Investors: HLMIX & HLIZX | Individual Investors: HLMNX

 

 

Portfolio Management Team

 

LOGO

 

Ferrill Roll, CFA

Co-Lead Portfolio Manager

 

Andrew West, CFA

Co-Lead Portfolio Manager

 

LOGO

 

Bryan Lloyd, CFA

Portfolio Manager

 

Babatunde Ojo, CFA

Portfolio Manager

LOGO

 

Patrick Todd, CFA

Portfolio Manager

Performance Summary

For the International Equity Portfolio, the Institutional Class gained 24.26%, the Institutional Class Z gained 24.30%, and the Investor Class gained 24.11% (net of fees and expenses) in the six-month period ended April 30, 2021. The Portfolio’s benchmark, the MSCI All Country World ex-US Index, gained 27.41% (net of source taxes).

Market Review

International stock markets increased in the six months ended April 30, as the rollout of several successful COVID vaccines led to economic rebounds across the globe. All sectors and regions finished in positive territory for the period.

The closing months of 2020 saw a dramatic rise in global stock markets, despite an escalation in the global pandemic. The starting gun for the run-up was Pfizer’s announcement of better-than-expected results for its COVID-19 vaccine trials and was followed in rapid fire by positive reports from Moderna, AstraZeneca, and Sinopharm. Accelerated approvals gave investors further hope for some return to normal commerce in 2021, even as COVID-19 hospitalizations in the US and Europe soared.

In 2021, signs of a global economic rebound multiplied as the vaccination efforts began in earnest. In March, the IMF raised its global GDP growth forecast for 2021 to 6.0%. In the US, among the world’s leaders in vaccination rates, retail sales climbed to the strongest level on record and restaurant bookings and the number of airline passengers, while still below pre-COVID-19 levels, continued to improve. The Biden administration passed a colossal

Fund Facts at April 30, 2021

 

  
     
Total Net Assets    $20,439.7M     
     
Sales Charge    None     
     
Number of Holdings    58     
     
Turnover (5 Year Average)    18%     
     
Dividend Policy    Annual     
 
  

Institutional Investors

   Individual Investors
   
  

Inst Class

  

Inst Class Z

  

Investor Class

       
Ticker   

HLMIX

   HLIZX    HLMNX
       
CUSIP   

412295107

   412295719    412295503
       
Inception Date   

5/11/1994

   7/17/2017    9/30/2005
       
Minimum Investment1   

$100,000

   $10,000,000    $5,000
       
Net Expense Ratio2   

0.81%3

   0.73%4    1.13%5
       
Gross Expense Ratio2   

0.81%

   0.73%    1.13%

1Lower minimums available through certain brokerage firms; 2As of the most recent Prospectus and based on expenses for the fiscal year end. The Net Expense Ratio is shown net of Harding Loevner’s contractual agreement through February 28, 2022. 3Harding Loevner’s contractual agreement caps the Net Expense Ratio at 1.00%. 4Harding Loevner’s contractual agreement caps the net expense ratio at 0.80%. 5Harding Loevner’s contractual agreement caps the net expense ratio at 1.25%. The Net Expense Ratio is applicable to investors.

US$1.9 trillion relief package, the third such stimulus measure since the pandemic began, sending direct payments to millions of Americans and extending unemployment insurance. In China, electricity generation and rail cargo volume rose substantially year over year, but consumer spending remained subdued despite much of daily life having returned to normal. The recovery in Europe was even more uneven, amid the emergence of new more virulent virus strains and problems with its vaccine rollout extending or renewing lockdowns.

Better economic data coupled with seemingly unlimited central bank liquidity led to rising management confidence and a surge in mergers and acquisition activity (M&A). Company CEOs were not the only market participants infected with high confidence; investors became more sanguine as well. The growth of special-purpose acquisition companies (SPACs), a “backdoor” means of taking private companies public with minimal regulatory scrutiny, accounted for an unprecedented 25% of all US deals. Retail trading activity also rose sharply, with a record number of people opening online accounts, and option volumes rising dramatically. The speculative frenzy extended to initial public offerings (IPOs) in many markets, with shares of newly listed companies (many of them still loss-making) being met by strong institutional and retail demand.

As homebuyers and corporate treasurers alike raced to lock in low interest rates, bond yields rose, with the yield on the US 10-

 

 

 

10

 

  


Table of Contents

Performance (% total return)

 

 
     For periods ended March 31, 2021      For periods ended April 30, 2021  
       
      1      3      5      10      Since Inception*      1      3      5      10      Since Inception*  
               
      Year      Years      Years      Years      May-94      Jul-17      Sep-05      Year      Years      Years      Years      May-94      Jul-17      Sep-05  
                             

Intl Equity Portfolio – Inst Class

     50.49        9.01        12.17        7.52        6.85                          45.66        9.56        12.36        7.19        6.91                    
                             

Intl Equity Portfolio – Inst Class Z

     50.54        9.10                               9.96                 45.77        9.65                               10.38           
                             

Intl Equity Portfolio – Investor Class

     50.00        8.66        11.81        7.16                          7.27        45.25        9.21        11.99        6.83                          7.39  
                             

MSCI All Country World ex-US Index

     49.41        6.51        9.76        4.93               7.27        5.27        42.98        6.98        9.83        4.73               7.93        5.43  

Returns are annualized for periods greater than 1 year. *Inception of the Institutional Class, May 11, 1994. Inception of the Institutional Class Z, July 17, 2017. Inception of the Investor Class, September 30, 2005. Index performance prior to January 1, 2001 cannot be shown since it relies on back-filled data.

Performance data quoted represents past performance; past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance of the Portfolio may be lower or higher than the performance quoted. Performance data current to the most recent month end may be obtained by calling (877) 435-8105 or visiting www.hardingloevnerfunds.com.

 

year reaching pre-pandemic levels in March. Commodity prices, particularly those linked with industrial activity such as iron ore and copper, jumped higher, while Brent crude rose to over US$60 per barrel. On a sector basis, Energy was the strongest performer, surging in lockstep with rising oil prices. Financials also performed strongly, aided by a steepening yield curve and surprisingly low credit defaults. Information Technology (IT) also outperformed despite heightened scrutiny from regulators in Europe, China, and the US. Less-cyclical sectors—Consumer Staples, Health Care, and Utilities—all underperformed for the period.

Viewed by geography, the eurozone outperformed as some of the countries hit hardest by the virus, such as Spain and Italy, began to recover. Canada was a big outperformer, helped by its large weighting in banks and Energy. In Europe outside the eurozone, the UK posted strong returns on the back of its expansive vaccination program. Japan significantly underperformed as the country instated a new, more stringent state of emergency in response to another virus wave. Emerging Markets (EMs) also underperformed as weakness in China due to its regulatory crackdowns on tech companies offset strong performance in Taiwan and Russia, where the global semiconductor shortage and the rise in the oil price helped the former’s IT and latter’s Energy companies, respectively.

Performance Attribution

The Portfolio underperformed due to both negative sector allocation and stock selection. Weak stocks in Consumer Discretionary and Materials detracted the most during the period. In the former, shares of Japan’s largest home furnishing retailer NITORI fell as investors worried about their hostile acquisition of competing furniture retail chain Shimachu, rather than celebrating their 34th consecutive year of earnings growth. In Materials, shares of German flavors-and-fragrance maker Symrise declined as the company experienced slower organic sales growth in its beverage and sweets segments and faced rising raw

material prices. The Portfolio’s overweight in Health Care and Consumer Staples also detracted from relative returns.

Strong stocks in Industrials helped offset relative weakness in other sectors, particularly Alfa Laval, a Swedish manufacturer of specialty heat-transfer, centrifugal-separation, and fluid-handling products. Shares rose as management pointed to strong order growth in the latest quarter as evidence that its business momentum is accelerating. Additionally, Swedish compressor maker Atlas Copco benefited from recovering demand for compressors and raising expectations for expanded industrial and semiconductor capex. The Portfolio’s overweight in IT and underweight in Consumer Discretionary were also helpful.

Viewed by geography, most of the Portfolio’s underperformance was due to weak stocks in Japan. Shares of Unicharm, a manufacturer of hygiene and household cleaning products, declined in response to rising input costs (like oil) and a market style shift to stocks of more-cyclical companies. Chugai Pharmaceutical was hurt by a muted three-year revenue growth outlook and falling off -label usage of its rheumatoid arthritis drug Actemra, whose early promise as a COVID-19 treatment has been dampened by subsequent clinical study results. Weak stocks in Europe outside the eurozone also hurt, particularly Switzerland-based pharmaceutical and diagnostic equipment manufacturer Roche. Shares lagged in the more cyclicals-focused market rally despite the company having posted positive performance. The Portfolio’s cash weight during this period of strong equity returns also dragged on relative performance.

Strong stocks in EMs partially offset the drag from Japan, especially South Korean electronics manufacturer Samsung Electronics. Share benefitted due to improved pricing for its DRAM memory chips. The company also announced a new capital returns policy in January and forecasted a rosy outlook for memory demand into 2021. Taiwanese semiconductor contract manufacturer TSMC was another strong performer; the company

 

 

 

 

11

 


Table of Contents

has enjoyed strong demand for its high-performance chips from Apple (who unveiled new Mac and iPad models which utilize the TSMC-manufactured M1 processor) and other customers like NVIDIA and Mediatek (who rely on TSMC to execute its own leading-edge designs). At the same time, TSMC legacy nodes saw unusually high demand on widespread chip shortages from auto to consumer applications. Strong stocks in Pacific ex-Japan also contributed, especially Singapore-based bank DBS Group, which has continued to show strong business momentum, supported by the financial strength it has demonstrated throughout the pandemic.

Perspective and Outlook

For the best part of our 30-year existence we’ve invested in high-quality, growing companies. That means we understand only too well the slings and arrows of performance that the market occasionally hurls the way of our quality-focused portfolio. During the recovery from the prolonged bear market that followed the bursting of the tech bubble in 2000, we suffered one of our worst periods of relative performance. As the profit slump—at the time the deepest since the 1930s—dragged into its second year, the US Federal Reserve led other central banks in further rounds of cutting interest rates in a bid to spur a stronger recovery. Investors who had fled the securities of barely profitable or highly leveraged companies re-considered their cautious stance. Companies that were priced as if they might be the next round of bankruptcies suddenly looked like probable survivors, and their share prices leapt higher as investors adjusted to the upgraded prognosis. As cyclical and financial risks receded, stocks of the most stable companies, with ultra-conservative balance sheets and resilient profit margins, no longer transfixed investors, whose eyes wandered to less-pristine corporate stories in hopes of a bargain. Over the ensuing 24 months, stocks of companies in the lowest tiers of quality, derided as junk, trounced by double digits those in the top tiers.

Judging by the performance of the different quintiles of the market sorted by our proprietary quality rankings, the shift in market style that coincided with the early November release of vaccine efficacy results matches in many ways the pattern of 2003-2004, and then some. Whereas two decades ago it took over two years for the bottom quintile to out-pace the top by thirteen percentage points, this latest go-round has produced a 21 percentage point gap between the same two groups in just five months, with a mostly monotonic progression of performance down the tiers of quality: the worse you were, the better you did.

The earlier episode drove home the perils of being too risk-averse! While wallowing in the depths of a deep recession and long bear market, we took comfort from the resilience and reasonable valuation of the best companies and—despite the obvious chasm in relative valuations that had opened up between stocks of the best and the next-best, let alone

the worst—ultimately lost sight of the opportunity cost of future returns from what we did not own.

Over the last couple of years, as valuations for high-quality and rapidly growing companies have risen steadily, we’ve had to make difficult trade-offs in attempting to balance our commitment to these company attributes against the prices their shares fetch. Historically our debate has mostly concerned the trade-off between valuation and growth, but in this nascent recovery from the pandemic, the real issue—at least as far as relative performance goes—has turned out to be related more to trading off valuation against quality. Growth, in contrast to quality, has not been a particularly good predictive factor recently: only the fastest growth quintile (sorted by our growth metric) has seriously lagged the index, while the other 80% of the market matched or bettered the market’s average performance since the beginning of November.

Although both high quality and faster growth have become highly priced in recent times, we’ve made no attempt to predict either inflation or interest rates, despite recognizing how these inputs have an immediate impact on stock valuations through their

Portfolio Positioning (%) at April 30, 2021

 

Country/Region

 

   Portfolio      Benchmark1  
     

Canada

     1.9        6.8  
     

Emerging Markets

     24.5        30.8  
     

Europe EMU

     22.5        20.8  
     

Europe ex-EMU

     24.9        19.0  
     

Frontier Markets2

     0.0         
     

Japan

     12.9        14.8  
     

Middle East

     1.2        0.4  
     

Pacific ex-Japan

     8.6        7.4  
     

Other3

     1.1         
     

Cash

     2.4         

Sector

 

  

Portfolio

 

    

Benchmark1

 

 
     

Comm Services

     4.4        7.1  
     

Consumer Discretionary

     2.4        13.5  
     

Consumer Staples

     12.3        8.4  
     

Energy

     2.7        4.4  
     

Financials

     16.4        18.9  
     

Health Care

     12.4        8.9  
     

Industrials

     15.1        11.8  
     

Information Technology

     20.8        12.8  
     

Materials

     10.1        8.5  
     

Real Estate

     0.0        2.6  
     

Utilities

     1.0        3.1  
     

Cash

     2.4         

1MSCI All Country World ex-US Index; 2Includes countries with less-developed markets outside the index. 3Includes companies classified in countries outside the index.

 

 

 

12

 

  


Table of Contents

influence on discount rates. Considering such attempts a fool’s errand, we prefer instead to focus on discerning the enduring characteristics of companies themselves—characteristics that tend to persist across business cycles and political eras.

Our investment process is designed to give analysts the freedom, with few exceptions, to “go anywhere,” and locate the best businesses even in out-of-favor industries or countries. By keeping our opportunity set broad, always on the lookout for companies with strong competitive positions and secular growth tailwinds, the goal is to continuously furnish portfolio managers with sufficient raw materials from which to assemble diversified and differentiated portfolios of high-quality growing businesses. Our risk guidelines, including our portfolio limits on countries, sectors, and single companies, limit the worst of those inclinations, and we alter those limits only rarely and with great deliberation. In other words, don’t expect us to follow the current trend of some growth- and momentum-oriented investors and to jettison our single holding limits to amass larger stakes in our favorite companies.

Portfolio Highlights

Even after the sharp underperformance of high-quality stocks during the period, we remained concerned about stretched valuations. We sold German sportswear brand Adidas due to a high valuation coupled with concerns for its future growth path, trimmed expensive stocks within the IT and Health Care sectors—dominant Taiwan-based semiconductor foundry TSMC, French industrial software maker Dassault Systèmes, and Swiss-based contract pharmaceutical manufacturer Lonza—and opportunistically added on weakness to some more attractively valued stocks such as Chinese e-commerce giant Alibaba and Japanese drugmaker Shionogi.

Additionally, we made several new purchases at attractive entry points. CSPC Pharmaceuticals is one of China’s major pharmaceutical companies with a strong national sales presence, a portfolio of novel and generic pharmaceuticals already in the market, and a strong pipeline of products in development. We bought the shares on weakness triggered by government-mandated price cuts to the company’s largest seller, a drug used to treat hypertension and prevent strokes. Despite this short-term setback, we expect that higher volumes for the drug combined with new approvals will propel profit growth for years to come.

In Materials, we purchased Australian mining company BHP. We believe the market has undervalued its enduring competitive advantage due to its low-cost iron and copper mining operations which has allowed the company to deliver consistent profits and cash flows across the inevitable ups and downs of the global metals cycle. While the variability of commodity prices prevents BHP from scoring in the top ranks of measured quality, we are willing to bear some of that uncertainty in return for a more attractive valuation given the company’s strong business fundamentals.

Top Ten Holdings by Weight at April 30, 2021
Company    Sector    Country    %
       
Infineon Technologies    Info Technology    Germany    4.1
       
Samsung Electronics    Info Technology    South Korea    3.9
       
TSMC    Info Technology    Taiwan    3.7
       
Atlas Copco    Industrials    Sweden    3.5
       
L’Oréal    Cons Staples    France    3.3
       
AIA Group    Financials    Hong Kong    3.2
       
Adyen    Info Technology    Netherlands    3.1
       
BHP    Materials    Australia    3.0
       
Tencent    Comm Services    China    2.6
       
Schneider Electric    Industrials    France    2.6

In Utilities, we implemented a new position in ENN Energy, one of the largest natural gas distributors in China’s oligopolistic energy market. The company’s key competitive advantages include its scale, its access to an extensive gas distribution network, exclusive end market supply agreements with cities, and cost-effective upstream gas supply agreements with overseas suppliers. ENN Energy should benefit from rising natural gas demand in China as the country shifts away from coal, as well as industry consolidation and procurement savings opportunities stemming from gas market liberalization in China.

 

Please read the separate disclosures page for important information, including the risks of investing in the Portfolio.

 

 

 

 

13

 


Table of Contents

International Small Companies Portfolio

Institutional Investors: HLMRX | Individual Investors: HLMSX

 

 

Portfolio Management Team

 

LOGO

Jafar Rizvi, CFA

Co-Lead Portfolio Manager

Anix Vyas, CFA

Co-Lead Portfolio Manager

 

 

Performance Summary

For the International Small Companies Equity Portfolio, the Institutional Class gained 22.29% and the Investor Class gained 22.16% (net of fees and expenses) in the six-month period ended April 30, 2021. The Portfolio’s benchmark, the MSCI All Country World ex-US Small Cap Index, gained 34.44% (net of source taxes).

Market Review

International small cap stocks rose in the six-month period ended April 30, 2021, with all sectors and regions ending in positive territory. Towards the beginning of the period, accelerated approvals of COVID-19 vaccines gave investors hope for some return to normal commerce in 2021 even as COVID-19 hospitalizations in the US and Europe soared. After a pause in January as the world stood agape at the fraught events transpiring on the US political landscape, many of the trends that began with the vaccine announcement in early November resumed.

Signs of a global economic rebound multiplied as the vaccination efforts began in earnest. The IMF raised its global GDP growth forecast for 2021 by 0.3% to 6.0% since its last update in October. In the US, which has been among the world’s leaders in vaccination rates, retail sales climbed to the strongest level on record. Restaurant bookings and the number of airline passengers, while still below pre-COVID-19 levels, also continued to improve. The Biden administration passed a colossal US$1.9 trillion relief package, the third such stimulus measure since the pandemic began, sending direct payments to millions of Americans and extending unemployment insurance. The recovery in Europe, however, remained precarious, amid the emergence of new more contagious virus strains and problems with its vaccine rollout extending or renewing lockdowns.

Fund Facts at April 30, 2021

 

     
Total Net Assets    $519.8M     
     
Sales Charge    None     
     
Number of Holdings    85     
     
Turnover (5 Yr. Avg.)    31%     
     
Dividend Policy    Annual     
 
  

Institutional Investors

   Individual Investors
 
  

Institutional Class

  

Investor Class

     
Ticker    HLMRX    HLMSX
     
CUSIP    412295875    412295883
     
Inception Date    6/30/2011    3/26/2007
     
Minimum Investment1    $100,000    $5,000
     
Net Expense Ratio2    1.15%3    1.40%4
     
Gross Expense Ratio2    1.23%    1.55%
     

1Lower minimums available through certain brokerage firms; 2As of the most recent Prospectus dated February 28, 2021 and based on the fiscal year ended October 31, 2020. The Net Expense Ratio is shown net of Harding Loevner’s contractual agreement through February 28, 2022. 3Harding Loevner’s contractual agreement caps the net expense ratio at 1.15%. 4Harding Loevner’s contractual agreement caps the net expense ratio at 1.40%. The Net Expense Ratio is applicable to investors.

Better economic data coupled with seemingly unlimited central bank liquidity led to rising management confidence and a surge in mergers and acquisition activity (M&A). Global M&A reached a new record of US$1.3 trillion led by the US. Company CEOs were not the only market participants infected with high confidence; investors became more sanguine as well. The growth of special-purpose acquisition companies (SPACs), a “backdoor” means of taking private companies public with minimal regulatory oversight, accounted for an unprecedented 25% of all US deals.

Sector performance reflected the improved economic outlook with all sectors generating positive returns. The cyclical Materials and Industrials sectors were among the best performers during the period, benefitting most from the pickup in growth expectations, while the defensive Health Care sector lagged. The Consumer Discretionary sector benefitted from optimism that broader vaccine rollouts would normalize demand for goods and services, and Financials also rebounded, aided by a steepening yield curve and surprisingly low credit defaults. Less cyclical sectors such as Consumer Staples and Utilities fared less well, although finishing the six-month period strong nonetheless.

Viewed geographically, the EMU was the best performer, as some of the countries hardest hit by the virus were buoyed most by the vaccine developments. Returns in the UK, the largest weight in Europe ex-EMU, were helped by a last-minute Brexit trade deal. Emerging Markets (EMs) also outperformed, with good returns

 

 

 

14

 

  


Table of Contents

Performance (% total return)

 

   
     For periods ended March 31, 2021      For periods ended April 30, 2021  
       
     1      3      5      10      Since Inception*      1      3      5      10      Since Inception*  
           
      Year      Years      Years      Years      Jun-11      Mar-07      Year      Years      Years      Years      Jun-11      Mar-07  
                         

Intl Small Companies Portfolio – Inst Class

     59.86        7.64        11.42               8.00                 50.89        9.84        12.35               8.47           
                         

Intl Small Companies Portfolio – Investor Class

     59.47        7.37        11.13        7.85                 7.11        50.48        9.55        12.06        7.77                 7.43  
                         

MSCI All Country World ex-US Small Cap Index

     69.82        6.61        10.40        6.32        6.53               58.37        7.80        10.79        6.30        6.96         

Returns are annualized for periods greater than 1 year. *Inception of the Institutional Class, June 30, 2011. Inception of the Investor Class, March 26, 2007. Index performance prior to June 1, 2007 cannot be shown since it relies on back-filled data.

Performance data quoted represents past performance; past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance of the Portfolio may be lower or higher than the performance quoted. Performance data current to the most recent month end may be obtained by calling (877) 435-8105 or visiting www.hardingloevnerfunds.com.

 

 

from commodity-driven markets such as Russia, Brazil, and South Africa. Pacific ex-Japan also fared well, helped by Australia, which rebounded alongside a global recovery in commodity prices. While the Nikkei hit a three-decade high this quarter, the positive investor sentiment appears geared to larger, more export-driven companies, weighing on small cap returns in Japan.

By style, value was the standout, further reversing its lengthy period of underperformance and continuing the rally started in November. The cheapest stocks, heavily concentrated among financial and energy companies, outperformed the most expensive stocks by more than 1,000 basis points. Similarly, lower-quality companies, typically those with higher leverage and more volatile revenues and earnings, outperformed high-quality companies by more than 2,000 basis points. Shares of low-growth companies outperformed modestly, though with a less muted effect across quintiles of growth.

Performance Attribution

The Portfolio’s underperformance was driven primarily by weak stocks.

Our stocks in the Information Technology (IT) sector, and particularly the software and services industry where the shift toward cheaper, more cyclical stocks was pronounced and where we have a large weight, hurt the most during the six-month period. Companies such as Israeli-based cybersecurity specialist CyberArk and Canada-based supply chain management software provider Kinaxis were among the Portfolio’s largest relative detractors. Performance across the Portfolio suffered from the same valuation-related headwinds.

Another large detractor in IT was Finnish instrument producer Vaisala, which manufactures weather instruments used at airports and other testing and measurement devices used by pharmaceutical and utility customers. The unprecedented (and, we

think, temporary) slump in airline traffic during the pandemic has caused airport authorities to curb capital improvements, putting a dent in Vaisala’s earnings. However, safety remains an important priority for the authorities, and we expect regular replacement of existing weather-sensing systems and new investments particularly in EMs to continue to support the company’s growth longer term.

Consumer Staples also weighed negatively on returns. Egyptian packaged snack food company Edita, whose packaged cakes and croissants are mostly consumed by young people “on the go,” was hit hard by the lockdown as Egyptian schools and universities were closed from March to October. The stock languished throughout the year, trading near five-year lows, not seen since the Egyptian pound devaluation in late 2016.

Performance was weak across most regions, in Europe and Japan particularly, where some of the sharpest rotations in valuation style occurred. In Europe outside the monetary union, Swedish videogame maker Paradox Interactive detracted from returns following weak fourth-quarter results. The December release of its new game Empire of Sin disappointed, as did its revelation of unexpectedly higher depreciation expense. Paradox did, however, report a significant rise in monthly active users, a good signal for future revenues. In EMs, a region in which our stock selection fared slightly better, Indian life insurer Max Financial provided the largest boost to returns. The Indian insurance regulator provided long-awaited approval of a partnership with Axis Bank, which permits the large India-based bank to purchase up to 12% of Max Financial. The approval creates the potential for greater revenue synergies between the two companies by providing some assurance that Axis will collaborate with Max rather than compete against it. Max Financial’s top-line growth was 21% year-over-year in the fourth quarter and its market share of the premium-based life insurance business grew.

 

 

 

 

15

 


Table of Contents

Perspective and Outlook

Many have described the past year as “COVID time,” referring to an alternation of the monotony of social distancing with the fear of infection and death, and how each day seemed simultaneously to crawl and to fly. A similar phenomenon presented in our asset class. Rarely, if ever, has there been a period when an entire multi-year market cycle seemed packed into twelve months. In fact, when looking back and trying to make sense of our own Portfolio’s experience, it feels more appropriate to talk of the three distinct phases of the cycle since March.

The first started the week beginning March 9, when the index coughed up the first 15% of its value in a week. The selling was especially fierce in some of the lower-quality reaches of the Small Cap Index, where investors fled from financially weak companies as they sought safety and quality above all else. Our Portfolio’s permanent aversion to such companies helped limit the damage during this period, much like in past periods of market distress.

The second phase started in early May, as massive liquidity injections by the world’s central banks were initiated to help limit the economic damage. As people began to look beyond the present business distress, fear receded and expectations of a V-shaped recovery took hold. Investors’ attention turned from strong balance sheets to sustainable growth prospects, providing a further tailwind to a Portfolio that is also highly tilted toward the fastest growers.

This phase lasted until early November, when a flurry of vaccine breakthroughs encouraged the thought of a return to normalcy in 2021. International small caps jumped by nearly 1,400 bps during the month, led predominantly by lower-quality companies that were, during the first phase, thought to be at greatest financial risk. In this “junk” rally, our Portfolio lagged, ultimately giving up nearly 425 bps of relative performance in November alone. This trend continued until the end of March, after which growth stocks staged a brief recovery in April of this year. It is difficult to determine whether this recovery was the start of another regime shift; however, our focus on the long-term remains un-wavering. Our process affords us flexibility to pursue a number of avenues for seeking returns but stooping to pick up cigar butts isn’t one of them.

There is value in pausing here to reflect on how international small caps have performed through other market cycles. With the ever-valid caveat that the past is not a guarantee of future returns, history does provide an empirical basis for thinking about the returns from small caps. While international small caps are indisputably more volatile than international large caps, their returns have been demonstrably higher, by an average of 320 bps a year over the past twenty years, enough to outperform large caps on a risk-adjusted basis over that period (Sharpe ratio of 0.40 vs. 0.25). As active managers, though, we are attracted to the potential afforded by this vast opportunity set of over 10,000

listed businesses to generate alpha. Lax listing requirements across many markets allow many sub-par companies to sneak into the international small cap index. Given the sheer number of listings and the dearth of sell-side research on all but the largest, investment approaches that discriminate between companies that score highly on objective measures of quality and those that score the opposite tend to do well.4

Of course, our approach goes further. We emphasize quality (financial strength, distinguished track records, able management) but also growth. Through our bottom-up process we identify durable competitive advantages that enable companies to grow earnings reliably. A portfolio that scores high on quality and growth may shine in market environments such as those of 2020’s first two phases. But a feature of such a portfolio is that it will often appear expensive on metrics such as price-to-earnings and price-to-book ratios. This has increasingly been the case during the last half-decade, when high-quality growth stocks were rising in popularity (and price) because a slow-growing economy and low interest rates encouraged

Portfolio Positioning (%) at April 30, 2021

 

Country/Region

 

  

Portfolio

 

    

Benchmark1

 

 
     

Canada

     1.9        6.5  
     

Emerging Markets

     21.9        24.2  
     

Europe EMU

     21.4        14.9  
     

Europe ex-EMU

     29.2        24.3  
     

Frontier Markets2

     7.6         
     

Japan

     12.0        18.7  
     

Middle East

     1.5        1.7  
     

Pacific ex-Japan

     0.7        9.7  
     

Other3

     0.8         
     

Cash

     3.0         

Sector

 

  

Portfolio

 

    

Benchmark

 

 
     

Communication Services

     8.0        4.1  
     

Consumer Discretionary

     4.9        12.6  
     

Consumer Staples

     10.0        5.5  
     

Energy

     1.6        2.3  
     

Financials

     6.5        10.6  
     

Health Care

     11.3        7.4  
     

Industrials

     17.6        21.0  
     

Information Technology

     25.6        11.7  
     

Materials

     8.2        11.2  
     

Real Estate

     0.9        10.3  
     

Utilities

     2.4        3.3  
     

Cash

     3.0         

1MSCI All Country World ex-US Small Cap Index; 2Includes countries with less-developed markets outside the index; 3Includes companies classified in countries outside the index.

 

 

4Clifford S. Asness, Andrea Frazzini, Ronen Israel, Tobias J. Moskowitz, and Lasse Heje Pedersen, AQR, “Size Matters, If You Control Your Junk,” SSRN (January 2015); among other publications.

 

 

 

16

 

  


Table of Contents

investors to seek growth at almost any cost. Our response to this growing challenge has been incremental; we have reacted to perceived overvaluations, selling for something more reasonably priced, one stock at a time. Unfortunately, an incremental approach is ineffective (“too little too late”) once a junk rally begins. Regardless, factor rotation is not driving our decisions. We have no particular skill in identifying when style factors will be in or out of favor. Factors can rotate a few times even within a year, as they did in 2020. Our focus remains on identifying high-quality companies that can grow throughout market cycles. And we pay attention to valuations.

Portfolio Highlights

Our aim is to construct a well-diversified Portfolio that can withstand the full spectrum of “known unknowns” including short-term economic developments and bond yield fluctuations. The Portfolio is invested in businesses able to grow during downturns, such as our software holdings, as well as those reliant on expanding economic activity for growth. One example of the latter that we exited this period, though not by choice, was Signature Aviation, the leading UK-based fixed-base operator (FBO) of business jets, which is being taken private by a consortium of private equity firms. Travel limitations imposed by the pandemic presented challenges, but the company was able to surmount them.

We made four new purchases in the six-month period, each in a different sector, resulting in changes within the Portfolio’s sector exposures. In Industrials, we added HomeServe, a UK-based provider of subscription-based home repair service memberships in the UK, US, France, and Spain. It has exclusive long-term agreements with numerous utilities and municipal partners, and a large network of tradespeople, enabling the company to serve customers efficiently at lower costs. Increasing household formation underpins our expectations of sustainable long-term growth for the company.

Another UK company added during the period was Cranswick, which makes pork and poultry products on a private label basis. The company has 16 production facilities focused on everything from pig breeding and broiler farms to feed mills to preparation and packaging plants. All adhere to the latest environmental, ethical treatment, and non-GMO standards, which we think will allow Cranswick to achieve superior growth and profitability. Its poultry business, which is relatively new, is growing quickly by leveraging Cranswick’s existing customer relationships and reputation as a high-quality protein manufacturer.

We also purchased Solasto, the second-largest provider of outsourced medical administration services in Japan. The company’s focus on raising employee productivity through the adoption of IT solutions allows it to provide more services without hiring more employees. This approach is essential in Japan because of the country’s aging society and labor scarcity, and we think this positions the company to continue to grow profitably.

Top Ten Holdings by Weight at April 30, 2021

Company

 

  

Sector

 

  

Country

 

  

%

 

       
Hoa Phat Group    Materials    Vietnam    4.3
       
Reply    Info Technology    Italy    3.0
       
STRATEC Biomedical    Health Care    Germany    2.6
       
Max Financial Services    Financials    India    2.5
       
RUBIS    Utilities    France    2.4
       
Abcam    Health Care    UK    2.2
       
Dechra Pharmaceuticals    Health Care    UK    2.2
       
Bechtle    Info Technology    Germany    2.2
       
Fuchs Petrolub    Materials    Germany    2.1
       
Tomra Systems    Industrials    Norway    2.1

Finally, we added Bankinter, a new Financials holding. This well-managed Spanish bank has been gaining share as the banking industry has consolidated in recent years. Tourism is an important industry in Spain. The prevalence of the virus in the country has been high, so Spain’s economy is poised for a big rebound as leisure travel, one pre-pandemic habit we expect to survive, resumes.

 

Please read the separate disclosures page for important information, including the risks of investing in the Portfolio.

 

 

 

 

17

 


Table of Contents

Emerging Markets Portfolio

Institutional Investors: HLMEX & HLEZX | Individual Investors: HLEMX

 

 

Portfolio Management Team

 

LOGO

 

Scott Crawshaw

Co-Lead Portfolio Manager

 

Craig Shaw, CFA

Co-Lead Portfolio Manager

 

Pradipta Chakrabortty

Portfolio Manager

 

Richard Schmidt, CFA

Portfolio Manager

The Institutional Emerging Markets Portfolio (Institutional Class and Institutional Class Z) and the Emerging Markets Portfolio (Advisor Class)—collectively, the “Portfolios”—are both managed in strict accordance with Harding Loevner’s Emerging Markets Equity strategy model portfolio. Therefore, the Portfolios have highly similar holdings and characteristics. We have provided a single commentary to cover both Portfolios. The specific performance and characteristics of each are presented separately in the tables that follow.

Performance Summary

For the Institutional Emerging Markets Portfolio, the Institutional Class rose 25.05% and Class Z rose 25.12% (net of fees and expenses). For the Emerging Markets Portfolio, the Advisor Class rose 24.97% (net of fees and expenses) in the six-month period ended April 30, 2021. The Portfolios’ benchmark, the MSCI Emerging Markets Index, rose 22.95% (net of source taxes).

Market Review

Stocks in Emerging Markets (EMs) rallied in the first half of the fiscal year as news late in 2020 that vaccines had demonstrated exceptional levels of efficacy in final trials provided the catalyst for upgrading of global growth expectations and renewal of interest in those markets and industries worst hit by the COVID-19 pandemic. This, in turn, also boosted EM currencies, with the majority making significant gains versus a persistently weak dollar. The prospect of a stronger, broader-based recovery combined with China’s continued economic health and anticipation of the Biden

Fund Facts at April 30, 2021

 

    
       
Sales Charge   None         
       
Number of Holdings   74         
       
Dividend Policy   Annual         
   
    Institutional Investors       

Individual Investors

     
Portfolio Assets   $6,768.7M    $4,569.7M
     
Turnover (5 Yr. Avg.)   19%    20%
     
    Inst Class   Inst Class Z    Advisor
     
Ticker   HLMEX   HLEZX    HLEMX
     
CUSIP   412295701   412295693    412295305
     
Inception Date   10/17/2005   3/5/2014    11/9/1998
     
Minimum Investment1   $500,000   $10,000,000     $5,000
     
Net Expense Ratio2   1.17%3   1.11%4      1.32%5
     
Gross Expense Ratio2   1.27%   1.19%     1.35%

1 Lower minimums available through certain brokerage firms; 2 As of the most recent Prospectus and based on the fiscal year end. 3 The Net Expense Ratio is shown net of Harding Loevner’s contractual agreement through February 28, 2022. Harding Loevner’s contractual agreement caps the net expense ratio at 1.17%. The Net Expense Ratio is applicable to investors. 4 The Net Expense Ratio is shown net of Harding Loevner’s contractual agreement through February 28, 2022. Harding Loevner’s contractual agreement caps the net expense ratio at the Portfolio’s contractual management fee. The Net Expense Ratio is applicable to investors. 5 The Net Expense Ratio is shown net of Harding Loevner’s contractual agreement. Harding Loevner’s contractual agreement caps the net expense ratio at 1.32%. The Net Expense Ratio is applicable to investors.

administration’s massive infrastructure plans also propelled commodity and Energy prices higher.

Latin America and emerging Europe were the strongest regions in the index, with EMs especially sensitive to commodity prices (e.g., Russia, South Africa, Brazil, Mexico) enjoying an especially strong bounce. Asia lagged mostly due to China, the largest EM, which was among the worst-performing markets despite keeping the virus under control and registering robust growth in both manufacturing and services. Concerns included tighter domestic borrowing conditions and continuing tensions with the US. Anti-trust actions against Chinese internet companies were another cause for concern. Although the fines levied by Chinese regulators against Tencent, Baidu, and JD.com for their monopolistic behavior were miniscule, Alibaba received a much larger (US$3 billion) punishment in April albeit one still modest in relation to the size of the company. Across the strait, Taiwan was among the strongest EMs, led by semiconductor stocks, especially TSMC, buoyed by the current global chip shortage.

Materials was the best-performing sector with the rise in commodity prices and signs of broader global economic expansion. In Financials, EM bank stocks, which were among those most battered by the virus during much of 2020, rose sharply. Stocks of companies that have benefited the most from the pandemic environment in the Information Technology (IT)

 

 

 

18

 

  


Table of Contents

Performance (% total return)

 

 
    For periods ended March 31, 2021     For periods ended April 30, 2021  
       
     1     3     5     10     Since Inception*     1     3     5     10     Since Inception*  
               
     Year     Years     Years     Years     Oct-05     Mar-14     Nov-98     Year     Years     Years     Years     Oct-05     Mar-14     Nov -98  
                             

Inst. Emerging Markets Portfolio – Inst. Class

    60.07       4.58       11.25       5.23       7.62                       49.65       6.28       11.35       4.99       7.68                  
                             

Inst. Emerging Markets Portfolio – Class Z

    60.29       4.74       11.47                     6.90               49.92       6.45       11.57                     7.05          
                             

Emerging Markets Portfolio – Advisor Class

    60.08       4.45       11.14       5.12                       11.14       49.62       6.15       11.22       4.88                       11.17  
                             

MSCI Emerging Markets Index

    58.39       6.48       12.07       3.65       7.45       7.08             48.71       7.51       12.50       3.59       7.58       7.36        

Returns are annualized for periods greater than 1 year. *Inception of Institutional Class, October 17, 2005. Inception of Class Z, March 5, 2014. Inception of the Advisor Class, November 9, 1998. Index performance prior to January 1, 2001 cannot be shown since it relies on back-filled data.

Performance data quoted represents past performance; past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance of the Portfolio may be lower or higher than the performance quoted. Performance data current to the most recent month end may be obtained by calling (877) 435-8105 or visiting www.hardingloevnerfunds.com.

 

sector also continued to enjoy strong gains, led by semiconductor and other hardware manufacturers. Consumer Discretionary was the only sector in the index to decline, weighed down by index heavyweight Alibaba and its regulatory woes.

Performance Attribution

The Portfolio outpaced the index in the first half of the fiscal year due to strong stocks in Consumer Staples, Energy, and Consumer Discretionary. Our underweight the latter lagging sector was also helpful.

In Staples, the re-mobilization of consumers in Latin America and EM Europe helped to revive the shares of three beverage businesses: UK-based Coca-Cola HBC, Mexico’s FEMSA, and Brazil’s Ambev. In Energy, higher oil prices boosted the shares of two Russian-based companies, Lukoil and oil and natural gas producer Novatek, as well as Tenaris, a high-end oil pipe manufacturer. All fared better than Brazil-based Petrobras, whose well-respected CEO was ousted by President Jair Bolsonaro due to disagreement over fuel prices. In Consumer Discretionary, strong holdings included duty-free retailer China Tourism Group Duty Free and Taiwan’s Eclat Textile, which reported that customers such as Under Armour have increased their sales forecasts for 2021. Our underweight versus the benchmark in embattled Alibaba also helped relative returns.

The Portfolio’s lack of holdings in the top-performing Materials sector was the main detractor this period.

By region, key positive contributors to relative returns were our overweights in Brazil and Mexico as well as the Portfolio’s off -benchmark investments in China-focused companies listed in Hong Kong. Hong Kong-listed power tool manufacturer Techtronic Industries has continued to gain share thanks to innovative new products, and semiconductor equipment manufacturer

ASM Pacific Technology is set to benefit from large-scale capital investment plans in the industry.

We lagged the index in Brazil where, in addition to Petrobras, shares of global industrial equipment producer WEG were down as investors grappled with the impact of rising commodity prices on the company’s margins. The Portfolio’s small weight in cash also dampened performance versus the index.

Perspective and Outlook

Even as humanity continues its determined battle to contain the coronavirus, the longer-term threat facing our species from climate change is capturing increasing attention. The shift to electric vehicles (EVs) undeniably represents a growth opportunity for investors, particularly in China given its massive addressable market and the government’s new commitment to achieve carbon neutrality by 2060. In recent years, a plethora of companies have sought to capitalize on EV growth in China, including foreign automakers, who have laid out aggressive plans to build out EV capabilities, many through partnerships and joint ventures with Chinese firms. The existence of a growing market, however, by no means guarantees that EV makers themselves will be solid long-term investments.

A major challenge for EV makers is the specter of even more competitors entering the scene. The legacy, ICE-based automobile industry has enjoyed high barriers to entry due to the massive fixed capital required to produce engines, giving rise to enormous economies of scale, and the fact that trust based on brand reputation is important in consumer purchase decisions. The manufacturing process for EVs is significantly less complex and key components can be outsourced, presenting a low barrier to entry, as evidenced by the growing number of consumer and technology brands developing their own EVs, including Apple, and China’s internet giant Baidu and smartphone maker Xiaomi.

 

 

 

 

19

 


Table of Contents

Amid the increasingly crowded field, achieving stand-alone dominance in EV manufacturing will likely require a company to achieve (and maintain) the automobile equivalent of the iPhone: a uniquely attractive combination of hardware, software, and aesthetics. Tesla has come as close as any company to hitting on all three, but whether its edge can prevail is an open question. The software domain would appear to provide the most scope for enduring differentiation, but we think a single EV-maker is less likely to win out here than a software/systems specialist, such as China’s Waymo or Baidu, that will partner with multiple manufacturers to achieve scale. Tesla has enviable first-mover advantage in hardware (including manufacturing cost efficiency) and some aspects of software, with its revered user interface. We think it’s likely, however, that as the diversity of customer preferences are revealed, others will challenge Tesla for leadership in certain areas, be it drive-ability, style, or entertainment.

We can only speculate about how the EV industry will ultimately shake out. This lack of fundamental foresight makes us wary of predicting long-term winners among today’s brands, though we will continue to watch for companies that offer sufficient quality characteristics and durable growth potential. In the meantime, we have chosen to gain exposure to the EV growth opportunity through other ways very much aligned with our focus on quality-growth companies. In common with all other industries, our goal with respect to EVs is to invest in firms that offer predictable growth in their core businesses augmented by new growth opportunities exploitable by farsighted management. Indeed, we already have three EV-related holdings that fit this something-old/something-new profile:

Hon Hai Precision

Hon Hai Precision, also known as Foxconn, is the world’s leading provider of electronics manufacturing services (EMS), producing such iconic products such as the iPhone, Amazon Kindle, and Sony PlayStation. With its expertise in both hardware and software, combined with its massive scale and powerful supply chain management, Hon Hai offers its clients unrivaled speed-to-market at large scale and low cost. Its assembly capabilities are augmented by its ability to make certain components, such as iPhone casings, itself, from scratch. This reduces Hon Hai’s costs and allows it to make larger investments in research and development than smaller competitors.

One of Hon Hai’s recent growth initiatives has been entering the automotive industry, specifically EVs. It already offers a thousand EV components and counts Tesla among its customers. Hon Hai is an attractive supplier to EV manufacturers because of its expertise in the production of light metal structural parts, its experience in managing complex supply chains, and its expertise in products that integrate software with hardware (Exhibit A: the iPhone). Hon Hai has already designed a chassis and mapped out a production schedule for new models for three brands in 2022. Hon Hai is also building its own hardware and software “open platform,” called MIH. With contributions from Hon Hai’s partners and third-party developers,

MIH promises EV-makers a way to reduce up-front development costs, shorten vehicle development time, and facilitate mass production. MIH has already attracted customers such as Chinese automaker Geely, Italy’s Fiat, and US-based Fisker. While it is still early days in EV at Hon Hai, it is targeting a 10% share of what it estimates will be a $500 billion market by 2025.

WEG

WEG is one of Brazil’s leading industrial companies, manufacturing a broad range of electrical equipment for the global market. WEG earns a majority of its revenues abroad and has been making considerable capital expenditures to bring the same high level of vertical integration it enjoys inside Brazil to its manufacturing plants in Mexico, China, and elsewhere. These investments should improve WEG’s cost structure, global market share, and margins. Against the backdrop of the rotten Brazilian economy of recent years, WEG has managed to grow consistently and generate high returns on capital.

WEG’s management has shown commendable foresight in steering the company towards growth opportunities in adjacent business.

Portfolio Positioning (%) at April 30, 2021

 

Country/Region

    

Institutional

HLMEX / HLEZX

 

 

    
Advisor
HLEMX
 
 
     Benchmark 1 
       

Brazil

     6.3        6.3        4.6  
       

China + Hong Kong2

     34.0        34.0        37.5  
       

India

     7.5        7.5        9.4  
       

Mexico

     5.0        5.0        1.7  
       

Russia

     7.7        7.7        3.0  
       

South Africa

     1.5        1.5        3.7  
       

South Korea

     9.2        9.2        13.4  
       

Taiwan

     11.5        11.6        14.6  
       

Small Emerging Markets3

     5.9        5.9        12.1  
       

Frontier Markets4

     1.7        1.7         
       

Developed Market Listed5

     7.3        7.4         
       

Cash

     2.3        2.2         
        

Sector

    
Institutional
HLMEX / HLEZX
 
 
    
Advisor
HLEMX
 
 
    
Benchmark

 
       

Comm Services

     9.3        9.3        11.7  
       

Consumer Discretionary

     16.2        16.2        17.4  
       

Consumer Staples

     9.2        9.3        5.5  
       

Energy

     5.0        5.0        4.7  
       

Financials

     21.9        21.9        17.9  
       

Health Care

     3.2        3.2        4.7  
       

Industrials

     8.6        8.6        4.4  
       

Information Technology

     22.8        22.8        21.2  
       

Materials

     0.0        0.0        8.6  
       

Real Estate

     0.0        0.0        2.0  
       

Utilities

     1.5        1.5        1.9  
       

Cash

     2.3        2.2         

1MSCI Emerging Markets Index; 2The Benchmark does not include Hong Kong; 3Includes the remaining emerging markets which, individually, comprise less than 5% of the index; 4Includes countries with less-developed markets outside the index; 5Includes emerging markets or frontier markets companies listed in developed markets, excluding Hong Kong.

 

 

 

20

 

  


Table of Contents

Its initiatives include developing electric traction systems for buses, trains, and other modes of transport. In 2019, WEG stepped up its activity in this segment by becoming a key part of the VW-coordinated “e-Consortium” focused on developing electrical mobility in Brazil. WEG supplies the powertrain system globally for all VW electric delivery trucks and also makes the motors to power the air conditioning and other auxiliary systems. WEG’s initiatives in electric mobility are currently just a small part of the company’s many climate-related growth opportunities. The company has a larger wind and solar energy business, for example, that includes manufacturing solar energy kits for home use that have been gaining popularity in many markets.

Silergy

A new holding this period is Silergy, a Taiwan-listed manufacturer of power-management integrated circuits (PMIC) used in a range of electronic equipment, from computer tablets to industrial robots. The company’s design and manufacturing platform is highly integrated: it operates its own chip fabrication (“fab”) facilities, which enables the company to stay a step ahead of competitors with more intelligent or efficient products. Silergy has steadily increased its share of the PMIC market and enjoyed about a 15% cumulative annual growth rate of revenues and profits over the last five years.

Silergy has been investing for years in R&D to produce PMICs suitable for automotive applications. The recent chip shortage has prompted automakers to expand their suppliers of PMICs, presenting an opportunity for Silergy to enter the highly competitive supply chain. Silergy’s automotive-related revenues will likely exceed 5% of sales in 2021 and could double next year. Management has been vocal about its attractive near-term opportunities in telematics, infotainment, advanced driver-assistance systems, and LED lighting.

Portfolio Highlights

In 2020 and the early weeks of 2021, shares of a small group of fast-growing companies posted exceptionally strong returns, even after these shares were already looking quite expensive. Starting in mid-February, many of the expensive growers suffered rising share price volatility and moderate to significant reversals. A spike in volatility can reflect rising controversy in the market’s interpretation of the investment thesis—perhaps in some cases there is less certainty over the path to profitable growth—but it could just as well be rising interest rate expectations that increase the discount demanded in the present for those rosy earnings projections.

High valuations can represent a significant risk to growth stocks and growth investors, risk that quickly multiplies if lofty growth expectations are not allied with fundamental quality providing the foundation for sustainable profit growth. We have avoided many of the highest flyers of 2020. The issue for us often comes down to the quality component of our process—we demand, among other markers of quality, a track record of profitability and cash

Top Ten Holdings by Weight at April 30, 2021

 

Company    Sector    Country     


Institutional

HLMEX /
HLEZX

 


 

    

Advisor

HLEMX

 

 

         

TSMC

   Info Technology    Taiwan      5.3        5.3  
         
Samsung Electronics    Info Technology    South Korea      4.8        5.1  
         
Tencent    Comm Services    China      4.7        4.7  
         
EPAM    Info Technology    US      3.9        4.6  
         
Alibaba    Cons
Discretionary
   China      3.0        3.9  
         
AIA Group    Financials    Hong Kong      2.7        2.7  
         
LG Household & Health Care    Cons Staples    South Korea      2.4        2.4  
         
Sberbank    Financials    Russia      2.2        2.2  
         
Tata Consultancy Services    Info Technology    India      2.2        2.2  
         
Techtronic Industries    Industrials    Hong Kong      2.2        2.2  

flow generation that we think is sustainable before we invest in a business. Many of 2020’s hot dots don’t meet those criteria. And a number that do are still trading at rarified valuations even after their recent loss in altitude, which eliminates them from consideration.

For our portfolio we continue to find high-quality growth companies beyond IT, e-commerce, and the other most obvious growth industries. One of our purchases this period is Country Garden Services (CGS), a leader in China’s consolidating property management industry. The country’s densely populated communities rely upon property managers to enhance their quality of living. CGS’s superior reputation for service—and its wide variety of offerings including housekeeping, babysitting, interior design, and even schooling—is helping it gain market share. It is also expanding into commercial property services. Our analyst foresees CGS achieving 29% annual sales growth over the next five years.

During this period, we also added to our position in Alibaba, taking advantage of its recent tussles with regulators. Despite the policy risks, the company’s e-commerce and explosively growing cloud-computing segments remain exceptionally strong, making its valuation look attractive, particularly compared to other high-growth North Asia EIT stocks.

 

 

 

 

21

 


Table of Contents

Chinese Equity Portfolio

Institutional Investors: HLMCX

 

 

Portfolio Management Team

 

LOGO

Pradipta Chakrabortty

Lead Portfolio Manager

Jingyi Li

Portfolio Manager

Wenting Shen, CFA

Portfolio Manager

Performance Summary

The Chinese Equity Portfolio was launched on December 16, 2020. The Institutional Class rose 7.20% (net of fees and expenses) since launch through April 30, 2021. The Portfolio’s benchmark, the MSCI China All Shares Index, rose 4.02% in this period (net of source taxes).

Market Review

China largely got the COVID-19 outbreak under control by June 2020, and in response its economy continued to pick up steam during the first half of the fiscal year. Business activities re-accelerated while stringent border controls stayed in place to maintain a COVID-19-free domestic environment. In January 2021, new cases were detected for the first time in months, but testing mandated by local governments and stay-in-place orders in a handful of cities proved effective in curtailing the outbreak. Because many migrant workers elected not to travel during the Chinese New Year, industrial production following the weeklong holiday resumed more quickly than in previous years, with industrial activity readings posting their 13th consecutive month of expansion.

In March 2021, China launched its 14th Five-Year Plan and its 2035 long-term plan. Policy discussions surrounding these plans have reemphasized past areas of priority such as technological innovation and domestic consumption, while continuing to press ahead with reforms of state-owned enterprises (SOEs) and financial markets. In a sign of how other priorities have moved up the focus list, officials revealed a surprising level of detail around a previous pledge to achieve peak carbon emissions by

Fund Facts at April 30, 2021

 

   
Total Net Assets    $4.2M
   
Sales Charge    None
   
Number of Holdings    37
   
Turnover (5 Yr. Avg.)   
   
Dividend Policy    Annual
   Institutional Class
   
Ticker    HLMCX
   
CUSIP    412295685
   
Inception Date    12/16/2020
   
Minimum Investment1    $100,000
   
Net Expense Ratio2    1.15%3
   
Gross Expense Ratio2    4.75%

1Lower minimums available through certain brokerage firms. 2As of the most recent Prospectus and based on expenses for the fiscal year end. The Net Expense Ratio is shown net of Harding Loevner’s contractual agreement through February 28, 2022. 3Harding Loevner’s contractual agreement caps the net expense ratio at 1.15%. The Net Expense Ratio is applicable to investors.

2030 and net carbon neutrality by 2060. Regarding actual policy changes, China also passed reforms to relieve the demographic pressures that have resulted in skilled labor shortages emerging in some cities by lifting urban residency (“hukou”) restrictions in Shandong and Jiangxi, two provinces that are home to nearly 150 million people. This makes rural migrants eligible for the social safety nets of the cities in which they already live and work, and is intended to attract their families and friends, as well as new graduates, to these cities.

Conversely, regulatory risk has risen for China’s leading internet companies, depressing sentiment towards their stocks as regulators in China took a harder line on anti-competitive practices. Although they issued only negligible penalties (the equivalent of US$75,000) for monopolistic behavior against Tencent, Baidu, and JD.com, a much larger fine of nearly US$3 billion was imposed on Alibaba for demanding exclusivity of some of its merchants. We see very little fundamental impact on Alibaba’s business prospects from this sanction. Accessing Alibaba’s massive customer base of robust spenders remains an attractive value proposition for the company’s participating merchants, and Alibaba’s management seems committed to invest in further lowering merchants’ operating cost on its platforms. The direct financial hit of the penalty to Alibaba’s earnings pales in importance compared to how it resolves the open-ended threat previously overhanging its shares—which look attractive today in our valuation models as many of Alibaba’s long-term initiatives, particularly in cloud services, are not adequately valued by the market.

 

 

 

22

 

  


Table of Contents

Performance (% total return)

 

     For periods ended March 31, 2021      For periods ended April 30, 2021  
   
     Calendar YTD      1 Year      Since Inception*      Calendar YTD      1 Year      Since Inception*  
   

Chinese Equity Portfolio – Institutional Class

     -0.57               4.40        2.10               7.20  
   

MSCI China All Shares Index

     -1.50               1.67        0.78               4.02  

Returns are annualized for periods greater than 1 year. *Inception date: December 16, 2020.

Performance data quoted represents past performance; past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance of the Portfolio may be lower or higher than the performance quoted. Performance data current to the most recent month end may be obtained by calling (877) 435-8105 or visiting www.hardingloevnerfunds.com.

 

Performance Attribution

The Portfolio’s outperformance was primarily due to strong holdings in Consumer Discretionary and Information Technology (IT) as well our overweights in Health Care and Industrials.

In Consumer Discretionary, duty-free shop operator China Tourism Group Duty Free rose as January’s COVID-19 uptick failed to dissuade travelers from flocking to tropical Hainan island to vacation. The company is benefitting from a recent increase in the quantity of Western luxury goods that can be brought from Hainan to the mainland duty-free, part of a multi-year initiative to incentivize spending domestically instead of in duty-free stores overseas.

We had broad-based positive stock selection in IT, where our holdings are primarily equipment and precision parts manufacturers such as ASM Pacific Technology (semiconductor equipment), Sunny Optical (optical components), and Silergy (electronic components). Shares of these companies performed well this period due to rising sales for their industrial customers in the automotive, smartphone, and semiconductor sectors.

Consumer Staples detracted from our performance as Foshan Haitian, a soy sauce and condiments producer, gave back some of its gains after a strong 2020. Our lack of Chinese bank holdings also hurt relative performance.

Perspective and Outlook

China has achieved a near-legendary transition from having an economy reliant on legacy-heavy industry and infrastructure investment to one defined by, among other facets, skilled labor, unprecedented internet connectivity, and rising incomes for a vast number of Chinese.1 This transition has been accompanied by a rise of consumer power, a significant portion of it expressed online. The figures are impressive—estimates place the size of China’s middle class between 400-700 million individuals; China is now the world’s biggest market for luxury goods, smartphones,

passenger cars, and beer, among many other products. It also comprises the majority of production for growing industries such as electric vehicles (EVs) and solar power. More than most other countries, China has increasingly identified innovation as a condition of growth and has pursued it through aggressive policies and private sector funding of R&D. The government continue to aid in the development of innovative, quality-growth businesses over a wider range of industries. Coupled with stock market reforms that have improved access to mainland companies, the result has been a vastly expanded opportunity set for foreign-based investors. More than 1,800 Chinese companies of US$1 billion in market capitalization or greater are now investable through the Shanghai and Shenzhen Stock Connect programs.

Most companies that we follow and rate in China have a strong competitive position within industries with favorable market dynamics. For example, larger companies, particularly internet and e-commerce-related enterprises, benefit from economies of scale in a colossal yet still rapidly growing domestic market. Because domestic rivalry is typically fierce, market leaders had to learn to evolve quickly. This for some has led to a virtuous circle: market growth provides strong free cash flow, which they can reinvest in R&D to improve product quality and customer experience, which strengthens their competitive position and their cash flow. The favorable dynamics extend beyond the industries that one expects to see in growth-oriented portfolios to areas like robotics, companies up and down the value chain in electric vehicles, and biomedical research, just to name a few of our favorite hunting grounds. This, in turn, contributes to a level of industry and sector diversification that we think is necessary to construct a portfolio of companies from a single country.

 

 

1Our China country specialists regularly stress the deep complexity of China’s economy, whose development, occurrent in staggered fashion across regions, has led to significant wealth disparity. At around US$10,000 GDP per capita nationally, China is now in the middle income bracket. But this belies a radical difference in prosperity. “Tier one” cities in mainland China (Beijing, Shanghai, Guangzhou, Shenzhen) have a combined population of nearly 80 million people and have ascended to high-income status, with per capita GDP of around US$22,000. Within Emerging Markets, these four cities enjoy GDP per capita that is exceeded only by Taiwan and South Korea.

 

 

 

 

23

 


Table of Contents

The investment approach for the Chinese Equity Portfolio is consistent with the other Portfolios offered by Harding, Loevner Funds, including our Emerging Markets (EM), International, and Global Equity Portfolios, each of which have been investing in China for over 20 years. We invest only in companies meeting, in our judgment, four criteria: they must possess a competitive advantage, generate sustainable superior long-term growth, have the financial strength to fund growth and withstand difficult conditions, and possess farsighted and dynamic management capable of exploiting these advantages for the benefit of shareholders. We identify investments based on the insights of our global industry specialists, with years of experience investing across multiple geographies and different stages of market maturity and product lifecycles, and our China specialists, who each bring formidable local expertise and knowledge. Our longer-term investment horizon should also provide a source of edge in the Chinese market, which even today remains heavily driven by retail investors with speculative inclinations, who often move as a herd, driving share prices far above or below fair value, creating (in the latter case) buying opportunities for fundamental investors like us.

Contemplating Investment Risks

One question that naturally arises when launching a China-focused Portfolio is how we approach the risks that accompany investing in this country. For Harding Loevner, the assessment of risk for any security, including Chinese securities, stems from our insistence on business quality as a condition of purchase. In not compromising our commitment to strong balance sheets in good times, we potentially lessen the risk of permanent losses relating to financial distress and can therefore place a higher degree of confidence in our estimates of long-term value. However, there are indeed some elements of company, quality, and industry specific to China that deserve focus. For example, relating to financial strength, some Chinese companies appear to be highly free-cash generative businesses, able to maintain robust cash balances despite their rapid growth—yet we have observed the occasional phenomenon of firms parking cash in opaque wealth management products issued by non-bank institutions.2 Another example of risk we evaluate while analyzing a company’s industry structure is whether sudden shifts in regulatory policy affect the bargaining power of buyers and suppliers.

The careful analysis of corporate governance is also of particular import as we scour the Chinese equity universe, especially for companies where government entities have significant ownership and presence in boards. In China, as elsewhere, our approach is focused on identifying signs of poor corporate governance that typically destroy shareholder value. If a potential problem surfaces, we contemplate and evaluate the risk of value destruction based on facts and circumstances. In such a large and diverse market, there are bound to be firms that are not up to the

 

 

2Part of the country’s shadow banking system, these products provide little transparency on underlying assets. Moreover, they are treated as off-balance sheet items and therefore, the institutions which manage them usually offer no implicit assumption of capital loss.

mark, but overall, the domestic Chinese equity market has been professionalized. A-share disclosure requirements are even more rigorous in certain areas than other major markets, including Hong Kong and the United States.3 Many Chinese businesses comport themselves in accordance with global audit standards, and all companies in our portfolio use a globally-recognized auditor.

Portfolio Highlights

The Chinese Equity Portfolio reflects the different dimensions of the country’s economic transition. Many of our portfolio companies target aspirational consumers, who increasingly expect high quality and sophisticated products and services, including in customized international travel (Trip.com Group), duty-free luxury goods (China Tourism Group), and online entertainment and social media (Tencent). However, China’s growth also rests on rising consumption across all segments of the population. Several holdings provide universal services, including Baidu in internet services, JD.com in online retail, and Foshan Haitian in branded soy sauce and condiments. Health Care also represents a potentially rich opportunity in this regard.

Portfolio Positioning (%) at April 30, 2021

 

Market

     Portfolio        Benchmark 1 
     

Mainland China + Hong Kong

     90.0        100.0  
     

Other Emerging Markets2

     6.3         
     

Cash

     3.7         

Sector

     Portfolio        Benchmark 1 
     

Comm Services

     14.1        14.1  
     

Consumer Discretionary

     29.1        25.1  
     

Consumer Staples

     5.6        9.2  
     

Energy

     0.0        1.3  
     

Financials

     4.0        15.7  
     

Health Care

     14.6        8.9  
     

Industrials

     18.2        7.5  
     

Information Technology

     9.3        8.3  
     

Materials

     0.0        4.5  
     

Real Estate

     0.0        3.4  
     

Utilities

     1.4        2.0  
     

Cash

     3.7         

1MSCI China All Shares Index; 2Includes countries listed in emerging markets excluding Mainland China and Hong Kong.

 

 

3For example, China requires both parent and consolidated financial statements, not just the consolidated statements unlike Hong Kong and the US. Additionally, mainland companies are required to furnish detailed cash flow statements quarterly for all companies whereas US and Hong Kong companies are not. The Shenzhen Stock Exchange also requires disclosing company visits to listed companies.

 

 

 

24

 

  


Table of Contents

Our largest overweight is in the Industrials sector, comprised of domestic leaders in China’s automation market. Over the past three decades, China has grown to become the “world’s factory,” with roughly 30% share of global manufacturing output today. It accounts for an even higher portion of world production in labor-intensive categories such as electronics and automobiles. China was able to establish manufacturing leads in these categories due in part to its sizable low-cost labor force, and also because entire supply chains with better logistical efficiency than elsewhere were created onshore thanks to supportive economic and regulatory policies, and substantial investment in what are now top-class transportation and broadband networks. However, the labor market has changed: wages have risen considerably, and that is set to continue as the number and proportion of working-age Chinese individuals peaked in 2015. Barring an unlikely opening to immigration, China will realize in the next few decades one of the largest drops in working age population of any country.

This prospect has spurred an increased emphasis on industrial automation. The density of robot use in China remains only 20% to 50% of levels in Japan, Korea, and Germany, which presents significant opportunities for Chinese automation companies to better meet the needs of a local market that had previously been underserved by global rivals. Shenzhen Inovance Technology is China’s largest producer of industrial automation control components. We think its customization strategy will actually be its biggest advantage over multinational rivals, as it funnels resources into developing products that better suit the needs of local industries like battery manufacturing that are much better represented in China than elsewhere. As the EV supply chain consolidates, strong secular EV demand combined with an expected shift to a more modular value chain, similar to that of smartphones, should help Inovance take further share of both EV powertrain components and the robots used to put the vehicles together. Another portfolio company, Haitian International, focuses on very large high-precision injection molding machines with better energy efficiency than competitors’ equipment. Its long-term growth will be propelled by capacity expansion and new product launches to meet increasing demand from domestic industries such as automobiles and home appliances.

It is worth noting that our Chinese Equity Portfolio has underweights in more cyclical areas of the market. The largest of these underweights is in Financials; we do not own any Chinese banks, as most do not meet our quality hurdle. Nor do we own stocks in the Materials and Energy sectors, where we prefer businesses favorably positioned at the lower end of global cost curves. We have yet to discover commodity-oriented companies in China meeting that criterion.

Top Ten Holdings by Weight at April 30, 2021

 

Company    Sector    Market    %
       
Alibaba    Cons Discretionary    Mainland China    10.9

Tencent

   Comm Services    Mainland China    7.1
       
China Tourism Group Duty Free    Cons Discretionary    Mainland China    4.5
       
WuXi Biologics    Health Care    Mainland China    4.2
       
AirTAC    Industrials    Taiwan    4.1
       
WuXi AppTec    Health Care    Mainland China    4.0
       
Techtronic Industries    Industrials    Hong Kong    3.5
       
Haitian International    Industrials    Mainland China    3.3
       
AIA Group    Financials    Hong Kong    3.1
       
Wuliangye Yibin    Cons Staples    Mainland China    2.9

 

 

 

 

Please read the separate disclosures page for important information, including the risks of investing in the Portfolio.

 

 

 

 

25

 


Table of Contents

Frontier Emerging Markets Portfolio

Institutional Investors: HLFMX & HLFFX | Individual Investors: HLMOX

 

 

Portfolio Management Team

 

LOGO

Pradipta Chakrabortty

Co-Lead Portfolio Manager

Babatunde Ojo, CFA

Co-Lead Portfolio Manager

Performance Summary

For the Frontier Emerging Markets Portfolio, the Institutional Class I gained 16.76%, the Institutional Class II gained 16.96% and the Advisor Class gained 16.44% (net of fees and expenses) in the six-month period ended April 30, 2021. The Portfolio’s benchmark the MSCI Frontier Emerging Markets Index, gained 10.22% (net of source taxes).

Market Review

Frontier Emerging Markets (FEM) rose, gaining 10% during the six-month period ended April 30, 2021. The period was turbulent, beginning with an escalation in the global pandemic towards the end of 2020, followed by vaccine breakthroughs that gave investors concrete hope for normalization in 2021, ultimately ending with a reversal of this rebound in January. Optimism over the clinical trial success of vaccines that initially lifted FEMs’ performance in late 2020 flagged as it became apparent just how much FEM countries (with a few exceptions, like the United Arab Emirates) would lag in their access to, and ability to roll out, the vaccines to their populations. These concerns were then amplified by new waves of COVID-19 infections and the emergence of even more contagious and deadly variants of the virus, prompting further mobility restrictions and business disruptions.

Companies that benefited from the pandemic and the abrupt shift to remote work and commerce, many of them within Information Technology (IT) and Health Care, far outpaced more cyclical sectors such as Financials and Consumer Discretionary, which nonetheless also finished in positive territory. Energy, however,

Fund Facts at April 30, 2021

 

 
       
Total Net Assets    $236.7M        
       
Sales Charge    None        
       
Number of Holdings    58        
       
Turnover (5 Yr. Avg.)    29%        
       
Dividend Policy    Annual        
 
  

Institutional Investors

  Individual Investors
   
   Inst Class I   Inst Class II   Investor Class
       
Ticker    HLFMX   HLFFX   HLMOX
       
CUSIP    412295867   412295735   412295859
       
Inception Date    5/27/2008   3/1/2017   12/31/2010
       
Minimum Investment1    $100,000   $10,000,000   $5,000
       
Net Expense Ratio2    1.68%3   1.35%4   2.00%5
       
Gross Expense Ratio2    1.68%   1.60%   2.12%

1Lower minimums available through certain brokerage firms. 2As of the most recent Prospectus and based on expenses for the fiscal year end. 3Harding Loevner has contractually agreed to cap the expense ratio at 1.75% through February 28, 2022. The expense ratio (without cap) is applicable to investors. 4The Net Expense Ratio is shown net of Harding Loevner’s contractual agreement through February 28, 2022. Harding Loevner’s contractual agreement caps the expense ratio at 1.35%. The Net Expense Ratio is applicable to investors. 5The Net Expense Ratio is shown net of Harding Loevner’s contractual agreement through February 28, 2022. Harding Loevner’s contractual agreement caps the expense ratio at 2.00%. The Net Expense Ratio is applicable to investors.

was the best-performing sector as global oil prices continued to climb amid continued production constraints imposed by OPEC+ and expectations of improved economic growth. Materials also outperformed, with mining companies buoyed by China’s surging demand for industrial metals as well as the Biden administration’s plans for a massive infrastructure spend. Industrials and Consumer Staples lagged, finishing down for the period.

Geographically, Europe performed best, led by Kazakhstan, thanks to Halyk Savings Bank, which reported strong earnings due to a strengthened competitive position within its market, a result of the company’s good asset quality, and its progress on several digital initiatives.

Latin America was among the period’s top performers due to a significant year-end rise in commodity prices. Colombia, an oil exporter, did especially well, as the rise in Brent crude price sparked a stock market rally and boosted the value of the Colombian peso against the US dollar.

The Middle East was the poorest-performing region, as the Lebanese market (which accounts for less than 1% of the index and was not represented in our portfolio) collapsed after prolonged political uncertainty and fiscal distress. The country has been grappling with a debt crisis for many years and eventually defaulted on its foreign debt obligations in March 2020.

 

 

 

26

 

  


Table of Contents

Performance (% total return)

 

 

                             
                                                
            For periods ended March 31, 2021                    For periods ended April 30, 2021         
     1      3      5      10      Since Inception*      1      3      5      10      Since Inception*  
      Year      Years      Years      Years      May-08      Mar-17      Dec-10      Year      Years      Years      Years      May-08      Mar-17      Dec-10  

Frontier EM Portfolio – Inst Class I

     44.23        -4.56        3.22        1.56        -0.87                          35.34        -2.89        2.95        1.50        -0.64                    

Frontier EM Portfolio – Inst Class II

     44.67        -4.30                               2.88                 35.93        -2.62                               3.58           

Frontier EM Portfolio – Investor Class

     43.72        -4.88        2.83        1.17                          0.72        35.06        -3.24        2.58        1.13                          1.00  

MSCI Frontier EM Index

     33.58        -4.29        2.46        1.45               1.70        0.75        26.27        -3.37        2.34        1.38               2.17        0.95  

Returns are annualized for periods greater than 1 year. *Inception of the Institutional Class I, May 27, 2008. Inception of the Institutional Class II, March 1, 2017. Inception of the Investor Class, December 31, 2010. Index performance prior to December 2, 2008 cannot be shown since it relies on back-filled data.

Performance data quoted represents past performance; past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance of the Portfolio may be lower or higher than the performance quoted. Performance data current to the most recent month end may be obtained by calling (877) 435-8105 or visiting www.hardingloevnerfunds.com.

 

Performance Attribution

By sector, strong stock selection in IT was a significant contributor. Among our top performers was UAE-based payment processor Network International. Although the company’s payment processing business for tourists visiting the UAE is still only about half what it was before COVID-19, its domestic UAE revenues have recovered to pre-pandemic levels and the company’s new CEO Nandan Mer voiced optimism about processing fee levels projected for 2021. EPAM (based in the US but with large operations in Belarus and other FEMs), which saw all of its customer segments grow in 2020, also contributed to our performance. Its life sciences and health care segment saw the biggest gain, but even the travel and consumer segment managed modest growth, with demand from its retail and e-commerce clients offsetting the slump in tourism-related businesses.

Strong stocks in Financials also helped, especially Halyk, Bancolombia, and Philippine-based Security Bank. At Bancolombia, strong cost control and better fee income from non-lending sources (such as debit and credit cards, insurance, trust, brokerage, and investment banking) offset still-rising loan provisioning. Excess capital leaves the bank well cushioned to absorb further credit losses. Similarly, at Security Bank, asset quality pressure remains, but the bank has imposed stricter underwriting standards that should protect it going forward. Additionally, its growth is supported by the Philippines government’s new infrastructure initiative.

Our stocks in Real Estate were among the top detractors, primarily due to the impact of fresh government-mandated lockdowns on Kuwait mall operator Mabanee. Stock selection in Energy also hurt relative performance. Most investors failed to see synergies arising from a decision by Colombian state-owned oil company Ecopetrol to acquire a controlling stake in state-owned electric utility ISA.

 

By region, Asian holdings benefited the portfolio, especially Vietnam-based steel producer Hoa Phat Group. Billet sales remained strong due to continued high levels of exports to China and other Asian markets. The Gulf States also contributed. UAE-based food and beverage producer Agthia rallied following its proposal to acquire several packaged foods companies with strong distribution in the UAE and neighboring Kuwait and Jordan.

Stock selection was weak in frontier Europe, particularly Polish video game maker CD Projekt. The company was hacked, delaying fixes for troubling bugs in its recent launch of Cyberpunk 2077.

Perspective and Outlook

Way back at the start of the 2010s, equity investors found much to like about FEMs. Young populations and rapidly modernizing societies seemed to offer the perfect nutrients for robust economic growth of the kind that was in short supply in many more developed parts of the world in the wake of the global financial crisis (GFC). And, for the next several years, FEM investors were not disappointed. From the third quarter of 2009 through third quarter 2014, frontier and small emerging markets roughly matched the performance of the US-led resurgence in developed markets (DMs), and they handily beat traditional emerging markets (EMs) by an average of seven percentage points a year. However, since FEMs’ September 2014 absolute peak there has been a complete reversal, with EMs outperforming FEMs by seven percentage points annually. FEMs’ underperformance of DMs has been even greater: an average of 10 percentage points a year.

Six years ago, it would have been hard to imagine the succession of crises about to batter FEMs emanating from without. First was the commodity price shock in the latter part of 2014. When the US shale boom led to oversupply in the global oil market and the Saudi-led oil cartel responded with a price war to maintain

 

 

 

 

27

 


Table of Contents

its market share, the price of crude plunged a staggering 68% between June 2014 and December 2015. This led to a deep economic recession in the oil-dependent countries—Colombia, Kazakhstan, Nigeria, and the Gulf states—which together accounted for 45% of the MSCI FEM Index at the start of the period.

A second major crisis occurred only a couple of years into recovery from the commodity shock. The triggers were the US Federal Reserve’s aggressive rate hikes and reduction of its financial asset purchase program, as well as escalating trade tensions between the US and China. This combination dealt another blow to FEM currencies, as nearly every floating currency fell against the US dollar.

A third set of challenges came from the churn in the FEM index itself. Over the past six years, MSCI made numerous changes to the index by promoting countries with large weights to EM status and eliminating them from the benchmark. The re-volving door stirred consternation among investors, many of whom came to view the FEM index as overly concentrated and a dumping ground for markets “not good enough” for EM status, contributing to record foreign investor outflows and compounding the fall in FEM stock prices.

Finally came the COVID-19 pandemic, and in particular, its impact on FEM banks. Financial institutions’ leveraged exposures to their domestic economies meant that many banks were placed in a difficult position as whole sectors shut down and governments suspended borrowers’ loan repayment obligations in a frantic attempt to keep businesses afloat. The damage to banks was felt across the frontier and emerging markets, and with Financials representing the largest (41% prior to the November Kuwait upgrade) share of any sector in the FEM index, the impact on the entire asset category was especially acute.

Given this dreary sequence of developments and more than a half-decade of underperformance, investors can be forgiven if they are tempted to give up on FEMs. But this could be “rearview-mirror investing” of the worst sort. We have always said that investing in FEMs requires patience and is only suited for those with a very long time-horizon. In the context of FEMs’ decades-long emergence, we believe the past six years should be viewed as a rutted detour, not a dead end, because the strong fundamentals identified at the start of the 2010s are, if anything, even stronger today. FEMs now account for a third of the world population, but only 6% of the global economy and only the tiniest fraction (less than 1%) of global equity capital markets. In other words, there is lots of room for these markets to begin to catch up. FEM governments are increasingly investing in social and physical infrastructure and implementing other sensible policies to support the growth of the private sector. These are among the reasons why the International Monetary Fund projects that frontier economies will continue to grow faster than their emerging and developed counterparts in the medium-term.

 

We expect strong economic growth will translate into corporate earnings growth and, ultimately, higher share prices. Some of the biggest improvement will take place among the highest-quality members of the Financials sector, whose superior financial strength compared to competitors and increased market share coming out of the COVID-19 crisis position them to benefit disproportionately from FEMs’ recovery and growth in the years ahead. We are encouraged by the records of the high-quality banks in our Portfolio (Halyk being a prime example), which corroborates our philosophy when it comes to investing in FEM banks. The thesis for us has always been simple. We only invest in high-quality banks capable of success across economic cycles. High-quality FEM institutions like Halyk have a number of advantages, including a strong balance sheet, a well-established distribution network, and funding costs that enable them to at least keep up with, if not perform better than, lower-quality banks in good economic times—and to significantly outperform and gain market share during periods of economic crisis, such as Halyk throughout the COVID-19 pandemic. A strong balance sheet and competent management invariably allow these high-quality companies to emerge from crises with a superior competitive position, which further solidifies their dominance. The fact that some of the most

Portfolio Positioning (%) at April 30, 2021

 

Region    Portfolio      Benchmark1  

Africa

     20.3        17.5  

Asia

     38.8        45.7  

Europe

     11.1        10.6  

Gulf States

     5.6        4.4  

Latin America

     13.5        21.4  

Middle East

     0.0        0.4  

Developed Markets Listed2

     8.4         

Cash

     2.3         
Sector    Portfolio      Benchmark1  

Communication Services

     6.6        8.8  

Consumer Discretionary

     5.4        1.0  

Consumer Staples

     15.7        7.0  

Energy

     3.9        5.0  

Financials

     33.3        33.2  

Health Care

     6.1        2.2  

Industrials

     4.5        11.6  

Information Technology

     12.5        4.9  

Materials

     5.1        8.8  

Real Estate

     4.6        14.0  

Utilities

     0.0        3.5  

Cash

     2.3         

1MSCI Frontier Emerging Markets Index; 2Includes frontier or small emerging markets companies listed in developed markets.

 

 

 

28

 

  


Table of Contents

well-run and innovative of these companies are now training their advantages on seizing the mantle of digital leadership in their marketplaces is another, potentially even more encouraging, factor in their favor.

Beyond banks, we see bright prospects for selected companies across a range of industries, including consumer, technology, hospitality, and health care.

Portfolio Highlights

MSCI upgraded Kuwait from frontier to EM status in November 2020, resulting in the country’s removal from the MSCI FEM Index. With Kuwait having accounted for 20%, its removal left the index even more concentrated in the Philippines, which saw its weight jump seven percentage points to one third of the benchmark at the end of 2020. Our portfolio has a single country risk limit of 20%, guaranteeing that we will continue to be significantly underweight in the Philippines. Though such country ceilings bring higher tracking error, the trade-off to reduce overall portfolio risk is worth making. Indeed, we see country diversification as being especially important in FEMs, as a means to manage individual political and currency risks that are typically higher than those in DMs.

This risk regime has been helpful to our strategy over the past few quarters, during which the Philippines market badly underperformed other FEMs, largely due to the havoc COVID-19 has wreaked on its economy. In this densely populated country of over 7,600 islands, the efficient flow of goods and services can be challenging in the best of times. The country’s GDP shrank 9.5% in 2020 as COVID-19 cases remained stubbornly high despite extensive quarantine measures taken by the government. Such unforeseeable calamities are precisely the reason we have country ceilings in place.

Nevertheless, the Philippines economy and its corporate earnings will rebound at some point. We have been using the sell-off as an opportunity to add to our Philippine positions at cheaper valuations. We added to our position in Jollibee Foods, the country’s dominant quick-service restaurant chain, whose 60% local market share is complemented by sizeable businesses in the US, China, and throughout Southeast Asia. Its shares became cheap after it posted record losses because many of its locations in the Philippines, and elsewhere, temporarily closed or faced declining traffic. Management has since taken sensible actions to lift Jollibee out of crisis and position it for faster recovery post-pandemic. By the last quarter of 2020, Jollibee was already back to generating profits.

We also added to our position in Wilcon Depot, the leading home improvement big-box retailer in the Philippines. Like Jollibee, the company was severely impacted by the country’s lockdowns, but we expect earnings to pick back up this year with a cyclical recovery in the construction sector and recent cuts in mortgage interest rates. Management is rolling out new stores across the provinces while enhancing its e-commerce platform and logistics capabilities.

Top Ten Holdings by Weight at April 30, 2021      
Company    Sector    Country      %  

Hoa Phat Group

   Materials      Vietnam        4.9  

Globant

   Info Technology      Argentina        4.8  

EPAM Systems

   Info Technology      US        4.7  

Safaricom

   Comm Services      Kenya        4.5  

Commercial International Bank

   Financials      Egypt        4.0  

SM Prime Holdings

   Real Estate      Philippines        3.8  

Banca Transilvania

   Financials      Romania        3.8  

Vietnam Dairy Products

   Cons Staples      Vietnam        3.5  

Universal Robina

   Cons Staples      Philippines        3.2  

Halyk Savings Bank

   Financials      Kazakhstan        3.0  
 

 

 

 

29

 


Table of Contents

Global Equity Research Portfolio

Institutional Investors: HLRGX

 

 

Portfolio Management Team

 

LOGO

Moon Surana, CFA

Portfolio Manager

Andrew West, CFA

Portfolio Manager

Performance Summary

For the Global Equity Research Portfolio, the Institutional Class gained 26.05% in the six-month period ended April 30, 2021. The Portfolio’s benchmark, the MSCI All Country World Index, gained 28.29% (net of source taxes).

Market Review

Global stock markets increased in the six months ended April 30, as the rollout of several successful COVID-19 vaccines led to economic rebounds across the globe. All sectors and regions finished in positive territory for the period.

Despite an escalation in the global pandemic, the closing months of 2020 saw a dramatic rise in global stock markets in response to startlingly positive final-stage vaccine clinical trial results. Accelerated approvals gave investors further hope for some return to normal commerce in 2021, even as COVID-19 hospitalizations in the US and Europe soared.

In March, the IMF raised its global GDP growth forecast for 2021 to 6.0%. In the US, among the world’s early leaders in vaccination rates, retail sales climbed to the strongest level on record and restaurant bookings and the number of airline passengers, while still below pre-COVID-19 levels, continued to improve. The Biden administration passed a colossal US$1.9 trillion relief package, the third such stimulus measure since the pandemic began, sending direct payments to millions of Americans and extending unemployment insurance. In China, electricity generation and rail cargo volume rose substantially year over year, but consumer spending remained subdued despite much of daily life having

Fund Facts at April 30, 2021

 

Total Net Assets   

$9.3M

Sales Charge   

None

Number of Holdings   

309

Turnover (5 Yr. Avg.)   

Dividend Policy   

Annual

 
    

Institutional Investors

 
Ticker   

HLRGX

 
CUSIP   

412295792

 
Inception Date   

12/19/2016

 
Minimum Investment1   

$100,000

 
Net Expense Ratio2   

0.80%3

 
Gross Expense Ratio2   

2.04%

1Lower minimums available through certain brokerage firms; 2The Expense Ratios are as of the most recent Prospectus and are based on expenses for the most recent fiscal year end. The Net Expense Ratio is shown net of Harding Loevner’s contractual agreement through February 28, 2022. 3Harding Loevner’s contractual agreement caps the net expense ratio at 0.80%. The Net Expense Ratio is applicable to investors.

returned to normal. The recovery in Europe was even more uneven, amid the emergence of new more virulent virus strains and problems with its vaccine rollout extending or renewing lockdowns.

Better economic data coupled with seemingly unlimited central bank liquidity led to rising management confidence and a surge in mergers and acquisition activity (M&A). Company CEOs were not the only market participants infected with high confidence; investors became more sanguine as well. The growth of special-purpose acquisition companies (SPACs), a “backdoor” means of taking private companies public with minimal regulatory scrutiny, accounted for an unprecedented 25% of all US deals. Retail trading activity also rose sharply, with a record number of people opening online accounts, and option volumes rising dramatically. The speculative frenzy extended to initial public offerings (IPOs) in many markets, with shares of newly listed companies (many of them still loss-making) being met by strong institutional and retail demand.

As homebuyers and corporate treasurers alike raced to lock in low interest rates, bond yields rose, with the yield on the US 10-year reaching pre-pandemic levels in March. Commodity prices, particularly those linked with industrial activity such as iron ore and copper, jumped higher, while Brent crude rose to over US$60 per barrel.

 

 

 

30

 

  


Table of Contents
Performance (% total return)                        
                                  
     For periods ended March 31, 2021      For periods ended April 30, 2021  
     
     Calendar      1      3      Since      Calendar      1      3      Since  
      YTD      Year      Years      Inception*      YTD      Year      Year      Inception*  

Global Equity Research Portfolio – Institutional Class

     3.84        56.86        12.97        15.86        7.33        46.76        14.44        16.42  

MSCI All Country World Index

     4.57        54.60        12.07        13.59        9.14        45.74        13.32        14.44  

Returns are annualized for periods greater than 1 year. *Inception date: December 19, 2016.

Performance data quoted represents past performance; past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance of the Portfolio may be lower or higher than the performance quoted. Performance data current to the most recent month end may be obtained by calling (877) 435-8105 or visiting www.hardingloevnerfunds.com.

 

On a sector basis, Energy was the strongest performer, surging in lockstep with rising oil prices. Financials also performed strongly, aided by a steepening yield curve and surprisingly low credit defaults. Information Technology (IT) also outperformed despite heightened scrutiny from regulators in Europe, China, and the US. Less-cyclical sectors—Consumer Staples, Health Care, and Utilities—all underperformed for the period.

Viewed by geography, the eurozone outperformed as some of the countries hit hardest by the virus, such as Spain and Italy, began to recover. Canada was a big outperformer, helped by its large weighting in banks and Energy. In Europe outside the eurozone, the UK posted strong returns on the back of its expansive vaccination program. Japan significantly underperformed as the country instated a new, more stringent state of emergency in response to another virus wave. Emerging Markets (EMs) also underperformed as weakness in China due to its regulatory crackdowns on tech companies off set strong performance in Taiwan and Russia, where the global semiconductor shortage and the rise in the oil price helped the former’s IT and latter’s Energy companies, respectively.

Performance Attribution

The Portfolio underperformed as stocks of high-quality growing companies lagged the broader market. On a sector basis, weak stocks in Materials and Consumer Discretionary detracted the most during the period. In the former, shares of US-based gas and chemical company Air Products, a steady business that benefits from durable long-term contracts with customers, lagged the broader market as more cyclical stocks outperformed. In Consumer Discretionary, shares of Japanese gas appliances manufacturer Rinnai lagged as the price of raw inputs such have copper have continued to increase. The Portfolio’s overweight in Consumer Staples also detracted.

Strong stocks in Financials helped, particularly US-based Signature Bank. The bank benefitted from expectations of higher interest rates, as well as resilient credit and deposit growth throughout the period. US-based SVB Financial Group also

contributed; the bank has benefited from rising expectations for increased economic growth and higher interest rates. The Portfolio’s underweight in Utilities and overweight in Industrials also helped.

Viewed by geography, weak stocks in Japan detracted the most from relative performance. Shares of Unicharm, a manufacturer of hygiene and household cleaning products, declined in response to rising input costs (like oil) and a market style shift to stocks of more-cyclical companies. Stocks in the US also detracted, particularly household and personal care products manufacturer Church & Dwight, which modestly declined over an ebbing of pandemic stay-at-home-related tailwinds and rising inflationary pressures. The Portfolio’s overweight in Japan and EMs, as well as its cash weight during this period of strong equity returns, also dragged on relative performance.

Strong stocks in EMs contributed, especially Taiwanese electronics manufacturer Hon Hai Precision. Share rose on the back of agreements with a pair of Chinese carmakers (Byton and Zhejiang Geely Holding Group) to help manufacture electric vehicles. Stocks in Europe outside the eurozone were also helpful, particularly UK-based aviation services company Signature Aviation. Shares increased as the company was a subject of a bidding war, before being ultimately acquired by Global Infrastructure Partners.

Perspective and Outlook

For the best part of our 30-year existence we’ve invested in high-quality, growing companies. That means we understand only too well the slings and arrows of performance that the market occasionally hurls the way of our quality-focused portfolio. During the recovery from the prolonged bear market that followed the bursting of the tech bubble in 2000 we suffered one of our worst periods of relative performance. As the profit slump—at the time the deepest since the 1930s—dragged into its second year, the US Federal Reserve led other central banks in further rounds of cutting interest rates in a bid to spur a stronger recovery.

 

 

 

 

31

 


Table of Contents

Investors who had fled the securities of barely profitable or highly leveraged companies reconsidered their cautious stance. Companies that were priced as if they might be the next round of bankruptcies suddenly looked like probable survivors, and their share prices leapt higher as investors adjusted to the upgraded prognosis. As cyclical and financial risks receded, stocks of the most stable companies, with ultra-conservative balance sheets and resilient profit margins, no longer transfixed investors, whose eyes wandered to less pristine corporate stories in hopes of a bargain. Over the ensuing 24 months, stocks of companies in the lowest tiers of quality, derided as junk, trounced by double digits those in the top tiers.

Judging by the performance of the different quintiles of the market sorted by our proprietary quality rankings, the shift in market style that coincided with the early November release of vaccine efficacy results matches in many ways the pattern of 2003-2004, and then some. Whereas two decades ago it took over two years for the bottom quintile to outpace the top by 19 percentage points, this latest go-round has produced a 23 percentage point gap between the same two groups in just five months, with a mostly monotonic progression of performance down the tiers of quality: the worse you were, the better you did.

The earlier episode drove home the perils of being too risk-averse! While wallowing in the depths of a deep recession and long bear market, we took comfort from the resilience and reasonable valuation of the best companies and—despite the obvious chasm in relative valuations that had opened up between stocks of the best and the next-best, let alone the worst—ultimately lost sight of the opportunity cost of future returns from what we did not own.

Over the last couple of years, as valuations for high-quality and rapidly growing companies have risen steadily, we’ve had to make difficult trade-offs in attempting to balance our commitment to these company attributes against the prices their shares fetch. Historically our debate has mostly concerned the trade-off between valuation and growth, but in this nascent recovery from the pandemic, the real issue—at least as far as relative performance goes—has turned out to be related more to trading off valuation against quality. Growth, in contrast to quality, has not been a particularly good predictive factor recently: only the fastest growth quintile (sorted by our growth metric) has seriously lagged the index, while the other 80% of the market matched or bettered the market’s average performance since the beginning of November.

Although both high quality and faster growth have become highly priced in recent times, we’ve made no attempt to predict either inflation or interest rates, despite recognizing how these inputs have an immediate impact on stock valuations through their influence on discount rates. Considering such attempts a fool’s errand, we prefer instead to focus on discerning

the enduring characteristics of companies themselves—characteristics that tend to persist across business cycles and political eras.

Our investment process is designed to give analysts the freedom, with few exceptions, to “go anywhere,” and locate the best businesses even in out-of-favor industries or countries. By keeping our opportunity set broad, always on the lookout for companies with strong competitive positions and secular growth tailwinds, the goal is to continuously furnish portfolio managers with sufficient raw materials from which to assemble diversified and differentiated portfolios of high-quality growing businesses. Our risk guidelines, including our portfolio limits on countries, sectors, and single companies, limit the worst of those inclinations, and we alter those limits only rarely and with great deliberation. In other words, don’t expect us to follow the current trend of some growth and momentum-oriented investors and to jettison our single holding limits to amass larger stakes in our favorite companies.

 

Portfolio Positioning (%) at April 30, 2021

 

  
Country/Region    Portfolio      Benchmark1  

Canada

     1.1        2.8  

Emerging Markets

     21.6        12.8  

Europe EMU

     13.2        8.6  

Europe ex-EMU

     10.0        7.9  

Frontier Markets2

     0.0         

Japan

     8.9        6.2  

Middle East

     0.0        0.2  

Pacific ex-Japan

     3.2        3.1  

US

     40.7        58.4  

Cash

     1.3         
Sector    Portfolio      Benchmark1  

Comm Services

     5.1        9.6  

Consumer Discretionary

     12.0        12.8  

Consumer Staples

     10.4        6.9  

Energy

     3.3        3.3  

Financials

     12.5        14.3  

Health Care

     15.2        11.3  

Industrials

     16.4        9.9  

Information Technology

     18.6        21.4  

Materials

     4.0        5.1  

Real Estate

     0.3        2.6  

Utilities

     0.9        2.8  

Cash

     1.3         

1MSCI All Country World Index; 2Includes countries with less-developed markets outside the index.

 

 

 

32

 

  


Table of Contents

Portfolio Highlights

The Global Equity Research Portfolio’s holdings are directly determined by analysts’ recommendations among Harding

Loevner’s collection of researched companies. During the six-month period ended April 30, 2021, our analysts recommended buying 57 companies and selling 41. Owing to recent analyst promotions and the ongoing expansion of our small cap coverage, the number of small companies in the Portfolio’s opportunity set has meaningfully increased in recent quarters. We ended the six-month period with 309 holdings in the Portfolio. In terms of our exposure to different sectors, our exposure to Financials, Energy, and IT increased the most while exposure to Industrials, Materials, and Health Care decreased. By region, our exposure to the US decreased the most while exposure to the eurozone increased the most.

Insofar as the relative valuations of many of our buy-rated small-cap stocks have resembled those of some of the most stretched areas of the broader market, this increase in small-cap holdings exacerbated our concerns about portfolio valuation risk and led us to implement new portfolio construction rules to manage it. Companies below US$5 billion in market cap are now allowed in the Portfolio only if they exhibit cheap relative valuations. We use our proprietary value rankings for this purpose, getting rid of the most-expensive half of our small cap companies among the pool of analyst-recommended stocks, while retaining or purchasing cheaper ones. We also made additions and trims to holdings as part of a new emphasis on reducing the valuation risk of our large-company holdings. The net impact of these changes was that the Portfolio now looks quite a bit less expensive than previously.

In Financials, we made net trims in the Portfolio, however strong performance increased the Portfolio weight. India-based HDFC Bank and HDFC Corp, and Indonesia-based Bank Rakyat were sold after the analyst downgraded them on valuation concerns. In Energy, we made net additions. Schlumberger, a US-based oil services company, was purchased as recovering energy prices made the analyst more optimistic about future performance. We also took the opportunity to add to Netherlands-based Vopak and Pakistan’s Oil & Gas Development Company after weakness.

Purchases and sales in IT were relatively balanced, but strong performance increased exposure. We made several new purchases including the Spanish travel technology company Amadeus and Argentina-based enterprise-level IT services leader Globant after our analysts upgraded these stocks. Amadeus has underperformed relative to the steep fall-off in on travel during the pandemic, but we expect the business to recover and believe the valuation is attractive enough to wait. In the case of Globant, we’ve increased our revenue growth forecast due to increasing demand from enterprises for digital transformation and used a recent pullback in the price of expensive tech stocks as an opportunity to act. We added to Hon Hai Precision, Cisco, US-based business and IT consulting firm Cognizant, and AAC Technologies, a Chinese manufacturer of miniaturized acoustic components, due to cheap relative valuation.

Top Ten Holdings by Weight at April 30, 2021   
Company    Sector   Country    %

UnitedHealth Group

   Health Care   US    1.2

Alphabet

   Comm Services   US    1.1

Cisco

   Info Technology   US    1.1

Cognizant Technology

   Info Technology   US    1.1

JPMorgan Chase

   Financials   US    1.1

Vertex Pharmaceuticals

   Health Care   US    1.0

AbbVie

   Health Care   US    1.0

Microsoft

   Info Technology   US    1.0

RGA

   Financials   US    1.0

MasterCard

   Info Technology   US    0.9

In Industrials, we made several sales and trims due to valuation concerns. These included the Japanese b2b e-commerce platform MonotaRO, Brazilian electric equipment manufacturer WEG, China-based automatic controls producer Shenzhen Inovance, and Honeywell, among others.

In Health Care, purchases and sales were mostly balanced, but poor performance saw the weight in the Portfolio decrease. We sold Switzerland-based Roche as our analyst expects more competition for its legacy oncology products from biosimilars. On the other hand, we purchased German lab equipment supplier Sartorius after a very strong year that saw its products play a key role in COVID-19 vaccine manufacturing. We also added several small cap companies: Swiss dental implant maker Straumann, UK monoclonal antibodies supplier Abiomed, and Penumbra, a US-based medical device company specializing in the treatment of strokes.

In the US our exposure decreased after several sales and trims. Kansas City Southern railroad and Tiffany were sold in the face of what appeared at the time to be imminent mergers (LVMH’s indeed completed its takeover of Tiffany in January). We also sold several companies, such as US-based industrial automation company Rockwell, due to valuation. First Republic Bank and Signature Bank were trimmed after strong outperformance left them looking relatively expensive.

Our exposure to the eurozone increased from the purchase of several smaller cap holdings. We also had some upgrades of existing companies and new companies added to our research universe.

Please read the separate disclosures page for important information, including the risks of investing in the Portfolio.

 

 

 

 

33

 


Table of Contents

International Equity Research Portfolio

Institutional Investors: HLIRX & HLMZX

 

 

Portfolio Management Team

 

LOGO

Moon Surana, CFA

Portfolio Manager

Andrew West, CFA

Portfolio Manager

Performance Summary

For the International Equity Research Portfolio, the Institutional Class gained 24.60% (net of fees and expenses) in the six-month period ended April 30, 2021. The Portfolio’s benchmark the MSCI All Country World ex-US Index, gained 27.41% (net of source taxes).

Market Review

International stock markets increased in the six months ended April 30, as the rollout of several successful COVID-19 vaccines led to economic rebounds across the globe. All sectors and regions finished in positive territory for the period.

The closing months of 2020 saw a dramatic rise in global stock markets, despite an escalation in the global pandemic. The starting gun for the run-up was Pfizer’s announcement of better-than-expected results for its COVID-19 vaccine trials and was followed in rapid fire by positive reports from Moderna, AstraZeneca, and Sinopharm. Accelerated approvals gave investors further hope for some return to normal commerce in 2021, even as COVID-19 hospitalizations in the US and Europe soared.

In 2021, signs of a global economic rebound multiplied as the vaccination efforts began in earnest. In March, the IMF raised its global GDP growth forecast for 2021 to 6.0%. In the US, among the world’s leaders in vaccination rates, retail sales climbed to the strongest level on record and restaurant bookings and the number of airline passengers, while still below pre-COVID-19 levels, continued to improve. The Biden administration passed a colossal US$1.9 trillion relief package, the third such stimulus measure since the pandemic began, sending direct payments to millions

Fund Facts at April 30, 2021

 

  
     
Total Net Assets   $15.4M     
     
Sales Charge   None     
     
Number of Holdings   223     
     
Turnover (5 Yr. Avg.)   46%     
     
Dividend Policy   Annual     
 
    Institutional Investors
   
    Inst Class    Inst Class Z
   
Ticker   HLIRX    HLMZX
   
CUSIP   412295826    412295743
   
Inception Date   12/17/2015   
   
Minimum Investment1   $100,000    $10,000,000
   
Net Expense Ratio2   0.75%3    0.75%3
   
Gross Expense Ratio2   1.40%    1.81%

1Lower minimums available through certain brokerage firms; 2As of the most relent Prospectus and based on expenses for the most recent fiscal year end. 3The Net Expense Ratio is shown net of Harding Loevner’s contractual agreement through February 28, 2022. Harding Loevner’s contractual agreement caps the net expense ratio at 0.75%. The Net Expense Ratio is applicable to investors.

of Americans and extending unemployment insurance. In China, electricity generation and rail cargo volume rose substantially year over year, but consumer spending remained subdued despite much of daily life having returned to normal. The recovery in Europe was even more uneven, amid the emergence of new more virulent virus strains and problems with its vaccine rollout extending or renewing lockdowns.

Better economic data coupled with seemingly unlimited central bank liquidity led to rising management confidence and a surge in mergers and acquisition activity (M&A). Company CEO’s were not the only market participants infected with high confidence; investors became more sanguine as well. The growth of special-purpose acquisition companies (SPACs), a “backdoor” means of taking private companies public with minimal regulatory scrutiny, accounted for an unprecedented 25% of all US deals. Retail trading activity also rose sharply, with a record number of people opening online accounts, and option volumes rising dramatically. The speculative frenzy extended to initial public offerings (IPOs) in many markets, with shares of newly listed companies (many of them still loss-making) being met by strong institutional and retail demand.

As homebuyers and corporate treasurers alike raced to lock in low interest rates, bond yields rose, with the yield on the US 10-year reaching pre-pandemic levels in March. Commodity prices, particularly those linked with industrial activity such as iron ore and copper, jumped higher, while Brent crude rose to over US$60 per barrel.

 

 

 

34

 

  


Table of Contents

Performance (% total return)

                       
     For periods ended March 31, 2021      For periods ended April 30, 2021
   
     1 Year    3 Years    5 Years    Since Inception*      1 Year    3 Years    5 Years    Since Inception*
                 

Intl Equity Research Portfolio – Institutional Class

   53.06    7.41    11.43      11.36      45.86    8.58    11.58    11.77
   

MSCI All Country World Ex-US Index

   49.41    6.51    9.76      9.27      42.98    6.98    9.83    9.71

Returns are annualized for periods greater than 1 year. *Inception date: December 17, 2015.

Performance data quoted represents past performance; past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance of the Portfolio may be lower or higher than the performance quoted. Performance data current to the most recent month end may be obtained by calling (877) 435-8105 or visiting www.hardingloevnerfunds.com.

 

On a sector basis, Energy was the strongest performer, surging in lockstep with rising oil prices. Financials also performed strongly, aided by a steepening yield curve and surprisingly low credit defaults. Shares of Information Technology (IT) companies also outpaced the index despite facing heightened scrutiny from regulators in Europe, China, and the US. Less-cyclical sectors—Consumer Staples, Health Care, and Utilities—all underperformed for the period.

Viewed by geography, the eurozone outperformed as some of the countries hit hardest by the virus, such as Spain and Italy, began to recover. Canada was a big outperformer, helped by its large weighting in banks and Energy. In Europe outside the eurozone, the UK posted strong returns on the back of its expansive vaccination program. Japan significantly underperformed as the country instated a new, more stringent state of emergency in response to another virus wave. Emerging Markets (EMs) also underperformed as weakness in China due to its regulatory crackdowns on tech companies offset strong performance in Taiwan and Russia, where the global semiconductor shortage and the rise in the oil price helped the former’s IT and latter’s Energy companies, respectively.

Performance Attribution

The Portfolio underperformed as stocks of high-quality, fast-growing companies lagged the broader market in the six-month period. The main detractors from relative returns were weak stocks in Materials and IT as well our overweight to the lagging Consumer Staples sector. Good stocks in Financials and Industrials along with the Portfolio’s underweight in Communications Services were helpful.

In Materials, German flavors-and-fragrance maker Symrise experienced slower organic sales growth in its beverage and sweets segments, and Danish industrial enzyme producer Novozymes reported an overall decline in organic growth. Another Danish company, natural food ingredients producer Chr. Hansen,

gave back some of the strong stock returns it generated in 2020. In IT, our underweight to Taiwan-based semiconductor manufacturer TSMC detracted; its stock soared on news that its rival Intel was experiencing production delays of its next-generation chip.

In Financials, our EM banking holdings, such as Bancolombia and Spain’s BBVA and Banco Santander, performed particularly well. With economic activity picking up, manufacturers everywhere are seeing more orders, but our Industrials holdings Techtronic Industries, a Hong Kong-based power-tool manufacturer, and Komatsu, a Japanese earth-moving equipment maker, were standouts. Steady investment by Techtronic in R&D has paid off in a series of successful products launches, while at Komatsu economic recovery has spurred a rebound in demand for its construction equipment.

Regionally, our holdings in Japan detracted most from relative returns. Shares of Unicharm, a Japanese manufacturer of hygiene and household cleaning products, declined in response to the rising costs of inputs (such as oil) and the market’s style shift favoring stocks of more-cyclical companies. Poor stocks in the eurozone also dragged on performance versus the index, notably Symrise.

Investments in Pacific ex-Japan were a large positive contributor to relative returns. Two banks in Singapore, DBS Group and OCBC Bank, outperformed after announcing better-than-expected fourth-quarter results. Both banks saw their loan books improving with fewer loans subject to a government-mandated loan-repayment moratorium. DBS has also seen growth in its wealth management business and credit card volume, leading to increased fee income.

Perspective and Outlook

For the best part of our 30-year existence we’ve invested in high-quality, growing companies. That means we understand only too well the slings and arrows of performance that the market

 

 

 

 

35

 


Table of Contents

occasionally hurls the way of our quality-focused portfolio. During the recovery from the prolonged bear market that followed the bursting of the tech bubble in 2000, we suffered one of our worst periods of relative performance. As the profit slump—at the time the deepest since the 1930s—dragged into its second year, the US Federal Reserve led other central banks in further rounds of cutting interest rates in a bid to spur a stronger recovery. Investors who had fled the securities of barely profitable or highly leveraged companies re-considered their cautious stance. Companies that were priced as if they might be the next round of bankruptcies suddenly looked like probable survivors, and their share prices leapt higher as investors adjusted to the upgraded prognosis. As cyclical and financial risks receded, stocks of the most stable companies, with ultra-conservative balance sheets and resilient profit margins, no longer transfixed investors, whose eyes wandered to less-pristine corporate stories in hopes of a bargain. Over the ensuing 24 months, stocks of companies in the lowest tiers of quality, derided as junk, trounced by double digits those in the top tiers.

Judging by the performance of the different quintiles of the market sorted by our proprietary quality rankings, the shift in market style that coincided with the early November release of vaccine efficacy results matches in many ways the pattern of 2003-2004, and then some. Whereas two decades ago it took over two years for the bottom quintile to outpace the top by thirteen percentage points, this latest go-round has produced a 21 percentage point gap between the same two groups in just five months, with a mostly monotonic progression of performance down the tiers of quality: the worse you were, the better you did.

The earlier episode drove home the perils of being too risk-averse! While wallowing in the depths of a deep recession and long bear market, we took comfort from the resilience and reasonable valuation of the best companies and—despite the obvious chasm in relative valuations that had opened up between stocks of the best and the next-best, let alone the worst—ultimately lost sight of the opportunity cost of future returns from what we did not own.

Over the last couple of years, as valuations for high-quality and rapidly growing companies have risen steadily, we’ve had to make difficult trade-offs in attempting to balance our commitment to these company attributes against the prices their shares fetch. Historically our debate has mostly concerned the trade-off between valuation and growth, but in this nascent recovery from the pandemic, the real issue—at least as far as relative performance goes—has turned out to be related more to trading off valuation against quality. Growth, in contrast to quality, has not been a particularly good predictive factor recently: only the fastest growth quintile (sorted by our growth metric) has seriously lagged the index, while the other 80% of the market matched or bettered the market’s average performance since the beginning of November.

Although both high quality and faster growth have become highly priced in recent times, we’ve made no attempt to predict either inflation or interest rates, despite recognizing how these inputs

have an immediate impact on stock valuations through their influence on discount rates. Considering such attempts a fool’s errand, we prefer instead to focus on discerning the enduring characteristics of companies themselves—characteristics that tend to persist across business cycles and political eras.

Our investment process is designed to give analysts the freedom, with few exceptions, to “go anywhere,” and locate the best businesses even in out-of-favor industries or countries. By keeping our opportunity set broad, always on the lookout for companies with strong competitive positions and secular growth tailwinds, the goal is to continuously furnish portfolio managers with sufficient raw materials from which to assemble diversified and differentiated portfolios of high-quality growing businesses. Our risk guidelines, including our portfolio limits on countries, sectors, and single companies, limit the worst of those inclinations, and we alter those limits only rarely and with great deliberation. In other words, don’t expect us to follow the current trend of some growth- and momentum-oriented investors and to jettison our single holding limits to amass larger stakes in our favorite companies.

 

Portfolio Positioning (%) at April 30, 2021

 

  

Country/Region

     Portfolio      Benchmark1
     

Canada

     1.6      6.8
     

Emerging Markets

     31.9      30.8
     

Europe EMU

     23.8      20.8
     

Europe ex-EMU

     20.4      19.0
     

Frontier Markets2

     0.0     
     

Japan

     15.3      14.8
     

Middle East

     0.0      0.4
     

Pacific ex-Japan

     6.1      7.4
     

Cash

     0.9     
     

Sector

     Portfolio      Benchmark1
     

Communication Services

     5.1      7.1
     

Consumer Discretionary

     12.2      13.5
     

Consumer Staples

     11.7      8.4
     

Energy

     4.1      4.4
     

Financials

     15.5      18.9
     

Health Care

     10.2      8.9
     

Industrials

     18.9      11.8
     

Information Technology

     13.4      12.8
     

Materials

     5.8      8.5
     

Real Estate

     0.7      2.6
     

Utilities

     1.5      3.1
     

Cash

     0.9     

1MSCI All Country World ex-US Index; 2Includes countries with less-developed markets outside the index.

 

 

 

36

 

  


Table of Contents

Portfolio Highlights

The International Equity Research Portfolio’s holdings are directly determined by analysts’ recommendations among Harding Loevner’s collection of researched companies. During the six-month period ended April 30, 2021, our analysts recommended buying 46 companies and selling 33. One of our associate analysts, Samuel Hosseini, was promoted to analyst, making his recommended purchases, including a number of small cap companies, newly eligible for the Portfolio. Owing to his and other recent promotions and the ongoing expansion of our small cap coverage, the number of international small companies in the Portfolio’s opportunity set has meaningfully increased in recent quarters. We ended the six-month period with 223 holdings in the Portfolio.

Our exposure to IT increased as a result of several new purchases, including a handful of small cap companies that newly became eligible for the strategy: Germany-based Nemetschek, a niche software supplier to the construction and media and entertainment industries; Taiwan-based semiconductor manufacturer Chipbond Technology; and China-based Sangfor Technologies, an enterprise cloud and network security vendor.

In Communication Services, we bought French market research and consulting firm Ipsos, Russian internet search firm Yandex, Cheil Worldwide (a South Korean marketing company affiliated with Samsung Electronics), and Scout24. The latter operates a leading real estate platform in Germany where agents, landlords, and individual sellers can list and display their properties for sale or rent. (Think of it as a mashup of Realtor.com, Apartments.com, and Craigslist.) The company is a dominant player with over 70% market share and enjoys a strong network effect.

In Health Care, we sold Grifols, a Spanish producer of blood plasma-based products, after the stock outperformed and the valuation looked less compelling to our analyst. We also sold Switzerland-based Roche, as our analyst expects more competition for its legacy oncology products from biosimilars. Analysts recommended Health Care purchases as well, including Italian-based diagnostics company DiaSorin. This business should continue to get a boost from strong demand for COVID-19-related tests.

By region, our exposure to the EMU increased the most during the six-month period while exposure to EMs shrank the most. Our increased investments in the EMU was largely the result of purchasing newly eligible smaller-cap holdings such as Nemetschek and Germany-based IT consultancy Bechtle. We also had some analyst upgrades of larger-cap companies, including Amadeus, an airline-reservation-management software business headquartered in Spain. The spread of effective vaccines has lifted both the outlook for a rebound in travel and Amadeus’s performance relative to the rest of IT. In EM, the number of upgrades and downgrades were balanced during the quarter, but we also made several trims due to high relative valuation,

Top Ten Holdings by Weight at April 30, 2021

 

  
Company    Sector   Country    %
       
Banco Santander    Financials   Spain    1.2
       
DBS Group    Financials   Singapore    1.2
       
OCBC Bank    Financials   Singapore    1.1
       
Brenntag    Industrials   Germany    1.1
       
Hakuhodo    Comm Services   Japan    1.1
       
Rio Tinto    Materials   UK    1.1
       
SE Banken    Financials   Sweden    1.1
       
Kubota    Industrials   Japan    1.0
       
BHP    Materials   Australia    1.0
       
BMW    Cons Discretionary   Germany    1.0

including Shenzhen Inovance, China’s largest producer of industrial automation control components and Naver, a South Korean social media company.

 

 

 

 

37

 


Table of Contents

Emerging Markets Research Portfolio

Institutional Investors: HLREX

 

 

Portfolio Management Team

 

LOGO

Moon Surana CFA

Portfolio Manager

Andrew West, CFA

Portfolio Manager

Performance Summary

For the Emerging Markets Equity Research Portfolio, the Institutional Class rose 22.17% (net of fees and expenses) in the six-month period ended April 30, 2021. The Portfolio’s benchmark, the MSCI Emerging + Frontier Markets Index, rose 22.87% (net of source taxes).

Market Review

Stocks in Emerging Markets (EMs) rallied in the first half of the fiscal year as news late in 2020 that vaccines had demonstrated exceptional levels of efficacy in final trials provided the catalyst for upgrading of global growth expectations and renewal of interest in those markets and industries worst hit by the COVID-19 pandemic. This, in turn, also boosted EM currencies, with the majority making significant gains versus a persistently weak dollar. The prospect of a stronger, broader-based recovery combined with China’s continued economic health and anticipation of the Biden administration’s massive infrastructure plans also propelled commodity and energy prices higher.

Latin America and emerging Europe were the strongest regions in the index, with EMs especially sensitive to commodity prices (e.g., Russia, South Africa, Brazil, Mexico) enjoying an especially strong bounce. Asia lagged mostly due to China, the largest EM, which was among the worst-performing markets despite keeping the virus under control and registering robust growth in both manufacturing and services. Concerns included tighter domestic borrowing conditions, and continuing tensions with the US. Antitrust actions against Chinese internet companies were another cause for concern. Although the fines levied by Chinese regulators

Fund Facts at April 30, 2021

 

   
Total Net Assets   $9.0M
   
Sales Charge   None
   
Number of Holdings   131
   
Turnover (5 Year Average)  
   
Dividend Policy   Annual
 
  Institutional Investors
 
  Institutional Class
   
Ticker   HLREX
   
CUSIP   412295776
   
Inception Date   12/19/2016
   
Minimum Investment1   $100,000
   
Net Expense Ratio2   1.15%3
   
Gross Expense Ratio2   2.40%

1Lower minimums available through certain brokerage firms; 2The Expense Ratios are are as of the most recent Prospectus and are based on expenses for the most recent fiscal year end. The Net Expense Ratio is shown net of Harding Loevner’s contractual agreement through February 28, 2022. 3Harding Loevner’s contractual agreement caps the Net Expense Ratio at 1.15%. The Net Expense Ratio is applicable to investors.

against Tencent, Baidu, and JD.com for their monopolistic behavior were miniscule, Alibaba received a much larger (US$3 billion) punishment in April albeit one still modest in relation to the size of the company. Across the strait, Taiwan was among the strongest EMs, led by semiconductor stocks, especially TSMC, buoyed by the current global chip shortage.

Materials was the best-performing sector with the rise in commodity prices and signs of broader global economic expansion. In Financials, EM bank stocks, which were among those most battered by the virus during much of 2020, rose sharply. Stocks of companies that have benefited the most from the pandemic environment in the Information Technology (IT) sector also continued to enjoy strong gains, led by semiconductor and other hardware manufacturers. Consumer Discretionary was the only sector in the index to decline, weighed down by index heavyweight Alibaba and its regulatory woes.

Performance Attribution

The Portfolio modestly underperformed the index in the first half of the fiscal year largely due to holdings in IT. Shares of Taiwanese mobile-device lens manufacturer Largan Precision were pressured by continued dampened demand due to the COVID-19 outbreak and the US sanctions on Chinese smartphone maker Huawei (a large customer). The impact of the global chip shortage on smartphone production has also been a concern. Another

 

 

 

38

 

  


Table of Contents

Performance (% total return)

 

     For periods ended March 31, 2021      For periods ended April 30, 2021  
   
      1 Year      3 Years      Since Inception*      1 Year      3 Years      Since Inception*  
   

Emerging Markets Research Portfolio – Institutional Class

     57.64        5.68        12.67        46.01        6.85        12.59  
   

MSCI Emerging + Frontier Markets Index

     58.09        6.35        13.21        48.55        7.42        13.59  

Returns are annualized for periods greater than 1 year. *Inception date: December 19, 2016.

Performance data quoted represents past performance; past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance of the Portfolio may be lower or higher than the performance quoted. Performance data current to the most recent month end may be obtained by calling (877) 435-8105 or visiting www.hardingloevnerfunds.com.

 

smartphone-component manufacturer, AAC Technologies, was a detractor on worries about rising competition in its core business making speakers and microphones. Relative returns were also hurt by the Portfolio’s underweights to IT and the top-performing Materials sector and an overweight in Consumer Staples.

Strong stocks in Consumer Staples and Consumer Discretionary were helpful, as was our underweight in the latter. In Staples, the re-mobilization of consumers in Latin America helped to revive the shares of two beverage businesses: Mexico’s FEMSA and Brazil’s Ambev. In Discretionary, duty-free retailer China Tourism Group Duty Free has enjoyed strong sales growth for its stores on the resort island of Hainan.

By geography, the key detractors included South Korean consumer-products company LG Household & Health Care, a Consumer Staples stock that lagged its local tech-heavy market. In India, shares of Hero Motocorp were hurt by concerns about the impact on automobile demand of the country’s intensifying new wave of COVID-19 cases. The Portfolio’s cash also dampened performance versus the index. Good stocks (FEMSA) and an overweight in Mexico were helpful.

Perspective and Outlook

Even as humanity continues its determined battle to contain the coronavirus, the longer-term threat facing our species from climate change is capturing increasing attention. The shift to electric vehicles (EVs) undeniably represents a growth opportunity for investors, particularly in China given its massive addressable market and the government’s new commitment to achieve carbon neutrality by 2060. In recent years, a plethora of companies have sought to capitalize on EV growth in China, including foreign automakers, who have laid out aggressive plans to build out EV capabilities, many through partnerships and joint ventures with Chinese firms. The existence of a growing market, however, by no means guarantees that EV makers themselves will be solid long-term investments.

A major challenge for EV makers is the specter of even more competitors entering the scene. The legacy, ICE-based automobile industry has enjoyed high barriers to entry due to the massive fixed capital required to produce engines, giving rise to enormous economies of scale, and the fact that trust based on brand reputation is important in consumer purchase decisions. The manufacturing process for EVs is significantly less complex and key components can be outsourced, presenting a low barrier to entry, as evidenced by the growing number of consumer and technology brands developing their own EVs, including Apple, and China’s internet giant Baidu and smartphone maker Xiaomi.

Amid the increasingly crowded field, achieving stand-alone dominance in EV manufacturing will likely require a company to achieve (and maintain) the automobile equivalent of the iPhone: a uniquely attractive combination of hardware, software, and aesthetics. Tesla has come as close as any company to hitting on all three, but whether its edge can prevail is an open question. The software domain would appear to provide the most scope for enduring differentiation, but we think a single EV-maker is less likely to win out here than a software/systems specialist, such as China’s Waymo or Baidu, that will partner with multiple manufacturers to achieve scale.

Tesla has enviable first-mover advantage in hardware and some aspects of software, with its revered user interface. We think it’s likely, however, that as the diversity of customer preferences are revealed, others will challenge Tesla for leadership in certain areas, be it drive-ability, style, or entertainment.

We can only speculate about how the EV industry will ultimately shake out. This lack of fundamental foresight makes us wary of predicting long-term winners among today’s brands, though we will continue to watch for companies that offer sufficient quality characteristics and durable growth potential. In the meantime, we have chosen to gain exposure to the EV growth opportunity through other ways very much aligned with our focus on quality-growth companies. In common with all other industries, our goal with respect to EVs is to invest in firms that offer predictable growth in their core businesses augmented by new growth opportunities

 

 

 

 

39

 


Table of Contents

exploitable by farsighted management. Indeed, we already have three EV-related holdings that fit this something-old/ something-new profile:

Hon Hai Precision

Hon Hai Precision, also known as Foxconn, is the world’s leading provider of electronics manufacturing services (EMS), producing such iconic products such as the iPhone, Kindle, and PlayStation. With its expertise in hardware and software, combined with its massive scale and powerful supply chain management, Hon Hai offers its clients unrivaled speed-to-market at large scale and low cost. Its assembly capabilities are augmented by its ability to make certain components, such as iPhone casings, itself, from scratch. This reduces Hon Hai’s costs and allows it to make larger investments in research and development than smaller competitors.

One of Hon Hai’s recent growth initiatives has been entering the automotive industry, specifically EVs. It already offers a thousand EV components and counts Tesla among its customers. Hon Hai is an attractive supplier to EV manufacturers because of its expertise in the production of light metal structural parts, its experience in managing complex supply chains, and its expertise in products that integrate software with hardware (Exhibit A: the iPhone). Hon Hai has already designed a chassis and mapped out a production schedule for new models for three brands in 2022. Hon Hai is also building its own hardware and software “open platform,” called MIH. With contributions from Hon Hai’s partners and third-party developers, MIH promises EV-makers a way to reduce up-front development costs, shorten vehicle development time, and facilitate mass production. MIH has already attracted customers such as Chinese automaker Geely, Italy’s Fiat, and US-based Fisker. While it is still early days in EV at Hon Hai, it is targeting a 10% share of what it estimates will be a US$500 billion market by 2025.

WEG

WEG is one of Brazil’s leading industrial companies, manufacturing a broad range of electrical equipment for the global market. WEG earns most of its revenues abroad and has been making considerable capital expenditures to bring the same high level of vertical integration it enjoys inside Brazil to its manufacturing plants in Mexico, China, and elsewhere. These investments should improve WEG’s cost structure, global market share, and margins. Against the backdrop of the rotten Brazilian economy of recent years, WEG has managed to grow consistently and generate high returns on capital.

WEG’s management has shown commendable foresight in steering the company towards growth opportunities in adjacent business. Its initiatives include developing electric traction systems for buses, trains, and other modes of transport. In 2019, WEG stepped up its activity in this segment

by becoming a key part of the VW-coordinated “e-Consortium” focused on developing electrical mobility in Brazil. WEG supplies the powertrain system globally for all VW electric delivery trucks and also makes the motors to power the air conditioning and other auxiliary systems. WEG’s initiatives in electric mobility are currently just a small part of the company’s many climate-related growth opportunities. The company has a larger wind and solar energy business, for example, that includes manufacturing solar energy kits for home use that have been gaining popularity in many markets.

Silergy

A new holding this period is Silergy, a Taiwan-listed manufacturer of power-management integrated circuits (PMIC) used in a range of electronics, from computer tablets to industrial robots. The company’s design and manufacturing platform is highly integrated: it operates its own chip fabrication (“fab”) facilities, which enables the company to stay a step ahead of competitors. The company has steadily increased its share of the PMIC market and enjoyed about

 

Portfolio Positioning (%) at April 30, 2021

 

  

Country/Region

     Portfolio        Benchmark 1 
     

Brazil

     5.1        4.6  
     

China + Hong Kong2

     37.2        37.2  
     

India

     4.6        9.3  
     

Mexico

     5.5        1.7  
     

Russia

     4.3        3.0  
     

South Africa

     1.0        3.7  
     

South Korea

     8.4        13.3  
     

Taiwan

     8.5        14.4  
     

Small Emerging Markets3

     18.5        11.9  
     

Frontier Markets4

     5.8        0.9  
     

Cash

     1.1         
     

Sector

     Portfolio        Benchmark 1 
     

Communication Services

     9.4        11.7  
     

Consumer Discretionary

     16.5        17.2  
     

Consumer Staples

     14.9        5.6  
     

Energy

     5.8        4.7  
     

Financials

     20.6        18.1  
     

Health Care

     6.2        4.7  
     

Industrials

     6.5        4.4  
     

Information Technology

     13.8        21.0  
     

Materials

     2.3        8.6  
     

Real Estate

     1.2        2.1  
     

Utilities

     1.7        1.9  
     

Cash

     1.1         

1MSCI Emerging + Frontier Markets Index; 2The Emerging Markets Research Portfolio’s end weight in China at April 30, 2021 is 37.2% and Hong Kong is 0.0%. The Benchmark does not include Hong Kong; 3Includes the remaining emerging markets which, individually, comprise less than 5% of the index; 4Includes emerging markets or frontier markets companies listed in developed markets.

 

 

 

40

 

  


Table of Contents

a 15% cumulative annual growth rate of revenues and profits over the last five years.

Silergy has been investing for years in R&D to produce PMICs suitable for automotive applications. The recent chip shortage has prompted automakers to expand their suppliers of PMICs, presenting an opportunity for Silergy to enter the highly competitive supply chain. Silergy’s automotive-related revenues will likely exceed 5% of sales in 2021 and could double next year. Management has been vocal about its attractive near-term opportunities in telematics, infotainment, advanced driver-assistance systems, and LED lighting.

Portfolio Highlights

The Emerging Markets Equity Research Portfolio’s holdings are directly determined by analysts’ recommendations among Harding Loevner’s collection of researched companies. During the six-month period ended April 30, 2021, our analysts recommended buying 23 companies and selling 17. One of our associate analysts, Samuel Hosseini, was promoted to analyst, making his recommended purchases, including a number of small cap companies, newly eligible for the Portfolio. Owing to this and other recent promotions and the ongoing expansion of our small cap coverage, the number of emerging markets small companies in the Portfolio’s opportunity set has increased in recent quarters. We ended the six-month period with 131 holdings in the Portfolio, an increase of eight from the beginning, driven by upgrades and new companies added to our research universe. In this period portfolio exposure to the Energy and Health Care sectors increased the most, while exposure to Consumer Staples fell the most. By country, exposure to China and small emerging markets increased the most while exposure to India fell.

Insofar as the relative valuations of many of our buy-rated small-cap stocks have resembled those of some of the most stretched areas of the broader market, we decided to implement new portfolio construction rules to manage this valuation risk. Companies below US$3 billion in market cap are now allowed in the Portfolio only if they exhibit cheap relative valuations. We use our proprietary value rankings for this purpose, getting rid of the most-expensive half of our small cap companies among the pool of analyst-recommended stocks, while retaining or purchasing cheaper ones. We also made additions and trims to holdings as part of a new emphasis on reducing the valuation risk of our large-company holdings. The net impact of these changes was that the Portfolio now looks quite a bit less expensive than previously.

In Energy, we added to several companies that had cheap valuations and improving prospects due to rising oil prices. These included Russia-based oil giant Lukoil, Colombian integrated oil and gas company Ecopetrol, and Romanian natural gas producer Romgaz.

In Health Care, we purchased Mouwasat Medical Services, which owns a portfolio of high-quality hospitals in Saudi Arabia that

Top Ten Holdings by Weight at April 30, 2021

 

 

Company

 

 

Sector

 

 

Country

 

   

 

%

 

 

 

       
Walmart de México   Cons Staples   Mexico     2.1  
       
Midea Group   Cons Discretionary   China     2.0  
       
CSPC Pharmaceutical Group   Health Care   China     2.0  
       
FEMSA   Cons Staples   Mexico     2.0  
       
Samsung Electronics   Info Technology   South Korea     2.0  
       
Gree Electric   Cons Discretionary   China     2.0  
       
Hon Hai Precision   Info Technology   Taiwan     2.0  
       
TSMC   Info Technology   Taiwan     1.9  
       
NCSoft   Comm Services   South Korea     1.9  
       
Ping An Insurance   Financials   China     1.8  

are the preferred health care option for many of the country’s largest employers. The company has been gaining market share from overcrowded and inefficient government hospitals and is well positioned to benefit from Saudi health care spending that is projected to grow from US$46 billion in 2019 to US$160 billion by 2031. We also added to China’s CSPC Pharmaceutical Group, whose shares look attractively valued relative to those of other Chinese companies. CSPC manufactures and distributes pharmaceutical products and invests heavily in R&D, supporting a strong pipeline of innovative treatments.

We reduced exposure to Consumer Staples, including trimming Godrej, an Indian personal and household care company, and Amorepacific, a South Korean cosmetics company, due to relatively expensive valuations.

We increased our exposure to China through additions to CSPC Pharmaceutical, Gree Electric, Ping An Insurance, home-appliance manufacturer Midea, online job-search platform 51job, and AAC Technologies. Our analysts’ fair value estimates indicated that all looked cheap on relative valuation. We also made several new purchases in China including Baidu, China’s leading internet search operator, after shares fells along with the general sell-off in Chinese IT sparked by increased regulatory pressures. Given Baidu’s business fundamentals remained strong, our analyst saw this as a good chance to buy at a reasonable valuation. We also made purchases of several new Chinese companies that were added to our coverage: YonYou Network Technology, a software developer and distributor; Country Garden Services, a property management company; Sangfor, a cybersecurity software and cloud computing provider; and Hefei Meyer, an optical inspection and sorting systems maker. The latter is one of the first companies recommended by Lee Gao, a new China analyst hired at the end of 2020 who is helping expand our coverage with more companies that meet our high-quality, durable-growth criteria.

The Portfolio’s weight in India fell due to a number of sales and trims due to valuation concerns, including HDFC Bank and its parent HDFC Corp. We also trimmed Godrej, Asian Paints, and IT consulting firm Tata Consultancy.

 

 

 

 

41

 


Table of Contents

Disclosures

The Portfolios invest in foreign securities, which will involve greater volatility and political, economic, and currency risks and differences in accounting methods. They also invest in emerging markets, which involve unique risks, such as exposure to economies less diverse and mature than the US or other more established foreign markets. Economic and political instability may cause larger price changes in emerging markets securities than other foreign securities.

Investments in small- and mid-cap companies involve additional risks such as limited liquidity and greater volatility.

Diversification does not guarantee a profit or prevent a loss in a declining market.

Long-term earnings growth and earnings per share growth are not a forecast of the Portfolios’ future performance.

The value of securities may fluctuate in response to various factors including, but not limited to, public health risks; these may be magnified if conditions and events adversely impact the global economy.

Companies held in the Portfolios during the first half of the fiscal year appear in bold type; only the first reference to a particular holding appears in bold. The Portfolios are actively managed; therefore holdings shown may not be current. Portfolio holdings and top ten holdings should not be considered recommendations to buy or sell any security. Please refer to the Portfolios of Investments in this report for complete Portfolio holdings. Current and future Portfolio holdings are subject to risk.

While the Portfolios have no sales charge, management fees and other expenses still apply. Please see the Prospectus for further details.

Sector & Geographic Exposure data is sourced from: Northern Trust, Harding Loevner Funds Portfolios, and MSCI Barra.

Expense Ratios: Differences may exist between the commentary data and similar information reported in the financial statements due to timing differences. Unless otherwise stated, the expense ratios presented are shown as of the most recent Prospectus date, February 28, 2021.

Five year average turnover data is calculated using a simple average of annual turnover figures for the past five fiscal years. These annual turnover figures utilize purchase, sales, and market value data which is not reflective of adjustments required pursuant to Generally Accepted Accounting Principles (GAAP). Accordingly, differences may exist between this data and similar information reported in the financial statements.

Quasar Distributors, LLC, Distributor.

Index Definitions

 

 

The MSCI All Country World Index is a free float-adjusted market capitalization index that is designed to measure equity market performance in the global developed and emerging markets. The Index consists of 49 developed and emerging market countries. Net dividends reinvested.

The MSCI All Country World ex-US Index is a free float-adjusted market capitalization index that is designed to measure equity market performance in the global developed and emerging markets, excluding the US. The Index consists of 48 developed and emerging market countries. Net dividends reinvested.

The MSCI All Country World ex-US Small Cap Index is a free-float market capitalization index that is designed to measure small cap developed and emerging market equity performance. The Index consists of 48 developed and emerging markets countries and targets companies within a market

capitalization range of USD 94-14,460 million (as of March 31, 2020) in terms of the companies’ full market capitalization. Net dividends reinvested.

The MSCI Emerging Markets Index is a free float-adjusted market capitalization index that is designed to measure equity market performance in the global emerging markets. The Index consists of 26 emerging market countries. Net dividends reinvested.

The MSCI China All Shares Index is a free float-adjusted market capitalization index that is designed to reflect an opportunity set capturing large and mid-cap China share classes listed in Hong Kong, Shanghai, Shenzhen, and outside of China.

The MSCI Emerging + Frontier Markets Index is a free float-adjusted market capitalization index that is designed to measure equity market performance in the global emerging markets and frontier markets. The Index consists of 26 emerging markets countries and 28 frontier markets countries. Net dividends reinvested.

The MSCI Frontier Emerging Markets Index is a free float-adjusted market capitalization index designed to measure equity market performance in all countries from the MSCI Frontier Markets Index and the lower size spectrum of the MSCI Emerging Markets Index. The Index consists of 28 frontier markets and 6 emerging markets. Net dividends reinvested.

The S&P 500 Index is an unmanaged index commonly used to measure performance of US stocks.

You cannot invest directly in these Indexes.

Term Definitions

 

 

Alpha is a measure a measure of risk-adjusted return.

Basis points are a common measurement used chiefly for interest rates and other percentages in finance. A basis point is one hundredth of one percent.

Dividend yield is the annual dividends per share divided by current price per share, expressed as a percent.

Economies of scale is the cost advantage that arises with increased output of a product.

Gross Domestic Product (GDP) is the monetary value of all finished goods and services produced within a country’s borders in a specific time period (usually calculated on an annual basis).

Market Capitalization is the total dollar market value of all of a company’s outstanding shares.

Return on Capital (ROC) is a calculation used to assess a company’s efficiency at allocating the capital under its control to profitable investments.

Sharpe Ratio is the return over the risk-free rate per unit of risk.

Tracking Error is a measure of how closely a portfolio follows the index to which it is benchmarked.

Turnover is calculated by dividing the lesser of Purchases or Sales by Average Capital.

 

 

 

42

 

  


Table of Contents

Item 2. Code of Ethics.

Not applicable.

Item 3. Audit Committee Financial Expert.

Not applicable.

Item 4. Principal Accountant Fees and Services.

Not applicable.

Item 5. Audit Committee of Listed Registrants.

Not applicable.

Item 6. Investments.

 

(a)

Schedule I is included as part of the report to shareholders filed under Item 1 of this report on Form N-CSR.

 

(b)

Not applicable.

Item 7. Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies.

Not applicable.

Item 8. Portfolio Managers of Closed-End Management Investment Companies.

Not applicable.

Item 9. Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers.

Not applicable.

Item 10. Submission of Matters to a Vote of Security Holders.

Not applicable.

Item 11. Controls and Procedures.


Table of Contents
(a)

The Registrant’s Principal Executive Officer and Principal Financial Officer, or persons performing similar functions, have concluded that the Registrant’s disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940, as amended (the “1940 Act”)) were effective as of a date within 90 days prior to the filing date of this report, based on their evaluation of the effectiveness of the Registrant’s disclosure controls and procedures as of the evaluation date.

 

(b)

There were no significant changes in the Registrant’s internal control over financial reporting (as defined in Rule 30a-3(d) under the 1940 Act) that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, the Registrant’s internal control over financial reporting.

Item 12. Disclosure of Securities Lending Activities for Closed-End Management Investment Companies.

Not applicable.

Item 13. Exhibits.

 

(a)(1)

Not applicable.

 

(a)(2)

Exhibit 99.CERT: Certifications pursuant to Rule 30a-2(a) of the Investment Company Act of 1940, as amended, are attached.

 

(a)(3)

Not applicable.

 

(a)(4)

Not applicable.

 

(b)

Exhibit 99.906: Certifications pursuant to Rule 30a-2(b) of the Investment Company Act of 1940, as amended, are attached hereto.


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Harding, Loevner Funds, Inc.

  

By

  

/s/ Richard T. Reiter

  
  

Richard T. Reiter

  
  

(Principal Executive Officer)

  

Date: July 2, 2021

  

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

 

By

  

/s/ Richard T. Reiter

  
  

Richard T. Reiter

  
  

(Principal Executive Officer)

  

Date: July 2, 2021

  

By

  

/s/ Tracy L. Dotolo

  
  

Tracy L. Dotolo

  
  

(Principal Financial Officer)

  

Date: July 2, 2021